{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Nokappa v3 Holdout Evaluation: Constant vs Cos300 vs Clip\n",
    "\n",
    "All three configs use **non-centered parameterization** with **kappa=1 (fixed)**, W=1e-4, 300 epochs.  \n",
    "- **Constant**: LR=0.1 constant  \n",
    "- **Cos300**: LR=0.1 → 0.001 cosine annealing  \n",
    "- **Clip**: LR=0.1 constant, grad_clip=5.0  \n",
    "\n",
    "Trained on batches 20–29 (200k–300k). Holdout: 390k–400k.\n",
    "\n",
    "**Pipeline:**\n",
    "1. Load & pool parameters from 10 training batches per config\n",
    "2. Diagnostic summary: gamma magnitude, top features, psi shifts\n",
    "3. Holdout prediction (fit δ on held-out data)\n",
    "4. Holdout loss + AUC comparison"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "36 PRS features + Sex + 10 PCs = 47 total features\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import torch\n",
    "import glob\n",
    "import os\n",
    "import sys\n",
    "import gc\n",
    "import warnings\n",
    "from pathlib import Path\n",
    "import matplotlib.pyplot as plt\n",
    "import matplotlib\n",
    "\n",
    "REPO_ROOT = Path('/Users/sarahurbut/aladynoulli2')\n",
    "sys.path.insert(0, str(REPO_ROOT / 'claudefile'))\n",
    "sys.path.insert(0, str(REPO_ROOT / 'claudefile' / 'aws_offsetmaster'))\n",
    "sys.path.insert(0, str(REPO_ROOT / 'pyScripts'))\n",
    "\n",
    "from nokappa_prediction_utils import fit_and_extract_pi\n",
    "from fig5utils import evaluate_major_diseases_wsex_with_bootstrap_dynamic_from_pi\n",
    "\n",
    "warnings.filterwarnings('ignore', category=RuntimeWarning)\n",
    "warnings.filterwarnings('ignore', category=FutureWarning)\n",
    "\n",
    "# ---------- Paths ----------\n",
    "DROPBOX = Path('/Users/sarahurbut/Library/CloudStorage/Dropbox')\n",
    "DATA_DIR = Path('/Users/sarahurbut/Library/CloudStorage/Dropbox-Personal/data_for_running/')\n",
    "COV_PATH = '/Users/sarahurbut/Library/CloudStorage/Dropbox-Personal/baselinagefamh_withpcs.csv'\n",
    "PCE_PATH = '/Users/sarahurbut/Library/CloudStorage/Dropbox-Personal/pce_prevent_full.csv'\n",
    "\n",
    "# Config dirs (trained on batches 20-29)\n",
    "CONFIGS = {\n",
    "    'constant': {\n",
    "        'dir': DROPBOX / 'nokappa_v3_W1e-4_b20_30',\n",
    "        'pattern': '*REPARAM_NOKAPPA_W0.0001_batch_*.pt',\n",
    "        'color': '#1f77b4',\n",
    "    },\n",
    "    'cos300': {\n",
    "        'dir': DROPBOX / 'nokappa_v3_cos300_b20_30',\n",
    "        'pattern': '*REPARAM_NOKAPPA_COS300_W0.0001_batch_*.pt',\n",
    "        'color': '#d62728',\n",
    "    },\n",
    "    'clip': {\n",
    "        'dir': DROPBOX / 'nokappa_v3_clip_b20_30',\n",
    "        'pattern': '*REPARAM_NOKAPPA_CLIP_W0.0001_batch_*.pt',\n",
    "        'color': '#2ca02c',\n",
    "    },\n",
    "}\n",
    "\n",
    "# Holdout range (no overlap with training 200k-300k)\n",
    "HOLDOUT_START = 390000\n",
    "HOLDOUT_END = 400000\n",
    "\n",
    "# PRS feature names\n",
    "prs_df = pd.read_csv('/Users/sarahurbut/aladynoulli2/prs_names.csv')\n",
    "PRS_NAMES = list(prs_df.columns) + list(prs_df.iloc[:, 0].values)\n",
    "FEATURE_NAMES = PRS_NAMES + ['Sex'] + [f'PC{i}' for i in range(1, 11)]\n",
    "print(f'{len(PRS_NAMES)} PRS features + Sex + 10 PCs = {len(FEATURE_NAMES)} total features')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Load & Pool Parameters"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== CONSTANT ===\n",
      "Found 10 files in /Users/sarahurbut/Library/CloudStorage/Dropbox/nokappa_v3_W1e-4_b20_30\n",
      "Loaded 10 checkpoints\n",
      "  Pooled: phi (21, 348, 52), gamma (47, 21), kappa=1.0000\n",
      "  mean|gamma| = 0.1354\n",
      "\n",
      "=== COS300 ===\n",
      "Found 10 files in /Users/sarahurbut/Library/CloudStorage/Dropbox/nokappa_v3_cos300_b20_30\n",
      "Loaded 10 checkpoints\n",
      "  Pooled: phi (21, 348, 52), gamma (47, 21), kappa=1.0000\n",
      "  mean|gamma| = 0.1248\n",
      "\n",
      "=== CLIP ===\n",
      "Found 10 files in /Users/sarahurbut/Library/CloudStorage/Dropbox/nokappa_v3_clip_b20_30\n",
      "Loaded 10 checkpoints\n",
      "  Pooled: phi (21, 348, 52), gamma (47, 21), kappa=1.0000\n",
      "  mean|gamma| = 0.1354\n",
      "\n",
      "Loaded configs: ['constant', 'cos300', 'clip']\n"
     ]
    }
   ],
   "source": [
    "def load_all_checkpoints(ckpt_dir, pattern):\n",
    "    \"\"\"Load phi, psi, kappa, gamma from all batch checkpoints.\"\"\"\n",
    "    files = sorted(glob.glob(os.path.join(str(ckpt_dir), pattern)))\n",
    "    print(f'Found {len(files)} files in {ckpt_dir}')\n",
    "\n",
    "    all_phi, all_psi, all_kappa, all_gamma = [], [], [], []\n",
    "    batch_stats = []\n",
    "\n",
    "    for fp in files:\n",
    "        ckpt = torch.load(fp, weights_only=False)\n",
    "\n",
    "        def _get(name):\n",
    "            if 'model_state_dict' in ckpt and name in ckpt['model_state_dict']:\n",
    "                return ckpt['model_state_dict'][name]\n",
    "            return ckpt.get(name)\n",
    "\n",
    "        phi = _get('phi')\n",
    "        psi = _get('psi')\n",
    "        gamma = _get('gamma')\n",
    "        kappa = _get('kappa')\n",
    "\n",
    "        if phi is None or gamma is None:\n",
    "            print(f'  Skip {Path(fp).name}: missing phi or gamma')\n",
    "            continue\n",
    "\n",
    "        phi_np = phi.detach().cpu().numpy() if torch.is_tensor(phi) else np.array(phi)\n",
    "        psi_np = psi.detach().cpu().numpy() if torch.is_tensor(psi) else (np.array(psi) if psi is not None else None)\n",
    "        gamma_np = gamma.detach().cpu().numpy() if torch.is_tensor(gamma) else np.array(gamma)\n",
    "        kappa_val = float(kappa) if kappa is not None else 1.0\n",
    "\n",
    "        all_phi.append(phi_np)\n",
    "        all_psi.append(psi_np)\n",
    "        all_kappa.append(kappa_val)\n",
    "        all_gamma.append(gamma_np)\n",
    "        batch_stats.append({'mean_abs_gamma': np.abs(gamma_np).mean()})\n",
    "\n",
    "    print(f'Loaded {len(all_phi)} checkpoints')\n",
    "    stats_df = pd.DataFrame(batch_stats)\n",
    "    return all_phi, all_psi, all_kappa, all_gamma, stats_df\n",
    "\n",
    "\n",
    "def pool_params(all_phi, all_psi, all_kappa, all_gamma):\n",
    "    phi = np.mean(np.stack(all_phi), axis=0)\n",
    "    kappa = float(np.mean(all_kappa))\n",
    "    gamma = np.mean(np.stack(all_gamma), axis=0)\n",
    "    psi_valid = [p for p in all_psi if p is not None]\n",
    "    psi = np.mean(np.stack(psi_valid), axis=0) if psi_valid else None\n",
    "    return phi, psi, kappa, gamma\n",
    "\n",
    "\n",
    "# Load all configs\n",
    "loaded = {}  # config_name -> (all_phi, all_psi, all_kappa, all_gamma, stats_df)\n",
    "pooled = {}  # config_name -> (phi, psi, kappa, gamma)\n",
    "\n",
    "for name, cfg in CONFIGS.items():\n",
    "    print(f'\\n=== {name.upper()} ===')\n",
    "    if not cfg['dir'].exists():\n",
    "        print(f'  Directory not found: {cfg[\"dir\"]} — SKIPPING')\n",
    "        continue\n",
    "    all_phi, all_psi, all_kappa, all_gamma, stats = load_all_checkpoints(cfg['dir'], cfg['pattern'])\n",
    "    if len(all_phi) == 0:\n",
    "        print(f'  No valid checkpoints — SKIPPING')\n",
    "        continue\n",
    "    loaded[name] = (all_phi, all_psi, all_kappa, all_gamma, stats)\n",
    "    phi, psi, kappa, gamma = pool_params(all_phi, all_psi, all_kappa, all_gamma)\n",
    "    pooled[name] = (phi, psi, kappa, gamma)\n",
    "    print(f'  Pooled: phi {phi.shape}, gamma {gamma.shape}, kappa={kappa:.4f}')\n",
    "    print(f'  mean|gamma| = {np.abs(gamma).mean():.4f}')\n",
    "\n",
    "print(f'\\nLoaded configs: {list(pooled.keys())}')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Diagnostic Summary"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 2a. Gamma magnitude per batch"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "n_configs = len(loaded)\n",
    "fig, ax = plt.subplots(figsize=(12, 5))\n",
    "n_batches = max(len(v[4]) for v in loaded.values())\n",
    "x = np.arange(n_batches)\n",
    "w = 0.8 / n_configs\n",
    "\n",
    "for i, (name, (_, _, _, _, stats)) in enumerate(loaded.items()):\n",
    "    color = CONFIGS[name]['color']\n",
    "    vals = stats['mean_abs_gamma'].values\n",
    "    offset = (i - n_configs / 2 + 0.5) * w\n",
    "    ax.bar(x[:len(vals)] + offset, vals, w, label=name, color=color)\n",
    "    ax.axhline(vals.mean(), color=color, ls='--', alpha=0.5,\n",
    "               label=f'{name} avg: {vals.mean():.4f}')\n",
    "\n",
    "ax.set_xlabel('Batch')\n",
    "ax.set_ylabel('Mean |gamma|')\n",
    "ax.set_title('Gamma magnitude per training batch')\n",
    "ax.set_xticks(x)\n",
    "ax.set_xticklabels([f'B{i+20}' for i in range(n_batches)])\n",
    "ax.legend()\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 2b. Top features per signature (|gamma|)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "=== CONSTANT: Top 5 features per signature ===\n",
      "  Sig  0 (|γ|=0.1055): Sex (+0.731), AF (+0.342), PC3 (+0.237), ISS (+0.234), T2D (+0.230)\n",
      "  Sig  1 (|γ|=0.0764): BMI (+0.231), Sex (+0.221), T2D (+0.219), ISS (+0.218), AST (+0.207)\n",
      "  Sig  2 (|γ|=0.0823): Sex (+0.335), T2D (+0.222), AST (+0.211), ISS (+0.197), BMI (+0.175)\n",
      "  Sig  3 (|γ|=0.0860): Sex (+0.572), AST (+0.204), T2D (+0.203), ISS (+0.202), BMI (+0.187)\n",
      "  Sig  4 (|γ|=0.2471): Sex (+3.071), PC1 (-2.210), PC2 (+0.455), PC4 (+0.444), AST (+0.318)\n",
      "  Sig  5 (|γ|=0.1039): Sex (+0.744), CAD (+0.289), T2D (+0.247), HT (+0.240), ISS (+0.198)\n",
      "  Sig  6 (|γ|=0.2280): PC1 (-4.154), PC2 (+1.775), Sex (-0.624), BC (+0.463), PC3 (-0.310)\n",
      "  Sig  7 (|γ|=0.0859): Sex (+0.298), HT (+0.250), AST (+0.235), T2D (+0.225), ISS (+0.216)\n",
      "  Sig  8 (|γ|=0.1020): Sex (-1.608), PC1 (+0.209), T2D (+0.204), AST (+0.178), HT (+0.159)\n",
      "  Sig  9 (|γ|=0.1352): PC2 (+1.458), PC3 (+0.932), PC1 (-0.282), Sex (+0.281), T2D (+0.231)\n",
      "  Sig 10 (|γ|=0.0908): PC1 (+0.310), Sex (+0.250), T2D (+0.223), AST (+0.207), ISS (+0.200)\n",
      "  Sig 11 (|γ|=0.2202): PC1 (-1.658), PC2 (+1.426), Sex (+0.815), ISS (+0.690), PC3 (+0.618)\n",
      "  Sig 12 (|γ|=0.2076): PC1 (-1.954), Sex (+1.675), PC9 (+0.435), PC3 (-0.415), CVD (+0.398)\n",
      "  Sig 13 (|γ|=0.1806): Sex (+4.796), T2D (+0.231), PC1 (+0.227), ISS (+0.201), PC (+0.194)\n",
      "  Sig 14 (|γ|=0.1308): PC1 (-1.439), Sex (+0.549), AST (+0.269), PC2 (+0.238), ISS (+0.237)\n",
      "  Sig 15 (|γ|=0.1443): T2D (+1.220), Sex (+0.895), PC1 (+0.488), ISS (+0.310), BMI (+0.275)\n",
      "  Sig 16 (|γ|=0.0910): Sex (+0.397), T2D (+0.233), ISS (+0.223), PC1 (+0.215), AST (+0.215)\n",
      "  Sig 17 (|γ|=0.0824): Sex (+0.395), AST (+0.202), T2D (+0.198), ISS (+0.183), HT (+0.172)\n",
      "  Sig 18 (|γ|=0.2308): Sex (-5.857), PC1 (-1.436), PC2 (-0.491), T2D (+0.197), AST (+0.173)\n",
      "  Sig 19 (|γ|=0.2128): PC1 (-5.740), PC2 (-0.469), BC (+0.265), PC3 (+0.244), PC4 (-0.240)\n",
      "  Sig 20 (|γ|=0.0000): AAM (+0.000), PD (+0.000), POAG (+0.000), PC (+0.000), PSO (+0.000)\n",
      "\n",
      "=== COS300: Top 5 features per signature ===\n",
      "  Sig  0 (|γ|=0.1182): Sex (+0.780), PC1 (-0.629), PC3 (+0.590), AF (+0.376), PC2 (+0.284)\n",
      "  Sig  1 (|γ|=0.0692): PC1 (+0.398), BMI (+0.255), ISS (+0.196), T2D (+0.195), PC3 (+0.186)\n",
      "  Sig  2 (|γ|=0.0759): PC2 (-0.322), Sex (+0.315), T2D (+0.203), BMI (+0.192), AST (+0.188)\n",
      "  Sig  3 (|γ|=0.0825): Sex (+0.592), PC1 (+0.482), BMI (+0.205), ISS (+0.180), AST (+0.180)\n",
      "  Sig  4 (|γ|=0.2069): PC1 (-2.585), Sex (+1.694), PC2 (+0.721), PC4 (+0.348), PC5 (-0.343)\n",
      "  Sig  5 (|γ|=0.1016): Sex (+0.767), PC1 (+0.468), CAD (+0.347), HT (+0.222), T2D (+0.220)\n",
      "  Sig  6 (|γ|=0.2301): PC1 (-4.300), PC2 (+2.377), PC3 (-0.406), BC (+0.356), PC9 (+0.267)\n",
      "  Sig  7 (|γ|=0.0796): PC1 (+0.517), Sex (+0.246), BMI (+0.227), HT (+0.224), AST (+0.208)\n",
      "  Sig  8 (|γ|=0.0974): Sex (-1.781), PC1 (+0.403), T2D (+0.161), BMI (+0.143), CVD (+0.124)\n",
      "  Sig  9 (|γ|=0.1708): PC2 (+2.748), PC3 (+1.693), PC1 (-0.393), BMI (+0.247), PC4 (+0.245)\n",
      "  Sig 10 (|γ|=0.0888): PC1 (+0.681), PC2 (-0.248), POAG (+0.246), T2D (+0.191), AST (+0.182)\n",
      "  Sig 11 (|γ|=0.1834): PC2 (+1.622), PC1 (-1.181), ISS (+0.596), Sex (+0.501), PC4 (+0.467)\n",
      "  Sig 12 (|γ|=0.1805): PC1 (-2.069), Sex (+0.986), PC2 (-0.485), PC3 (-0.400), PC9 (+0.319)\n",
      "  Sig 13 (|γ|=0.1213): Sex (+2.506), PC1 (+0.517), PC (+0.274), AST (+0.161), BMI (+0.157)\n",
      "  Sig 14 (|γ|=0.1449): PC1 (-1.887), PC2 (+0.633), Sex (+0.574), PC3 (+0.367), AST (+0.267)\n",
      "  Sig 15 (|γ|=0.1327): T2D (+1.160), Sex (+0.867), PC1 (+0.777), PC2 (-0.276), ISS (+0.273)\n",
      "  Sig 16 (|γ|=0.0864): PC1 (+0.544), Sex (+0.397), BMI (+0.221), ISS (+0.211), T2D (+0.209)\n",
      "  Sig 17 (|γ|=0.0767): PC1 (+0.446), Sex (+0.373), BMI (+0.181), AST (+0.179), T2D (+0.173)\n",
      "  Sig 18 (|γ|=0.1913): PC1 (-3.945), Sex (-1.610), PC2 (-0.432), T2D (+0.234), BMI (+0.211)\n",
      "  Sig 19 (|γ|=0.1828): PC1 (-5.201), PC4 (-0.352), BC (+0.238), PC2 (-0.233), MEL (+0.206)\n",
      "  Sig 20 (|γ|=0.0000): AAM (+0.000), PD (+0.000), POAG (+0.000), PC (+0.000), PSO (+0.000)\n",
      "\n",
      "=== CLIP: Top 5 features per signature ===\n",
      "  Sig  0 (|γ|=0.1055): Sex (+0.731), AF (+0.342), PC3 (+0.237), ISS (+0.234), T2D (+0.230)\n",
      "  Sig  1 (|γ|=0.0764): BMI (+0.231), Sex (+0.221), T2D (+0.219), ISS (+0.218), AST (+0.207)\n",
      "  Sig  2 (|γ|=0.0823): Sex (+0.335), T2D (+0.222), AST (+0.211), ISS (+0.197), BMI (+0.175)\n",
      "  Sig  3 (|γ|=0.0860): Sex (+0.572), AST (+0.204), T2D (+0.203), ISS (+0.202), BMI (+0.187)\n",
      "  Sig  4 (|γ|=0.2471): Sex (+3.071), PC1 (-2.210), PC2 (+0.455), PC4 (+0.444), AST (+0.318)\n",
      "  Sig  5 (|γ|=0.1039): Sex (+0.744), CAD (+0.289), T2D (+0.247), HT (+0.240), ISS (+0.198)\n",
      "  Sig  6 (|γ|=0.2280): PC1 (-4.154), PC2 (+1.775), Sex (-0.624), BC (+0.463), PC3 (-0.310)\n",
      "  Sig  7 (|γ|=0.0859): Sex (+0.298), HT (+0.250), AST (+0.235), T2D (+0.225), ISS (+0.216)\n",
      "  Sig  8 (|γ|=0.1020): Sex (-1.608), PC1 (+0.209), T2D (+0.204), AST (+0.178), HT (+0.159)\n",
      "  Sig  9 (|γ|=0.1352): PC2 (+1.458), PC3 (+0.932), PC1 (-0.282), Sex (+0.281), T2D (+0.231)\n",
      "  Sig 10 (|γ|=0.0908): PC1 (+0.310), Sex (+0.250), T2D (+0.223), AST (+0.207), ISS (+0.200)\n",
      "  Sig 11 (|γ|=0.2202): PC1 (-1.658), PC2 (+1.426), Sex (+0.815), ISS (+0.690), PC3 (+0.618)\n",
      "  Sig 12 (|γ|=0.2076): PC1 (-1.954), Sex (+1.675), PC9 (+0.435), PC3 (-0.415), CVD (+0.398)\n",
      "  Sig 13 (|γ|=0.1806): Sex (+4.796), T2D (+0.231), PC1 (+0.227), ISS (+0.201), PC (+0.194)\n",
      "  Sig 14 (|γ|=0.1308): PC1 (-1.439), Sex (+0.549), AST (+0.269), PC2 (+0.238), ISS (+0.237)\n",
      "  Sig 15 (|γ|=0.1443): T2D (+1.220), Sex (+0.895), PC1 (+0.488), ISS (+0.310), BMI (+0.275)\n",
      "  Sig 16 (|γ|=0.0910): Sex (+0.397), T2D (+0.233), ISS (+0.223), PC1 (+0.215), AST (+0.215)\n",
      "  Sig 17 (|γ|=0.0824): Sex (+0.395), AST (+0.202), T2D (+0.198), ISS (+0.183), HT (+0.172)\n",
      "  Sig 18 (|γ|=0.2308): Sex (-5.857), PC1 (-1.436), PC2 (-0.491), T2D (+0.197), AST (+0.173)\n",
      "  Sig 19 (|γ|=0.2128): PC1 (-5.740), PC2 (-0.469), BC (+0.265), PC3 (+0.244), PC4 (-0.240)\n",
      "  Sig 20 (|γ|=0.0000): AAM (+0.000), PD (+0.000), POAG (+0.000), PC (+0.000), PSO (+0.000)\n"
     ]
    }
   ],
   "source": [
    "def top_features_per_sig(gamma_pooled, feature_names, n_top=5):\n",
    "    \"\"\"For each signature k, show top features by |gamma|.\"\"\"\n",
    "    P, K = gamma_pooled.shape\n",
    "    rows = []\n",
    "    for k in range(K):\n",
    "        weights = gamma_pooled[:, k]\n",
    "        order = np.argsort(-np.abs(weights))\n",
    "        top_feats = []\n",
    "        for idx in order[:n_top]:\n",
    "            name = feature_names[idx] if idx < len(feature_names) else f'Feat{idx}'\n",
    "            top_feats.append(f'{name} ({weights[idx]:+.3f})')\n",
    "        rows.append({\n",
    "            'sig': k,\n",
    "            'mean_abs': np.abs(weights).mean(),\n",
    "            'top_features': ', '.join(top_feats)\n",
    "        })\n",
    "    return pd.DataFrame(rows)\n",
    "\n",
    "\n",
    "for name, (phi, psi, kappa, gamma) in pooled.items():\n",
    "    print(f'\\n=== {name.upper()}: Top 5 features per signature ===')\n",
    "    df_top = top_features_per_sig(gamma, FEATURE_NAMES)\n",
    "    for _, row in df_top.iterrows():\n",
    "        print(f'  Sig {row[\"sig\"]:2d} (|γ|={row[\"mean_abs\"]:.4f}): {row[\"top_features\"]}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAACTUAAAPdCAYAAABRVB6HAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjkuMywgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/GU6VOAAAACXBIWXMAAA9hAAAPYQGoP6dpAAEAAElEQVR4nOzdd5hU1f0/8M/MALsUadIFAUUFezfY0Ggk2E00tihi71FjTEjRaIxYYotR7GAUY429azTFHo0tsYuIKIgNBKm79/eHv50vwy6wcGedmeX1ep55Hrh7z9zP3J2Zve85Z87JJEmSBAAAAAAAAAAAQJnIlroAAAAAAAAAAACABRnUBAAAAAAAAAAAlBWDmgAAAAAAAAAAgLJiUBMAAAAAAAAAAFBWDGoCAAAAAAAAAADKikFNAAAAAAAAAABAWTGoCQAAAAAAAAAAKCsGNQEAAAAAAAAAAGXFoCYAAAAAAAAAAKCsGNQELDd++9vfRiaTKep9brPNNrHNNtsU9T6XRxMnTozq6up48sknS13Kt25Zn5efffZZtG3bNu6///4mqAoAgAVlMpn47W9/W7T7e+KJJyKTycQTTzxRtPtcXh199NHxve99r9RllMSyPi9/8YtfxGabbVb8ggCA5VZD17cHHXRQ9OvXr2Q1NbWm6Bsodu5YXt1yyy3RuXPnmDFjRqlL+dYt6/PywQcfjHbt2sXUqVOLXxRASgY1QTNw1llnxZ133vmtHOuyyy6LsWPHprqPuoBTd2vZsmWsssoqceCBB8Z7771XnELLUG1tbfz5z3+O733ve9GlS5do2bJldOvWLXbYYYe48sorY86cOaUusWTOOOOM2GyzzWKLLbbIbzvooIMKnift27eP9dZbL84///yCc1U3KGjB51O/fv3i+OOPjy+//LLesebOnRsXX3xxbLDBBtG+ffvo2LFjrLXWWnH44YfHG2+88W083KJYccUV49BDD43f/OY3pS4FAKhw//3vf2OvvfaKVVZZJdq0aRNdunSJrbfeOu65554G93/99dfj+9//frRr1y46d+4cBxxwQIMffNbW1sa5554b/fv3j+rq6lh33XXjL3/5S6pat9lmm4Jrv86dO8cmm2wS1157bdTW1qa673I2fvz4OPbYY2P11VePNm3aRJs2bWLNNdeMY445Jl555ZVSl1cy48ePj6uvvjp++ctf5re9//77Bc+RXC4XK6+8cuyxxx7x0ksvFbRfcL+6zDFkyJC47777Gjzeq6++GnvuuWf07ds3qqurY6WVVorvfe97cckllzTlwyy6E044IV5++eW4++67S10KAEBqC38+XHet/Otf/zqmT59e6vKazPTp0+P3v/99bLzxxtGhQ4eoqqqKvn37xt57773I69nlQU1NTZx22mlx3HHHRbt27fLb+/XrV/A86datW2y11VZxxx13FLRfOHO2bt061l133bjooosazJxTp06Nn/zkJzFw4MBo3bp1dOvWLTbddNP4+c9/XlGDqr7//e/HgAEDYtSoUaUuBaCeFqUuAEjvrLPOij333DN23333Jj/WZZddFl26dImDDjoo9X0df/zxsckmm8S8efPixRdfjCuvvDLuu+++ePXVV6NXr17piy0js2bNij322CMeeuih2HzzzePkk0+O7t27x+effx5///vf4+ijj45nn302rrnmmlKX+q2bOnVqXHfddXHdddfV+1lVVVVcffXVERHx5Zdfxu233x4nn3xyPP/883HTTTcV7Dt69Oho165dzJw5Mx577LG45JJL4sUXX4x//etfBfv98Ic/jAceeCD23XffOOyww2LevHnxxhtvxL333hubb755DBw4sOkebJEdeeSR8cc//jH+9re/xXe/+91SlwMAVKgJEybEV199FcOHD49evXrF119/HbfffnvsuuuuccUVV8Thhx+e3/fDDz+MrbfeOjp06BBnnXVWzJgxI/7whz/Eq6++Gs8991y0atUqv++vfvWrOPvss+Owww6LTTbZJO66667Yb7/9IpPJxD777LPM9fbu3Tv/QevUqVPjz3/+cxxyyCHx1ltvxdlnn73sJ6JM3XvvvbH33ntHixYtYv/994/11lsvstlsvPHGG/HXv/41Ro8eHePHj4++ffuWutRv3cUXXxz9+/ePbbfdtt7P9t1339hxxx2jpqYmXn/99Rg9enQ88MAD8cwzz8T666+f3+973/teHHjggZEkSUyYMCFGjx4du+yySzzwwAMxdOjQ/H5PPfVUbLvttrHyyivHYYcdFj169IiJEyfGM888ExdffHEcd9xx38ZDLooePXrEbrvtFn/4wx9i1113LXU5AEAzddVVV32rXzyo+3x4xowZ8fDDD8fvf//7+Nvf/hZPPvlk0VdwKLV33nknhg4dGhMmTIg99tgjDjzwwGjXrl1MnDgx7r///th5553jz3/+cxxwwAGlLvVbd88998Sbb75ZkGPrrL/++vHTn/40IiI++uijuOKKK+IHP/hBjB49Oo488sj8fgtmzk8//TRuvPHGOPHEE2Pq1Knx+9//Pr/f559/HhtvvHFMnz49Dj744Bg4cGB89tln8corr8To0aPjqKOOKhhYVe6OOOKIOPnkk+P000+PFVZYodTlAPyfBKh4bdu2TYYPH/6tHGuttdZKhgwZkuo+Hn/88SQikltvvbVg+x//+MckIpKzzjor1f0vymmnnZYU+21vyJAhjTofRxxxRBIRyUUXXdTgz996663k0ksvLWptleKCCy5IWrdunXz11VcF24cPH560bdu2YFtNTU2y8cYbJxGRTJo0KUmS//u9Tp06tWDfvffeO4mI5Nlnn81ve+6555KISH7/+9/Xq2P+/PnJp59+WqyH1Whpn5drr712csABBxSxIgCAb66N1ltvvWSNNdYo2H7UUUclrVu3TiZMmJDf9sgjjyQRkVxxxRX5bR9++GHSsmXL5Jhjjslvq62tTbbaaqukd+/eyfz585epriFDhiRrrbVWwbaZM2cmvXv3Ttq2bZvMnTt3me53SSIiOe2004p2f3WZ6PHHH1/sfu+8807Stm3bZNCgQclHH31U7+fz5s1LLr744uSDDz4oWm2VYu7cuUmXLl2SX//61wXbx48fn0REct555xVsv/vuu5OISA4//PD8togoeI4mSZL873//SyIiGTZsWMH2HXfcMenatWvyxRdf1KtlypQpKR/NsknzvLztttuSTCaTvPvuu8UtCgBYLjX2+rYpLOrz4R/84AdJRCRPPfVUkxy3sX0DS6Mx13fz5s1L1l577aRt27bJv/71rwb3eeihh5L777+/qLVVil133TXZcsst623v27dvstNOOxVs+/jjj5O2bdsmq6++en5bQ5lz1qxZSd++fZMVVlihIMuee+65SUQkTz75ZL3jTZs2LZk1a1bah7PU0jwvp0yZkuRyueSaa64pblEAKVl+DpbCpEmT4pBDDolevXpFVVVV9O/fP4466qiYO3dufp/33nsv9tprr+jcuXO0adMmvvOd79Sb6rNu+bVbbrklfv/730fv3r2juro6tttuu3jnnXcK9n377bfjhz/8YfTo0SOqq6ujd+/esc8++8S0adMi4pvp8mfOnBnXXXddfjrMulmUJkyYEEcffXSsscYa0bp161hxxRVjr732ivfff7/gGGPHjo1MJhNPPvlknHTSSdG1a9do27Zt7LHHHgXLSPTr1y/++9//xt///vf8sRZcm/fdd9+Nd999d5nPb91MM+PHj89vu+yyy2KttdaKqqqq6NWrVxxzzDENLil26623xkYbbRStW7eOLl26xI9//OOYNGlSo457ww035Nt27tw59tlnn5g4cWK9/a688spYddVVo3Xr1rHpppvGP//5z0bd/8SJE+Pqq6+O73//+/GTn/ykwX1WW221OProowu2/eEPf4jNN988VlxxxWjdunVstNFGcdttt9Vrm8lk4thjj41bb7011lxzzWjdunUMHjw4Xn311YiIuOKKK2LAgAFRXV0d22yzTb3f/zbbbBNrr712vPLKKzFkyJBo06ZNDBgwIH+sv//977HZZptF69atY4011ohHH320oH1jn2eLcuedd8Zmm23WqG8sZLPZ/HNuSfe/1VZbRUQUPCfr/r3gMnd1crlcrLjiikus4ZNPPolDDjkkunfvHtXV1bHeeuvVm2WqbsmLP/zhD/nnTVVVVWyyySbx/PPPL/b+hwwZEuutt16DP1tjjTUKvi0e8c03y++5555IkmSJtQMAlaNY2SMi4pJLLom11lor2rRpE506dYqNN944brzxxsUeP5fLRZ8+fepde99+++2x8847x8orr5zftv3228fqq68et9xyS37bXXfdFfPmzSu4xs1kMnHUUUfFhx9+GE8//XR++7Rp0+KNN97IZ5ylVffYZ86cmc8vjT03jbm2W5RJkybFwQcfHN27d4+qqqpYa6214tprr62334cffhi77757tG3bNrp16xYnnnhio5eePvfcc2PmzJkxZsyY6NmzZ72ft2jRIo4//vjo06dPftsrr7wSBx10UKyyyipRXV0dPXr0iIMPPjg+++yzgrZ1y3S89dZb8eMf/zg6dOgQXbt2jd/85jeRJElMnDgxdtttt2jfvn306NEjzj///IL2C+ba008/PVZaaaVYYYUVYs8994xp06bFnDlz4oQTTohu3bpFu3btYsSIEfUe95gxY+K73/1udOvWLaqqqmLNNdeM0aNHN+rc/Otf/4pPP/00tt9++0bt31DebMigQYOiS5cu9bLtu+++G2uttVZ07NixXptu3bo1qobG5NaDDjoo2rVrF5MmTYrdd9892rVrF127do2TTz45ampqFnnfjz/+eGQymXrLZ0RE3HjjjZHJZAped3Xn7a677mpU7QDA8q0x+WRhBx10UPTr1y///wU/M73wwgujb9++0bp16xgyZEi89tprBW3rZtf/+OOPl7nmha//Zs6cGT/96U+jT58+UVVVFWussUb84Q9/qPe56vz58+N3v/td/jPdfv36xS9/+ctGXcPPmTMnTjvttBgwYEBUVVVFnz594pRTTqnXds6cOXHiiSdG165dY4UVVohdd901Pvzww0Y9rltvvTVee+21+M1vftPg59wRETvssEMMGzYs///PP/88Tj755FhnnXWiXbt20b59+xg2bFi8/PLLBe2KcY2ftr/in//8Z+y1116x8sor58/hiSeeGLNmzVriuZk9e3Y8+OCDjc4IPXr0iEGDBi0xI1RXV8cmm2wSX331VXzyySf57e+++27kcrn4zne+U69N+/bto7q6eok1/Oc//4lhw4ZF+/bto127drHddtvFM888U7BPY/vwFjZjxoxo27Ztg/1SH374YeRyuYLl5rp16xbrrruujACUHcvPQSN99NFHsemmm8aXX34Zhx9+eAwcODAmTZoUt912W3z99dfRqlWrmDJlSmy++ebx9ddfx/HHHx8rrrhiXHfddbHrrrvGbbfdFnvssUfBfZ599tmRzWbj5JNPjmnTpsW5554b+++/fzz77LMRETF37twYOnRozJkzJ4477rjo0aNHTJo0Ke6999748ssvo0OHDnH99dfHoYceGptuuml+Os1VV101IiKef/75eOqpp2KfffaJ3r17x/vvvx+jR4+ObbbZJv73v/9FmzZtCuo57rjjolOnTnHaaafF+++/HxdddFEce+yxcfPNN0dExEUXXZRfh/hXv/pVRER0794933677baLiCUPNlmUug+N6waW/Pa3v43TTz89tt9++zjqqKPizTffjNGjR8fzzz8fTz75ZLRs2TIivrmgGzFiRGyyySYxatSomDJlSlx88cXx5JNPxn/+858GP3Su8/vf/z5+85vfxI9+9KM49NBDY+rUqXHJJZfE1ltvXdD2mmuuiSOOOCI233zzOOGEE+K9996LXXfdNTp37lzQgdCQBx54IGpqauLHP/7xUp2Piy++OHbdddfYf//9Y+7cuXHTTTfFXnvtFffee2/stNNOBfv+85//jLvvvjuOOeaYiIgYNWpU7LzzznHKKafEZZddFkcffXR88cUXce6558bBBx8cf/vb3wraf/HFF7HzzjvHPvvsE3vttVeMHj069tlnnxg3blyccMIJceSRR8Z+++0X5513Xuy5554xceLE/PSjS/s8W9C8efPi+eefj6OOOqrR52Xh58mi1D0PO3XqlN9WtyTHuHHjYosttogWLZbuz+CsWbNim222iXfeeSeOPfbY6N+/f9x6661x0EEHxZdfflkvHNx4443x1VdfxRFHHBGZTCbOPffc+MEPfhDvvfde/vm7sAMOOCAOO+yweO2112LttdfOb3/++efjrbfeil//+tcF+2+00UZx4YUXxn//+9+C/QGAylXM7HHVVVfF8ccfH3vuuWf85Cc/idmzZ8crr7wSzz77bOy3334Fx505c2bMmjUrpk2bFnfffXc88MADsffee+d/PmnSpPjkk09i4403rlfzpptuGvfff3/+///5z3+ibdu2MWjQoHr71f18yy23jIiIO+64I0aMGBFjxoxZ5mWu33vvvcjlctGxY8dGn5ulvbZb0JQpU+I73/lO/gP7rl27xgMPPBCHHHJITJ8+PU444YT8Mbbbbrv44IMP4vjjj49evXrF9ddfX+96fFHuvffeGDBgQGy22WaNPhePPPJIvPfeezFixIjo0aNH/Pe//40rr7wy/vvf/8YzzzxTb+mNvffeOwYNGhRnn3123HfffXHmmWdG586d44orrojvfve7cc4558S4cePi5JNPjk022SS23nrrgvajRo2K1q1bxy9+8Yt455134pJLLomWLVtGNpuNL774In7729/GM888E2PHjo3+/fvHqaeemm87evToWGuttWLXXXeNFi1axD333BNHH3101NbW5rPNojz11FORyWRigw02aNR5aWyOmDZtWnzxxRf5XF2nb9++8fTTT9e7Tm+spcmtNTU1MXTo0Nhss83iD3/4Qzz66KNx/vnnx6qrrrrI7LTNNttEnz59Yty4cfU+exg3blysuuqqMXjw4Py2Dh06xKqrrhpPPvlknHjiiUv9eACA5Udj8snS+POf/xxfffVVHHPMMTF79uy4+OKL47vf/W68+uqr+f6GSZMmxaBBg2L48OExduzYZap7weu/JEli1113jccffzwOOeSQWH/99eOhhx6Kn/3sZzFp0qS48MIL8+0OPfTQuO6662LPPfeMn/70p/Hss8/GqFGj4vXXX29wAHmd2tra2HXXXeNf//pXHH744TFo0KB49dVX48ILL4y33nor7rzzzoJj3HDDDbHffvvF5ptvHn/729/qfea/KPfcc09ExFL1N7z33ntx5513xl577RX9+/ePKVOmxBVXXBFDhgyJ//3vf9GrV6+C/dNc40ek66+49dZb4+uvv46jjjoqVlxxxXjuuefikksuiQ8//DBuvfXWxT7OF154IebOnRsbbrhho87LvHnzYuLEiY36snPdoLwFr9v79u0bNTU1cf3118fw4cMbdcwF/fe//42tttoq2rdvH6ecckq0bNkyrrjiithmm23yXzZf0JL68BbWrl272GOPPeLmm2+OCy64IHK5XP5nf/nLXyJJkth///0L2my00UYFz1WAslDSeaKgghx44IFJNptNnn/++Xo/q62tTZIkSU444YQkIpJ//vOf+Z999dVXSf/+/ZN+/folNTU1SZL831SsgwYNSubMmZPf9+KLL04iInn11VeTJEmS//znPw0u07awRS0/9/XXX9fb9vTTTycRkfz5z3/ObxszZkwSEcn222+ffyxJkiQnnnhiksvlki+//DK/bXHLz/Xt2zfp27fvYmtNkv97/Ndee20yderU5KOPPkruu+++pF+/fkkmk0mef/755JNPPklatWqV7LDDDvnzliRJ8qc//SnfNkm+WXKgW7duydprr10wlee9996bRERy6qmn5rctvMzX+++/n+RyuXpLkb366qtJixYt8tvrjrH++usX/L6uvPLKJCKWOJXniSeemERE8tJLLxVsnzNnTjJ16tT8beGlzxb+/c2dOzdZe+21k+9+97sF2yMiqaqqSsaPH5/fdsUVVyQRkfTo0SOZPn16fvvIkSOTiCjYd8iQIUlEJDfeeGN+2xtvvJFERJLNZpNnnnkmv/2hhx5KIiIZM2bMIutMkoafZw155513kohILrnkkno/q1t+ru78vPPOO8lZZ52VZDKZZN11183vV/d7ffPNN5OpU6cm77//fnLttdcmrVu3Trp27ZrMnDkzv29tbW3+8Xbv3j3Zd999k0svvbRg+ZTFueiii5KISG644Yb8trlz5yaDBw9O2rVrlz/XdUterLjiisnnn3+e3/euu+5KIiK555576tVf58svv0yqq6uTn//85wXHPv7445O2bdsmM2bMKNj+1FNPJRGR3HzzzY16DABA+Stm9thtt93qTZ2/KHVLJtddB+65554F1zLPP//8Iq/xfvaznyURkcyePTtJkiTZaaedklVWWaXefjNnzkwiIvnFL36R31aXRxa8xlyUIUOGJAMHDsxfI77++uvJ8ccfn0REsssuuyzVuWnstV2S1F8G4pBDDkl69uxZ7xp+n332STp06JC/Rq47xi233FJwDgYMGLDE5TmmTZuWRESy++671/vZF198UZAlFrwmb+j6/C9/+UsSEck//vGP/La669AFl2ObP39+0rt37ySTySRnn312wfFat25dkDvrct3aa69dsOzfvvvum2QymXrLtw0ePLheXmyo1qFDhzb43FnYj3/842TFFVest73uWvz0009Ppk6dmkyePDl54oknkg022CCJiOT222/P7xsRySGHHJJMnTo1+eSTT5J///vfyfe///0Gl697+OGHk1wul+RyuWTw4MHJKaeckjz00EONWvJwaXLr8OHDk4hIzjjjjIL72GCDDZKNNtqoYNvCz8uRI0cmVVVVBRn+k08+SVq0aNHgMiY77LBDMmjQoCXWDwAs3xqTTxpafm748OEF139112mtW7dOPvzww/z2Z599NomI5MQTT6y3b0P9Hgtb+PPh8ePHJ1dccUVSVVWVdO/ePZk5c2Zy5513JhGRnHnmmQVt99xzzySTySTvvPNOkiRJ8tJLLyURkRx66KEF+5188slJRCR/+9vf8tsWXubr+uuvT7LZbEEOSZIkufzyywuWKKs7xtFHH12w33777deo5ec22GCDpGPHjvW2z5gxoyAjTJs2Lf+z2bNnF/SzJMk357iqqqrgurMY1/hp+ysaygijRo1KMpnMEj/Hv/rqqwv62BbUt2/fZIcddsifn5dffjnZZ599kohIjjvuuPx+C2fON954I593F16+bvLkyUnXrl2TiEgGDhyYHHnkkcmNN95YcD2+OLvvvnvSqlWrgiWhP/roo2SFFVZItt566/y2penDW/h5Wden88ADDxQce911122wb+uss85KIqJkS2wDNMTyc9AItbW1ceedd8Yuu+zS4LeS677pev/998emm26a/8ZxxDcjoQ8//PB4//3343//+19BuxEjRhR8i6Fuuaz33nsvIr755mRExEMPPRRff/31UtfdunXr/L/nzZsXn332WQwYMCA6duwYL774Yr39Dz/88IJv7W611VZRU1MTEyZMaNTx3n///aWapenggw+Orl27Rq9evWKnnXbKL6O38cYbx6OPPhpz586NE044IbLZ/3urOuyww6J9+/b5pSP+/e9/xyeffBJHH310wVSeO+20UwwcOLDBJSbq/PWvf43a2tr40Y9+FJ9++mn+1qNHj1httdXi8ccfLzjGkUceWfD7Ouigg/K/o8WZPn16RES95dXuv//+6Nq1a/5WN4tQnQV/f1988UVMmzYtttpqqwZ/d9ttt13BVL51I/h/+MMf5mdUWnB73XOsTrt27WKfffbJ/3+NNdaIjh07xqBBgwq+DdBQ+6V9ni2obgmMBWdTWtDMmTPz52fAgAHxy1/+MgYPHtzgN2LWWGON6Nq1a/Tr1y8OPvjgGDBgQDzwwAMFM0VlMpl46KGH4swzz4xOnTrFX/7ylzjmmGOib9++sffeeze4tOGC7r///ujRo0fsu++++W0tW7aM448/PmbMmBF///vfC/bfe++9Cx7bwq/xhnTo0CF22223/DclIr75pvbNN9+cX7ZkQXX3/+mnny62dgCgMhQ7e3Ts2DE+/PDDJS6BGxFxwgknxCOPPBLXXXddDBs2LGpqagqWk6ib7r+qqqpe27pr8bp9Zs2a1aj9Ir65rk6SpNGzNL3xxhv5a8RBgwbFJZdcEjvttFN+6bfGnpulvbarkyRJ3H777bHLLrtEkiQFWWLo0KExbdq0/HXw/fffHz179ow999wz375Nmzb5WXYXZ1E5IuKbWXkWzBKXXnpp/mcLXp/Pnj07Pv300/xyCA1dnx966KH5f+dyudh4440jSZI45JBD8ts7duwYa6yxRoPXsQceeGDBLKSbbbZZJEkSBx98cMF+m222WUycODHmz5/fYK3Tpk2LTz/9NIYMGRLvvffeEpcj/OyzzxaZIyIiTjvttOjatWv06NEjttlmm3j33XfjnHPOiR/84AcF+11zzTXRtWvX6NatW2y88cbx2GOPxSmnnBInnXRSwX7f+9734umnn45dd901Xn755Tj33HNj6NChsdJKK8Xdd9+92FqXJbceeeSRBf/faqutFpsjIr75XcyZM6dg2fKbb7455s+f3+A3+Tt16iRHAACL1dh8sjR23333WGmllfL/33TTTWOzzTYrmPm1X79+kSTJUs3SVPf5cP/+/eOII46IAQMGxH333Rdt2rSJ+++/P3K5XBx//PEFbX76059GkiTxwAMPRETka1j4WvCnP/1pRMRi+xtuvfXWGDRoUAwcOLAgI9Qtg1fX31B3jIVrqZvtdUmmT5/eYEb41a9+VZARFpyZt6qqKt/PUlNTE5999lm0a9cu1lhjjQYzQppr/Ih0/RULZoSZM2fGp59+GptvvnkkSRL/+c9/Fn1iYsn9DQ8//HD+/Ky33npx6623xgEHHBDnnHNOwX4LZs6BAwfGeeedF7vuumu952P37t3j5ZdfjiOPPDK++OKLuPzyy2O//faLbt26xe9+97t6SxsuqKamJh5++OHYfffdY5VVVslv79mzZ+y3337xr3/9K58J6yxLH972228fvXr1inHjxuW3vfbaa/HKK68sMiNE6G8Ayovl56ARpk6dGtOnT1/iFPMTJkxocFmAuiUXJkyYUHAfK6+8csF+dRcLX3zxRURE9O/fP0466aS44IILYty4cbHVVlvFrrvuGj/+8Y8bNZhm1qxZMWrUqBgzZkxMmjSp4AKqoQ+Il1RPsZ166qmx1VZbRS6Xiy5dusSgQYPyy4HVXYStscYaBW1atWoVq6yySv7ni9ovImLgwIHxr3/9a5HHf/vttyNJklhttdUa/HndRXvdMRber2XLlgUXm4tSd5E+Y8aMgu1bbLFFPPLIIxERcd5558WTTz5Z8PN77703zjzzzHjppZcK1qVuKCgu/Lure34svDRe3faFf6e9e/eud78dOnRoVPulfZ41ZFEX99XV1fnpdOvWau/du3eD+95+++3Rvn37mDp1avzxj3+M8ePHFwSgOlVVVfGrX/0qfvWrX8XHH38cf//73+Piiy+OW265JVq2bBk33HDDIuucMGFCrLbaagUD7SIKX+MLWtbX1IEHHhg333xz/POf/4ytt946Hn300ZgyZUoccMAB9fatO3fL8gECAFB+ip09fv7zn8ejjz4am266aQwYMCB22GGH2G+//WKLLbao13bgwIExcODAiPjmemSHHXaIXXbZJZ599tnIZDL5a6sFr03rzJ49OyL+7wPo1q1bN2q/ZdGvX7+46qqrIpPJRHV1day22mrRrVu3/M8be26W9tquztSpU+PLL7+MK6+8Mq688soG9/nkk0/y9zFgwIB612oN5ZeFLSpHRERcccUV8dVXX8WUKVPqfRD9+eefx+mnnx433XRTvo46jcmBHTp0iOrq6ujSpUu97XWdBEtqH9FwFqmtrY1p06bll3d48skn47TTTounn3663hd5pk2btsTcu7hOgsMPPzz22muvyGaz0bFjx1hrrbUaHGi32267xbHHHhtz586N559/Ps4666z4+uuv6z0vIiI22WST+Otf/xpz586Nl19+Oe6444648MILY88994yXXnop1lxzzQZrWdrcWl1dHV27di3Y1qlTpyXmiIEDB8Ymm2wS48aNyw9KGzduXHznO9+JAQMG1Ns/SRI5AgBYrMbmk6XR0Ofxq6++etxyyy2p7rfu8+GWLVtG7969C5YTnjBhQvTq1atgQE1E/Wv/CRMmRDabrXft1KNHj+jYseNiB4+8/fbb8frrr9e7jquzYEbIZrP1ljtuTEaI+CYnNHRdfvTRR8fOO+8cEfWXpqutrY2LL744Lrvsshg/fnzU1NTkf9bQ0mtprvGXtn1E4eflH3zwQZx66qlx991317v+TdvfsNlmm8WZZ54ZmUwm2rRpE4MGDSpYTq5OXeasra2Nd999N37/+9/H1KlTC76gUKdnz54xevTouOyyy+Ltt9+Ohx56KM4555w49dRTo2fPngVfIlnQ1KlT4+uvv27w9z5o0KCora2NiRMnxlprrZXfviz9DdlsNvbff/8YPXp0fP3119GmTZsYN25cVFdXx1577VVvf/0NQDkyqAlKaMH1axe04AXX+eefHwcddFDcdddd8fDDD8fxxx8fo0aNimeeeWaRgzvqHHfccTFmzJg44YQTYvDgwdGhQ4fIZDKxzz77RG1t7TLVU0zrrLNObL/99k1y341RW1sbmUwmHnjggQYfe0PfdlgWdR1Dr732Wqy33nr57V27ds0//oUH0vzzn/+MXXfdNbbeeuu47LLLomfPntGyZcsYM2ZM3HjjjfWOsajfXWN/p2naL+3zbEF1QWdRF925XK7Rz5Gtt9463/Gyyy67xDrrrBP7779/vPDCCw12SER8Ezj22Wef+OEPfxhrrbVW3HLLLTF27Nj84Lq0lvU1NXTo0OjevXvccMMNsfXWW8cNN9wQPXr0aPBc1J27hTudAAAivvkw9M0334x77703Hnzwwbj99tvjsssui1NPPTVOP/30xbbdc88944gjjoi33nor1lhjjejZs2dERHz88cf19v3444+jc+fO+UEjPXv2jMcff7zeoIm6tr169Vrmx9S2bduS54iIbzoKhg8f3uA+6667burjdOjQIXr27BmvvfZavZ/VDdpqaKbcH/3oR/HUU0/Fz372s1h//fWjXbt2UVtbG9///vcbnQOX5jp2WbPEu+++G9ttt10MHDgwLrjggujTp0+0atUq7r///rjwwgsblSUW9+H9aqut1qjnSe/evfP77bjjjtGlS5c49thjY9ttt603q1OdVq1axSabbBKbbLJJrL766jFixIi49dZb47TTTlvi8RpjUeeuMQ488MD4yU9+Eh9++GHMmTMnnnnmmfjTn/7U4L5ffPGFHAEANBsLfj6c1rIM6KitrY111lknLrjgggZ/vvCAnmU1cODAeOmll2LSpEkFM16tvvrqsfrqq0dE1Bt8c9ZZZ8VvfvObOPjgg+N3v/tddO7cObLZbJxwwglL1VfU1P0NNTU18b3vfS8+//zz+PnPfx4DBw6Mtm3bxqRJk+Kggw5aqv6GhvrPunTp0qiMsHDm3GKLLWLDDTeMX/7yl/HHP/6xwTaZTCb/O9hpp51itdVWi3Hjxi1yUNOyWNb+hgMPPDDOO++8uPPOO2PfffeNG2+8MXbeeecGv0SivwEoRwY1QSN07do12rdv3+CHyQvq27dvvPnmm/W2v/HGG/mfL4t11lkn1llnnfj1r38dTz31VGyxxRZx+eWXx5lnnhkRi77Avu2222L48OFx/vnn57fNnj17iUtsLc63NTq77ly9+eabBbMhzZ07N8aPH5+/oFxwv7ppXOu8+eabiz3nq666aiRJEv37989f7C+ulrfffrvgGPPmzYvx48cXDFRqyLBhwyKXy8W4ceNi//33X+y+dW6//faorq6Ohx56qODbxGPGjGlU+29TmufZyiuvHK1bt47x48cXtaZ27drFaaedFiNGjIhbbrmlYGm9hrRs2TLWXXfdePvtt/NLEDakb9++8corr0RtbW3BQKm0r/GF5XK52G+//WLs2LFxzjnnxJ133hmHHXZYg6Gl7tzVfasIAKhsTZE92rZtG3vvvXfsvffeMXfu3PjBD34Qv//972PkyJENftO0Tt0ScXXfhl1ppZWia9eu8e9//7vevs8991ysv/76+f+vv/76cfXVV8frr79eMHvNs88+m/95U2nsuVnWa7uuXbvGCiusEDU1NUv8QLxv377x2muv1Rvc1VB9Ddlpp53i6quvjueeey423XTTJe7/xRdfxGOPPRann356nHrqqfntb7/9dqOO92265557Ys6cOXH33XcXfOO4blmOJRk4cGCMGzeuUTM6LY0jjjgiLrzwwvj1r38de+yxxxIzcN0yLA0N9quTJrcurX322SdOOumk+Mtf/hKzZs2Kli1bxt57793gvo3JswDA8q2x+WRpNHRt+tZbbxUsV1Zsffv2jUcffTS++uqrgtmaGsoItbW18fbbbxd83jplypT48ssvl9jf8PLLL8d222232GvIumO8++67BbP0NDYj7LzzznHTTTfFuHHj4pRTTmlUm9tuuy223XbbuOaaawq2f/nll2U1eOXVV1+Nt956K6677ro48MAD89vrVrxYkrovmI8fPz7WWWedotW17rrrxo9//OO44oor4uSTT643Y9LCVllllejUqdNiM0LXrl2jTZs2i8yu2Wy2aAPh1l577dhggw1i3Lhx0bt37/jggw/ikksuaXDf8ePHR5cuXRY54xhAKTQ8dQVQIJvNxu677x733HNPgx/g142C3nHHHeO5556Lp59+Ov+zmTNnxpVXXhn9+vVb5FT0izJ9+vR6axGvs846kc1mC5ZyaNu2bYMDSHK5XL0R2pdccknB1KJLa1HHivjmm7bvvvvuMt/3grbffvto1apV/PGPfyx4DNdcc01MmzYtdtppp4j45gPkbt26xeWXX15wTh544IF4/fXX8/s15Ac/+EHkcrk4/fTT652nJEnyU7huvPHG0bVr17j88stj7ty5+X3Gjh3b6IE7Bx98cDzwwAOL/IZsQ99kyGQyBb+r999/P+68884lHu/bluZ51rJly9h4440bfF2ltf/++0fv3r0L1sN+++2344MPPqi375dffhlPP/10dOrUabEX6zvuuGNMnjw5br755vy2+fPnxyWXXBLt2rWLIUOGFK3+Aw44IL744os44ogjYsaMGQ2ubx0R8cILL0SHDh0KpqEFACpXsbPHwssStGrVKtZcc81IkiTmzZsXEVFvibKIbwbw//nPf47WrVsX5Jgf/vCHce+998bEiRPz2x577LF46623Cqau32233aJly5Zx2WWXFdR++eWXx0orrRSbb755fvu0adPijTfeaPRSAkvS2HOzrNd2uVwufvjDH8btt9/eYOfO1KlTC2r56KOP4rbbbstv+/rrrxe5bN3CTjnllGjTpk0cfPDBMWXKlHo/X9Q3ohfeftFFFzXqeN+mhmqdNm1ao7/IMXjw4EiSJF544YWi1tWiRYv46U9/Gq+//nrcdddd+e11M48t7P7774+IxS8Xkia3Lq0uXbrEsGHD4oYbbohx48bF97///QY7qqZNmxbvvvtuwWsRAGBhjc0nS+POO++MSZMm5f//3HPPxbPPPhvDhg3Lb5s3b1688cYbix0UsjR23HHHqKmpqff5/IUXXhiZTCZ/7B133DEi6l8/182+tLjrth/96EcxadKkuOqqq+r9bNasWTFz5syIiPyxFp7xp7HX7D/60Y9izTXXjN/97nfxzDPPNLhPQzlh4W233nprwe+hHDSUEZIkiYsvvrhR7TfaaKNo1apVk/Q3nHLKKTFv3ryCmbieffbZ/O91Qc8991x89tlni80IuVwudthhh7jrrrsKZuCdMmVK3HjjjbHllltG+/bti1b/AQccEA8//HBcdNFFseKKKxa83hb0wgsvxODBg4t2XIBiMFMTNNJZZ50VDz/8cAwZMiQOP/zwGDRoUHz88cdx6623xr/+9a/o2LFj/OIXv4i//OUvMWzYsDj++OOjc+fOcd1118X48ePj9ttvX+QSWIvyt7/9LY499tjYa6+9YvXVV4/58+fH9ddfn/8Qvc5GG20Ujz76aFxwwQXRq1ev6N+/f2y22Wax8847x/XXXx8dOnSINddcM55++ul49NFHG1wjubE22mijGD16dJx55pkxYMCA6NatW/6bptttt11ENLwEwtLq2rVrjBw5Mk4//fT4/ve/H7vuumu8+eabcdlll8Umm2ySH+DRsmXLOOecc2LEiBExZMiQ2HfffWPKlClx8cUXR79+/eLEE09c5DFWXXXVOPPMM2PkyJHx/vvvx+677x4rrLBCjB8/Pu644444/PDD4+STT46WLVvGmWeeGUcccUR897vfjb333jvGjx8fY8aMKZhFanEuuuiiGD9+fBx33HFx0003xS677BLdunWLTz/9NJ588sm45557Ci5wd9ppp7jgggvi+9//fuy3337xySefxKWXXhoDBgyIV155Jd3JLbK0z7PddtstfvWrX8X06dOLepHesmXL+MlPfhI/+9nP4sEHH4zvf//78fLLL8d+++0Xw4YNi6222io6d+4ckyZNiuuuuy4++uijuOiiixa71MPhhx8eV1xxRRx00EHxwgsvRL9+/eK2226LJ598Mi666KJ6a7KnscEGG8Taa68dt956awwaNCg23HDDBvd75JFHYpdddrHGNQA0I8XMHjvssEP06NEjtthii+jevXu8/vrr8ac//Sl22mmn/LXLEUccEdOnT4+tt946VlpppZg8eXKMGzcu3njjjTj//PMLlmX+5S9/Gbfeemtsu+228ZOf/CRmzJgR5513XqyzzjoxYsSI/H69e/eOE044Ic4777yYN29ebLLJJnHnnXfGP//5zxg3blzBNdcdd9wRI0aMiDFjxsRBBx2U+vw19tykubY7++yz4/HHH4/NNtssDjvssFhzzTXj888/jxdffDEeffTR+PzzzyMi4rDDDos//elPceCBB8YLL7wQPXv2jOuvvz7atGnTqMey2mqrxY033hj77rtvrLHGGrH//vvHeuutF0mSxPjx4+PGG2+MbDabX1qhffv2sfXWW8e5554b8+bNi5VWWikefvjhos+MWgw77LBDtGrVKnbZZZf8QP6rrroqunXr1qjOqy233DJWXHHFePTRR+vNfpTWQQcdFKeeemqcc845sfvuu0fEN8tuf/3117HHHnvEwIEDY+7cufHUU0/FzTffHP369St4/i8sTW5dFgceeGDsueeeERHxu9/9rsF9Hn300UiSJHbbbbeiHhsAaH4ak0+WxoABA2LLLbeMo446KubMmZMfZLHgrEOTJk2KQYMGxfDhw2Ps2LGpH8Muu+wS2267bfzqV7+K999/P9Zbb714+OGH46677ooTTjghVl111YiIWG+99WL48OFx5ZVXxpdffhlDhgyJ5557Lq677rrYfffdY9ttt13kMQ444IC45ZZb4sgjj4zHH388tthii6ipqYk33ngjbrnllnjooYdi4403jvXXXz/23XffuOyyy2LatGmx+eabx2OPPRbvvPNOox5Ly5Yt44477oihQ4fGlltuGT/4wQ9iq622yi/Tdvfdd8cHH3xQMABr5513jjPOOCNGjBgRm2++ebz66qsxbty4RvdvfFsGDhwYq666apx88skxadKkaN++fdx+++2LXXZ6QdXV1bHDDjvEo48+GmeccUZRa1tzzTVjxx13jKuvvjp+85vfxIorrhjXX399jBs3LvbYY4/8gKrXX389rr322qiuro5f/vKXi73PM888Mx555JHYcsst4+ijj44WLVrEFVdcEXPmzIlzzz23qPXvt99+ccopp8Qdd9wRRx11VLRs2bLePp988km88sorccwxxxT12ACpJUCjTZgwITnwwAOTrl27JlVVVckqq6ySHHPMMcmcOXPy+7z77rvJnnvumXTs2DGprq5ONt100+Tee+8tuJ/HH388iYjk1ltvLdg+fvz4JCKSMWPGJEmSJO+9915y8MEHJ6uuumpSXV2ddO7cOdl2222TRx99tKDdG2+8kWy99dZJ69atk4hIhg8fniRJknzxxRfJiBEjki5duiTt2rVLhg4dmrzxxhtJ37598/skSZKMGTMmiYjk+eefb7DOxx9/PL9t8uTJyU477ZSssMIKSUQkQ4YMyf+sb9++Sd++fZd4Hhf1+Bvypz/9KRk4cGDSsmXLpHv37slRRx2VfPHFF/X2u/nmm5MNNtggqaqqSjp37pzsv//+yYcffliwz2mnnZY09LZ3++23J1tuuWXStm3bpG3btsnAgQOTY445JnnzzTcL9rvsssuS/v37J1VVVcnGG2+c/OMf/0iGDBlScA4WZ/78+cmYMWOS7373u0nnzp2TFi1aJF26dEm222675PLLL09mzZpVsP8111yTrLbaaklVVVUycODAZMyYMQ0+hohIjjnmmIJtdc+l8847r2B7Q+d+yJAhyVprrVWv3r59+yY77bRTve0LH6+xz7NFmTJlStKiRYvk+uuvL9g+fPjwpG3btktsX3dOpk6dWu9n06ZNSzp06JD/HU2ZMiU5++yzkyFDhiQ9e/ZMWrRokXTq1Cn57ne/m9x2221LPFbdfdQ93latWiXrrLNO/jVbZ1HnP0m+OX+nnXZavfobcu655yYRkZx11lkN/vz1119PIqLeewIAUPmKlT2uuOKKZOutt05WXHHFpKqqKll11VWTn/3sZ8m0adPy+/zlL39Jtt9++6R79+7566Ptt98+ueuuuxqs7bXXXkt22GGHpE2bNknHjh2T/fffP5k8eXK9/WpqapKzzjor6du3b9KqVatkrbXWSm644YZ6+9XlkYWvqRqyqGvXhTXm3CRJ467tkqT+NVxd22OOOSbp06dP0rJly6RHjx7Jdtttl1x55ZUF+02YMCHZddddkzZt2iRdunRJfvKTnyQPPvhgvay1OO+8805y1FFHJQMGDEiqq6uT1q1bJwMHDkyOPPLI5KWXXirY98MPP0z22GOPpGPHjkmHDh2SvfbaK/noo48WeR268HX0oq7DFz73i8p1i8qXDR3v7rvvTtZdd92kuro66devX3LOOeck1157bRIRyfjx45d4Xo4//vhkwIABBdsWdy2+sIayVJ3f/va3Bb+jBx54IDn44IOTgQMHJu3atUtatWqVDBgwIDnuuOOSKVOmLPFYSdK43Lqo87+oLLjw8zJJkmTOnDlJp06dkg4dOtTLmXX23nvvZMstt2xU3QAAS8onDfUlDB8+vKC/YMHrtPPPPz/p06dPUlVVlWy11VbJyy+/XHC8un0b8/ny4j4fXtBXX32VnHjiiUmvXr2Sli1bJquttlpy3nnnJbW1tQX7zZs3Lzn99NOT/v37Jy1btkz69OmTjBw5Mpk9e3bBfg31DcydOzc555xzkrXWWiupqqpKOnXqlGy00UbJ6aefXpDBZs2alRx//PHJiiuumLRt2zbZZZddkokTJy7y+q4hX375ZXLGGWckG2ywQf76tE+fPsmee+6Z3HPPPQX7zp49O/npT3+a9OzZM2ndunWyxRZbJE8//XS9x1CMa/y0/RX/+9//ku233z5p165d0qVLl+Swww5LXn755UZnxr/+9a9JJpNJPvjgg4Lti+rvWNjiMucTTzxR8Dt65ZVXkp/97GfJhhtumO/z6dmzZ7LXXnslL7744hKPlSRJ8uKLLyZDhw5N2rVrl7Rp0ybZdtttk6eeeqpgn6Xpw1tcn9WOO+6YRES9+68zevTopE2bNsn06dMbVTvAtyWTJMswNyQAFNEhhxwSb731Vvzzn/8sdSll5eKLL44TTzwx3n///QbX6T7hhBPiH//4R7zwwgtmagIAYLnz3nvvxcCBA+OBBx7IzxzMN8so9urVK3bZZZe45ppr6v188uTJ0b9//7jpppvM1AQAfGvef//96N+/f5x33nlx8sknl7ocmqmamppYc80140c/+tEiZy1dXu2xxx7x6quvLnJWsA022CC22WabuPDCC7/lygAWb+nWwgKAJnDaaafF888/H08++WSpSykbSZLENddcE0OGDGlwQNNnn30WV199dZx55pkGNAEAsFxaZZVV4pBDDomzzz671KWUlTvvvDOmTp0aBx54YIM/v+iii2KdddYxoAkAgGYnl8vFGWecEZdeemnMmDGj1OWUjY8//jjuu+++OOCAAxr8+YMPPhhvv/12jBw58luuDGDJzNQEAGVk5syZcffdd8fjjz8eV111Vdx1112x6667lrosAACgzD377LPxyiuvxO9+97vo0qVLvPjii6UuCQAgz0xN8O0bP358PPnkk3H11VfH888/H++++2706NGj1GUBLJUWpS4AAPg/U6dOjf322y86duwYv/zlLw1oAgAAGmX06NFxww03xPrrrx9jx44tdTkAAECJ/f3vf48RI0bEyiuvHNddd50BTUBFMlMTAAAAAAAAAABQVrKlLgAAAAAAAAAAAGBBzX75udra2vjoo49ihRVWiEwmU+pyAADKWpIk8dVXX0WvXr0imzX+HRYmXwAANJ58AUsmYwAANI58sXxq9oOaPvroo+jTp0+pywAAqCgTJ06M3r17l7oMKDvyBQDA0pMvYNFkDACApSNfLF+a/aCmFVZYISIiXn3jrfy/l1abZE7qOubnqlO1r576VuoaaiaPT9U+Gbh1qvYtvpiQqn1ExPxOfVO1z379eeoaklatU7Wf27pz6hqqvvooVfukZbtU7Wtbt0/VPiJifpKufatZ6X+XUTs/VfNPW6yYqn23r9K9JiMiZnZeNVX7dp/8L3UNc3uulfo+0srOnZWqfWbezFTtp7dK/7pul033fIxM+hHpmXnp/t5l5qf7PSRV6d6bIiLmpfx727JmduoaWkx9N1X7mo4rpa4hzQrDX301I1ZZd8Nlvm6C5q4Y+aJ1piZ1HXOSXKr2bb8swrX5m8+lap/ZaKdU7VtMfSdV+4iI+d1WT9U+7d++iEh9TVrTrlvqElp++l7KGrqmap9Up/+bkzJeRHZOuuvBiIhM7bxU7T/NpDsP3aenuwaJiJjdNd1ronryf1PXMK/baqnvI63M/HS/y7S+btEm9X20jnSPIcm1Sl1DdvZXqdqnfU0lrdKfx7TnIVMzN3UNLT7/IFX7+R2KkC+S2mVu+tVXX8Wq68gXsDj6MP6PPgx9GHX0Yfx/+jD0Yfx/+jD+/13ow1ju+zD0Xyyfmv2gprrpWldYYYVo337ZLmLKIhDMTv8mWfNVug9zkvbp3hxazE//GOanrCGbS/9hUtoPxea2SX8xXRXpPhhMWjWDQNCiCB8ypwwEc1qmOw/tI/1rIreM72t12s1qm7qGuSlrKIbs3HR/zjJz011MJ1Xpz8EKZREI0l0MZ+al+z0Uo0MzfSBI33nTYna611VNMS7Gi/F8MOU9NKgY+aIsBjXVFOHavG26D8ozafNFEa5j0uaLtH/7IiL9oKYV0l+HtJyT7vmQ9m9XUp3+MaQf1FSEv5016TLKnGzKfJGkf123SnltXz0z/etyXhnki8z89J8dpNGiRfrzWBaDmlLeRdrXVFKV/jyWxaCmeele22n/1kVEqkFNdeQLWDR9GP9HH4Y+jDr6MP4/fRj6MP4/fRj//y70YejDqGsuXyxXLDQIAAAAAAAAAACUFYOaAAAAAAAAAACAsmJQEwAAAAAAAAAAUFYMagIAAAAAAAAAAMqKQU0AAAAAAAAAAEBZMagJAAAAAAAAAAAoKwY1AQAAAAAAAAAAZcWgJgAAAAAAAAAAoKwY1AQAAAAAAAAAAJQVg5oAAAAAAAAAAICyYlATAAAAAAAAAABQVgxqAgAAAAAAAAAAyopBTQAAAAAAAAAAQFkxqAkAAAAAAAAAACgrBjUBAAAAAAAAAABlpSIGNV166aXRr1+/qK6ujs022yyee+65UpcEAABUMBkDAAAoFvkCAACaRtkParr55pvjpJNOitNOOy1efPHFWG+99WLo0KHxySeflLo0AACgAskYAABAscgXAADQdMp+UNMFF1wQhx12WIwYMSLWXHPNuPzyy6NNmzZx7bXXlro0AACgAskYAABAscgXAADQdMp6UNPcuXPjhRdeiO233z6/LZvNxvbbbx9PP/10g23mzJkT06dPL7gBAABELH3GkC8AAIBF0YcBAABNq6wHNX366adRU1MT3bt3L9jevXv3mDx5coNtRo0aFR06dMjf+vTp822UCgAAVIClzRjyBQAAsCj6MAAAoGmV9aCmZTFy5MiYNm1a/jZx4sRSlwQAAFQo+QIAACgmGQMAABqvRakLWJwuXbpELpeLKVOmFGyfMmVK9OjRo8E2VVVVUVVV9W2UBwAAVJilzRjyBQAAsCj6MAAAoGmV9UxNrVq1io022igee+yx/Lba2tp47LHHYvDgwSWsDAAAqEQyBgAAUCzyBQAANK2ynqkpIuKkk06K4cOHx8YbbxybbrppXHTRRTFz5swYMWJEqUsDAAAqkIwBAAAUi3wBAABNp+wHNe29994xderUOPXUU2Py5Mmx/vrrx4MPPhjdu3cvdWkAAEAFkjEAAIBikS8AAKDplP2gpoiIY489No499thSlwEAADQTMgYAAFAs8gUAADSNbKkLAAAAAAAAAAAAWJBBTQAAAAAAAAAAQFkxqAkAAAAAAAAAACgrBjUBAAAAAAAAAABlxaAmAAAAAAAAAACgrBjUBAAAAAAAAAAAlBWDmgAAAAAAAAAAgLJiUBMAAAAAAAAAAFBWDGoCAAAAAAAAAADKikFNAAAAAAAAAABAWTGoCQAAAAAAAAAAKCsGNQEAAAAAAAAAAGXFoCYAAAAAAAAAAKCsGNQEAAAAAAAAAACUlRalLuDbUlubRE1tsmyNM8WtpWRW/0669kltuva189O1L4a0jyEikpatU7Vf1qdhQQ2t2qVrn82lLyKlZX491smkH5OZtO6QroSUT+mkRVW6O4iITCblG1Q2/Z+BeSlfVrkivMdmWrRKdwcp359yaX8PEel/F0V4f0v7usqkPI81LapTtY+IiJRvLUku5XMpoiivq7SSFM/JNG1heZIqX7QswvtETco3vCJcm2c32CFV+yTl365k/txU7b+5k5R/P4uRL1q1TX0fadW26ZTuDkp8LRYRZfH3d17rdOcxNzfd86m2eoVU7SOKcG1ehGupmmy6+8gl6Z9PSas2qe8jjVxSjHyR7jwW5Yowbb6oSfc+Py+3Yqr2EelfE0kxMk45SPMeWwbvz1Ap9GGEPowIfRh17fVhRIQ+jIjQh1FHH8Y39GEs930Y+i+WT2ZqAgAAAAAAAAAAyopBTQAAAAAAAAAAQFkxqAkAAAAAAAAAACgrBjUBAAAAAAAAAABlxaAmAAAAAAAAAACgrBjUBAAAAAAAAAAAlBWDmgAAAAAAAAAAgLJiUBMAAAAAAAAAAFBWDGoCAAAAAAAAAADKikFNAAAAAAAAAABAWTGoCQAAAAAAAAAAKCsGNQEAAAAAAAAAAGXFoCYAAAAAAAAAAKCsGNQEAAAAAAAAAACUFYOaAAAAAAAAAACAsmJQEwAAAAAAAAAAUFYMagIAAAAAAAAAAMqKQU0AAAAAAAAAAEBZKftBTf/4xz9il112iV69ekUmk4k777yz1CUBAAAVSr4AAACKScYAAICmU/aDmmbOnBnrrbdeXHrppaUuBQAAqHDyBQAAUEwyBgAANJ0WpS5gSYYNGxbDhg1r9P5z5syJOXPm5P8/ffr0pigLAACoQPIFAABQTDIGAAA0nbKfqWlpjRo1Kjp06JC/9enTp9QlAQAAFUq+AAAAiknGAACAxmt2g5pGjhwZ06ZNy98mTpxY6pIAAIAKJV8AAADFJGMAAEDjlf3yc0urqqoqqqqqSl0GAADQDMgXAABAMckYAADQeM1upiYAAAAAAAAAAKCyGdQEAAAAAAAAAACUlbJffm7GjBnxzjvv5P8/fvz4eOmll6Jz586x8sorl7AyAACg0sgXAABAMckYAADQdMp+UNO///3v2HbbbfP/P+mkkyIiYvjw4TF27NgSVQUAAFQi+QIAACgmGQMAAJpO2Q9q2mabbSJJklKXAQAANAPyBQAAUEwyBgAANJ1sqQsAAAAAAAAAAABYkEFNAAAAAAAAAABAWTGoCQAAAAAAAAAAKCsGNQEAAAAAAAAAAGXFoCYAAAAAAAAAAKCsGNQEAAAAAAAAAACUFYOaAAAAAAAAAACAsmJQEwAAAAAAAAAAUFYMagIAAAAAAAAAAMqKQU0AAAAAAAAAAEBZMagJAAAAAAAAAAAoKwY1AQAAAAAAAAAAZcWgJgAAAAAAAAAAoKy0KHUBAACwJLNnz465c+eWuoxo1apVVFdXl7oMAAAghXLJFxEyBgAAVDr5omkZ1NQYtbWp7yLJpb2D9DWkvo9Muom9klbt0h0/ojjnQQ2RSfkQknTNIyIi9Vkswu8hyZb2LTCTFONMplOMc5DNFKGQtFK/JmqKVMiyS1K+x2Zq5xepkmWX9vmUnT87dQ01uZQXasU4j+XwdyLN8ynlc7EpzJ49O1Zs3S6+jtK/Vnv06BHjx49vdqGApZdEimuiIrzX1EbagFEGUv7dyLTtWJw60ijCe345XIekfhzzU35o0yr9Nem8lA+hqgh//+bXlvj6vqbyrwcjInJp80VRAmuJz2WmVeq7SHsaMsW4pk37OVIu3XloMe/rVO0jImpbtUnVPlNThA+1yyFfNDPllC8iZAyKRB/GN/RhNJsa9GH8/7vQh6EP4/8rh88O9GHowyiqZX0+6b9YouaYLwxqAgCgrM2dOze+jprYP1aKViVcPXlu1Ma4yZNi7ty5zSoQAADA8qRc8kWEjAEAAJVOvmh6BjUBAFARWkW25KEAAABoHuQLAACgWOSLpmNQEwAAFSEXRViSJs3xSz/jNgAAUCSlzhcRMgYAADQX8kXTMVQMAAAAAAAAAAAoK2ZqAgCgIuQymchlSvdVh1xkIprpNx0AAGB5U+p8ESFjAABAcyFfNB0zNQEAAAAAAAAAAGXFoCYAAAAAAAAAAKCsWH4OAICKkM1E5Eo4e2s2ollO3QoAAMujUueLCBkDAACaC/mi6ZipCQAAAAAAAAAAKCsGNQEAAAAAAAAAAGXF8nMAAFSEXCYTuUzp5m/NRYnnjgUAAIqm1PkiQsYAAIDmQr5oOmZqAgAAAAAAAAAAyopBTQAAAAAAAAAAQFmx/BwAABUhl/nmVrLjl+7QAABAkZU6X0TIGAAA0FzIF03HTE0AAAAAAAAAAEBZMVMTAAAVIZfJRC5Tuq865KLEX7MAAACKptT5IkLGAACA5kK+aDpmagIAAAAAAAAAAMpK2Q9qGjVqVGyyySaxwgorRLdu3WL33XePN998s9RlAQAAFUi+AAAAikW+AACAplX2g5r+/ve/xzHHHBPPPPNMPPLIIzFv3rzYYYcdYubMmaUuDQCAb1EuU/oblU++AAAgovTZQsZoHuQLAAAiSp8rmnO+aFHqApbkwQcfLPj/2LFjo1u3bvHCCy/E1ltvXaKqAACASiRfAAAAxSJfAABA0yr7QU0LmzZtWkREdO7cucGfz5kzJ+bMmZP///Tp07+VugAAgMojXwAAAMWypHwRIWMAAMDSKPvl5xZUW1sbJ5xwQmyxxRax9tprN7jPqFGjokOHDvlbnz59vuUqAQBoCrlMpuQ3mhf5AgBg+VXqbCFjND+NyRcRMgYAQHNU6lzRnPNFRQ1qOuaYY+K1116Lm266aZH7jBw5MqZNm5a/TZw48VusEAAAqBTyBQAAUCyNyRcRMgYAACyNill+7thjj4177703/vGPf0Tv3r0XuV9VVVVUVVV9i5UBAPBtyERpR+Q3z+84LL/kCwCA5Vup80VdDTQPjc0XETIGAEBzJF80nbIf1JQkSRx33HFxxx13xBNPPBH9+/cvdUkAAECFki8AAIBikS8AAKBplf2gpmOOOSZuvPHGuOuuu2KFFVaIyZMnR0REhw4donXr1iWuDgAAqCTyBQAAUCzyBQAANK2yH9Q0evToiIjYZpttCraPGTMmDjrooG+/IAAASiKXyUQuU7oJVHPNdvLW5Yt8AQBAROnzRYSM0RzIFwAARMgXTansBzUlSVLqEgAAgGZCvgAAAIpFvgAAgKaVLXUBAAAAAAAAAAAACyr7mZoAACAiIpf55lay45fu0AAAQJGVOl9EyBgAANBcyBdNx0xNAAAAAAAAAABAWTFTEwAAFeGbbzqU7qsOzfVbDgAAsDwqdb6IkDEAAKC5kC+ajpmaAAAAAAAAAACAsmJQEwAAAAAAAAAAUFYsPwcAQEX4ZvrWEh6/dIcGAACKrNT5IkLGAACA5kK+aDpmagIAAAAAAAAAAMqKQU0AAAAAAAAAAEBZsfwcAAAVIZfJRC5Tuvlbc1HiuWMBAICiKXW+iJAxAACguZAvmo6ZmgAAAAAAAAAAgLJiUBMAAAAAAAAAAFBWLD8HAEBFyGYiciWcPdW3AQAAoPkodb6IkDEAAKC5kC+aTnN9XAAAAAAAAAAAQIVabmZqymYzkcsu49C4JP3Yr9SD8jJlMP4sqS1t+4jU5yGTJOlrSKkoIzRTnockk7KIIvwus+lfFall5n6d8h7aFqWONJKUz+lMEX6XtSlfVsV4TWRq5qe/kxLL1JbBYyjG+3QatUU4fi79XaSWTXl5VYS/+Zn5c5a9bc2yt21quUwmcmn/hqU5fhn87aJ8ZNM8H4vwOs+mvawtRr4odT4o9d+tKNK1VMr3tWLUkPr5kPZvXxEeQy7tU7oI12JVLWpStZ9VBt87q0n53tJcPmRKmy+SXLozsawfXy0odb4oh78TlX78KM57dJJrVYRK0snMm7Xsbecve9umVup8ESFjUEgfRhGUQ8bQh/ENfRhFoQ9DH0Y50YcR+jDqlLAPQ//FEmoog79dTaEMrjIBAAAAAIDF+cc//hG77LJL9OrVKzKZTNx5551LbPPEE0/EhhtuGFVVVTFgwIAYO3Zsk9cJAABQLAY1AQAAAABAmZs5c2ast956cemllzZq//Hjx8dOO+0U2267bbz00ktxwgknxKGHHhoPPfRQE1cKAABQHM1lZnAAAJq5XKZIU6Av6/FLd2gAAKDISp0vIpY+YwwbNiyGDRvW6P0vv/zy6N+/f5x//vkRETFo0KD417/+FRdeeGEMHTp0KY8OAAAsSiXmi0phpiYAAAAAACiR6dOnF9zmzJlTlPt9+umnY/vtty/YNnTo0Hj66aeLcv8AAABNzaAmAAAAAAAokT59+kSHDh3yt1GjRhXlfidPnhzdu3cv2Na9e/eYPn16zJo1qyjHAAAAaEqWnwMAoCKUevrW5jp1KwAALI9KnS8i/i9jTJw4Mdq3b5/fXlVVVZqCAACAZVJO+aK5MagJAAAAAABKpH379gWDmoqlR48eMWXKlIJtU6ZMifbt20fr1q2LfjwAAIBiM6gJAICKkMtkIpcp3VcdclHir1kAAABFU+p8EdH0GWPw4MFx//33F2x75JFHYvDgwU16XAAAWN4sD/miVLKlLgAAAAAAAFi8GTNmxEsvvRQvvfRSRESMHz8+Xnrppfjggw8iImLkyJFx4IEH5vc/8sgj47333otTTjkl3njjjbjsssvilltuiRNPPLEU5QMAACw1g5oAAAAAAKDM/fvf/44NNtggNthgg4iIOOmkk2KDDTaIU089NSIiPv744/wAp4iI/v37x3333RePPPJIrLfeenH++efH1VdfHUOHDi1J/QAAAEvL8nMAAFSEXETkSjh7ai4p3bEBAIDiKnW+iFj6jLHNNttEkiy60dixYxts85///GcpKwMAAJZGJeaLSmGmJgAAAAAAAAAAoKwY1AQAAAAAAAAAAJQVy88BAFARsplM5DKlm781W8JjAwAAxVXqfFFXAwAAUPnki6ZjpiYAAAAAAAAAAKCsGNQEAABN4B//+Efssssu0atXr8hkMnHnnXcusc0TTzwRG264YVRVVcWAAQNi7NixTV4nAAAAAACwfKmUPgyDmgAAqAi5TOlvS2PmzJmx3nrrxaWXXtqo/cePHx877bRTbLvttvHSSy/FCSecEIceemg89NBDy3C2AACAxSl1tliWjAEAAJSnUueK5tyHUfaDmkaPHh3rrrtutG/fPtq3bx+DBw+OBx54oNRlAQDAYg0bNizOPPPM2GOPPRq1/+WXXx79+/eP888/PwYNGhTHHnts7LnnnnHhhRc2caXLF/kCAAAoFvkCAIBKVSl9GC2a9N6LoHfv3nH22WfHaqutFkmSxHXXXRe77bZb/Oc//4m11lqr1OUBAPAtyWUykcuU7qvMdceePn16wfaqqqqoqqpKff9PP/10bL/99gXbhg4dGieccELq++b/yBcAAESUPl/U1UBlky8AAIgor3zR3Powyn6mpl122SV23HHHWG211WL11VeP3//+99GuXbt45plnSl0aAADLoT59+kSHDh3yt1GjRhXlfidPnhzdu3cv2Na9e/eYPn16zJo1qyjHQL4AAACKR74AAKDcNLc+jLKfqWlBNTU1ceutt8bMmTNj8ODBDe4zZ86cmDNnTv7/C49CAwCANCZOnBjt27fP/78Y33CgNOQLAACgWBqTLyJkDAAAmlZz68OoiEFNr776agwePDhmz54d7dq1izvuuCPWXHPNBvcdNWpUnH766d9yhQAANLVc5ptbKY8fEdG+ffuCQFAsPXr0iClTphRsmzJlSrRv3z5at25d9OMtz+QLAABKnS/qaqDyLU2+iJAxAACao3LKF82tD6Psl5+LiFhjjTXipZdeimeffTaOOuqoGD58ePzvf/9rcN+RI0fGtGnT8reJEyd+y9UCAMDSGzx4cDz22GMF2x555JHFfsOXZSNfAAAAxbI0+SJCxgAAoDKVqg+jImZqatWqVQwYMCAiIjbaaKN4/vnn4+KLL44rrrii3r5VVVUVP30WAACVb8aMGfHOO+/k/z9+/Ph46aWXonPnzrHyyivHyJEjY9KkSfHnP/85IiKOPPLI+NOf/hSnnHJKHHzwwfG3v/0tbrnllrjvvvtK9RCaLfkCAAAolqXJFxEyBgAA5aFS+jAqYlDTwmprawvWnAYAoPnLZTKRy5Ru/talPfa///3v2HbbbfP/P+mkkyIiYvjw4TF27Nj4+OOP44MPPsj/vH///nHffffFiSeeGBdffHH07t07rr766hg6dGhxHgCLJF8AACx/Sp0v6mqg+ZEvAACWP5WYLyqlD6PsBzWNHDkyhg0bFiuvvHJ89dVXceONN8YTTzwRDz30UKlLAwCARdpmm20iSZJF/nzs2LENtvnPf/7ThFUhXwAAAMUiXwAAUKkqpQ+j7Ac1ffLJJ3HggQfGxx9/HB06dIh11103Hnroofje975X6tIAAPgWZTOZyJbwmw6lPDbFI18AABBR+nxRVwOVTb4AACBCvmhKZT+o6Zprril1CQAAQDMhXwAAAMUiXwAAQNPKlroAAAAAAAAAAACABZX9TE0AABARkcllIpMt3fSpmWY6dSsAACyPSp0vImQMAABoLuSLpmOmJgAAAAAAAAAAoKwY1AQAAAAAAAAAAJQVy88BAFARsrlMZEs4fWu2mU7dCgAAy6NS54sIGQMAAJoL+aLpmKkJAAAAAAAAAAAoKwY1AQAAAAAAAAAAZcXycwAAVIZcNjLZEo7JzySlOzYAAFBcpc4XETIGAAA0F/JFkzFTEwAAAAAAAAAAUFbM1AQAQEXIZDORyWVKd/wo3bEBAIDiKnW+iJAxAACguZAvmo6ZmgAAAAAAAAAAgLJiUBMAAAAAAAAAAFBWLD8HAEBFyOYykS3h9K3ZZjp1KwAALI9KnS8iZAwAAGgu5IumY6YmAAAAAAAAAACgrCw3MzW1zmWi9TKOjPu6pir98VMOiqudOjF1Ddlsul/3WzUdUrXvsEL/VO0jIrrWzEjVPjN/duoasjM/S9V+bou2qWv4pDbdffTKfZ2qfcuPX0vV/psi1k3VPDdtUuoSaqvTPadz7dqlaj+/Y69U7SMiZsyrTdX+o+pVU9ewSm2619XHc9P/KerRujpV+8y8WanaVxVh5HVu+pRU7Z+c2TF1DRv2SPecbjPto1TtM1+lOwcREZn2PVO1n1XdOXUN0zqtnqp9+1bpx5zPrUmWue2sIrwmYXlQlcss8/v/1zVFLmZZTPsk9V1kqtJdk74/N13O6tJlUKr2ERFta9NdAxRDds5Xqdp/1WKF1DV8Wts+Vfu+2XRP6hafvZ+qfURETdd0f39zMz5NXUNt63T5okWrTqnaf91h5VTtIyKidtmvISIiJrful7qE3ilz+5S5LVPX0K2qtNdDxfhiZ9p88U50S11D//ZtUrVP+/lLbvrHqdpHRNR07JOq/byUnztERExpm+7ztA4tipAvssv+u/yqZS718WF5oQ9DH0aEPow6+jC+oQ9DH0YdfRjf0IehD0P/xfLJbx0AgIqQyWYjky3dRKOZJF1HLwAAUD5KnS8iZAwAAGgu5IumY/k5AAAAAAAAAACgrJipCQCAipDNZSJbjPVYlvX4UbpjAwAAxVXqfBEhYwAAQHMhXzQdMzUBAAAAAAAAAABlxaAmAAAAAAAAAACgrFh+DgCAipDJZSJTwulbM8106lYAAFgelTpfRMgYAADQXMgXTcdMTQAAAAAAAAAAQFkxqAkAAAAAAAAAACgrlp8DAKAifDN9a+nG5GeitmTHBgAAiqvU+SJCxgAAgOZCvmg6ZmoCAAAAAAAAAADKipmaAACoCNlcJrK5TOmOH6U7NgAAUFylzhcRMgYAADQX8kXTMVMTAAAAAAAAAABQVgxqAgAAAAAAAAAAyorl5wAAqAiZTCYy2dJNn5qpbZ5TtwIAwPKo1PkiQsYAAIDmQr5oOmZqAgAAAAAAAAAAyopBTQAAAAAAAAAAQFmx/BwAABUhm8tGNle6MfnZxPcBAACguSh1voiQMQAAoLmQL5pO83xUAAAAAAAAAABAxaqoQU1nn312ZDKZOOGEE0pdCgAA0AzIGAAAQLHIFwAAUFwVs/zc888/H1dccUWsu+66pS4FAIASyOQykcllSnf8pHTHpmnIGAAAy69S54sIGaO5kS8AAJZf8kXTqYiZmmbMmBH7779/XHXVVdGpU6fF7jtnzpyYPn16wQ0AAGBBjc0Y8gUAALAk+jAAAKBpVMSgpmOOOSZ22mmn2H777Ze476hRo6JDhw75W58+fb6FCgEAaGp133Qo5Y3mo7EZQ74AAGieSp0tZIzmRR8GAMDyrdS5ojnni7If1HTTTTfFiy++GKNGjWrU/iNHjoxp06blbxMnTmziCgEAgEqyNBlDvgAAABZHHwYAADSdFqUuYHEmTpwYP/nJT+KRRx6J6urqRrWpqqqKqqqqJq4MAACoREubMeQLAABgUfRhAABA0yrrQU0vvPBCfPLJJ7Hhhhvmt9XU1MQ//vGP+NOf/hRz5syJXC5XwgoBAPi2ZHPZyOZKN9FoNin7SU5pBBkDAICI0ueLCBmjOZAvAACIkC+aUlkPatpuu+3i1VdfLdg2YsSIGDhwYPz85z8XBgAAgKUiYwAAAMUiXwAAQNMq60FNK6ywQqy99toF29q2bRsrrrhive0AAABLImMAAADFIl8AAEDTKutBTQAAkJfLRCaXKd3xkxIeGwAAKK5S54sIGQMAAJoL+aLJVNygpieeeKLUJQAAAM2IjAEAABSLfAEAAMVTcYOaAABYPmUzmchmS/dNg2ymeX7LAQAAlkelzhd1NQAAAJVPvmg62VIXAAAAAAAAAAAAsCCDmgAAAAAAAAAAgLJi+TkAACpCJpeNTK50Y/Iztb4PAAAAzUWp80WEjAEAAM2FfNF0muejAgAAAAAAAAAAKpZBTQAAAAAAAAAAQFmx/BwAABUhm8tENpcp3fFrS3dsAACguEqdLyJkDAAAaC7ki6ZjpiYAAAAAAAAAAKCsGNQEAAAAAAAAAACUFcvPAQBQETK5TGRKOH1rpplO3QoAAMujUueLCBkDAACaC/mi6ZipCQAAAAAAAAAAKCtmagIAoCJkctnI5Eo3Jj9T6/sAAADQXJQ6X0TIGAAA0FzIF02neT4qAAAAAAAAAACgYhnUBAAAAAAAAAAAlJXlZvm5GfNqIzOvdpnatq/9OvXxa3PtUrXP9Fg1fQ3VK6Rqv2rLuana56ZPTtU+IqKmfY9U7Wtbtk5dQyZJUrUvxkjCPpOeTtW+pu8GqdrP7bVuqvYREXNrUp7H9j1T11DbplOq9rNmL9t7Sp2uU19P1T4iYoWe66Vq3336u6lrqG2xYqr2Xduka/9NEenenyKT7pU5a36650JERG6F7qnafyfdW3xERGTmp/t7V9uua7r2rTukah8RMTdJ97usrp2duoYVpr6Zqv38jr1T11DdomqZ285N+TxoStlcRDaXKd3x07/UaUZmz6+Nlsv4/t8ul/7JNDdllEs6r5S6hiTl38++reakat/i07dTtY+ImN9p5VTtk2z6SJ2bMTVV+6r26X+Xff93d7o72GBYqubzu62e7vgREeniRdS2TX9NOrsq3bXMjNnzU7Xv8+X/UrWPiJiXMuv1nf1B6hqS2nS5vVvK6+pvikiZ3JN07/PL+PFVgUzKzNw/5Xt8RERmzoxU7ZPWHVO1n9cx/ftjTSbd+3yLmvT5YqUv30rVvqZT39Q1VOdaLnvjJN3f+6ZU6nwRIWNQSB+GPowIfRh19GF8Qx+GPow8fRgRoQ8jQh+G/osl1NBM84WZmgAAAAAAAAAAgLJiUBMAAAAAAAAAAFBWlpvl5wAAqGyZbCYy2dJN31rKYwMAAMVV6nxRVwMAAFD55IumY6YmAAAAAAAAAACgrJipCQCAipDNZiObK92Y/GyN7wMAAEBzUep8ESFjAABAcyFfNJ3m+agAAAAAAAAAAICKZVATAAAAAAAAAABQViw/BwBARcjkMpHJZUp6fAAAoHkodb6oqwEAAKh88kXTMVMTAAAAAAAAAABQVgxqAgAAAAAAAAAAyorl5wAAqAiZXDYyudKNyS/lsQEAgOIqdb6oqwEAAKh88kXTaZ6PCgAAAAAAAAAAqFgGNQEAAAAAAAAAAGXF8nMAAFSETDYbmWwJl58r4bEBAIDiKnW+qKsBAACofPJF02mejwoAAAAAAAAAAKhYZmoCAKAiZHPZyOZKNya/lMcGAACKq9T5oq4GAACg8skXTad5PioAAAAAAAAAAKBilf2gpt/+9reRyWQKbgMHDix1WQAAQAWSLwAAgGKRLwAAoGlVxPJza621Vjz66KP5/7doURFlAwBQTLlsZEo5fWoznbp1eSRfAABQ8nzx/2ug8skXAADIF02nIq6uW7RoET169Ch1GQAAQDMgXwAAAMUiXwAAQNOpiKFab7/9dvTq1StWWWWV2H///eODDz5Y5L5z5syJ6dOnF9wAAADqyBcAAECxLE2+iJAxAABgaZT9oKbNNtssxo4dGw8++GCMHj06xo8fH1tttVV89dVXDe4/atSo6NChQ/7Wp0+fb7liAACaQib7zfStJbtly/7SmUaQLwAAiCiDfCFjNAtLmy8iZAwAgOZIvmg6Zf+ohg0bFnvttVesu+66MXTo0Lj//vvjyy+/jFtuuaXB/UeOHBnTpk3L3yZOnPgtVwwAAJQr+QIAACiWpc0XETIGAAAsjRalLmBpdezYMVZfffV45513Gvx5VVVVVFVVfctVAQDQ1DLZ0n7ToLl+y2F5J18AACyfSp0v6mqgeVlSvoiQMQAAmiP5oulU3KOaMWNGvPvuu9GzZ89SlwIAAFQ4+QIAACgW+QIAAIqr7Ac1nXzyyfH3v/893n///Xjqqadijz32iFwuF/vuu2+pSwMAACqMfAEAABSLfAEAAE2r7Jef+/DDD2PfffeNzz77LLp27RpbbrllPPPMM9G1a9dSlwYAwLcok8tGJpcr4fFrSnZsike+AAAgovT54psaZIxKJ18AABAhXzSlsh/UdNNNN5W6BAAAoJmQLwAAgGKRLwAAoGmV/fJzAAAAAAAAAADA8qXsZ2oCAICIuulbSzcmv5THBgAAiqvU+aKuBgAAoPLJF02neT4qAAAAAAAAAACgYpmpCQCAipDNZiObLd2Y/FIeGwAAKK5S54u6GgAAgMonXzSd5vmoAAAAAAAAAACAimVQEwAAAAAAAAAAUFYsPwcAQEXI5LKRyZVuTH4pjw0AABRXqfNFXQ0AAEDlky+aTvN8VAAAAAAAAAAAQMUyqAkAAAAAAAAAACgrlp8DAKAilHr61uY6dSsAACyPSp0v6moAAAAqn3zRdJrnowIAAAAAAAAAACqWQU0AAAAAAAAAAEBZsfwcAAAVIZPJRiZbwuXnMr4PAAAAzUWp80VdDQAAQOWTL5pO83xUAAAAAAAAAABAxVpuZmqqbpGN1i2WbQxXEm1SHz879+tU7Wur2qauIWmV7j5qW6U7D5k2nVK1j4jITfsoVfs5zz2YuoZPtj06VfvOqSuISLqsnO4Ocule+rmZn6U7fkRkWq+Yqn1tMZ5PX05K1b6m1Uqp2s/v0CtV+4iIlmmHpmbT/xlIWrZO1T5XOzd1DZFrlap5bVW6w7eMTLo7iIj5mXS/i6ovJqSuYW6nvqnaz8+ley60KMJ5zKa8i8zsr1LXUNOuS+r7SCtJ8Tc7aTW/iJUUVyaXjUyuhDM1lfDYlJ+qFtmoXsZ8kalJ/7evVcrnY02HnqlrSH0dkdSmal6U68EZn6ZqX/PW86lreHPN3VK1752kLiGqVlkvVfv5KfNF9usvUrWPiJjfOt3zYVar9qlraP311FTtayLdY5jXa91U7SMisrOmpbuD2vTXEUnLlJ/BpHxviYhIUr6/za1J98JsVYRLjrm16e6kzefvp65hdud+qdrXpnx/y6WPFzE/ZREti5Av5qc8j1GEb+omLZY9cyctWqY+flMpdb6oqwHq6MPQhxGhDyNPH0ZE6MOICH0Y/58+jG/ow9CHof9iyTU0R83zUQEAAAAAAAAAABXLoCYAAAAAAAAAAKCsLDfLzwEAUNlKPX1rc526FQAAlkelzhd1NQAAAJVPvmg6zfNRAQAAAAAAAAAAFcugJgAAAAAAAAAAoKxYfg4AgIqQzWUjW8LpU0t5bAAAoLhKnS/qagAAACqffNF0muejAgAAAAAAAAAAKpaZmgAAqAiZbCYy2dKNyc9kMyU7NgAAUFylzhd1NQAAAJVPvmg6ZmoCAAAAAAAAAADKikFNAAAAAAAAAABAWbH8HAAAFSGTy0YmV8Ll50p4bAAAoLhKnS/qagAAACqffNF0muejAgAAAAAAAAAAKpZBTQAAAAAAAAAAQFmx/BwAABWh1NO3NtepWwEAYHlU6nxRVwMAAFD55Ium0zwfFQAAAAAAAAAAULEMagIAAAAAAAAAAMqK5ecAAKgImUw2MtkSLj+X8X0AAABoLkqdL+pqAAAAKp980XTK/lFNmjQpfvzjH8eKK64YrVu3jnXWWSf+/e9/l7osAACgQskYAABAscgXAADQdMp6pqYvvvgitthii9h2223jgQceiK5du8bbb78dnTp1KnVpAAB8yzK5XGRzuZIen8onYwAAEFH6fFFXA5VNvgAAIEK+aEplPajpnHPOiT59+sSYMWPy2/r371/CigAAgEomYwAAAMUiXwAAQNMq6+Xn7r777th4441jr732im7dusUGG2wQV1111WLbzJkzJ6ZPn15wAwAAiFj6jCFfAABQTi699NLo169fVFdXx2abbRbPPffcIvcdO3ZsZDKZglt1dfW3WG3zpw8DAACaVlkPanrvvfdi9OjRsdpqq8VDDz0URx11VBx//PFx3XXXLbLNqFGjokOHDvlbnz59vsWKAQBoKplctuQ3Kt/SZgz5AgCgeSp1tliWjHHzzTfHSSedFKeddlq8+OKLsd5668XQoUPjk08+WWSb9u3bx8cff5y/TZgwIe2pYwH6MAAAiKjMfFEpyvpR1dbWxoYbbhhnnXVWbLDBBnH44YfHYYcdFpdffvki24wcOTKmTZuWv02cOPFbrBgAAChnS5sx5AsAAJrawrP2zJkzp8H9LrjggjjssMNixIgRseaaa8bll18ebdq0iWuvvXaR953JZKJHjx75W/fu3ZvqYSyX9GEAAEDTKutBTT179ow111yzYNugQYPigw8+WGSbqqqqaN++fcENAAAgYukzhnwBAEBT69OnT8HMPaNGjaq3z9y5c+OFF16I7bffPr8tm83G9ttvH08//fQi73vGjBnRt2/f6NOnT+y2227x3//+t0kew/JKHwYAADStFqUuYHG22GKLePPNNwu2vfXWW9G3b98SVQQAQKmUevrU5jp16/JGxgAAIKL0+aKuhoiIiRMnFgxsqaqqqrfvp59+GjU1NfVmWurevXu88cYbDd7/GmusEddee22su+66MW3atPjDH/4Qm2++efz3v/+N3r17F/GRLL/kCwAAIsorXzQ3ZT2o6cQTT4zNN988zjrrrPjRj34Uzz33XFx55ZVx5ZVXlro0AACgAskYAACUm6aarWfw4MExePDg/P8333zzGDRoUFxxxRXxu9/9rujHWx7JFwAA0LTKelDTJptsEnfccUeMHDkyzjjjjOjfv39cdNFFsf/++5e6NAAAvmWZbDYy2RLO1FTCY1M8MgYAABGlzxd1NTRWly5dIpfLxZQpUwq2T5kyJXr06NGo+2jZsmVssMEG8c477yxVnSyafAEAQETl5YtKUvaPauedd45XX301Zs+eHa+//nocdthhpS4JAAAa7dJLL41+/fpFdXV1bLbZZvHcc88tct+xY8dGJpMpuFVXV3+L1S4fZAwAACpNq1atYqONNorHHnssv622tjYee+yxgtmYFqempiZeffXV6NmzZ1OVuVySLwAAqGTl3odR9oOaAACgUt18881x0kknxWmnnRYvvvhirLfeejF06ND45JNPFtmmffv28fHHH+dvEyZM+BYrBgAAytVJJ50UV111VVx33XXx+uuvx1FHHRUzZ86MESNGRETEgQceGCNHjszvf8YZZ8TDDz8c7733Xrz44ovx4x//OCZMmBCHHnpoqR4CAABQRiqhD6Osl58DAIA6mVw2MrkSLj+3DMe+4IIL4rDDDst3Mlx++eVx3333xbXXXhu/+MUvGj5OJtPo5SMAAIBlU+p8UVfD0th7771j6tSpceqpp8bkyZNj/fXXjwcffDC6d+8eEREffPBBZBdYcuKLL76Iww47LCZPnhydOnWKjTbaKJ566qlYc801i/o4AABgeVeJ+SKiMvowDGoCAIClMH369IL/V1VVRVVVVb395s6dGy+88ELBN6Wz2Wxsv/328fTTTy/y/mfMmBF9+/aN2tra2HDDDeOss86KtdZaq3gPAAAAqFjHHntsHHvssQ3+7Iknnij4/4UXXhgXXnjht1AVAABQLppbH4bl5wAAYCn06dMnOnTokL+NGjWqwf0+/fTTqKmpyX9ruk737t1j8uTJDbZZY4014tprr4277rorbrjhhqitrY3NN988Pvzww6I/DgAAAAAAoHlpbn0YZmoCAKAiZLKZ0i4/l81ERMTEiROjffv2+e0NfcNhWQ0ePDgGDx6c///mm28egwYNiiuuuCJ+97vfFe04AACwvCt1vqirAQAAqHzllC+aWx+GQU0AALAU2rdvXxAIFqVLly6Ry+ViypQpBdunTJnS6PWmW7ZsGRtssEG88847y1QrAAAAAACw/GhufRiWnwMAgCbQqlWr2GijjeKxxx7Lb6utrY3HHnus4JsMi1NTUxOvvvpq9OzZs6nKBAAAAAAAljOV0odhpiYAACpCJpuNTLaUy88t/bFPOumkGD58eGy88cax6aabxkUXXRQzZ86MESNGRETEgQceGCuttFJ+TeszzjgjvvOd78SAAQPiyy+/jPPOOy8mTJgQhx56aFEfCwAALO9KnS/qagAAACpfpeaLSujDMKgJAACayN577x1Tp06NU089NSZPnhzrr79+PPjgg9G9e/eIiPjggw8iu0DQ+OKLL+Kwww6LyZMnR6dOnWKjjTaKp556KtZcc81SPQQAAAAAAKAZqoQ+DIOaAACoCJlsLjLZXEmPvyyOPfbYOPbYYxv82RNPPFHw/wsvvDAuvPDCZToOAADQeKXOF3U1AAAAla+S80W592GY3xYAAAAAAAAAACgrBjUBAAAAAAAAAABlxfJzAABUhmzum1spjw8AADQPpc4XdTUAAACVT75oMmZqAgAAAAAAAAAAyspyM1PTnPm1MXt+7TK1XSEzN/Xx57dsk6p99afvpK6hJmX7bLJs569O7qspKSuImN9p5VTtW22+W+oaVsp8lar97Eyn1DUk1e3T3cH8dM/p2rYrpjt+RNTUJKnaZ2dPS11DbfvuqdpXz8+kap/7ZGKq9hERs1p3SdW+1fzZqWuY0yLd+1su3Wn85j5q0j2ns3Nmpmpf06pjqvYREVWR7j027fM5IqLFvK9TtW85J937Y9K6Q6r2ERHzctWp2te2Sf8e3XLKG6na13RYKXUN2dnL/rvIzp6R+viwPEiTL1q0aJX6+HOTdN9PaTu1CPki5TVh0qptqva5rz5J1T4iYl6XVVO1z6y9deoaBmTT/f2syaa/Nq+tXiFV+0zN/JIePyIi7SVl9fx014MRETXtuqZq33p2utTe8qNXUrWPiJjba91U7XPTP05dQ03Ka8JMbbrnY0REJmW+qE75+cmc2nTXtBERrTLpapjfqXfqGlqmzBeZuelel2n/zkRE5Fqly7tFyRefvJWqfdrP0iIiMvOW/bODzLw5qY8Pywt9GPowIvRh5OnDiAh9GBH6MOrow/iGPgx9GPovlk/LzaAmAAAqXDb7za2UxwcAAJqHUueLuhoAAIDKJ180meb5qAAAAAAAAAAAgIplpiYAACpCJpeLTC5X0uMDAADNQ6nzRV0NAABA5ZMvmo6ZmgAAAAAAAAAAgLJiUBMAAAAAAAAAAFBWLD8HAEBlyOa+uZXy+AAAQPNQ6nxRVwMAAFD55IsmY6YmAAAAAAAAAACgrBjUBAAAAAAAAAAAlBXLzwEAUBmy2RIvP+f7AAAA0GyUOl/U1QAAAFQ++aLJNM9HBQAAAAAAAAAAVCwzNQEAUBEy2WxkSvhNg1IeGwAAKK5S54u6GgAAgMonXzSd5vmoAAAAAAAAAACAimVQEwAAAAAAAAAAUFYsPwcAQGXI5CKyudIeHwAAaB5KnS/qagAAACqffNFkzNQEAAAAAAAAAACUFYOaAAAAAAAAAACAsmL5OQAAKkO2xNO3lnrqWAAAoHhKnS/qagAAACqffNFkzNQEAAAAAAAAAACUlbIf1NSvX7/IZDL1bsccc0ypSwMAACqMfAEAABSLfAEAAE2r7Jefe/7556Ompib//9deey2+973vxV577VXCqgAA+LZlstnIZEs3Jr+Ux6Z45AsAACJKny/qaqCyyRcAAETIF02p7Ac1de3ateD/Z599dqy66qoxZMiQBvefM2dOzJkzJ///6dOnN2l9AABA5ZAvAACAYlnafBEhYwAAwNKoqKFac+fOjRtuuCEOPvjgyGQyDe4zatSo6NChQ/7Wp0+fb7lKAACaRDZX+hvNinwBALAcK3W2kDGancbkiwgZAwCgWSp1rmjG+aKiBjXdeeed8eWXX8ZBBx20yH1GjhwZ06ZNy98mTpz47RUIAABUDPkCAAAolsbkiwgZAwAAlkbZLz+3oGuuuSaGDRsWvXr1WuQ+VVVVUVVV9S1WBQAAVCL5AgAAKJbG5IsIGQMAAJZGxQxqmjBhQjz66KPx17/+tdSlAABQCtlsaadPzVbUJKcsgXwBALCcK3W+qKuBZkG+AABYzskXTaZiHtWYMWOiW7dusdNOO5W6FAAAoMLJFwAAQLHIFwAA0DQqYlBTbW1tjBkzJoYPHx4tWlTM5FIAAEAZki8AAIBikS8AAKDpVMQV9qOPPhoffPBBHHzwwaUuBQCAEsnkcpHJlW761lIem+KSLwAAKHW+qKuByidfAAAgXzSdihjUtMMOO0SSJKUuAwAAaAbkCwAAoFjkCwAAaDoVMagJAAAim/3mVsrjAwAAzUOp80VdDQAAQOWTL5pM83xUAAAAAAAAAABAxTKoCQAAAAAAAAAAKCuWnwMAoDJkc9/cSnl8AACgeSh1vqirAQAAqHzyRZMxUxMAAAAAAAAAAFBWDGoCAAAAAAAAAADKiuXnAACoCJlsLjIlnD61lMcGAACKq9T5oq4GAACg8skXTcdMTQAAAAAAAAAAQFkxqAkAAAAAAAAAACgrlp8DAKAyZLIR2RKOyc/4PgAAADQbpc4XdTUAAACVT75oMs3zUQEAAAAAAAAAABXLTE0AAFSETDYXmWyupMcHAACah1Lni7oaAACAyidfNB0zNQEAAAAAAAAAAGXFoCYAAAAAAAAAAKCsLDfLz7VtmY12LZdxDNfc2vQFpJzpK2nVrgg1tErVPFNbk6p9bau2qdpHRESS8neRK/1TviZJUt9HkmtZhErSFJD+NdEym3JMZRFqiNp099Eim0l3+HYrpmpfDEV5XaaUS3cav5FpBmN00z6GlM/niIhI+7rMpnuPTYrwe6ypTfce2yLtOYhIfR6K8f6W5u9EUs7Tk2azEaWsrxjPD5qN/8fevUfJVdX5Av9Vdac7LxIIhHSiCS/RKELgooN6uRIWuUDk8lAuirIUkJGRkVEmDEpmBHnIysBVZHByzfgEZ8TXFTOId+EooujAgEEjeEUkTJQIJLzTdCCd7qpz/wjVEklCp/epPqeqP5+1zlqpx679O9X1ON/sXftM6qjH5I6Rvl+Lfy3VJ+6S/iCJn3ep+aI2cVpS+1x0jk9+iMrAs0ntN9XS88X47p2S2meJOatSH0xqHxHRkfq2yuH7t5L4GF2JB8b1ydOT2uehlsNnS2o8yOP1lCX+/0nUNiXXkCr12Lpagn1Izkg5HLsNJn7E5vG/UNm4iUntU79vIxL/H6rMeb3ofNGoAZ5nDCOMYUQYw8iLMYyIMIaRF2MYzzOGYQyjocAxDOMXw6ihDbXnXgEAAAAAAAAAAC3LpCYAAAAAAAAAAKBUil/HEgAAhqNaLXb51DZduhUAAMakovNFowYAAKD1yRdN0557BQAAAAAAAAAAtCwrNQEA0BIqHR1R6egotH8AAKA9FJ0vGjUAAACtT75oHis1AQAAAAAAAAAApWJSEwAAAAAAAAAAUCpOPwcAQGuodmzeiuwfAABoD0Xni0YNAABA65MvmsZKTQAAAAAAAAAAQKmY1AQAAAAAAAAAAJSK088BANAail6+tU2XbgUAgDGp6HzRqAEAAGh98kXTWKkJAAAAAAAAAAAoFZOaAAAAAAAAAACAUnH6OQAAWkKlWo1Ktbg5+UX2DQAA5KvofNGoAQAAaH3yRfO0514BAAAAAAAAAAAty0pNAAC0hkpHRLWj2P4BAID2UHS+aNQAAAC0PvmiaazUBAAAAAAAAAAAlEqpJzXVarW44IILYq+99ooJEybEPvvsE5deemlkWVZ0aQAAQAuSMQAAgLzIFwAA0FylPv3c5ZdfHp/5zGfi2muvjf322y9WrFgRp59+ekydOjU++MEPFl0eAACjqVKJqBQ4J79SKa5vciNjAAAQEcXni0YNtDT5AgCAiJAvmqjUk5puu+22OP744+OYY46JiIg999wzvvrVr8add95ZcGUAAEArkjEAAIC8yBcAANBcpT793Jve9Ka4+eab47e//W1ERPzyl7+Mn/70p7Fw4cJttunv74/e3t4tNgAAgIgdzxjyBQAAsC3GMAAAoLlKvVLT+eefH729vTF37tzo6OiIWq0Wl112WZxyyinbbLNkyZK4+OKLR7FKAABGRaVa8OnnSv17AIZpRzOGfAEA0KaKzheNGmhpxjAAAIgI+aKJSr1X3/jGN+IrX/lKXHfddfHzn/88rr322vjEJz4R11577TbbLF68ONavXz+0rVmzZhQrBgAAymxHM4Z8AQAAbIsxDAAAaK5Sr9R03nnnxfnnnx8nn3xyRETsv//+8fvf/z6WLFkSp5566lbbdHd3R3d392iWCQDAKMgq1cgK/KVBkX2Tnx3NGPIFAEB7KjpfNGqgtRnDAAAgQr5oplLv1bPPPhvV6pYldnR0RL1eL6giAACglckYAABAXuQLAABorlKv1HTsscfGZZddFnPmzIn99tsvfvGLX8SVV14Z733ve4suDQAAaEEyBgAAkBf5AgAAmqvUk5o+/elPxwUXXBB/+Zd/GY8++mjMmjUr/uIv/iIuvPDCoksDAGC0VaqbtyL7p+XJGAAARETx+aJRAy1NvgAAICLkiyYq9aSmnXbaKa666qq46qqrii4FAABoAzIGAACQF/kCAACaqz2nagEAAAAAAAAAAC2r1Cs1AQDAkEpl81Zk/wAAQHsoOl80agAAAFqffNE0VmoCAAAAAAAAAABKxUpNAAC0hmp181Zk/wAAQHsoOl80agAAAFqffNE07blXAAAAAAAAAABAyzKpCQAAAAAAAAAAKBWnnwMAoCVklWpkleLm5BfZNwAAkK+i80WjBgAAoPXJF83TnnsFAAAAAAAAAAC0LJOaAAAAAAAAAACAUnH6OQAAWkOlunkrsn8AAKA9FJ0vGjUAAACtT75omvbcKwAAAAAAAAAAoGWZ1AQAAAAAAAAAAJSK088BANAail6+tU2XbgUAgDGp6HzRqAEAAGh98kXTtOdeAQAAAAAAAAAALWvMrNT0XC2LcbVsRG0n5tB/tZLWvjLwbHoR2dT0x0hQ3bQh+THqE3dJal8Z6E+vYUJaDeNSXwwRUUl8LrPunZLa13KYD1mrj+z9mKdKbSCpfa3Sndb/YPrrsVJJez1V+59JriH1JT3Cj+YtdA5sTGqfdYxLLyJVbVNS86wj/Su9kvg8Jqum70NHpH7hpn9Gp/4t83geKvVaIW2bruhfOrTprxwYmf6sI/qzjhG17c7heDD11Vh99qnkGmqTpye1r2zqS2pfXb82qX1ERDZ+SlL71H2ISM8X3dX0g6nq+seS2temzkxqn3WOT2ofERH1waTmlSz9ecyyelL7wXraO7uyMf3YvpL4vu7I4bOlvtOMtPY5vJ6q/Wnv7Xr35KT2HTlkpEpyvuhKrqG6aX3aAyQee+XxWuhMfF+P9FjhhcYl/p9gNq4nuYYYTHg9JX4+N1XR+aJRAzzPGEYYwwhjGA3GMDYzhmEMo8EYxmbGMGLMj2EYvxhGDW2oPfcKAAAAAAAAAABoWSY1AQAAAAAAAAAApTJmTj8HAEBryyqVyApcPjXLY2lfAACgFIrOF40aAACA1idfNI+VmgAAAAAAAAAAgFIxqQkAAAAAAAAAACgVp58DAKA1VKqbtyL7BwAA2kPR+aJRAwAA0Prki6Zpz70CAAAAAAAAAABalpWaAABoDZXK5q3I/gEAgPZQdL5o1AAAALQ++aJprNQEAAAAAAAAAACUiklNAAAAAAAAAABAqTj9HAAAraFS3bwV2T8AANAeis4XjRoAAIDWJ180TXvuFQAAAAAAAAAA0LJGPKlpcHAwfvCDH8Q//dM/xTPPPBMREQ8//HD09fXlVhwAADA2yBcAAECeZAwAAGh9Izr93O9///s4+uij48EHH4z+/v747//9v8dOO+0Ul19+efT398eyZcvyrhMAgDEuq1QjK3D51CL7bnfyBQAAo63ofNGogeaQMQAAGE3yRfOMaK8+9KEPxete97p46qmnYsKECUPXv/Wtb42bb745t+IAAID2J18AAAB5kjEAAKA9jGilpp/85Cdx2223RVdX1xbX77nnnvHQQw/lUhgAADA2yBcAAECeZAwAAGgPI5rUVK/Xo1arvej6P/zhD7HTTjslFwUAAC9SqUZUC1w+tU2Xbi0D+QIAgFFXdL5o1EBTyBgAAIwq+aJpRrRXRx55ZFx11VVDlyuVSvT19cXHPvaxeMtb3pJXbRER8cwzz8Q555wTe+yxR0yYMCHe9KY3xc9+9rNc+wAAAIozmvkiQsYAAIB2ZwwDAADaw4hWavrEJz4RRx99dLzmNa+JjRs3xrve9a64//77Y7fddouvfvWruRb453/+5/GrX/0q/vmf/zlmzZoV//Iv/xILFiyIX//61/Gyl70s174AACixSrXYXxq06a8cymA080WEjAEAQBSfLxo10BTGMAAAGFXyRdOMaFLT7Nmz45e//GV8/etfj1/+8pfR19cXZ5xxRpxyyikxYcKE3Ip77rnn4lvf+lb867/+a7z5zW+OiIiLLroovvOd78RnPvOZ+PjHP55bXwAAQDFGK19EyBgAADAWGMMAAID2sMOTmgYGBmLu3Llx4403ximnnBKnnHJKM+qKiIjBwcGo1Woxfvz4La6fMGFC/PSnP91qm/7+/ujv7x+63Nvb27T6AACANKOZLyJ2PGPIFwAA0FqMYQAAQPvY4fWnxo0bFxs3bmxGLS+y0047xRvf+Ma49NJL4+GHH45arRb/8i//Erfffns88sgjW22zZMmSmDp16tA2e/bsUakVAIAmayzfWuRG7kYzX0TseMaQLwAA2lTR2ULGaBpjGAAAjLqic0Ub54sR7dUHPvCBuPzyy2NwcDDvel7kn//5nyPLsnjZy14W3d3dcfXVV8c73/nOqFa3XvrixYtj/fr1Q9uaNWuaXiMAADByo5kvInYsY8gXAADQeoxhAABAe9jh089FRPzsZz+Lm2++Of7t3/4t9t9//5g0adIWt19//fW5FBcRsc8++8SPf/zj2LBhQ/T29sbMmTPjHe94R+y9995bvX93d3d0d3fn1j8AANBco5kvInYsY8gXAADQeoxhAABAexjRpKadd945TjzxxLxr2a5JkybFpEmT4qmnnorvfe97ccUVV4xq/wAAFKzo5VPbdOnWMigiX0TIGAAAY1rR+aJRA01hDAMAgFElXzTNiCY1felLX8q7jm363ve+F1mWxate9apYtWpVnHfeeTF37tw4/fTTR60GAACgeUYzX0TIGAAA0O6MYQAAQHsY0aSm0bR+/fpYvHhx/OEPf4hp06bFiSeeGJdddlmMGzeu6NIAABhFWaUSWYG/NMgqlcL6Jl8yBgAAReeLRg20PvkCAAD5onlGNKlpr732isp2npD//M//HHFBf+rtb397vP3tb8/t8QAAgHIZzXwRIWMAAEC7M4YBAADtYUSTms4555wtLg8MDMQvfvGLuOmmm+K8887Loy4AAGCMkC8AAIA8yRgAANAeRjSp6UMf+tBWr1+6dGmsWLEiqSAAANiqSnXzVmT/NIV8AQDAqCs6XzRqoClkDAAARpV80TS57tXChQvjW9/6Vp4PCQAAjFHyBQAAkCcZAwAAWkuuk5r+z//5PzFt2rQ8HxIAABij5AsAACBPMgYAALSWEZ1+7qCDDopKpTJ0OcuyWLt2bTz22GPxv//3/86tOAAAGFKpbN6K7J+mkC8AABh1ReeLRg00hYwBAMCoki+aZkSTmo4//vgtAkG1Wo3p06fH/PnzY+7cubkVBwAAtD/5AgAAyJOMAQAA7WFEk5ouuuiinMsAAADGKvkCAADIk4wBAADtoTqSRh0dHfHoo4++6PonnngiOjo6kosCAIAXqVSL32gK+QIAgFFXdLaQMZpKxgAAYFQVnSvaOF+MaK+yLNvq9f39/dHV1ZVUEAAAMLbIFwAAQJ5kDAAAaA87dPq5q6++OiIiKpVKfP7zn4/JkycP3Var1eLWW291PmoAAJoiq1QjK/CXBkX23a7kCwAAilJ0vmjUQL5kDAAAiiBfNM8OTWr61Kc+FRGbf+WwbNmyLZZp7erqij333DOWLVuWb4UAAEBbki8AAIA8yRgAANBedmiq1urVq2P16tVx2GGHxS9/+cuhy6tXr4777rsvvve978UhhxzSrFoBAKDlLF26NPbcc88YP358HHLIIXHnnXdu9/7f/OY3Y+7cuTF+/PjYf//94//+3/87SpWOPvkCAAB2jHyxfTIGAADsmLJnjBGtP3XLLbfELrvsknctAACwbZVq8dsO+vrXvx6LFi2Kj33sY/Hzn/885s2bF0cddVQ8+uijW73/bbfdFu985zvjjDPOiF/84hdxwgknxAknnBC/+tWvUp+9UpMvAAAYdUVnixFkDPli+GQMAABGVdG5oo3HMHbo9HMv9Ic//CFuuOGGePDBB2PTpk1b3HbllVcmFwYAAK3uyiuvjPe9731x+umnR0TEsmXL4rvf/W588YtfjPPPP/9F9/+Hf/iHOProo+O8886LiIhLL700vv/978c//uM/tv0pEuQLAADYPvlix8gYAACwfa2QMUY0qenmm2+O4447Lvbee+/4zW9+E6997Wvjd7/7XWRZFv/lv/yXvGvMRZZt3kaiUhtI7r82wr6HVEc8/+yPsnpa887utPbjJia1j4iIzq60GjrGpddQHdECZ0Mq6RWMaJblFhJfC9UcdiKtgpykPg+JT0Q2bkJS+4iIcakvhY6091RERK2e9gHXkcMLKuuenNS+srE3uYZUnU8/nNS+NrUnvYjU75p6Lb2GRKmvx3FZf3oRqZ/RlF5v75afGd3d3dHd/eLjpE2bNsVdd90VixcvHrquWq3GggUL4vbbb9/qY99+++2xaNGiLa476qijYvny5emFl1gr5ovBehYDI/zMmbDxyeT+B8ZPS2o/Po98kfh5V5+Q9sv5ykD6Z3a9K+14rFofTK4hNV/koiPt9VBJzZpJrTfbNPLfbEVExPjEfYiIqAxueuk7bb+KpNZZ96TE/tP3IY98MZj4gujMIa8OdKXli87E11MtS/9cGL/ml0ntB2bPS64h9f+RUjN7JYfP6NTPlu5qDv/7kZov6jl8viVkvUpWfE5sBcPJGPLFjmnFjGEMI4xhhDGMIcYwNjOGYQzjecYwnmcMwxgGw9JuYxgjesUuXrw4/uZv/ibuueeeGD9+fHzrW9+KNWvWxGGHHRYnnXRS3jUCAEBklUrhW0TE7NmzY+rUqUPbkiVLtlrv448/HrVaLWbMmLHF9TNmzIi1a9dutc3atWt36P7tQr4AAGC0FZ0tdjRjyBc7RsYAAGA0FZ0r2nkMY0TTGe+999746le/uvkBOjvjueeei8mTJ8cll1wSxx9/fJx11lm5FgkAAGWxZs2amDJlytDlrf3CgR0jXwAAMJbJGPmTMQAAGKvaLV+MaFLTpEmThs5BPXPmzHjggQdiv/32i4jNs7kAACBvKUvx59V/RMSUKVO2CATbsttuu0VHR0esW7dui+vXrVsXPT1bX265p6dnh+7fLuQLAABGW9H5olFDxPAyhnyxY2QMAABGU6vli4jWyRgjOv3cG97whvjpT38aERFvectb4txzz43LLrss3vve98Yb3vCGXAsEAIBW1NXVFQcffHDcfPPNQ9fV6/W4+eab441vfONW27zxjW/c4v4REd///ve3ef92IV8AAMD2yRc7RsYAAIDta5WMMaKVmq688sro6+uLiIiLL744+vr64utf/3rsu+++ceWVV+ZaIAAAtKpFixbFqaeeGq973eviz/7sz+Kqq66KDRs2xOmnnx4REe95z3viZS972dA5rT/0oQ/FYYcdFp/85CfjmGOOia997WuxYsWK+OxnP1vkbjSdfAEAAC9Nvhg+GQMAAF5aK2SMEU1q2nvvvYf+PWnSpFi2bFluBQEAwNbUsyzqBa7fOpK+3/GOd8Rjjz0WF154YaxduzYOPPDAuOmmm2LGjBkREfHggw9GtfrHxVPf9KY3xXXXXRcf/ehH42//9m9j3333jeXLl8drX/va3PajjOQLAABGW9H5olHDjpAvhk/GAABgNLVivohojYwxoklNDZs2bYpHH3006vX6FtfPmTMnqSgAAGgXZ599dpx99tlbve1HP/rRi6476aST4qSTTmpyVeUkXwAAwPbJFztGxgAAgO0re8YY0aSm3/72t3HGGWfEbbfdtsX1WZZFpVKJWq2WS3EAAED7ky8AAIA8yRgAANAeRjSp6fTTT4/Ozs648cYbY+bMmVGpVPKuCwAAtpA9vxXZP80hXwAAMNqKzheNGmgOGQMAgNEkXzTPiCY1rVy5Mu66666YO3du3vUAAABjjHwBAADkScYAAID2MKJJTa95zWvi8ccfz7sWAADYpnq2eSuyf5pDvgAAYLQVnS8aNdAcMgYAAKNJvmie6kgaXX755fHhD384fvSjH8UTTzwRvb29W2wAAADDJV8AAAB5kjEAAKA9jGilpgULFkRExBFHHLHF9VmWRaVSiVqtll4ZAAAwJsgXAABAnmQMAABoDyOa1HTLLbfkXQcAAGxXlmWRZcWtn1pk3+1OvgAAYLQVnS8aNdAcMgYAAKNJvmieEU1qOuyww/KuAwAAGKPkCwAAIE8yBgAAtIcRTWq6++67t3p9pVKJ8ePHx5w5c6K7uzupMAAAYGyQLwAAgDzJGAAA0B5GNKnpwAMPjEqlss3bx40bF+94xzvin/7pn2L8+PEjLg4AABrq2eatyP5pDvkCAIDRVnS+aNRAc8gYAACMJvmieaojafTtb3879t133/jsZz8bK1eujJUrV8ZnP/vZeNWrXhXXXXddfOELX4gf/vCH8dGPfjTvegEAgDYjXwAAAHmSMQAAoD2MaFLTZZddFv/wD/8QZ5xxRuy///6x//77xxlnnBGf+tSn4pOf/GSccsop8elPfzq+/e1vb/dxbr311jj22GNj1qxZUalUYvny5VvcnmVZXHjhhTFz5syYMGFCLFiwIO6///6RlAwAAJRUXvkiQsYAAACMYQAAQLsY0aSme+65J/bYY48XXb/HHnvEPffcExGbl3d95JFHtvs4GzZsiHnz5sXSpUu3evsVV1wRV199dSxbtizuuOOOmDRpUhx11FGxcePGkZQNAECLywrcaJ688kWEjAEAwPAVmS9kjOYyhgEAwGiTL5qjcySN5s6dG3//938fn/3sZ6OrqysiIgYGBuLv//7vY+7cuRER8dBDD8WMGTO2+zgLFy6MhQsXbvW2LMviqquuio9+9KNx/PHHR0TEl7/85ZgxY0YsX748Tj755K226+/vj/7+/qHLvb29O7x/AADA6MkrX0TknzHkCwAAaD3GMAAAoD2MaFLT0qVL47jjjouXv/zlccABB0TE5l8+1Gq1uPHGGyMi4j//8z/jL//yL0dc2OrVq2Pt2rWxYMGCoeumTp0ahxxySNx+++3bDARLliyJiy++eMT9AgBQTvVs81Zk/zTHaOSLiJFlDPkCAKA9FZ0vGjXQHMYwAAAYTfJF84xoUtOb3vSmWL16dXzlK1+J3/72txERcdJJJ8W73vWu2GmnnSIi4t3vfndSYWvXro2IeNEvJWbMmDF029YsXrw4Fi1aNHS5t7c3Zs+enVQLAADQPKORLyJGljHkCwAAaD3GMAAAoD2MaFJTRMROO+0U73//+/OsJRfd3d3R3d1ddBkAAMAOkC8AAIA8yRgAAND6hj2p6YYbboiFCxfGuHHj4oYbbtjufY877rjkwnp6eiIiYt26dTFz5syh69etWxcHHnhg8uMDANBasiyLLCtu/dQi+25Ho50vImQMAAD+qOh80aiB/BjDAACgKPJF8wx7UtMJJ5wQa9eujd133z1OOOGEbd6vUqlErVZLLmyvvfaKnp6euPnmm4cCQG9vb9xxxx1x1llnJT8+AABQnNHOFxEyBgAAtDNjGAAA0H6GPampXq9v9d8p+vr6YtWqVUOXV69eHStXroxp06bFnDlz4pxzzomPf/zjse+++8Zee+0VF1xwQcyaNWu7gQQAACi/ZuSLCBkDAADGKmMYAADQfqo7cufbb789brzxxi2u+/KXvxx77bVX7L777nHmmWdGf3//sB9vxYoVcdBBB8VBBx0UERGLFi2Kgw46KC688MKIiPjwhz8cf/VXfxVnnnlmvP71r4++vr646aabYvz48TtSNgAAbaBego185Z0vImQMAACGp+hsIWM0hzEMAACKUHSuaOd8sUOTmi655JL4f//v/w1dvueee+KMM86IBQsWxPnnnx/f+c53YsmSJcN+vPnz5w+dW/CF2zXXXBMRm5eBveSSS2Lt2rWxcePG+MEPfhCvfOUrd6RkAACgpPLOFxEyBgAAjGXGMAAAoL3s0KSmlStXxhFHHDF0+Wtf+1occsgh8bnPfS4WLVoUV199dXzjG9/IvUgAAMiy4jfyJV8AAFCUorOFjNEcMgYAAEUoOle0c77YoUlNTz31VMyYMWPo8o9//ONYuHDh0OXXv/71sWbNmvyqAwAA2pZ8AQAA5EnGAACA9rJDk5pmzJgRq1evjoiITZs2xc9//vN4wxveMHT7M888E+PGjcu3QgAAoC3JFwAAQJ5kDAAAaC+dO3Lnt7zlLXH++efH5ZdfHsuXL4+JEyfGf/tv/23o9rvvvjv22Wef3IsEAIB6tnkrsn/yJV8AAFCUovNFowbyJWMAAFAE+aJ5dmhS06WXXhpve9vb4rDDDovJkyfHtddeG11dXUO3f/GLX4wjjzwy9yIBAID2I18AAAB5kjEAAKC97NCkpt122y1uvfXWWL9+fUyePDk6Ojq2uP2b3/xmTJ48OdcCAQCA9iRfAAAAeZIxAACgvezQpKaGqVOnbvX6adOmJRUDAADbkmVZZFlx66cW2Xe7ky8AABhtReeLRg00h4wBAMBoki+ap1p0AQAAAAAAAAAAAC9kUhMAAAAAAAAAAFAqIzr9HAAAjLb681uR/QMAAO2h6HzRqAEAAGh98kXzWKkJAAAAAAAAAAAoFSs1AQDQErKIyLJi+wcAANpD0fmiUQMAAND65IvmsVITAAAAAAAAAABQKiY1AQAAAAAAAAAApTJmTj83KfpjUvSPqG3fuCnp/W/qS2o/uMuc5Bo61j+cVsOkXZPaPzJxdlL7iIip1Y6k9uN2Sa+ha+2v0x5gt72Ta6g+tz6p/eDEXZLaP9w3mNQ+IuJlk9M+fjqeWZdcw8Dur0xq31lP678yOLLPpBda88xAWg1XXJZcw3N/97mk9vvs3JVcw0OJr8k59Q1J7Wsdk5PaR0Q8NSXtc/63j29MruHgGeOT2g+Mm5jUfsLvf5bUPiJicI/XJ7Xv/P09yTX0zn5dUvvJfWnf1xERWdLfIvHDrYnqWRb1AtdvLbJvymdSdTAmV0f2/fPUuLRjsYiIqR2VpPaD01+RXEO177Gk9lln2jHAusl7JLWPiJiY+Dufwa70v+UuT/8uqX09MadFRFQG044pBzrSjiEefzY9X8yYmJYvKht7k2vYuHPaa7KzlvYdnFXT/4tn3WB3UvvK5z6VXMMzf/nJpPZ7TEnPF+v7a0ntd6umZb1ax4Sk9hERT77s4LT2G9Keg4iIPSalvSY3VdL+lpP+8POk9hER/S87KKn9uLW/Sq7h8d1em9R+l/607+uIiHrC/yPVE99PzVR0vmjUAA3GMIxhRBjDaDCGsZkxDGMYDcYwNjOGYQzD+MVL19COrNQEAAAAAAAAAACUiklNAAAAAAAAAABAqYyZ088BANDasue3IvsHAADaQ9H5olEDAADQ+uSL5rFSEwAAAAAAAAAAUCpWagIAoCXUs81bkf0DAADtoeh80agBAABoffJF81ipCQAAAAAAAAAAKBWTmgAAAAAAAAAAgFJx+jkAAFpDFpEVuXxqmy7dCgAAY1LR+eL5GgAAgDYgXzSNlZoAAAAAAAAAAIBSMakJAAAAAAAAAAAoFaefAwCgJdQji3qB66cW2TcAAJCvovNFowYAAKD1yRfNY6UmAAAAAAAAAACgVExqAgAAAAAAAAAASsXp5wAAaAlZtnkrsn8AAKA9FJ0vGjUAAACtT75oHis1AQAAAAAAAAAApWKlJgAAWkI927wV2T8AANAeis4XjRoAAIDWJ180j5WaAAAAAAAAAACAUil0UtOtt94axx57bMyaNSsqlUosX758i9uvv/76OPLII2PXXXeNSqUSK1euLKROAACg/OQLAAAgTzIGAAAUq9BJTRs2bIh58+bF0qVLt3n7oYceGpdffvkoVwYAQNlkWfEb5SZfAAAwXEVnCxmjNcgYAAAMR9G5op3zRWeRnS9cuDAWLly4zdvf/e53R0TE7373u1GqCAAAaFXyBQAAkCcZAwAAilXopKZm6O/vj/7+/qHLvb29BVYDAAC0MvkCAADIk4wBAADDV+jp55phyZIlMXXq1KFt9uzZRZcEAEAO6pEVvjH2yBcAAO2p6GwhY4xdMgYAQPspOle0c75ou0lNixcvjvXr1w9ta9asKbokAACgRckXAABAnmQMAAAYvrY7/Vx3d3d0d3cXXQYAADnLss1bkf0z9sgXAADtqeh80aiBsUfGAABoP/JF87TdSk0AAAAAAAAAAEBrK3Slpr6+vli1atXQ5dWrV8fKlStj2rRpMWfOnHjyySfjwQcfjIcffjgiIu67776IiOjp6Ymenp5CagYAAMpJvgAAAPIkYwAAQLEKXalpxYoVcdBBB8VBBx0UERGLFi2Kgw46KC688MKIiLjhhhvioIMOimOOOSYiIk4++eQ46KCDYtmyZYXVDABAMepZVvhGuckXAAAMV9HZQsZoDTIGAADDUXSuaOd8UehKTfPnz49sO0/saaedFqeddtroFQQAALQs+QIAAMiTjAEAAMUqdKUmAAAAAAAAAACAP1XoSk0AADBctfrmrcj+AQCA9lB0vmjUAAAAtD75onms1AQAAAAAAAAAAJSKlZoAAGgJ9SyLepYV2j8AANAeis4XjRoAAIDWJ180j5WaAAAAAAAAAACAUjGpCQAAAAAAAAAAKBWnnwMAoCXUsyxqTj8HAADkoOh80agBAABoffJF81ipCQAAAAAAAAAAKBWTmgAAAAAAAAAAgFJx+jkAAFpCPSt2+dR6e67cCgAAY1LR+aJRAwAA0Prki+axUhMAAAAAAAAAAFAqJjUBAAAAAAAAAACl4vRzAAC0hFp981Zk/wAAQHsoOl80agAAAFqffNE8VmoCAAAAAAAAAABKZcys1FTvHB/1zvEjartu/UBy/z2TJyW1n/Tso8k1PDxpr6T2MzY9m9Z+cENS+4iIvnG7J7Xvrvcn1zBw/y+S2j+y0yuTa1hXf1lS+/+y4Ymk9rNH+F56oY5H1iS1z3Ko4cmBjqT2u0ZfWgHr09/XGzvnpLX/yLLkGvaYlPZV0lFJLiFmx1NpNTyT9reY0pX2GR8RMdg9Jan9Tt05fKVnaVO464lzpTfu8fqk9hERjz07mNR+59mvS66hq5r2on528qzkGiakHDfUNiX33yz1LIt6lhXaPwzp6Nq8jcAzz6bni1o97fW4azX9uHhd525J7Xevpz0Pu29K+/6PiHiiMiOp/dTu9N8J1R/6bVL7NfssSK7h4U1pxxGHPJf2t5jZ2Z3UPiKic92qpPa1ibsk17C+v5bUfvdKWmbu6HssqX1ERGXntPf1I39+RXINr5kyss/Who5I/1ni9MEnk9pXEv//ZOKkXZPaR0QMdE1Oat9ZTX8eK7W0z/nB6rik9n0vOyipfURE30BiRpqxf3INUxJD84aOtP9Li4iYtKl3xG2rmzYm998sReeLRg3QYAzDGEaEMYwGYxibGcMwhjFUgzGMzYxhGMMwfvGSNbQjKzUBAAAAAAAAAAClYlITAAAAAAAAAABQKmPm9HMAALS2WpZFrcDlU4vsGwAAyFfR+aJRAwAA0Prki+axUhMAAAAAAAAAAFAqJjUBAAAAAAAAAACl4vRzAAC0hHpE1AtcPbVeXNcAAEDOis4XjRoAAIDWJ180j5WaAAAAAAAAAACAUrFSEwAALaFWz6JW4E8diuwbAADIV9H5olEDAADQ+uSL5rFSEwAAAAAAAAAAUComNQEAAAAAAAAAAKXi9HMAALSELMuinhW3fGpWYN8AAEC+is4XjRoAAIDWJ180j5WaAAAAAAAAAACAUjGpCQAAAAAAAAAAKBWnnwMAoCXUss1bkf0DAADtoeh80agBAABoffJF81ipCQAAAAAAAAAAKBWTmgAAAAAAAAAAgFJx+jkAAFpCPcuinhW3fmqRfQMAAPkqOl80agAAAFqffNE8ha7UdOutt8axxx4bs2bNikqlEsuXLx+6bWBgID7ykY/E/vvvH5MmTYpZs2bFe97znnj44YeLKxgAACg1GQMAAMiLfAEAAMUqdFLThg0bYt68ebF06dIX3fbss8/Gz3/+87jgggvi5z//eVx//fVx3333xXHHHVdApQAAFK1WzwrfKD8ZAwCA4Sg6W8gYrUG+AABgOIrOFe2cLwo9/dzChQtj4cKFW71t6tSp8f3vf3+L6/7xH/8x/uzP/iwefPDBmDNnzmiUCAAAtBAZAwAAyIt8AQAAxSp0UtOOWr9+fVQqldh55523eZ/+/v7o7+8futzb2zsKlQEAAK3opTKGfAEAAAyXMQwAAMhXoaef2xEbN26Mj3zkI/HOd74zpkyZss37LVmyJKZOnTq0zZ49exSrBACgWepZVvhGexlOxpAvAADaU9HZQsZoP8YwAADGrqJzRTvni5aY1DQwMBBvf/vbI8uy+MxnPrPd+y5evDjWr18/tK1Zs2aUqgQAAFrFcDOGfAEAALwUYxgAANAcpT/9XCMM/P73v48f/vCH2/2FQ0REd3d3dHd3j1J1AABAq9mRjCFfAAAA22MMAwAAmqfUk5oaYeD++++PW265JXbdddeiSwIAoCC1bPNWZP+0PhkDAICI4vNFowZam3wBAECEfNFMhU5q6uvri1WrVg1dXr16daxcuTKmTZsWM2fOjP/5P/9n/PznP48bb7wxarVarF27NiIipk2bFl1dXUWVDQAAlJSMAQAA5EW+AACAYhU6qWnFihVx+OGHD11etGhRRESceuqpcdFFF8UNN9wQEREHHnjgFu1uueWWmD9//miVCQBACdSzLOpZcT81KLJvhk/GAABgOIrOF40aKDf5AgCA4ZAvmqfQSU3z58+PbDtP7PZuAwAA+FMyBgAAkBf5AgAAilUtugAAAAAAAAAAAIAXKnSlJgAAGK56PYt6vcDTzxXYNwAAkK+i80WjBgAAoPXJF81jpSYAAAAAAAAAAKBUTGoCAAAAAAAAAABKxennAABoCfUsolbg6qltunIrAACMSUXni0YNAABA65MvmsdKTQAAAAAAAAAAQKmY1AQAAAAAAAAAAJSK088BANAS6lkW9ay49VOL7BsAAMhX0fmiUQMAAND65IvmsVITAAAAAAAAAABQKlZqAgCgJdSyLGoF/tKgyL4BAIB8FZ0vGjUAAACtT75oHis1AQAAAAAAAAAApWJSEwAAAAAAAAAAUCpOPwcAQEuo17Oo14tbPrXIvgEAgHwVnS8aNQAAAK1PvmgeKzUBAAAAAAAAAAClMmZWanpuMItxgyObmbb3pFpy/4PVcUntq8+tT66hZ3JX2gPU0+bAVTc+k9Z/REzqmpTUvuOZR5NrqP3Z8Unte7rT33Yvi7TXQ9YxIal9f9eUpPYREZt22ymp/U61vuQado0NSe2fiLTX4+67zEpqHxGx59S09/Wkx36TXMOGzrlpD1AfTK4hG5/2ehrs2DOp/TMdk5PaR0RMrqS1f83A75JrqPfPSGo/PvFvWZ+4S1L7iIidx3cktZ9QTZ/FPu6Re5LaD07bM7mGbNzIP+ezzvT3JIwFz9WyGFcb2WfGy3dKywYREc+OMNs0dKxPPy6ekfi5nQ2mfflVBvqT2kdE7NL9bFL76lNPJddQf/Wbk9q/rCs9X7y8M+15yCppr+l618Sk9hERz+2edkzamaV//02vph2HPL0p7Zhy2vipSe0jInabkLYPPRsfT65hU8xOe4AS5Iss8f8uNiZm9oiIrsR8scfDtyfXUJ99QFL7ybWBpPZZR/r3bSXx86mrUk+uofOJ3ye1r+yc/n8P2bjuhLbp39cwVhjDMIYRYQyjwRjGZsYwjGE0GMPYzBiGMQzjF2PTmJnUBABAa6tFxAjnkOTWPwAA0B6KzheNGgAAgNYnXzSP088BAAAAAAAAAAClYqUmAABaQj3Lop4V91OHIvsGAADyVXS+aNQAAAC0PvmieazUBAAAAAAAAAAAlIpJTQAAAAAAAAAAQKk4/RwAAC2hlmVRK3D51CL7BgAA8lV0vmjUAAAAtD75onms1AQAAAAAAAAAAJSKSU0AAAAAAAAAAECpmNQEAEBLqNezqBW41evNW7r1ySefjFNOOSWmTJkSO++8c5xxxhnR19e33Tbz58+PSqWyxfb+97+/aTUCAEA7KTpfNDtjAAAAo6fd80WRYxidIy0aAADIxymnnBKPPPJIfP/734+BgYE4/fTT48wzz4zrrrtuu+3e9773xSWXXDJ0eeLEic0uFQAAAAAAGEOKHMMwqQkAgJbQ+LVBkf03w7333hs33XRT/OxnP4vXve51ERHx6U9/Ot7ylrfEJz7xiZg1a9Y2206cODF6enqaUhcAALSzovNFowYAAKD1tXO+KHoMw+nnAABgB/T29m6x9ff3Jz3e7bffHjvvvPNQGIiIWLBgQVSr1bjjjju22/YrX/lK7LbbbvHa1742Fi9eHM8++2xSLQAAAAAAQOtqtzEMKzUBAMAOmD179haXP/axj8VFF1004sdbu3Zt7L777ltc19nZGdOmTYu1a9dus9273vWu2GOPPWLWrFlx9913x0c+8pG477774vrrrx9xLQAAAAAAQOtqtzEMk5oAAGgJRS/f2uh7zZo1MWXKlKHru7u7t3r/888/Py6//PLtPua999474nrOPPPMoX/vv//+MXPmzDjiiCPigQceiH322WfEjwsAAGNB0fmiUQMAAND6ypQv2m0Mw6QmAADYAVOmTNkiEGzLueeeG6eddtp277P33ntHT09PPProo1tcPzg4GE8++eQOnWv6kEMOiYiIVatWmdQEAAAAAABjULuNYZjUBAAATTB9+vSYPn36S97vjW98Yzz99NNx1113xcEHHxwRET/84Q+jXq8PHeQPx8qVKyMiYubMmSOqFwAAAAAAGBtaZQyjukP3BgCAgtTqf1zCtZitOfv16le/Oo4++uh43/veF3feeWf8+7//e5x99tlx8sknx6xZsyIi4qGHHoq5c+fGnXfeGRERDzzwQFx66aVx1113xe9+97u44YYb4j3veU+8+c1vjgMOOKA5hQIAQBspPl80L2NERDz55JNxyimnxJQpU2LnnXeOM844I/r6+rbbZv78+VGpVLbY3v/+9zevSAAAaBPtnC+KHsOwUhMAABTsK1/5Spx99tlxxBFHRLVajRNPPDGuvvrqodsHBgbivvvui2effTYiIrq6uuIHP/hBXHXVVbFhw4aYPXt2nHjiifHRj360qF0AAABK5JRTTolHHnkkvv/978fAwECcfvrpceaZZ8Z111233Xbve9/74pJLLhm6PHHixGaXCgAAlFyRYxiFrtR06623xrHHHhuzZs2KSqUSy5cv3+L2iy66KObOnRuTJk2KXXbZJRYsWBB33HFHMcUCAECTTJs2La677rp45plnYv369fHFL34xJk+ePHT7nnvuGVmWxfz58yMiYvbs2fHjH/84nnjiidi4cWPcf//9ccUVVwzrPNntTsYAAKDV9Pb2brH19/cnPd69994bN910U3z+85+PQw45JA499ND49Kc/HV/72tfi4Ycf3m7biRMnRk9Pz9A21jOGfAEAAMWOYRQ6qWnDhg0xb968WLp06VZvf+UrXxn/+I//GPfcc0/89Kc/jT333DOOPPLIeOyxx0a5UgAAilb80q1Z0U8BwyBjAAAwHEVnixdmjNmzZ8fUqVOHtiVLliTt2+233x4777xzvO51rxu6bsGCBVGtVl9yws1XvvKV2G233eK1r31tLF68eOiX1mOVfAEAwHAUnSvaeQyj0NPPLVy4MBYuXLjN29/1rndtcfnKK6+ML3zhC3H33XfHEUccsdU2/f39W/ySpbe3N59iAQCA0ss7Y8gXAAA025o1a7b4xXJ3d3fS461duzZ23333La7r7OyMadOmxdq1a7fZ7l3velfsscceMWvWrLj77rvjIx/5SNx3331x/fXXJ9XTyoxhAABAsQqd1LQjNm3aFJ/97Gdj6tSpMW/evG3eb8mSJXHxxRePYmUAAIyGon9p0K6/chjLhpMx5AsAgPZUdL5o1BARMWXKlGGdhuH888+Pyy+/fLv3uffee0dcz5lnnjn07/333z9mzpwZRxxxRDzwwAOxzz77jPhxxwpjGAAAY1eZ8kW7KfT0c8Nx4403xuTJk2P8+PHxqU99Kr7//e/Hbrvtts37L168ONavXz+0rVmzZhSrBQAAym5HMoZ8AQBAWZx77rlx7733bnfbe++9o6enJx599NEt2g4ODsaTTz4ZPT09w+7vkEMOiYiIVatW5bof7cYYBgAANE/pV2o6/PDDY+XKlfH444/H5z73uXj7298ed9xxx4uWz23o7u5OXp4XAABoXzuSMeQLAADKYvr06TF9+vSXvN8b3/jGePrpp+Ouu+6Kgw8+OCIifvjDH0a9Xh+aqDQcK1eujIiImTNnjqjescIYBgAANE/pV2qaNGlSvOIVr4g3vOEN8YUvfCE6OzvjC1/4QtFlAQAwyurPL99a1FZv06VbxyIZAwCAovNFMzPGq1/96jj66KPjfe97X9x5553x7//+73H22WfHySefHLNmzYqIiIceeijmzp0bd955Z0REPPDAA3HppZfGXXfdFb/73e/ihhtuiPe85z3x5je/OQ444ICm1Nku5AsAANo5XxSt9JOa/lS9Xo/+/v6iywAAANqEjAEAQLv5yle+EnPnzo0jjjgi3vKWt8Shhx4an/3sZ4duHxgYiPvuuy+effbZiIjo6uqKH/zgB3HkkUfG3Llz49xzz40TTzwxvvOd7xS1Cy1LvgAAgPwUevq5vr6+Lc7HvXr16li5cmVMmzYtdt1117jsssviuOOOi5kzZ8bjjz8eS5cujYceeihOOumkAqsGAADKSsYAAICIadOmxXXXXbfN2/fcc8/Isj/+knv27Nnx4x//eDRKaynyBQAAFKvQSU0rVqyIww8/fOjyokWLIiLi1FNPjWXLlsVvfvObuPbaa+Pxxx+PXXfdNV7/+tfHT37yk9hvv/2KKhkAgILUss1LqBbZP+UnYwAAMBxF54tGDZSbfAEAwHDIF81T6KSm+fPnb/FrkD91/fXXj2I1AABAq5MxAACAvMgXAABQrEInNQEAwHDV6gWv1FTwrywAAID8FJ0vGjUAAACtT75onmrRBQAAAAAAAAAAALyQSU0AAAAAAAAAAECpOP0cAAAtoejlW9t16VYAABiLis4XjRoAAIDWJ180j5WaAAAAAAAAAACAUjGpCQAAAAAAAAAAKBWnnwMAoCUM1rPoKHD51ME2XboVAADGoqLzRaMGAACg9ckXzWOlJgAAAAAAAAAAoFRMagIAAAAAAAAAAErF6ecAAGgJtXoWtQKXTy2ybwAAIF9F54tGDQAAQOuTL5rHSk0AAAAAAAAAAECpWKkJAICWUC/4lw71Nv2VAwAAjEVF54tGDQAAQOuTL5rHSk0AAAAAAAAAAECpmNQEAAAAAAAAAACUypg5/Vw9y6KWjXC5raye3H/WkfgAfU8m1xATpiY1z7omJbWv1DYltd9cROLfopI+j69SryW1H0h/OUVHwc9DVw7TIbOsktS+0t+fXkRHV1r7tF3IRUdqDTm8L6uJNdRy+CrqrG1Me4D6YFLzMizmODj9FcmPUenvS2pfHUz7O1SfW5/UPiJi/MRd0h4g8TM+IpI/Y1O/Z1JVsmL7355ayvFcTv1DQ9JywtX011KlkvgF/NTD6TWM605qn3XvlNS+ujH9e6M2ebek9lln4vFkRFQG045r610Tk2vo2LQhrYbE799KDpk79TdblU3PJleQjRuf1L5WT/yPgxyex0ricXH1uaeSa6juMjvtAVJzXkRUEo9Ls45xSe3zeEekRsWN+/635Bq6El8PqfkkEt+TERFdOTxGqkpqztr0XHoRCZ8NeXy+NkvR+aJRAzQYwwhjGBHGMBqMYWxmDMMYRoMxjIgwhhERY34Mw/jFS9fQjqzUBAAAAAAAAAAAlIpJTQAAAAAAAAAAQKmMmdPPAQDQ2mopp/vKqX8AAKA9FJ0vGjUAAACtT75oHis1AQAAAAAAAAAApWKlJgAAWkLRv3Ro1185AADAWFR0vmjUAAAAtD75onms1AQAAAAAAAAAAJSKSU0AAAAAAAAAAECpOP0cAAAtoejlW9t16VYAABiLis4XjRoAAIDWJ180j5WaAAAAAAAAAACAUjGpCQAAAAAAAAAAKBWnnwMAoCXUsnrU6vVC+wcAANpD0fmiUQMAAND65IvmsVITAAAAAAAAAABQKiY1AQAAAAAAAAAApeL0cwAAtIR6PYtaPSu0fwAAoD0UnS8aNQAAAK1PvmgeKzUBAAAAAAAAAAClYqUmAABaQq2eRbXAXxoU/SsLAAAgP0Xni0YNAABA65MvmsdKTQAAAAAAAAAAQKkUOqnp1ltvjWOPPTZmzZoVlUolli9fvs37vv/9749KpRJXXXXVqNUHAAC0FhkDAADIi3wBAADFKnRS04YNG2LevHmxdOnS7d7v29/+dvzHf/xHzJo1a5QqAwCgbAbrEYP1rMCt6GeA4ZAxAAAYjuLzhYzRCuQLAACGQ75ons4iO1+4cGEsXLhwu/d56KGH4q/+6q/ie9/7XhxzzDGjVBkAANCKZAwAACAv8gUAABSr0ElNL6Ver8e73/3uOO+882K//fYbVpv+/v7o7+8futzb29us8gAAgBazoxlDvgAAALbFGAYAADRXqSc1XX755dHZ2Rkf/OAHh91myZIlcfHFFzexKgAAilCrZ1GtZ4X2T+vb0YwhXwAAtKei80WjBlqbMQwAACLki2aqFl3Attx1113xD//wD3HNNddEpVIZdrvFixfH+vXrh7Y1a9Y0sUoAAKBVjCRjyBcAAMDWGMMAAIDmK+1KTT/5yU/i0UcfjTlz5gxdV6vV4txzz42rrroqfve73221XXd3d3R3d49SlQAAjJaif+nQrr9yGEtGkjHkCwCA9lR0vmjUQOsyhgEAQIN80TylndT07ne/OxYsWLDFdUcddVS8+93vjtNPP72gqgAAgFYlYwAAAHmRLwAAoPkKndTU19cXq1atGrq8evXqWLlyZUybNi3mzJkTu+666xb3HzduXPT09MSrXvWq0S4VAABoATIGAACQF/kCAACKVeikphUrVsThhx8+dHnRokUREXHqqafGNddcU1BVAACUUdHLt7br0q3tRsYAAGA4is4XjRooN/kCAIDhkC+ap9BJTfPnz48sG/4Tu61zUAMAAETIGAAAQH7kCwAAKFa16AIAAAAAAAAAAABeqNCVmgAAYLjq9azQ5VPrbbp0KwAAjEVF54tGDQAAQOuTL5rHSk0AAAAAAAAAAECpWKkJAICWUKtnUSnwlwZF/8oCAADIT9H5olEDAADQ+uSL5rFSEwAAAAAAAAAAUComNQEAAAAAAAAAAKXi9HMAALSELMsiK3D51Cxrz6VbAQBgLCo6XzRqAAAAWp980TxWagIAAAAAAAAAAErFpCYAAAAAAAAAAKBUnH4OAICWUK9nUS9w+dYi+wYAAPJVdL5o1AAAALQ++aJ5rNQEAAAAAAAAAACUiklNAAAAAAAAAABAqTj9HAAALSHLssiy4pZPLbJvAAAgX0Xni0YNAABA65MvmsdKTQAAAAAAAAAAQKmMmZWaqpVKdFQqI2ucw4S2eupjTO1JrqGS1ZPaZx1pL5fs2d6k9hERMS2xhpG+Bl74GNWOpPa1HGZIVgY2JrXPxu+U1j6p9WZpr8aI6rNPJddQmzorqX3fprS9mJ7D67Ga+BD1px9PrqGe+PE0rgTTa+uJ74m+jamv6IjJiU9E6md8RERUEw8LKmn7MDBhl7T+IyL1I7Z7/SPJNXxgn5OS2n967Q+Ta6h3TRpx26yS9j3XTFk9iyz5oCqtf2ioVivRMdIv4qyW3H+tnvaZm03fI7mGotX7n0t/kMSMk/zdGRFZZ3dS+0219M+mcQP9Se2zxGOA1GOIiIjUb6+ODU8m1zC4655J7Z99diCtgM6utPYREan/b9C3Pr2GVPXB5IfIOsYltR8cNzGpfd/G9O+JCRPS3hXpaTWi3j3yY9KIiGri63Fg4q5J7fPQ9UwO+WKvtya1v/rx25JryMZNGHnbzvT3ZLMUnS8aNUCDMQxjGBHGMBqMYWxmDMMYRoMxjOcZwxjzYxjGL166hnZUgo9hAAAAAAAAAACAPzKpCQAAAAAAAAAAKJUxc/o5AABaW72eRb3A5VOL7BsAAMhX0fmiUQMAAND65IvmsVITAAAAAAAAAABQKiY1AQAAAAAAAAAApeL0cwAAtISsvnkrsn8AAKA9FJ0vGjUAAACtT75oHis1AQAAAAAAAAAApWKlJgAAWkKWZZFlWaH9AwAA7aHofNGoAQAAaH3yRfNYqQkAAAAAAAAAACgVk5oAAAAAAAAAAIBScfo5AABaQr2eRb1e3PKpRfYNAADkq+h80agBAABoffJF81ipCQAAAAAAAAAAKBWTmgAAAAAAAAAAgFJx+jkAAFpCVs8iK3D51CL7BgAA8lV0vmjUAAAAtD75onms1AQAAAAAAAAAAJSKSU0AAAAAAAAAAECpOP0cAACtoejlW9t06VYAABiTis4Xz9cAAAC0AfmiaQpdqenWW2+NY489NmbNmhWVSiWWL1++xe2nnXZaVCqVLbajjz66mGIBAIDSkzEAAIC8yBcAAFCsQldq2rBhQ8ybNy/e+973xtve9rat3ufoo4+OL33pS0OXu7u7R6s8AABKpJ5lUcmK+6VBvcC+GT4ZAwCA4Sg6XzRqoNzkCwAAhkO+aJ5CJzUtXLgwFi5cuN37dHd3R09PzyhVBAAAtDIZAwAAyIt8AQAAxSr09HPD8aMf/Sh23333eNWrXhVnnXVWPPHEE9u9f39/f/T29m6xAQAANOxIxpAvAACA7TGGAQAAzVPoSk0v5eijj463ve1tsddee8UDDzwQf/u3fxsLFy6M22+/PTo6OrbaZsmSJXHxxRePcqUAADRblmWR1YtbPjVr06Vbx5odzRjyBQBAeyo6XzRqoLUZwwAAIEK+aKZST2o6+eSTh/69//77xwEHHBD77LNP/OhHP4ojjjhiq20WL14cixYtGrrc29sbs2fPbnqtAABA+e1oxpAvAACAbTGGAQAAzVX608+90N577x277bZbrFq1apv36e7ujilTpmyxAQAAbM1LZQz5AgAAGC5jGAAAkK9Sr9T0p/7whz/EE088ETNnziy6FAAARllWL/j0cwUvHUtzyBgAAGNT0fmiUQPtRb4AABib5IvmKXRSU19f3xa/WFi9enWsXLkypk2bFtOmTYuLL744TjzxxOjp6YkHHnggPvzhD8crXvGKOOqoowqsGgAAKCsZAwAAyIt8AQAAxSp0UtOKFSvi8MMPH7rcOI/0qaeeGp/5zGfi7rvvjmuvvTaefvrpmDVrVhx55JFx6aWXRnd3d1ElAwBQkHo9olLgLw3q9cK6ZgfIGAAADEfR+aJRA+UmXwAAMBzyRfMUOqlp/vz5kWXb/sN+73vfG8VqAACAVidjAAAAeZEvAACgWNWiCwAAAAAAAAAAAHihQldqAgCA4cqybLu/kB2N/gEAgPZQdL5o1AAAALQ++aJ5rNQEAAAAAAAAAACUiklNAAAAAAAAAABAqTj9HAAALSGrb96K7B8AAGgPReeLRg0AAEDrky+ax0pNAAAAAAAAAABAqZjUBAAAAAAAAAAAlIrTzwEA0BLq9Swq9azQ/gEAgPZQdL5o1AAAALQ++aJ5rNQEAAAAAAAAAACUipWaAABoCVk9i6zAXxoU2TcAAJCvovNFowYAAKD1yRfNY6UmAAAAAAAAAACgVExqAgAAAAAAAAAASsXp5wAAaAlFL9/arku3AgDAWFR0vmjUAAAAtD75onms1AQAAAAAAAAAAJSKSU0AAAAAAAAAAECpOP3ccFTT5351VNLaVwaeTa6h3jUh7QFqg0nNK5N2Tus/IqKeWEO9ll5DonHVxBdDRGRdE5PaVwb60wroHJ/WPtJnVNYn7ZpcQ6U2kNR+0ri091SlP/31uKmWtoxg1y67J9eQw0u6cNX+DUntp3bvnFxDJauntU/8fIyIiMQaso6upPadtY1J7SMi+qtpn095fLYsXfX1pPa1HD5j21U9y6KSFbd8ar3Avimfej2L2kiX8+1MzxddHWmPUUn87ouIqE+YmvYAlcR9GJ92TBwREYOb0moYTP/uyjrGJbXv7sohX4zrTmpfSXwes2r6f03UExNGbfJuyTWkvh4mjkt7LcSzaX+HiPTjucpOuyTX0AbxIvm4dmp38ceDHVl6vkj9bEjVmcP/pQ2OS/uuqU9Mf08sfeCbSe0HE79n2lnR+aJRA+TCGMZmxjByYQxjM2MYxjDKxBjG84xhGMMoMfmieazUBAAAAAAAAAAAlIqVmgAAaAlZPYtspCvj5NQ/AADQHorOF40aAACA1idfNI+VmgAAAAAAAAAAgFIxqQkAAAAAAAAAACgVp58DAKAlZFnBp5/L2nPpVgAAGIuKzheNGgAAgNYnXzSPlZoAAAAAAAAAAIBSMakJAAAAAAAAAAAoFaefAwCgJWT1LOpFnn6u4KVjAQCA/BSdLxo1AAAArU++aB4rNQEAAAAAAAAAAKVipSYAAFpClmWRZQWu1FRg3wAAQL6KzheNGgAAgNYnXzSPlZoAAAAAAAAAAIBSMakJAAAAAAAAAAAoFaefAwCgJWT1LLJ6gaefK7BvAAAgX0Xni0YNAABA65MvmsdKTQAAAAAAAAAAQKmY1AQAAAAAAAAAAJSK088BANAS6vUsosDlU+ttunQrAACMRUXni6EaAACAlidfNI+VmgAAAAAAAAAAgFIpdFLTrbfeGscee2zMmjUrKpVKLF++/EX3uffee+O4446LqVOnxqRJk+L1r399PPjgg6NfLAAAUGryBQAAkCcZAwAAilXopKYNGzbEvHnzYunSpVu9/YEHHohDDz005s6dGz/60Y/i7rvvjgsuuCDGjx8/ypUCAFC0rF4rfKPc5AsAAIar6GwhY7QGGQMAgOEoOle0c77oLLLzhQsXxsKFC7d5+9/93d/FW97ylrjiiiuGrttnn322+5j9/f3R398/dLm3tze9UAAAaKLLLrssvvvd78bKlSujq6srnn766Zdsk2VZfOxjH4vPfe5z8fTTT8d//a//NT7zmc/Evvvu2/yCS0q+AAAA8iRjAABAsWMYha7UtD31ej2++93vxitf+co46qijYvfdd49DDjlkq8u7vtCSJUti6tSpQ9vs2bNHp2AAAJqq6F84NPNXDps2bYqTTjopzjrrrGG3ueKKK+Lqq6+OZcuWxR133BGTJk2Ko446KjZu3Ni0OluZfAEAwAsVnS3a+ZfUY4WMAQBAQ9G5op3HMEo7qenRRx+Nvr6++Pu///s4+uij49/+7d/irW99a7ztbW+LH//4x9tst3jx4li/fv3QtmbNmlGsGgAAdtzFF18cf/3Xfx3777//sO6fZVlcddVV8dGPfjSOP/74OOCAA+LLX/5yPPzwwy/5H+hjlXwBAADkScYAAGCsKHIMo9DTz21PvV6PiIjjjz8+/vqv/zoiIg488MC47bbbYtmyZXHYYYdttV13d3d0d3ePWp0AAIwtf3pqgCKOP1evXh1r166NBQsWDF03derUOOSQQ+L222+Pk08+eVTraQXyBQAAkCcZAwCAMmq3MYzSrtS02267RWdnZ7zmNa/Z4vpXv/rV8eCDDxZUFQAARcnq9YKXbt38H9azZ8/e4lQBS5YsGfXnYu3atRERMWPGjC2unzFjxtBtbEm+AADghYrPF3/MGLQmGQMAgIYy5Yt2G8Mo7aSmrq6ueP3rXx/33XffFtf/9re/jT322KOgqgAAGOvWrFmzxakCFi9evNX7nX/++VGpVLa7/eY3vxnl6scu+QIAAMiTjAEAQBm12xhGoaef6+vri1WrVg1dXr16daxcuTKmTZsWc+bMifPOOy/e8Y53xJvf/OY4/PDD46abborvfOc78aMf/ai4ogEAGNOmTJkSU6ZMecn7nXvuuXHaaadt9z577733iGro6emJiIh169bFzJkzh65ft25dHHjggSN6zHYgXwAAAHmSMQAAaDXtNoZR6KSmFStWxOGHHz50edGiRRERceqpp8Y111wTb33rW2PZsmWxZMmS+OAHPxivetWr4lvf+lYceuihRZUMAEBBslotslqt0P53xPTp02P69OlNqWWvvfaKnp6euPnmm4cCQG9vb9xxxx1x1llnNaXPViBfAAAwXEXni0YNlJuMAQDAcLRivmiVMYxCJzXNnz8/sizb7n3e+973xnvf+95RqggAAEbfgw8+GE8++WQ8+OCDUavVYuXKlRER8YpXvCImT54cERFz586NJUuWxFvf+taoVCpxzjnnxMc//vHYd999Y6+99ooLLrggZs2aFSeccEJxO1Iw+QIAAMiTjAEAAMWOYRQ6qQkAAIYry2qR1QtcqSlrXt8XXnhhXHvttUOXDzrooIiIuOWWW2L+/PkREXHffffF+vXrh+7z4Q9/ODZs2BBnnnlmPP3003HooYfGTTfdFOPHj29anQAA0C6KzheNGgAAgNbX7vmiyDEMk5oAAKBg11xzTVxzzTXbvc+f/jq4UqnEJZdcEpdcckkTKwMAAAAAAMayIscwqkmtAQAAAAAAAAAAcmalJgAAWkJWL/j0cwUvHQsAAOSn6HzRqAEAAGh98kXzWKkJAAAAAAAAAAAoFZOaAAAAAAAAAACAUjGpCQCAltBYvrXIDQAAaA9FZ4tmZ4zLLrss3vSmN8XEiRNj5513Ht5zkmVx4YUXxsyZM2PChAmxYMGCuP/++5tWIwAAtIuic0U7j2GY1AQAAAAAAG1k06ZNcdJJJ8VZZ5017DZXXHFFXH311bFs2bK44447YtKkSXHUUUfFxo0bm1gpAADAtnUWXQAAAAAAAIxVvb29W1zu7u6O7u7upMe8+OKLIyLimmuuGdb9syyLq666Kj760Y/G8ccfHxERX/7yl2PGjBmxfPnyOPnkk5PqAQAAGAmTmgAAaAlFL5/arku3AgDAWFR0vmjUEBExe/bsLa7/2Mc+FhdddNGo1rJ69epYu3ZtLFiwYOi6qVOnxiGHHBK33367SU0AALAdZcoX7cakJgAAAAAAKMiaNWtiypQpQ5dTV2kaibVr10ZExIwZM7a4fsaMGUO3AQAAjDaTmgAAaAlZvV7wSk31wvoGAADyVXS+aNQQETFlypQtJjVty/nnnx+XX375du9z7733xty5c3OpDwAAGJ4y5Yt2Y1ITAAAAAACU3LnnnhunnXbadu+z9957j+ixe3p6IiJi3bp1MXPmzKHr161bFwceeOCIHhMAACCVSU0AAAAAAFBy06dPj+nTpzflsffaa6/o6emJm2++eWgSU29vb9xxxx1x1llnNaVPAACAlzJmJjVVKpu3EclyLWVkKtX0x6gm/rmztOXKss7xaf1HRHXThrQaqh3JNaT+Leo5vJ6yjnFJ7SsFL32Xi8TXY0RE1tmd1L6S+rfM4X1dGfEH22Z5vC/TKsjnPVEZl7YfldpAehHtII/vmlZXTX8Okt9X9cHkGiLl8y31eKGJ6vVaRIHfYfV2+P4kN9VqJTqqxQWMLEt8jDw+81MfI/HzLhs3Ma3/iKg+tz6ths6u5BpS1XI4lqomPpep+aIUkTuHz/h69+S0Bxhs/e+ZrCvxOYhIz3o5fL5lifkil+O5ouWQuZP/FiXIJyP+qn9elsfrMTFf5JF3692TRtw268jh/+KapOh8MVRDkzz44IPx5JNPxoMPPhi1Wi1WrlwZERGveMUrYvLkzZ/Xc+fOjSVLlsRb3/rWqFQqcc4558THP/7x2HfffWOvvfaKCy64IGbNmhUnnHBC0+rkj4xhhDGMMIbRYAzj+YcwhmEMo9HeGMZmJcgIhRvrYxjGL166hjZU3r86AAAAAACwwy688MK49tprhy4fdNBBERFxyy23xPz58yMi4r777ov16/84yfvDH/5wbNiwIc4888x4+umn49BDD42bbropxo9PH1AGAAAYCZOaAAAAAACgjVxzzTVxzTXXbPc+f7r6Z6VSiUsuuSQuueSSJlYGAAAwfCY1AQDQErJ6LbICl08tsm8AACBfReeLRg0AAEDrky+ax4knAQAAAAAAAACAUrFSEwAALaHoXzq0668cAABgLCo6XzRqAAAAWp980TxWagIAAAAAAAAAAErFpCYAAAAAAAAAAKBUnH4OAIDWUKtFVi1w+dRaey7dCgAAY1LR+eL5GgAAgDYgXzSNlZoAAAAAAAAAAIBSMakJAAAAAAAAAAAoFaefAwCgJWRZLaJe3PKpWdaeS7cCAMBYVHS+GKoBAABoefJF81ipCQAAAAAAAAAAKBWTmgAAAAAAAAAAgFJx+jkAAFpCVq8Xe/q5er2wvgEAgHwVnS+GagAAAFqefNE8VmoCAAAAAAAAAABKxUpNAAC0hKxeK3ilpmJ/ZQEAAOSn6HwxVAMAANDy5IvmsVITAAAAAAAAAABQKoVOarr11lvj2GOPjVmzZkWlUonly5dvcXulUtnq9r/+1/8qpmAAAKDUZAwAACAv8gUAABSr0ElNGzZsiHnz5sXSpUu3evsjjzyyxfbFL34xKpVKnHjiiaNcKQAARcvq9cI3yk/GAABgOIrOFjJGa5AvAAAYjqJzRTvni84iO1+4cGEsXLhwm7f39PRscflf//Vf4/DDD4+999672aUBAAAtSMYAAADyIl8AAECxCp3UtCPWrVsX3/3ud+Paa6/d7v36+/ujv79/6HJvb2+zSwMAAFrQcDKGfAEAAAyHMQwAAMhfy0xquvbaa2OnnXaKt73tbdu935IlS+Liiy8epaoAABgtWb0WUa8V2z9tZTgZQ74AAGhPReeLoRpoG8YwAADGLvmieapFFzBcX/ziF+OUU06J8ePHb/d+ixcvjvXr1w9ta9asGaUKAQCAVjKcjCFfAAAAw2EMAwAA8tcSKzX95Cc/ifvuuy++/vWvv+R9u7u7o7u7exSqAgBgNBX9S4d2/ZXDWDXcjCFfAAC0p6LzxVANtAVjGAAAY5t80TwtsVLTF77whTj44INj3rx5RZcCAAC0ARkDAADIi3wBAADNUehKTX19fbFq1aqhy6tXr46VK1fGtGnTYs6cORER0dvbG9/85jfjk5/8ZFFlAgAALULGAAAA8iJfAABAsQqd1LRixYo4/PDDhy4vWrQoIiJOPfXUuOaaayIi4mtf+1pkWRbvfOc7iygRAICSqNdrUXH6OV6CjAEAwHAUnS8iZIxWIF8AADAc8kXzFDqpaf78+ZFl2Xbvc+aZZ8aZZ545ShUBAACtTMYAAADyIl8AAECxqkUXAAAAAAAAAAAA8EKFrtQEAADDldXqEZUCTz9XqxfWNwAAkK+i88VQDQAAQMuTL5rHSk0AAAAAAAAAAECpWKkJAICWkGW1iHqBKzVlxf7KAgAAyE/R+WKoBgAAoOXJF81jpSYAAAAAAAAAAKBUTGoCAAAAAAAAAABKxennAABoCVm9FlEp8PRzBS8dCwAA5KfofDFUAwAA0PLki+axUhMAAAAAAAAAAFAqJjUBAAAAAAAAAACl4vRzAAC0hKKXb23XpVsBAGAsKjpfDNUAAAC0PPmieazUBAAAAAAAAAAAlIpJTQAAAAAAAAAAQKk4/RwAAC2h6OVb23XpVgAAGIuKzhdDNQAAAC1Pvmgek5oAAGgNtYHICu4fAABoE0Xni+drAAAA2oB80TRjZlJTvZ5FrT6yl1FlsD+5/8FKd1L7rKMruYaoJv65K8WfrbA+fmpS+0r/M8k1VDZtSGpf65iQXEN0Jr4eBtJf06lqhX+qR2SJz2N1sJLWf7UjqX0ucnhfp/4pR/rZ/EIdUU9qn/q3qGU5vKCzxH3I4zO6M+17ojLwXFL7rHN8UvuIiCzxwyWX79tUedRQHyymbZN0dXVFT09PrP31N4ouJXp6eqKrqwSvEwo3UMti0wg/cyb3PZLe/8SZSe3rE9KOqyMisq5Jae0Tj8UqgxuT2kdEDE6bk/YAOXz/dj75YFL7ge4pyTUMJOascc8+kdS+FunP4zOb0o6ldsnh2PzJjWm/huvqSMwXE3ZOah8RsTHxWKpzXNr/fUSkH9f2DaS9FiIidhqXVsOmStrn26Za+j50ZYnHdKn/hxQRg9W056Ez8bi0v3NiUvuIiFrie2JCDs9jNfX/oab05FDDyLNedVP693XeypQvImQM/sgYRhjDCGMYQ4xhRIQxjIgwhvE8YxjPM4ZhDMP4xUtqx3wxZiY1AQDQmsaPHx+rV6+OTZs2FV1KdHV1xfjx6eEVAAAoRpnyRYSMAQAArUy+aD6TmgAAKL3x48e33YE4AABQDPkCAADIi3zRXMWvxQkAAAAAAAAAAPACJjUBAAAAAAAAAAClYlITAAAAAAAAAABQKiY1AQAAAAAAAAAApWJSEwAAAAAAAAAAUComNQEAAAAAAAAAAKViUhMAAAAAAAAAAFAqJjUBAAAAAAAAAAClYlITAAAAAAAAAABQKiY1AQAAAAAAAAAApWJSEwAAAAAAAAAAUComNQEAAAAAAAAAAKViUhMAAAAAAAAAAFAqJjUBAAAAAAAAAAClYlITAAAAAAAAAABQKoVOarr11lvj2GOPjVmzZkWlUonly5dvcXtfX1+cffbZ8fKXvzwmTJgQr3nNa2LZsmXFFAsAAJSafAEAAORJxgAAgGIVOqlpw4YNMW/evFi6dOlWb1+0aFHcdNNN8S//8i9x7733xjnnnBNnn3123HDDDaNcKQAAUHbyBQAAkCcZAwAAitVZZOcLFy6MhQsXbvP22267LU499dSYP39+RESceeaZ8U//9E9x5513xnHHHTdKVQIAAK1AvgAAAPIkYwAAQLEKXanppbzpTW+KG264IR566KHIsixuueWW+O1vfxtHHnnkNtv09/dHb2/vFhsAAIB8AQAA5EnGAACA5ir1pKZPf/rT8ZrXvCZe/vKXR1dXVxx99NGxdOnSePOb37zNNkuWLImpU6cObbNnzx7FigEAgLKSLwAAgDzJGAAA0Fyln9T0H//xH3HDDTfEXXfdFZ/85CfjAx/4QPzgBz/YZpvFixfH+vXrh7Y1a9aMYsUAAEBZyRcAAECeZAwAAGiuzqIL2Jbnnnsu/vZv/za+/e1vxzHHHBMREQcccECsXLkyPvGJT8SCBQu22q67uzu6u7tHs1QAAKDk5AsAACBPMgYAADRfaVdqGhgYiIGBgahWtyyxo6Mj6vV6QVUBAACtSL4AAADyJGMAAEDzFbpSU19fX6xatWro8urVq2PlypUxbdq0mDNnThx22GFx3nnnxYQJE2KPPfaIH//4x/HlL385rrzyygKrBgAAyki+AAAA8iRjAABAsQqd1LRixYo4/PDDhy4vWrQoIiJOPfXUuOaaa+JrX/taLF68OE455ZR48sknY4899ojLLrss3v/+9xdVMgAAUFLyBQAAkCcZAwAAilXopKb58+dHlmXbvL2npye+9KUvjWJFAABAq5IvAACAPMkYAABQrOpL3wUAAAAAAAAAAGD0mNQEAAAAAAAAAACUiklNAAAAAAAAAABAqZjUBAAAAAAAAAAAlIpJTQAAAAAAAAAAQKmY1AQAAAAAAAAAAJSKSU0AAAAAAAAAAECpmNQEAAAAAAAAAACUiklNAAAAAAAAAABAqZjUBAAAAAAAAAAAlIpJTQAAAAAAAAAAQKmY1AQAAAAAAAAAAJSKSU0AAAAAAAAAAECpmNQEAAAAAAAAAACUiklNAAAAAAAAAABAqXQWXcBoqVQqUa1URtQ26xiX3H9HdWR9D6kPJtcQgxvT2ndNSmqeVTvS+o9Ifh46nngwuYTBma9Oaj8u9bUQEbEph9dDwUb4dsxVddNzSe1rlclJ7SuD/Unt85DL+zLRhGcfTX6M+uTpOVQycp15vK8rafOMK4ObkkvIOhIPCxL3IY/vuo5q4j5kteQaSiHlb5H6d4QxoqOyeRuJ2k4z0vvP0r57qv0bkmvIEj+36907Fdo+IqIykJaROh9dlVxDbfo+Se1H+jp8oerG3sQHSPv+zeNQaqeuxO+v/npyDdPGpR1HPDmQdmxe3fBEUvuIiAnj095XWQ7HEakvh2lP/Ca5hoGe1yS174rE/7vozOG/6ypdac1T/w8pIjoKPq7sqqS/r5NfkDk8B/XxUwuvIRs38tdkNq74//uAVmEMI4xhhDGMMjGGYQyjwRjG84xhGMPI00j/FsYvxiR/dQAAAAAAAAAAoFRMagIAAAAAAAAAAErFpCYAAAAAAAAAAKBUTGoCAAAAAAAAAABKxaQmAAAAAAAAAACgVExqAgAAAAAAAAAASsWkJgAAAAAAAAAAoFRMagIAAAAAAAAAAErFpCYAAAAAAAAAAKBUTGoCAAAAAAAAAABKxaQmAAAAAAAAAACgVExqAgAAAAAAAAAASsWkJgAAAAAAAAAAoFRMagIAAAAAAAAAAErFpCYAAAAAAAAAAKBUTGoCAAAAAAAAAABKxaQmAAAAAAAAAACgVAqd1HTrrbfGscceG7NmzYpKpRLLly/f4vZ169bFaaedFrNmzYqJEyfG0UcfHffff38xxQIAAKUmXwAAAHmSMQAAoFiFTmrasGFDzJs3L5YuXfqi27IsixNOOCH+8z//M/71X/81fvGLX8Qee+wRCxYsiA0bNhRQLQAAUGbyBQAAkCcZAwAAitVZZOcLFy6MhQsXbvW2+++/P/7jP/4jfvWrX8V+++0XERGf+cxnoqenJ7761a/Gn//5n2+1XX9/f/T39w9d7u3tzb9wAACgdOQLAAAgTzIGAAAUq9CVmrancVA/fvz4oeuq1Wp0d3fHT3/60222W7JkSUydOnVomz17dtNrBQAAyk2+AAAA8iRjAABA85V2UtPcuXNjzpw5sXjx4njqqadi06ZNcfnll8cf/vCHeOSRR7bZbvHixbF+/fqhbc2aNaNYNQAAUEbyBQAAkCcZAwAAmq+0k5rGjRsX119/ffz2t7+NadOmxcSJE+OWW26JhQsXRrW67bK7u7tjypQpW2wAAMDYJl8AAAB5kjEAAKD5OosuYHsOPvjgWLlyZaxfvz42bdoU06dPj0MOOSRe97rXFV0aAADQYuQLAAAgTzIGAAA0V2lXanqhqVOnxvTp0+P++++PFStWxPHHH190SQAAQIuSLwAAgDzJGAAA0ByFrtTU19cXq1atGrq8evXqWLlyZUybNi3mzJkT3/zmN2P69OkxZ86cuOeee+JDH/pQnHDCCXHkkUcWWDUAAFBG8gUAAJAnGQMAAIpV6KSmFStWxOGHHz50edGiRRERceqpp8Y111wTjzzySCxatCjWrVsXM2fOjPe85z1xwQUXFFUuAABQYvIFAACQJxkDAACKVeikpvnz50eWZdu8/YMf/GB88IMfHMWKAACAViVfAAAAeZIxAACgWNWiCwAAAAAAAAAAAHghk5oAAAAAAAAAAIBSMakJAAAAAAAAAAAoFZOaAAAAAAAAAACAUjGpCQAAAAAAAAAAKBWTmgAAAAAAAAAAgFIxqQkAAAAAAAAAACgVk5oAAAAAAAAAAIBSMakJAAAAAAAAAAAoFZOaAAAAAAAAAACAUjGpCQAAAAAAAAAAKBWTmgAAAAAAAAAAgFIxqQkAAAAAAAAAACiVzqILaLYsyyIi4plnnhnxY9TqG5PrGBg3mNR+0zN9yTXUB9PmsGXj6kntq8/lsA8DafvQ2bchuYbB3pG/liIiBrrSnseIiHGb0vajUq8lta8NVJLaR0RsrGVpNWxM+ztERES1K6n5M5W0v+WEvvT3xLPjepPaD+Tw2dLfkVZD14b0v2W93p3UvtKf9p56dlza6zkiYqCa9hiVgf7kGrKOjqT21U3PJrWvb0p/HgcraYc2nVna93VERGfi+6qeTUyuIauO/G/ZOGZqHEMBW8ojX9Q70o8Hn8vSPrOzHI4BsnGbktrXE7+6qs/mkZESvzdyyBe17rRjoTyOzauJx9aVxO+MPPahnvi11dmffkya+p54ZiDtfT1+Q/p7YjAxX1TzOLbPJiS1H5fD59vAxLTnIeppx5S1xGPaiIiOxLdVZTD9/8KyStr/4aRmnKw7/fs2WeJzEJGeL2qJ76mIiKiO/AUlX8BLM4bxR8YwjGE0GMN4njEMYxjPM4axmTEMYxjyxdjU9pOaGi/sA179yoIrAQBoHc8880xMnTq16DKgdBr5Yt5rXlVwJQAArUO+gG0zhgEAsGPki7GlkrX5NLZ6vR4PP/xw7LTTTlGpvHhmdm9vb8yePTvWrFkTU6ZMGVEfqY9RdHs15NNeDeWpoR32oQw1tMM+lKGGdtiHMtTQDvtQhhqG0z7LsnjmmWdi1qxZUa06UzH8qZfKFxGt8V5XQ/PbqyGf9mrIp70aylNDO+xDGWpoh30oQw2jsQ/yBby0Zo9htMPnVRlqaId9KEMN7bAPZaihHfahDDW0wz6UoYZ22Ac15NN+NGqQL8amtl+pqVqtxstf/vKXvN+UKVNG/ObM6zGKbq+GfNqroTw1tMM+lKGGdtiHMtTQDvtQhhraYR/KUMNLtfcLB9i24eaLiPK/19UwOu3VkE97NeTTXg3lqaEd9qEMNbTDPpShhmbvg3wB2zdaYxjt8HlVhhraYR/KUEM77EMZamiHfShDDe2wD2WooR32QQ35tG92DfLF2GP6GgAAAAAAAAAAUComNQEAAAAAAAAAAKUy5ic1dXd3x8c+9rHo7u4u7DGKbq+GfNqroTw1tMM+lKGGdtiHMtTQDvtQhhraYR/KUEMe+wC8tKLfq+3weVWGGtphH8pQQzvsQxlqaId9UEM+7dWQT3s15NM+r8cAtq8d3uvtUEM77EMZamiHfShDDe2wD2WooR32oQw1tMM+qCGf9mWpgfZTybIsK7oIAAAAAAAAAACAhjG/UhMAAAAAAAAAAFAuJjUBAAAAAAAAAAClYlITAAAAAAAAAABQKiY1AQAAAAAAAAAApWJSEwBAkz322GPx2GOPFV0GAADQBuQLAAAgL/IFZWdSU4Ki3uDnnHPOqPcJZbd69eqk9r/5zW9yquTFvv71rw/rfj/84Q9z6e/xxx/P5XHKJsuyEbd98skno16vD+u+jz32WKxYsSKefvrpEfdXtMceeyx+/etfv+j6X//61zv8vfXcc8/Fr371q/jVr34Vzz33XC71pfwtIyL6+/tf8j69vb3bvG24nxef//zn46CDDopJkybFpEmT4uCDD45rrrlmuGVGvV6Pv/u7v4tp06bF3Llz45WvfGXstttucdFFFyU/B3kYzvMIjC75AspDvvijds0XESM/Lt2RfBEhY7xQq+aLiOIzhnwB7Cj5AsqjzPkiYngZI698EdG+GUO+GL4y54uIsTGGIV/QSkxq2kF5vMEfe+yxuPrqq+MDH/hAfOADH4hPf/rTO/QFfuutt460/IiI+MhHPjL07xtvvHHEj/PrX/86Fi1aFMccc0wcc8wxce6558a99967Q+23t72UVatWxb//+7+/6PrbbrstHnjggZds/8lPfjK+9KUvvej6L33pS/GpT31qeDsREXfffXd885vfjG9+85txzz33DLtdww9+8IN461vfGvvtt1/st99+ceKJJ+7wwWFqDal/y7/5m7+Jz33ucy+6/vOf//wWr7dtOfTQQ3eo3q058cQTh/79P/7H/9jh9u9617uSa9iW8847b1j3+5u/+Zukfr7zne/E9OnTY//994+Xv/zlcdttt+1Q+9///vexfv36ocs333xzfPCDH4xPfOITwz54yOvzZWv22GOPYd3v4osvHgp5GzdujMMOOyxe8YpXRE9PT3zve9/bbtvPf/7zsd9++8Vf/dVfxdy5c+OGG24YUa2pk2FWrFgR3/jGN4Yu/8Vf/EW8/e1vj7e//e3/v707j4qqbvw4/hlEXMAFFDQVlMWNTUEwS3FHSlNRE9dc6ykVRXPPTNBfqZiZZi7lI7gmuGKlPR1xV8xd3DdIXFJRQMREUb6/PziMjMDMZe7IHYbP6xyPzHLvfGeAmfvmboiLi9M5fXBwMFJTU/Ndn5qaijFjxkgaQ1ZWFj7//HPY29tj8ODBGDRoEBwcHDB+/Hg8f/5c8nPJ6+DBgwgODoaDg4PO+7711ltYsWJFgbe98847Oqdv27at+us2bdpo3Jb3/aIwK1aswNKlS7FgwQL8888/uHPnDubPn48ff/yxwM+OgsybNw8nTpzAyZMn8fDhQ6SmpuL48eM4evQo5s+fL2kecj/r8r6/9uvXT+M2Ka8jEb157AtNcpZLle4LwDgawxB9IXcM7Av2RS5TaAw5fQEYR2PI7QtAfmOU9L4AlG8M9gURSWGoFZRyGkNuXwDGsQ6DffGK0uswlO4LQH5jGHNfANIaQ25fAFyHAbAvchljXwClax2GIfoCkPd5x74gyUQpolKpRPXq1YWtra2wtbUV1atXV/+ztbWVNI85c+aIgIAAkZiYqL4uMTFRvP/++2LevHk6p4+Pjxd2dnZiyJAhYuHCheL7778XQ4YMEW+99ZY4f/68pDE0atRIXLhwQZw/f77Af7p4eXkV+HVR7Nu3T9SoUUOEhoaKmJgYsW3bNhEaGipq1aolDh06JGkebdu2LfRfu3btdE7fuXPnAp/v+fPnRZcuXXRO36xZM5GVlZXv+qysLOHh4aFz+ocPH4qWLVsKZ2dn0aNHDxEYGCicnZ1F69atRWpqqs7phRBiy5YtwtHRUURERIgzZ86I06dPi4iICOHs7Cy2b99eLGMwxPfS29u7wOtfvnwp3NzcdE7ftGlTSY8jdR76zE/f3wUp6tSpUyxj8PDwEBcvXhRCCHHkyBHRunXrIk3v6+srbt++LYQQ4vjx48LGxkZ8++23YsiQIWLw4MGS5mGI95fCSH0dGzduLLKzs4UQQixZskS0b99evHjxQly6dEk0a9ZM67Surq7i/v37Qgghrl+/Llq0aFHkcf7888/C29tb7NmzRzx69EikpaWJPXv2CB8fH7Fy5UpJ8/D39xdnzpzRGNfevXvFjh07ROfOnXVO7+vrW+ht7u7uksYQHBwsPv30U/H48WP1denp6WLEiBFi5MiRkuYhRM7P4tixY0W9evWEpaWliIiIEA8ePNA5naOjo+jQoYPo2rWr+nuSS8rvuLb3BCnT+/j4iJs3b+a7PikpSfj4+OicXgghPD09RUpKSr7rHz58KDw9PSXNQ+5nndzXgYh0k9sY7ItX5C6XKt0XQijfGHL7whBjYF/kYF/kMIXGkNMXQhhHY8jtCyHkN0ZJ74vX76dEY7AviEoHpftCCPmNIbcvhDCOdRjsixxKr8Mwhr4QQv7nnDH3hRDSlosNMQauw2Bf5DKWvhCi9K7DMERfCCHv8459QVKZK71RVXH69NNPcezYMfj5+aFPnz5o0aJFkeexfv167N27F9bW1urr6tWrh7Vr16Jdu3Y6t1SePn06li9fjsDAQI3rY2Ji8MUXX2Dbtm06x3Dr1i2MGjWqwD0rVCqVQQ8BWZhZs2Zh48aN8PPzU1/XvXt3dOzYEaGhofjzzz91zmPPnj2yxpCcnAxXV9d817u6uuLmzZs6p3/27BnMzfP/Cpibm0s6zOO0adPg5+eHr7/+GmZmOQc9E0Jg2rRp+OKLL7BkyRKd85g/fz62b98Od3d39XVNmjSBr68vPvvsM3Tt2vWNj8EQ38vMzMwCrzczM5P0Wj548EDrWEeOHKlzHkIIPH36FNnZ2eqv8/6OVKxYUev0iYmJCAoKKvT2vFudF5VKpZJ0v8uXL6N58+b5rhdCQKVS4ejRo1qnNzc3R6NGjQAAb7/9Nh4/flykcWZmZqJWrVoAgDVr1uA///kPxo8fDyEEPD09izSvN0Hq61iuXDn1ff/44w/069cPZcqUQcOGDfHy5Uud09ra2gIAnJyc9Nqif/ny5YiJiUGdOnXU17Vt2xZbtmxBz549MXToUJ3zSE1N1XjNXV1d1Vvq/9///Z+k6Qsj9RCsf/zxB65evapxXaVKlbB48WI0aNBA5/STJ0/Gli1b4OzsjD59+mD69Olo1qwZhgwZIunxq1atil27dmHBggXw8fHBokWL0L17dwDSfhby3uf1+0uZ/t9//9X4Huayt7fHv//+q3N6IGfvyLzLC7lsbGyKdDpEOZ91cl8HItJNbmOwL16Ru1yqdF8AyjeG3L4wxBjYFznYFzlMoTHk9EXu9Eo3hty+yJ1HYaQ0Rknvi9fvp0RjsC+ISgel+wKQ3xjsixym0BeA8uswjKEvAPmNYcx9AUj7HJfbFwDXYQDsi7zzKExx9AWgfGOYQl8A8j7v2BckVanaqGnp0qXIzs7G3r17ERkZieDgYLRt2xYjRoyAs7OzpHnI/QW/ePFivhgAchbCpB7m0sXFRdaC/+3btzFp0iQIIdRf5xUeHq5zHklJSRoLkblatmyJGzduSBqHrsPQtm7dWuvtDx8+LPS2jIwMnY9vbm6OxMREODo6alyfkJBQYCi8bu/evTh//rx6QRzIeYOdNWuWxgK+Ng8ePCjwvm5ubpIO52uIMRjie1mlShWcPHkS3t7eGtefOnUKVapU0Tn9ixcv8ODBA1nnaE1LS4Obm5t6Hnk/QFUqFRISErROX716dYwaNUrvx7e1tVV/wOaOQaVSQQgh+bzG9erVw8aNG/UeQ3JyskZYvX5ZV1hlZ2cjOzsbZmZm2LVrFxYuXAigaAsOct9fJk6cWODjCSE0DiurTeXKlbF7927UrFkT+/btU78GL1++1LkwnHfMQgjcunVL4zlIeX80xMYwry/Q5/25uHv3rs7pPT09ERkZmW/he/Xq1fDw8JA0hsKYmZlJ+pnYtGkTbG1t0bdvXwQGBqJq1ap6LYSOGzcOnTp1wqBBg7B9+3b1z6Uuhf0sCiFw584dndOXL1++0NvKlSsnaQxlypTJ9weK3DGUKVNG0jzkftblvg8IITTeE4QQJnvueqLiJrcx2BevyF0uVbovAOUbQ25fGGIM7Isc7IscptAYcvoi7/hzH1OJxpDbF8Cba4yS0heA8o3BviAqHZTuC0B+Y8jtC8A41mGwL3IovQ7DGPoCkN8YSvcFIL8x5PYFwHUYAPsil9J9ASjfGKbQF4C8zzv2BUlVqjZqAnLezNq3b4/GjRtjw4YNmDNnDjw8PCRv1CT3F9zS0rLQ23RtiW0oeT/Q8n597949WFlZSZqHtvtJnUfbtm3h6emp3mI272uqUql0RkGbNm0QGhqK0NBQjetnzZpV4ELu60JDQxEQEIBp06apF2ZPnjyJb775BnPnztU5ffny5TUWxHOVKVNG6wdJXnJ/HgwxBkN8L8PDwxEYGIjhw4drvJYrV67EunXrdE7/1ltv4auvvpL0WIX5+++/ZU1vZWWV75y1RZGcnCzr8QHAwsJC0jmXC/Pxxx9rjOP1y7oEBQXB398f1atXh5mZGdq1awcgJ5IrVaokaR6Fvb9IpS1kFy1aJGkey5cvR0hICO7du4f58+ejdu3aAIDdu3ejc+fOWqfNHbNKpUJ6ejqmT5+OypUrFylWDbExTNOmTbFq1SoMHjxY4/o1a9agSZMmOqfP3SNg1apVGr+Tjx8/lnTEDgBo3rw5Zs+ejalTp2pcP3fuXPj6+uqc/vr16zh27BiioqLw9ddfo0GDBsjIyMCjR48k/bEg72vu5uaGv/76CzNmzICXlxeePHmic3ptP4tS3uPPnDkDOzu7AscldQO71/9YAbz6Q4HUOJL7WZf3feD194Thw4dLGgMR6SanMdgXr8hdLlW6LwDlG8MQPw9yx8C+yMG+yGEKjSGnLwDjaAy5fQHIb4yS3heA8o3BviAqPZTsC8B0GoN9YRrrMIyhLwD5jaF0XwDyG0NuXwBchwGwL3Ip3ReA8o1hCn0ByPu8Y1+QVCohZ9fFEub+/fvYtGkTtmzZAgsLC/Tq1QuBgYGoVq2a5HnUq1cPZmZmhf6C69qaukaNGvne5IGcN5g1a9ZI2oI1Li4O77zzjvpyVlYWzp49i9q1a6NGjRqSnwsApKSkYNOmTYiOjkZiYiK6deuGBQsW6JzO2toa/v7+BT6P2NhYpKSk6JxHVFQUNm3ahDt37qBr164ICgqCk5OT5LGnp6djyJAhiI+PV39IxsfHw8PDAxEREZI+cE6dOoXvvvsOFy5cAAA0btwY48ePh5eXl85pnZ2d8cMPP+S7XgiBkJAQXLt2Tec8LC0t4ebmVuA8Ll68qHMLVkOMwRDfSwC4c+cOli5dqvFajhw5Un0oUG28vLxw6tQpSY+jTVZWFnbu3InLly+rxxAQEICyZcvqnHbw4MFYtWqV7DHEx8drPL7UPV4AYOrUqZg9e7bsMcgRFxeHu3fvwt/fXx2FV65cQUZGRr49WaRKSUlB1apVC4zXonj27JnkjYLkWLRoEebNm6de6LSyssKECRMwZswYSdObm5vDxsZGY28X4NWCpJTDwd6+fRuBgYGoXLkymjZtCgA4ffo0Hj16hG3bthW4F0VBYmNjNX4nO3bsKGk6IGeBdtiwYRrvsadPn4anpyciIiJQtWpVyfMCgMOHD2PDhg2IiYmBi4sLYmNjtd7/yy+/LPBQtYcPH8bMmTPxxx9/FOnx85o/fz7Gjx+v9/TFqaDPujNnzqi/D7o+68LDw/PtbUREhiW3MdgXr8hdLjWGvgCUbQy5fWGIMbAvcrAvXmFjKN8YhuoLQP/GMOW+AEpOY7AviIyf0n0ByG8MQ/YFoNw6DPZFDqXXYRhDXwCGaQxj6AtA/8ZgX+jGvii5fQEYV2OUlL4A5DUG+4KkKlUbNZmbm8PNzQ09e/ZE9erV821lKOXQ6XIVttCRu4eBlDF8+umnCAkJgaurK1JTU9GiRQtYWFggJSUFc+fOxcCBA7VO/+jRI2zduhUbNmzAtWvXEBgYiA0bNuDWrVuSn8e+ffu03l6ULcafPHmCX3/9FZs2bcLdu3cxa9Ys9dbVUly7dg0XL14EkPOB5+Liglu3bhXpQ1Mfus4pGxERoXMeug6Pqmurd0OMITo6GsnJyfkWXM+dOwc7Ozv07t1b5zxyPX36FNevXweQEysVKlSQNF1WVhbKli2rsTDdqFGjIh1iMikpCe3atYODgwO8vLwghMDp06dx+/Zt7N69W+fPw759+7Rueaxrz5uUlBR069YN//zzD5o0aQIhhDrWY2JiJC1ArVq1SusYBg0apHMev/76K8LDw9W/E66urpg4caLOc5sDOYccLVu2rDqiLl68iJ07d8LBwQEffvihzukBICwsDH369EGjRo2QmZmJ9957D/Hx8TA3N8eaNWsQEBCgdfpWrVrh4MGDAIB+/frhl19+Ud/m7e2NkydP6hzDzJkztd6ubY+asLAwnDx5EgsXLkS9evUA5JyvfNy4cWjSpAnCwsJ0Pr4h7dq1S+P9rUOHDgB0H043MzMTy5Ytw7Vr1+Dh4YHhw4dLOiR1Qa5fv64RFS4uLnrNJ1dWVhY2bdqEfv36ab3f1atXcf/+fbRs2VLj+sOHD6NGjRqSj7BYEAcHByQlJek9/Z07dyT/wQN4dV75vFJTUws8HPzrduzYASEEEhMTUbduXQghULNmTbi7u0vaG07q7w0R6U/pxjCVvgAM1xgltS8A+cv3cvvCEGNgX+RgX+QwhcaQ0xe54zeWxtC3LwDDNYYp9gVQvI3BviAybUr3BSC/MeT2BWBc6zBKc18Ayq/DMIa+AOQ3htJ9AchvDEP0BcB1GOyLHMbaF4BxNEZJ6QtAXmOwL0iqUnX6uS+//FL9S/n6eRilHkZN1xuIg4OD1tvz7uFQ0B4GUhw4cADLly8HAKxcuRKurq7YunUr7t27h06dOumMAjs7OzRv3hzh4eHqPSY2b94s6bFzyT3MZV55z28q9bzeueLi4nDr1i34+fmhZs2aiI+Px4ABA7B//37cvHlT67Tx8fEICwuDtbU1Jk+ejJEjRyIuLg5OTk746aef0KJFC63TT5w4UeO8x/p4+vQpGjVqBCAnjvIeyvXQoUM6g0DbAn/uh7gumzdvxpgxY/J96Jqbm2Px4sWSoiArKwuTJ0/GmjVr4ODgACEEbt68iUGDBmH27NmwsLDQOv3jx4/RrVs33L17F56ennr9wX7q1Kn4/PPP851XeunSpZgyZQrWrl2rdfrFixerv46NjUXHjh01tlLXFQXTpk2Dn58fvv76a/XW/EIITJs2DV988YXGeaELc+7cOfXXa9aswUcffaS+LOU9asmSJVi1ahXmzp2r3iPhxIkT+OKLL5CUlKTznNudOnVCZGQkXFxccPnyZbz77rsYOHAgdu7cib/++gvz5s3TOYaoqCj1QndERATMzMyQnJyMa9euYcCAATqDIO8hOS9duqRxm9RtcGfOnAl3d3f1H3+Ksu3uunXrcO7cOY2fWUdHR0RFRcHd3V1SEORdGPf09MSwYcP03qCoY8eO6j0TDh48iNGjRyMmJkbn+9vgwYNRtmxZ+Pn5YefOnbh06ZLko2TkunHjBqpWrQpnZ2c4OzsjNjYWixYtgoODA0aPHq1zj5P09HT8+OOPuHXrFj744AMEBARgyZIlmD9/Pjw8PHQGwdixYwv8matatSpCQkLw22+/Fen55CV3e+4WLVpICop9+/Zh2LBhePLkCZo1a4YffvhBvUdfhw4dJC2s5z0f+YkTJwDkLD+cO3cOP/30kzoUC5OdnV3gYedzFddh44lMmdzGYF+8YqjGUKovAOUbQ25fAPIbg32Rg32RwxQaQ05fAMbVGPr2BSC/MUy5L4DiaQz2BVHpoHRfAPIbQ25fAMa1DqM09wWg/DoMY+gLQH5jKN0XgPzGkNsXANdhAOyLXEr3BWDcjVFS+gKQ1xjsC5JMkMjKyhK///67pPuqVCrRqFEj4evrK3x9fYWPj4/6n6+vr87p09LSREREhAgICBDOzs5i/Pjxonbt2kUab9OmTdVfd+rUSaxZs0Z9uUmTJjqnj4yMFJ07dxb169cXEydOFEePHhWOjo5FGsOZM2dEz549xfDhw8WVK1dEx44dhaWlpfDw8BBHjhyRNI+NGzeKoKAg8e6774pvvvlGXLt2rUhjmDBhgmjQoIHo27ev8PLyEpMmTRLVq1cX8+fPF//++6/O6Zs3by42b94sVq5cKapXry42b94sMjMzRWxsrPDx8dE5vYeHh3B3dxezZs0SV65cKdLYc3l5eRX4dUGXpbhy5YqYNWuWcHNz0/g50Ubbz627u7ukeQQHB4tPP/1UPH78WH1denq6GDFihBg5cqTO6T/77DMxZcoU8fLlS/V12dnZYurUqWLEiBGSxtCgQQO9biuI1Ncur0aNGmmMP9eLFy9Eo0aNijw/fcbQsGFDkZaWlu/61NRU0bBhQ53T5/1+T5kyRYwePVoIIcTz58+Fm5ubpDHkHXe3bt3Ezz//XOBthTHE78Q///wjfvjhB9G+fXvx3nvvif/+978iJSVF0rT169fX67a8goKCxIABA8SyZctE9+7dRUhIiKTpCnLkyBExbtw4Ua9ePWFpaSkiIiLEgwcPdE6X93uZlZWl1/uJr6+vuH37thBCiOPHjwsbGxvx7bffiiFDhojBgwfrnL5bt27io48+EsuWLRO9evUS7777rmjZsqU4fvy45McvjKenp87pnzx5UuC/jIwMUadOHZ3TT5w4scB/EyZMEJUrV5b0HJo1ayYuXLgghBBiy5YtokGDBmLv3r1CCP1+x/O6efOmpOUOCwsL4ejoKOrVq6f+l3u5qJ/9RFQ0UhuDffGK3MZQui+EUL4xDN0XQhS9MdgX+ZXWvhDCNBpDTl8IYVyNoW9fCCG/MUp6XwihfGOwL4hKt+LqCyHkN4bcvhDCONZhsC9yKL0Owxj6Qgj5jaF0Xwhh2MbQdwxch8G+yKV0XwihfGOYcl8IIa0x2BckVandqOnly5fizz//FMOHDxe1a9cWgYGBkqabM2eOaNmypejRo4f45ZdfREZGRpEe18LCQrRq1UocPnxYfV29evWKNI/3339frFixQvz++++iatWq6g+Ip0+fisaNG0ueT0pKilixYoXw9/cXFSpUEJ9//rnYv3+/pGnlLkwLkRNYHh4e4sMPPxQffvih6N27t8Y/XRo3bqxe+H/48KGoWLGiuH79uqTHFkLzDfn1hUapcXXhwgURGhoq3NzchJeXl5gzZ45ISEjQawyvf0BI/cBITEwUs2fPFk2bNhU+Pj6iWrVqRRqDi4tLobc5OzvLmsfLly8lzcMQC9PaFniKujCkT4xp+37p8+Gvzxi0LfQXNQh8fX3Fr7/+qr4s9Y+8rVu3FrGxseL8+fOiSpUq4tatW0KInO+llDHUqVNH/Pjjj2Lx4sXqr3Mv29vbSxpDXnfu3BHfffedqFGjhoiMjNR5/y5duohffvkl3/UbNmwQ77//vqTHNMQGRZMmTRIuLi4iICBArFy5Ujx8+LBInxWG+AODh4eH+uuQkBAxZcoUIUROrEv5g0HeiHzx4oWoXr265D/YCCGEk5OTXrflyrvwm/t17j8pr6WVlZVYtmyZiIyMzPevWrVqkp7D66/T9evXhYeHh1i1apXeK5bzKmpkE9Gbp09jsC9ekdsYSveFEMo3hiH6Qgh5jcG+kH9/IUyjL4QwvcYoal8IYRyNIbcvhJDfGCW9L4RQvjHYF0SljxJ9IYT8xjBUXwih7DoM9kX+MSixDsMY+kII+Y2hdF8IYdjG0HcMXIehiX1R+GVd5PaFEMo3hqn3hRC631vYFyRVqTr9nBAC+/btw4YNG/DHH3/Ax8cHBw8eREJCguTDl02ePBmTJ09GQkICoqOjERAQgLfeegtTp05VHypRm59++gnR0dEYPHgwAgMD0bt3b8mHZcy1cuVKzJgxA3fv3sX69etRrVo1AEBMTAz69+8veT7W1tYYPnw4hg8fjuTkZGzevBkzZszA7t27dU77/Plz9OzZEwAwZ84c9dft27dHVlaWpMffs2eP5LEWpHz58upzHtvY2KBBgwbqw+JJkfd1z3vIVADqQ2/q0rhxY8yYMQMzZszA+fPn1T8TNjY2OHLkSJHG8PrPgZSfi+bNm+PZs2fo168fNm/eDCcnJzg6OsLR0VHS+AHA09MTkZGRGDJkiMb1q1evlnw+6MLkPTSvNuXLly/wNS9TpgzKly8v6bGSk5MLPDyqECLfoZrfhPT0dOzYsaPAx3/8+PEbf3wAqFGjBvbt25fv0Mr79++HnZ2dzulbt26NwYMHo2bNmrh37x78/f0BAPfu3ZN86NHly5cjJCQE9+7dw/z581G7dm0AwO7du9G5c2ed03/88cdITk7O9zUADB8+XNIYgFfv91FRUTh69Cj69euX7xDFBVm6dCl69OiB5cuXq9/TT548ifT0dGzdulXSY+eezxuA3qed27RpE2xtbdG3b18EBgaiatWqRfqsiI+PV3/PhRBIS0uDnZ2d+tzI9+/f1zmP7OxsZGdnw8zMDLt27cLChQsBSD+UcN7D35YpUwb29vZFOk99mzZtEBoaitDQUI3rZ86cCT8/P53T79mzB1WrVlUf+nnXrl2IiYlB3bp1MXr0aJ3Tv/3223Bzc0OrVq3y3TZ79mxJz6FSpUpITExUvyc7OTlh79696Nmzp/pc4/qKi4tD5cqVdd7v3LlzSE5Ohq2trazHI6LCyW0M9sUrchtD6b4AlG8MuX0ByG8M9oVhmEJfAKbTGPr2BWAcjSG3LwD5jVHS+wJQvjHYF0Slg9J9AchvDEP1BaDsOgz2Rf4xKLEOwxj6ApDfGEr3BWAajcG+YF/kktsXgPKNYcp9AUhrDPYFSaUSQuZJGUuQt956C05OThg9ejS6du0KS0tLODo6IjExUa/5/fXXX4iOjsZvv/2GuXPnIjAwUPK0qamp2LJlC6KionDw4EGMGDECgYGBkv+QkislJQWbN29GVFSU+pzWRTnnqL68vb3V59LM+3VBl98Ua2tr9QKLEAK7du1SXwaA6OhordObm5vDxsZG/WFpbW2tntejR4/w/PlzyWPJzMzEjh07EBUVhUOHDqFTp05YuXKl5Ofw+viFEIiNjUVKSorW6YcOHYq9e/eiTZs2CAoKQqdOndCgQQMkJCRIHvvt27fRvXt3VKpUSWMB6PHjx9i2bRvq1Kmjcx4DBgyAu7s7pk6dqnH93LlzcebMGaxfv17r9M7Ozvjhhx/yXS+EQEhICK5du6ZzDLrOEzxjxgytt/v6+kKlUkEIgQsXLsDNzU09BpVKhaNHj2qdfujQoVpv13bu8Fy2trbqMbz+MyllIe7s2bMIDAxE69atNb6X+/fvx9atW+Hp6al1+uzsbERFReHu3bv48MMPYW9vDwA4deoU7t+/r/Nc0kUxe/bsfD8vhhIcHIwjR47Az88PQUFBeOedd4o8j9jYWPU53V1dXbWe8/d1ue8tADS+l0XZoAgAjh07hqioKMTExKBBgwY4duwYrl69iipVqhT5+ehj5syZ2LdvH6pXr46LFy/i9OnTMDMzQ0JCAgYOHIjDhw9rnV7u65Ceno4hQ4YgPj4eTZo0UZ+n3sPDAytXrtR5nvrmzZtj27ZtqFWrFk6cOIFOnTph2rRpOHv2LADdv5M+Pj6Ii4vTCLyisrS0RHx8PJydnTWuz8rKQnR0NAYMGKBzHrnvTXmlpKTA2toaq1atgqurq9bpGzdujCdPnqBBgwbo06cPevXqpf6+EJFhGLIxSnNfAMo3hty+AJRvDLl9AchvDPZFDvZFDlNoDEP0BaB8Y7Av5PUFoHxjsC+ISgdj6QvAMI3BvijZfZH3eSi1DsMY+gKQ3xhK9wUgvzHk9gXAdRgA+8JQ5PYFoHxjmEJfAPIag31BUpWqjZrCwsKwadMmVKtWDUFBQejVqxfeeeedIm0Acvz4cURHR2PPnj3w9vZGUFAQ2rZtizJlyug9rtw9DKKjoyXtYfDo0SNs3boVGzZswLVr1xAYGIgNGzbg1q1beo+hqAyxMB0fH4+wsDBYW1tj8uTJGDlyJOLi4uDk5ISff/4Zb7/9ttbpo6OjkZycDHd3d43rz507Bzs7O/Tu3Vv/JyjBs2fP8PvvvyM6OhoHDhxAhw4dEBQUhICAAMkfIIZ4DllZWfjf//6HqKgo7Nu3D2lpaVi/fj38/f1Rrlw5yc8n7wJQ48aN0bFjR8nTpqWlYdiwYeoPbgA4c+aM+oM79+ejMIb4g71UhS2I3rhxQ+t0devWpc8DCQAAHLxJREFUNdgY3qSnT59i/fr1Gguz/fv3L9LW5cWhsD8czJw5U+t0X331lc55m5mZwcbGRr0Qlft/UTcqMiaHDx/Ghg0bEBMTAxcXF8TGxhbL48bFxeHu3bvw9/eHlZUVAODKlSvIyMiQvHefvm7cuIEqVargwYMHuHjxIoQQ+Omnn9C2bVuMHj1a5/ubp6cn4uPjAQBjx45FhQoVMHv2bAgh4OnpqQ6Dwhjij1teXl44deqUrHm8/t6kUqlQrVq1fHvnaSOEwP79+xEdHY3t27fD3d0dffr0QY8ePYotMolMmdzGYF+8IrcxSnpfAPIbw1DPwRCNwb5gXxS3N9UY7AvDKcl9ASjfGOwLotLBGPsCKFpjsC9ymEJfAMazDkPJvgCKrzFMvS+AktMY7AvpSmNfACV/HYYh+gKQ3xjsC5KiVG3UlOvcuXOIiorCxo0bcePGDYSHh6N79+5wcHDQOa2ZmRk8PDzQvn17mJub59vyMDw8/E0NW61cuXJo3rw5wsPD1VvwyjnilFLefvttTJ48GY8ePcKkSZOwfPlydOnSBYcOHcLkyZNx7NgxrdP36dMHY8aMyXdIxkOHDmHx4sX45Zdf3uTwYWZmhl69eqF///7o3Lmz+sPpwoULsLW1lXSoPLnPITk5GcnJyeqtXJ89e4YdO3Zg3bp12Lp1K16+fKnns9PP9evXNcLCxcWlWB9fCqkf8pmZmcjOzgYASYd2Xr16tdbbBw0aJG2ACsrd0+J1b2JhurCFJXNzc7i7u6Nnz56oXr06Xv+IGjVqlMHGUFJkZGQAAKysrNQLd68fnvdNyMzMxLJly3Dt2jV4eHhg+PDhep9OTx8F7aXwxRdf4Ny5cxBCIDIyUuv07u7uiI+Ph5mZGdzd3bFw4UL13ioeHh46g8De3l7rnjgjR47U+RwMMQ9Dy87Oxp49ezB+/HhcunQJmZmZxT4GIlOlb2OwLwynpPcFIL8xDPEcjKkx2BeFKwl9AbAxjBH7Qr++AJRvDPYFUenCvlAe+yKHKa3DKM19AZhGY7AvjE9p7Qug5K/DYF9QSVK8v91Gwt3dHe7u7pg1axZOnTqF5cuXY+zYsZIWngrb2vrevXvqrUDfNLnntDYWcs9pnZiYWOA5Zlu2bInPPvvMsIMtwIcffoiQkJB8Y0hNTcWsWbMkRYnc5xAcHIwxY8aoL5crVw49evSAra2t5HNqG8LatWsxcOBAODs749atWxoLLAsXLkRISIjW6YtzYbqw7TgXLlyIp0+fYsqUKQCA+vXro2zZsnjx4gXGjRuHcePGaZ1v3oWLNWvW4KOPPlJfLq7fT7kL9HnP/fymFfaa3Lp1C5s2bcLWrVthYWGB3r17o0ePHpL2ljE1ixYtwrx58/DkyRMAOVEwceJESedSNoTBgwejbNmy8PPzw86dO3Hx4kV8//33xfLYQE6U1KpVC0DO79R//vMfjB8/Xr2Xgi59+vSBv78/qlevDjMzM7Rr1w4AkJCQgEqVKumc/sWLF3jw4EGh7xlSGGIehnTgwAFs3LgRMTExcHd3x+eff670kIhMir6Nwb4wnJLeF4D8xjDEczCGxmBfmEZfAGwMY8K+kNcXgPKNwb4gKl3YF8pjX+QwhXUYcvsCKL7GeFN9AZhGY7AvjEdp7wug5K/DYF9QiSJKqYcPH4qffvpJdOjQQTg5OYmQkBC95rF8+XL1PMaOHWv4gWqRkpIiVqxYIfz9/UWFChXE559/Lvbv31+sY5DDy8urwK8LulwQFxeXQm9zdnbWf2AS+fr6Fnqbu7u7pHnIfQ6GGIMhyP1eqlQq0aRJEzFu3DgxceJEMWHCBPW/iRMnvrGx5uXt7S0eP36svty0aVMhhBBZWVmiVatWRXqM3GmpcFJeozt37ojvvvtO1KhRQ0RGRhbDqIxHaGio6Nq1q0hMTFRfl5CQILp37y6++uqrYhlD3veQrKwsSb/LhuTm5iZevnyp/nrXrl0Fjk2bw4cPiy1btmj8bl++fFmcOHFC57SGeL7F/ZoV5MCBAyI4OFjY29uLTp06iRUrVoiUlBSlh0VksuQ2BvtCnpLeF0LIX743xHMwhsZgX2hiX0jDxigc+8IwfSGEso3BviAqfdgXymJf5DCFdRhyv5dCFF9jFEdf5J2eCse+KBz7IkdJX4fBvqCSpFQdqamgczlfunSpSOdyNsQ8DMXa2hrDhw/H8OHD1ee0njFjhs5zWhuL+Ph42NnZqc9pbWdnB+DVOa118fT0RGRkJIYMGaJx/erVq+Hh4fEmhqwhJSWl0NuePn0qaR5yn0NqaqrsMRiCyLMVr3hti97XLxckLi4OGzduxN69e+Hj44OgoCC0a9fujewdUNh4srOzNfZWyt0C2NzcXL2luVQlcc+j4jB//nyMHz8eALTu/SKEwL59+xAVFYWjR4+iX79+Be4NZMrWrVuHc+fOwcLCQn2do6MjoqKi4O7ujrCwsDc+hrJly6q/Lu7DtgLy91IAoD7EeV4NGjSQNK2U967imIdc06dPR9++ffHVV19JOqQ4ERWd3D5gXxhOSe8LQH5jGOI5GENjsC80sS8Kx8aQhn1hmL4AlG0M9gVR6cC+MB7sixymsA5Dbl8AxdcYxdEXABujMOwLadgXOUr6Ogz2BZUkKmEMP7HFxBDncjaV80Gbgtu3b6N79+6oVKkSvL29AQAnT57E48ePsW3bNtSpU+eNPn6vXr3QtWvXAhfmt27diq1bt+qch9znYIgxGELe8zy/fs5nqeeAznXkyBFs3LgRO3bswOzZsxEYGChpuszMTDx+/Djfh15ycjIqVaqE8uXLA0CBAQbkLCScPn063/mnnzx5Ai8vL1y5ckXycyjqcy4tHBwckJSUpPU+wcHBOHLkCPz8/BAUFFTgAl1p0KBBg0J/5rTdZkjm5uawsbEBAPUfb6ytrd/I+ckLExcXh7t378Lf318d7VeuXEFGRob6PfNNycrK0ggjpeZBRMZPbh+wL4yH0n0ByF++N8RzMIbGYF9oYl8Ujo0hDfsih5J9AcjvA/YFUenAvjAdptAXgGmswzBkXwD6NYYx9QXAxigM+0Ia9sUrJXkdBvuCSpJStVHTqlWrEB0djatXr6rP5dynTx8kJCQU6zzIsGJjY3HhwgUAQOPGjdGxY8dieVxDRom+z8EYwgh4tfCQd8EBeLXXyvPnzyXN5++//0ZUVBR+/fVX2NnZ4csvv5T8of/JJ5/ggw8+QPfu3TWu3759O3bs2IFly5Zpnf6bb75BXFwcli5dqn7dbt26heDgYPj4+ODLL7/UOn3uuaALeg2KcwHKmNnb2+PmzZta72NmZgYbGxv1niK5/5e21/GDDz7AwIED0bdvX43ro6KisGrVKuzYsUOhkRER0evk9gH7wvgo1ReA4Zbv5TwHY2gM9gX7Qio2hjTsCyKikoN9YXpMoS+Akr0Ow1B9AejfGEr3BcDGkIJ9IQ37goiKW6naqClXamoqtmzZgqioKBw8eBAjRoxAYGAg/Pz8inUeZBqUjBJjGoMc3377LbZv347q1aujd+/e6NatGywtLYs0Dx8fHxw/frzA2zw8PHD27Fmd81i0aBHCw8ORmZkJIQQqVqyICRMmYMyYMTwcq0T//vtvgdcLIdCoUSOdQUA5bt68iR49euSL/fT0dGzduhUODg4Kj5CIiF4ntw/YF5SXMSzfG8MY9MW+MC1sDPnYF0REJQ/7ggzJGJbtjWEMcshtDPaF8WBfyMe+IKLiVio3asor91zO0dHRep/L2RDzICrNzMzMUL9+fVSuXBlA/vM5Hz16VOc8GjZsiMuXLxd4W6NGjXDp0iXJ43n8+DEASD7nLb3i6Oio3tvjdSqVinuFFVHe2Hd1dUWHDh0UHhEREUkhtw/YF0TysC9MCxvDcNgXREQlE/uCSHlyG4N9YTzYF4bDviCi4lLqN2oiIuXduHFD6+1169bVOY9OnTph4sSJ8Pf317h+165dmDNnDnbt2qV1+iVLlmi9feTIkTrHQGQomZmZWLZsGa5duwYPDw8MHz4c5ubmSg+LiIiIqERgXxBpYl8QERERySO3MdgXZErYF0RU3PgOQ0SKK2iB/8GDB6hWrZrkw6YuWLAAXbt2RZs2bTQOd7l//35s375d5/TJyclFGzQVKisrCzt37lTvedK4cWMEBASgbNmyCo+s5Bg8eDDKli0LPz8/7Ny5E5cuXcKCBQuUHhYRERFRicC+MD1sDHnYF0RERETyyG0M9oVxYV/Iw74gouLGIzURkeJiY2MxadIkWFtbIzQ0FJ988gnS0tLw4sULREZGokuXLpLm8/TpU6xfv17j3NwDBgxAhQoV3uTwKY+kpCS0a9cODg4O8PLyghACp0+fxu3bt7F7927UqVNH6SGWCHnPo/7ixQs0b94cJ0+eVHhURERERCUD+8K0sDHkY18QERERyWOIxmBfGAf2hXzsCyIqbtyoiYgU5+Xlhf/+97949OgRunXrht27d8PX1xdXrlxB7969cebMmTc+hqCgIERHRwMAxo8fj/nz56tv69ChA2JjY9/4GEzBgAED8O6772LUqFEa1y9duhSHDh3C2rVrFRpZyeLt7a0RAa9fJiIiIqLCsS9MCxtDPvYFERERkTxKNwb7wnDYF/KxL4iouPH0c0RkFHIPuerg4ABfX18AQIMGDWBmZiZ73g4ODkhKStJ6n6tXr6q/3rNnj8ZtKSkpssdQWhw/fhzr1q3Ld/2IESPw/fffF/+ASqj4+HjY2dkBAIQQSEtLg52dHYQQUKlUuH//vsIjJCIiIjJu7AvTwcaQj31BREREJN+bagz2RfFiX8jHviCi4saNmohIcUIIPH36FNnZ2ShbtiyePn2K3IPIST2Y3JIlSwqd95MnT3ROr+2811LOiU05LC0t9bqNNL148ULpIRARERGVWOwL08LGkI99QURERCSP3MZgXxgP9oV87AsiKm7cqImIFJeWlgY3Nzf1wr+rqytUKpV6q24pxo8fjwkTJsDcPP/b2suXL3VO/+jRI+zcuRPZ2dl49OgRduzYASAnKtLT04vwbEq35OTkAgNNCIEHDx4oMCIiIiIiKm3YF6aFjUFERERESpPbGOwL48G+ICIqeVRC6m6KRERGrFWrVliwYIH6sK952dvb4+bNm1qnHzp0qNbbIyIiZI2vtAgLC9N6+4wZM4ppJERERERE+mNfGA82BhERERGVdOwL48G+ICIqebhRExEpbu3atRg4cCAAYN++fWjTpo36toULFyIkJETnPG7cuIEqVaqgatWq+W5LS0sr8HoqXlFRUejTp4/SwyAiIiIiE8e+KD3YGERERERUHOQ2BvuiZGBfEBEZJ27URESK8/b2xsmTJ/N9XdDlojpx4gSioqIQHh6u9X6rV6/WevugQYP0HgPlcHBwQFJSktLDICIiIiITx74oPdgYRERERFQc3lRjsC+MC/uCiMg45T95KxFRMcu7beXr21nqs91lfHw8NmzYgE2bNqFWrVro0aOHzmnOnj2r/nrNmjX46KOP1JelnBObdOM2tERERERUHNgXpQcbg4iIiIiKgyEbg31hvNgXRETGiRs1EZHi8i50v74ALnWB/OLFi4iKikJ0dDRsbW3Ru3dvPHv2DHv37pU0/bx589Rf79q1S+MyGQbjioiIiIiKA/ui9GBjEBEREVFxkNsY7IuSgX1BRGScePo5IlKcubk5bGxsIIRAWloarK2tAeRsFf/o0SM8f/5c5zzMzMzQsmVLrFy5EvXr1wcAODk5ISEhocjjkXtKitLM1ta2wAX/3O9tVlaWAqMiIiIiotKEfWFa2BhEREREpDS5jcG+MB7sCyKikodHaiIixb148UL2PPbs2YPo6GgEBASgWbNmCAoKQnZ2tgFGR0WRnJys9BCIiIiIqJRjX5gWNgYRERERKU1uY7AvjAf7goio5OGRmojIpGRnZ2PPnj2IiopCTEwMWrVqhcDAQI1zTBckd+v8gva0UKlUuH//fnEMn4iIiIiIjAj7goiIiIiIDIV9QUREVHTcqImITNaLFy+wa9cuREVFISIiQunhEBERERFRCca+ICIiIiIiQ2FfEBERScONmojIZDx+/BgWFhYoV64cbty4gWPHjsHJyQne3t5KD42IiIiIiEoY9gURERERERkK+4KIiEg/ZkoPgIjIEBYsWIBGjRqhcePGmD9/Pvz9/bF582YMGDAAX3/9tdLDIyIiIiKiEoR9QUREREREhsK+ICIi0h+P1EREJsHNzQ3Hjh3DkydP4OjoiKSkJNjY2ODp06fw8fHB+fPnlR4iERERERGVEOwLIiIiIiIyFPYFERGR/syVHgARkSFYWFigYsWKqFixIlxcXGBjYwMAqFChAsqVK6fw6IiIiIiIqCRhXxARERERkaGwL4iIiPTHjZqIyCSkp6dj586dyM7ORkZGBnbs2AEAEEIgPT1d4dEREREREVFJwr4gIiIiIiJDYV8QERHpj6efIyKTMHToUK23R0REFNNIiIiIiIiopGNfEBERERGRobAviIiI9MeNmoiIiIiIiIiIiIiIiIiIiIiIyKjw9HNEZBJWr16t9fZBgwYV00iIiIiIiKikY18QEREREZGhsC+IiIj0x42aiMgknD17Vv31mjVr8NFHH6kvq1QqJYZEREREREQlFPuCiIiIiIgMhX1BRESkP55+johMjpeXF06dOqX0MIiIiIiIyASwL4iIiIiIyFDYF0REREVjpvQAiIgMjXs2EBERERGRobAviIiIiIjIUNgXRERERcONmoiIiIiIiIiIiIiIiIiIiIiIyKjw9HNEZBJsbW2hUqkghEBaWhqsra0BAEIIqFQq3L9/X+EREhERERFRScG+ICIiIiIiQ2FfEBER6Y8bNRERERERERERERERERERERERkVHh6eeIiIiIiIiIiIiIiIiIiIiIiMiocKMmIiIiIiIiIiIiIiIiIiIiIiIyKtyoiYiIiIiIiIiIiIiIiIiIiIiIjAo3aiIiIiIiIiIiIiIiIiIiIiIiIqPCjZqIiIiIiIiIiIiIiIiIiIiIiMiocKMmIjJJQ4YMgUqlgkqlgoWFBVxcXDBz5ky8ePECALB371717SqVCra2tujcuTPOnj2rMZ/k5GSMGDECDg4OKFeuHGrWrImAgAAcOnSo0McODQ3VmHfuv127dhnkueWOPS0tzSDzIyIiIiIi3dgYRERERERkKOwLIiIiacyVHgAR0Zvy3nvvISIiAs+ePcOOHTswatQolC1bFlOnTlXf5/Lly6hcuTLu3LmDiRMnokuXLrh27RosLCwAAL169cLz58+xatUqODk54d69e4iNjcXDhw+1Prabm1u+ALCxsTH8k5QpKysLZcuWVXoYREREREQlAhtDNzYGEREREZE07Avd2BdERMQjNRGRycrdK6Fu3boYMWIEOnbsiO3bt2vcx87ODjVr1oS3tzfGjh2Lmzdv4tKlSwCAtLQ0HDhwAHPnzkW7du1Qt25dNG/eHFOnTkW3bt20Pra5uTlq1qyp8S83Mg4ePAg/Pz9UqFAB9vb2GDNmDJ48eaKeds2aNfDx8UGlSpVQs2ZN9O/fH/fv3wcA/P3332jXrh0AwNraGiqVCkOGDAEA1KtXD99//73GOJo2bYrQ0FD1ZZVKhaVLl6Jbt26wtLTE119/DQCIiYmBt7c3ypcvDycnJ4SFhan3CCEiIiIiohxsDDYGEREREZGhsC/YF0REpBs3aiKiUqNChQp4/vx5gbc9evQIGzZsAAD1gruVlRWsrKywbds2PHv2zCBjuH79Ot577z306tUL8fHxiIqKwsGDBxEcHKy+T1ZWFmbNmoUzZ85g27Zt+Pvvv9UL/fb29ti8eTOAnD00/vnnHyxcuLBIYwgNDUWPHj1w9uxZDBs2DAcOHMCgQYMQEhKCCxcuYPny5YiMjFTHAhERERERFYyNkYONQUREREQkH/siB/uCiIjy4unniMjkCSEQGxuL//3vfxg9erTGbXXq1AEA9V4G3bp1Q6NGjQDk7KkQGRmJTz75BMuWLYO3tzfatGmDvn37wtPTU+tjnj17FlZWVurLrq6uOHr0KGbPno0BAwZg7NixAID69etj0aJFaNOmDZYuXYry5ctj2LBh6umcnJywaNEi+Pr6IiMjA1ZWVupDwNrZ2aFq1apFfj369++PoUOHqi8PGzYMU6ZMweDBg9WPOWvWLEyaNAkzZswo8vyJiIiIiEwdG0MTG4OIiIiISH/sC03sCyIiyosbNRGRyfrtt99gZWWFrKwsZGdno3///hqHMQWAAwcOoGLFijhy5Ai++eYbLFu2TOP2Xr16oUuXLjhw4ACOHDmCnTt3Ijw8HCtWrFDveVCQhg0bahwmtly5cgCAM2fOID4+HuvWrVPfJoRAdnY2EhMT0bhxY5w4cQKhoaE4c+YMUlNTkZ2dDQBISkqCq6urzFcF8PHx0bh85swZHDp0SGOvhpcvXyIzMxP//vsvKlasKPsxiYiIiIhMARujYGwMIiIiIqKiY18UjH1BRER5caMmIjJZ7dq1w9KlS2FhYYFatWrB3Dz/W56joyOqVq2Khg0b4v79++jTpw/279+vcZ/y5cvD398f/v7+mD59Oj7++GPMmDFDaxBYWFjAxcUl3/UZGRn49NNPMWbMmHy3OTg44MmTJwgICEBAQADWrVsHW1tbJCUlISAgoNDDzuYyMzODEELjuqysrHz3s7S0zDemsLAw9OzZM999y5cvr/UxiYiIiIhKEzYGG4OIiIiIyFDYF+wLIiLSjRs1EZHJsrS0LHChvDCjRo3C7NmzsXXrVvTo0aPQ+7m6umLbtm16jcnb2xsXLlwodFxnz57Fw4cPMWfOHNjb2wMAjh8/rnGf3PNlv3z5UuN6W1tb/PPPP+rL6enpSExMlDSmy5cvF+m1IiIiIiIqjdgYbAwiIiIiIkNhX7AviIhINzOlB0BEZCwqVqyITz75BDNmzIAQAg8fPkT79u2xdu1axMfHIzExERs3bkR4eDi6d++u12NMnjwZhw8fRnBwME6fPo2rV68iJiYGwcHBAHL2dLCwsMAPP/yAhIQEbN++HbNmzdKYR926daFSqfDbb78hOTkZGRkZAID27dtjzZo1OHDgAM6ePYvBgwejTJkyOsf01VdfYfXq1QgLC8P58+dx8eJFbNiwAV9++aVez5GIiIiIiHKwMdgYRERERESGwr5gXxARlUbcqImIKI/g4GBcvHgRGzduhJWVFd5++20sWLAArVu3hru7O6ZPn45PPvkEixcv1mv+np6e2LdvH65cuQI/Pz94eXnhq6++Qq1atQDk7KkQGRmJjRs3wtXVFXPmzMG3336rMY/atWsjLCwMU6ZMQY0aNdQxMXXqVLRp0wYffPABunTpgsDAQDg7O+scU0BAAH777Tf8+eef8PX1RYsWLbBgwQLUrVtXr+dIRERERESvsDHYGEREREREhsK+YF8QEZU2KvH6yUuJiIiIiIiIiIiIiIiIiIiIiIgUxCM1ERERERERERERERERERERERGRUeFGTUREREREREREREREREREREREZFS4URMRERERERERERERERERERERERkVbtRERERERERERERERERERERERERGhRs1ERERERERERERERERERERERGRUeFGTUREREREREREREREREREREREZFS4URMRERERERERERERERERERERERkVbtRERERERERERERERERERERERERGhRs1ERERERERERERERERERERERGRUeFGTUREREREREREREREREREREREZFS4URMRERERERERERERERERERERERmV/wcaS88U+qtj1wAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 2400x1000 with 6 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Gamma heatmap (PRS only, first 36 features, exclude healthy sig)\n",
    "n_prs = 36\n",
    "n_plots = len(pooled)\n",
    "fig, axes = plt.subplots(1, n_plots, figsize=(8 * n_plots, 10))\n",
    "if n_plots == 1:\n",
    "    axes = [axes]\n",
    "\n",
    "for ax, (name, (phi, psi, kappa, gamma)) in zip(axes, pooled.items()):\n",
    "    g = gamma[:n_prs, :20]  # PRS x disease sigs\n",
    "    vmax = np.abs(g).max()\n",
    "    im = ax.imshow(g.T, aspect='auto', cmap='RdBu_r', vmin=-vmax, vmax=vmax)\n",
    "    ax.set_xlabel('PRS Feature')\n",
    "    ax.set_ylabel('Signature')\n",
    "    ax.set_title(f'{name}: Pooled Gamma (PRS only)')\n",
    "    ax.set_xticks(range(n_prs))\n",
    "    ax.set_xticklabels(PRS_NAMES, rotation=90, fontsize=7)\n",
    "    ax.set_yticks(range(20))\n",
    "    plt.colorbar(im, ax=ax, shrink=0.8)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 2c. Psi shifts from initialization"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Psi flips from initialization (pooled):\n",
      "  (v2 nokappa reference: nolr=0, reparam_v1=13, nokappa_v2=2)\n",
      "\n",
      "  constant: 8/348 diseases flipped\n",
      "  cos300: 0/348 diseases flipped\n",
      "  clip: 8/348 diseases flipped\n",
      "\n",
      "Per-batch mean |psi - psi_init|:\n",
      "  constant: mean=0.992974  (per batch: ['0.9908', '1.0089', '0.9684', '0.9760', '1.0103', '0.9838', '0.9987', '1.0006', '1.0060', '0.9863'])\n",
      "  cos300: mean=0.710905  (per batch: ['0.7060', '0.7207', '0.6987', '0.7017', '0.7347', '0.7054', '0.7184', '0.7195', '0.7096', '0.6944'])\n",
      "  clip: mean=0.992974  (per batch: ['0.9908', '1.0089', '0.9684', '0.9760', '1.0103', '0.9838', '0.9987', '1.0006', '1.0060', '0.9863'])\n"
     ]
    }
   ],
   "source": [
    "# Load initial psi\n",
    "initial_psi = torch.load(str(DATA_DIR / 'initial_psi_400k.pt'), weights_only=False)\n",
    "init_psi_np = initial_psi.detach().cpu().numpy() if torch.is_tensor(initial_psi) else np.array(initial_psi)\n",
    "K_dis = 20\n",
    "argmax_init = np.argmax(init_psi_np[:K_dis], axis=0)\n",
    "\n",
    "print('Psi flips from initialization (pooled):')\n",
    "print(f'  (v2 nokappa reference: nolr=0, reparam_v1=13, nokappa_v2=2)\\n')\n",
    "\n",
    "for name, (phi, psi, kappa, gamma) in pooled.items():\n",
    "    if psi is None:\n",
    "        print(f'  {name}: psi=None (no psi data)')\n",
    "        continue\n",
    "    argmax_pooled = np.argmax(psi[:K_dis], axis=0)\n",
    "    flips = (argmax_init != argmax_pooled).sum()\n",
    "    print(f'  {name}: {flips}/348 diseases flipped')\n",
    "\n",
    "# Per-batch psi drift from init\n",
    "print('\\nPer-batch mean |psi - psi_init|:')\n",
    "for name, (all_phi, all_psi, all_kappa, all_gamma, _) in loaded.items():\n",
    "    diffs = []\n",
    "    for psi_b in all_psi:\n",
    "        if psi_b is not None:\n",
    "            diff = np.abs(psi_b[:K_dis] - init_psi_np[:K_dis]).mean()\n",
    "            diffs.append(diff)\n",
    "    print(f'  {name}: mean={np.mean(diffs):.6f}  (per batch: {[\"{:.4f}\".format(d) for d in diffs]})')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "phi correlations (pairwise):\n",
      "  constant vs cos300: 0.9717\n",
      "  constant vs clip: 1.0000\n",
      "  cos300 vs clip: 0.9717\n",
      "\n",
      "psi correlations (pairwise):\n",
      "  constant vs cos300: 0.9362\n",
      "  constant vs clip: 1.0000\n",
      "  cos300 vs clip: 0.9362\n",
      "\n",
      "gamma correlations (pairwise):\n",
      "  constant vs cos300: 0.8733\n",
      "  constant vs clip: 1.0000\n",
      "  cos300 vs clip: 0.8733\n"
     ]
    }
   ],
   "source": [
    "# Cross-config correlations (pairwise)\n",
    "config_names = list(pooled.keys())\n",
    "for param_name in ['phi', 'psi', 'gamma']:\n",
    "    idx = {'phi': 0, 'psi': 1, 'gamma': 3}[param_name]\n",
    "    print(f'\\n{param_name} correlations (pairwise):')\n",
    "    for i in range(len(config_names)):\n",
    "        for j in range(i + 1, len(config_names)):\n",
    "            a = pooled[config_names[i]][idx]\n",
    "            b = pooled[config_names[j]][idx]\n",
    "            if a is not None and b is not None:\n",
    "                corr = np.corrcoef(a.flatten(), b.flatten())[0, 1]\n",
    "                print(f'  {config_names[i]} vs {config_names[j]}: {corr:.4f}')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 3. Holdout Prediction\n",
    "\n",
    "Fix φ, ψ, γ (pooled from training). Fit δ on holdout (390k–400k). Extract π."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading data...\n",
      "Holdout: 10000 individuals (390000-400000)\n",
      "Y: torch.Size([10000, 348, 52]), E: torch.Size([10000, 348]), G: (10000, 47)\n"
     ]
    }
   ],
   "source": [
    "# Load holdout data\n",
    "print('Loading data...')\n",
    "Y_full = torch.load(str(DATA_DIR / 'Y_tensor.pt'), weights_only=False)\n",
    "E_full = torch.load(str(DATA_DIR / 'E_enrollment_full.pt'), weights_only=False)\n",
    "G_full = torch.load(str(DATA_DIR / 'G_matrix.pt'), weights_only=False)\n",
    "essentials = torch.load(str(DATA_DIR / 'model_essentials.pt'), weights_only=False)\n",
    "disease_names = essentials['disease_names']\n",
    "refs = torch.load(str(DATA_DIR / 'reference_trajectories.pt'), weights_only=False)\n",
    "signature_refs = refs['signature_refs']\n",
    "del refs\n",
    "prevalence_t = torch.load(str(DATA_DIR / 'prevalence_t_corrected.pt'), weights_only=False)\n",
    "\n",
    "# Slice holdout\n",
    "idx = list(range(HOLDOUT_START, HOLDOUT_END))\n",
    "Y_holdout = Y_full[idx]\n",
    "E_holdout = E_full[idx]\n",
    "G_holdout = G_full[idx]\n",
    "del Y_full, E_full, G_full\n",
    "gc.collect()\n",
    "\n",
    "# Add sex + PCs to G\n",
    "fh = pd.read_csv(COV_PATH)\n",
    "sex = fh['Sex'].map({'Female': 0, 'Male': 1}).astype(int).values if 'Sex' in fh.columns else fh['sex'].values\n",
    "sex_h = sex[HOLDOUT_START:HOLDOUT_END]\n",
    "pc_cols = [f'f.22009.0.{i}' for i in range(1, 11)]\n",
    "pcs = fh.iloc[HOLDOUT_START:HOLDOUT_END][pc_cols].values\n",
    "G_with_sex = np.column_stack([G_holdout, sex_h, pcs])\n",
    "\n",
    "# PCE data for AUC\n",
    "pce_df = pd.read_csv(PCE_PATH).iloc[HOLDOUT_START:HOLDOUT_END].reset_index(drop=True)\n",
    "if 'Sex' not in pce_df.columns and 'sex' in pce_df.columns:\n",
    "    pce_df['Sex'] = pce_df['sex'].map({0: 'Female', 1: 'Male'}).fillna('Unknown')\n",
    "if 'sex' not in pce_df.columns and 'Sex' in pce_df.columns:\n",
    "    pce_df['sex'] = pce_df['Sex'].map({'Female': 0, 'Male': 1}).fillna(-1)\n",
    "if 'age' not in pce_df.columns and 'Age' in pce_df.columns:\n",
    "    pce_df['age'] = pce_df['Age']\n",
    "\n",
    "print(f'Holdout: {len(idx)} individuals ({HOLDOUT_START}-{HOLDOUT_END})')\n",
    "print(f'Y: {Y_holdout.shape}, E: {E_holdout.shape}, G: {G_with_sex.shape}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "============================================================\n",
      "CONSTANT: fitting delta on holdout (200 epochs)...\n",
      "============================================================\n",
      "Pre-calculated phi GP loss: 26.4495\n",
      "Using fixed gamma with shape: torch.Size([47, 21])\n",
      "Using fixed kappa: 1.000000\n",
      "Initializing delta (reparam) with 20 disease + 1 healthy\n",
      "  lambda = mean(gamma) + delta (gamma in forward)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:55: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.prevalence_t = torch.tensor(prevalence_t, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:99: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.signature_refs = torch.tensor(signature_references, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:129: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.Y = torch.tensor(Y, dtype=torch.float32)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Epoch 0 (REPARAM): Loss=15.8108, LR=1.0e-01\n",
      "Epoch 10 (REPARAM): Loss=81.8111, LR=9.9e-02\n",
      "Epoch 20 (REPARAM): Loss=35.6794, LR=9.7e-02\n",
      "Epoch 30 (REPARAM): Loss=22.2181, LR=9.4e-02\n",
      "Epoch 40 (REPARAM): Loss=17.3290, LR=9.0e-02\n",
      "Epoch 50 (REPARAM): Loss=15.5892, LR=8.5e-02\n",
      "Epoch 60 (REPARAM): Loss=14.9038, LR=7.9e-02\n",
      "Epoch 70 (REPARAM): Loss=14.5694, LR=7.2e-02\n",
      "Epoch 80 (REPARAM): Loss=14.3683, LR=6.5e-02\n",
      "Epoch 90 (REPARAM): Loss=14.2240, LR=5.7e-02\n",
      "Epoch 100 (REPARAM): Loss=14.1102, LR=5.0e-02\n",
      "Epoch 110 (REPARAM): Loss=14.0170, LR=4.2e-02\n",
      "Epoch 120 (REPARAM): Loss=13.9404, LR=3.4e-02\n",
      "Epoch 130 (REPARAM): Loss=13.8785, LR=2.7e-02\n",
      "Epoch 140 (REPARAM): Loss=13.8299, LR=2.1e-02\n",
      "Epoch 150 (REPARAM): Loss=13.7932, LR=1.5e-02\n",
      "Epoch 160 (REPARAM): Loss=13.7670, LR=1.0e-02\n",
      "Epoch 170 (REPARAM): Loss=13.7497, LR=6.0e-03\n",
      "Epoch 180 (REPARAM): Loss=13.7394, LR=3.2e-03\n",
      "Epoch 190 (REPARAM): Loss=13.7341, LR=1.5e-03\n",
      "  Holdout loss: 13.7316  |  NaN in pi: 0\n",
      "\n",
      "============================================================\n",
      "COS300: fitting delta on holdout (200 epochs)...\n",
      "============================================================\n",
      "Pre-calculated phi GP loss: 15.6798\n",
      "Using fixed gamma with shape: torch.Size([47, 21])\n",
      "Using fixed kappa: 1.000000\n",
      "Initializing delta (reparam) with 20 disease + 1 healthy\n",
      "  lambda = mean(gamma) + delta (gamma in forward)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:55: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.prevalence_t = torch.tensor(prevalence_t, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:99: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.signature_refs = torch.tensor(signature_references, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:129: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.Y = torch.tensor(Y, dtype=torch.float32)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Epoch 0 (REPARAM): Loss=15.8295, LR=1.0e-01\n",
      "Epoch 10 (REPARAM): Loss=78.5492, LR=9.9e-02\n",
      "Epoch 20 (REPARAM): Loss=34.5988, LR=9.7e-02\n",
      "Epoch 30 (REPARAM): Loss=22.1849, LR=9.4e-02\n",
      "Epoch 40 (REPARAM): Loss=17.7288, LR=9.0e-02\n",
      "Epoch 50 (REPARAM): Loss=16.1697, LR=8.5e-02\n",
      "Epoch 51 (REPARAM): Early stop (no improvement for 50 epochs, best=15.8295 at epoch 0)\n",
      "  Holdout loss: 16.0694  |  NaN in pi: 0\n",
      "\n",
      "============================================================\n",
      "CLIP: fitting delta on holdout (200 epochs)...\n",
      "============================================================\n",
      "Pre-calculated phi GP loss: 26.4495\n",
      "Using fixed gamma with shape: torch.Size([47, 21])\n",
      "Using fixed kappa: 1.000000\n",
      "Initializing delta (reparam) with 20 disease + 1 healthy\n",
      "  lambda = mean(gamma) + delta (gamma in forward)\n",
      "Epoch 0 (REPARAM): Loss=15.8108, LR=1.0e-01\n",
      "Epoch 10 (REPARAM): Loss=81.8111, LR=9.9e-02\n",
      "Epoch 20 (REPARAM): Loss=35.6794, LR=9.7e-02\n",
      "Epoch 30 (REPARAM): Loss=22.2181, LR=9.4e-02\n",
      "Epoch 40 (REPARAM): Loss=17.3290, LR=9.0e-02\n",
      "Epoch 50 (REPARAM): Loss=15.5892, LR=8.5e-02\n",
      "Epoch 60 (REPARAM): Loss=14.9038, LR=7.9e-02\n",
      "Epoch 70 (REPARAM): Loss=14.5694, LR=7.2e-02\n",
      "Epoch 80 (REPARAM): Loss=14.3683, LR=6.5e-02\n",
      "Epoch 90 (REPARAM): Loss=14.2240, LR=5.7e-02\n",
      "Epoch 100 (REPARAM): Loss=14.1102, LR=5.0e-02\n",
      "Epoch 110 (REPARAM): Loss=14.0170, LR=4.2e-02\n",
      "Epoch 120 (REPARAM): Loss=13.9404, LR=3.4e-02\n",
      "Epoch 130 (REPARAM): Loss=13.8785, LR=2.7e-02\n",
      "Epoch 140 (REPARAM): Loss=13.8299, LR=2.1e-02\n",
      "Epoch 150 (REPARAM): Loss=13.7932, LR=1.5e-02\n",
      "Epoch 160 (REPARAM): Loss=13.7670, LR=1.0e-02\n",
      "Epoch 170 (REPARAM): Loss=13.7497, LR=6.0e-03\n",
      "Epoch 180 (REPARAM): Loss=13.7394, LR=3.2e-03\n",
      "Epoch 190 (REPARAM): Loss=13.7341, LR=1.5e-03\n",
      "  Holdout loss: 13.7316  |  NaN in pi: 0\n",
      "\n",
      "============================================================\n",
      "HOLDOUT LOSS SUMMARY\n",
      "  constant: 13.7316\n",
      "  cos300: 16.0694\n",
      "  clip: 13.7316\n",
      "  → Best: constant (loss=13.7316)\n"
     ]
    }
   ],
   "source": [
    "# Fit delta on holdout for each config\n",
    "holdout_results = {}  # config_name -> {'pi': ..., 'loss': ...}\n",
    "\n",
    "for name, (phi, psi, kappa, gamma) in pooled.items():\n",
    "    print(f'\\n{\"=\"*60}')\n",
    "    print(f'{name.upper()}: fitting delta on holdout (200 epochs)...')\n",
    "    print(f'{\"=\"*60}')\n",
    "\n",
    "    pi, loss = fit_and_extract_pi(\n",
    "        Y_holdout, E_holdout, G_with_sex,\n",
    "        phi, psi, kappa, gamma,\n",
    "        signature_refs, prevalence_t, disease_names,\n",
    "        num_epochs=200, learning_rate=0.1,\n",
    "    )\n",
    "\n",
    "    n_nan = torch.isnan(pi).sum().item() if torch.is_tensor(pi) else 0\n",
    "    holdout_results[name] = {'pi': pi, 'loss': loss}\n",
    "    print(f'  Holdout loss: {loss:.4f}  |  NaN in pi: {n_nan}')\n",
    "\n",
    "print(f'\\n{\"=\"*60}')\n",
    "print('HOLDOUT LOSS SUMMARY')\n",
    "for name, data in holdout_results.items():\n",
    "    print(f'  {name}: {data[\"loss\"]:.4f}')\n",
    "best = min(holdout_results.items(), key=lambda x: x[1]['loss'])\n",
    "print(f'  → Best: {best[0]} (loss={best[1][\"loss\"]:.4f})')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 4. AUC Comparison (Dynamic 10-Year)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Evaluating constant...\n",
      "\n",
      "Evaluating ASCVD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.732 (0.716-0.746) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.699-0.734) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (Dynamic 10-Year Risk)...\n",
      "AUC: 0.708 (0.683-0.733) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 9860 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.714 (0.685-0.745) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.691-0.739) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (Dynamic 10-Year Risk)...\n",
      "AUC: 0.663 (0.619-0.698) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (Dynamic 10-Year Risk)...\n",
      "AUC: 0.726 (0.699-0.753) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.676 (0.646-0.702) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.663 (0.638-0.694) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.686 (0.662-0.714) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 9970 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.603 (0.584-0.628) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.634 (0.598-0.690) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.581 (0.541-0.620) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.706 (0.669-0.741) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.1%) (from 4386 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.675 (0.637-0.719) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 9995 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.746 (0.674-0.809) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 9977 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.608 (0.582-0.642) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (Dynamic 10-Year Risk)...\n",
      "AUC: 0.524 (0.500-0.553) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 9894 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (Dynamic 10-Year Risk)...\n",
      "AUC: 0.527 (0.502-0.563) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 9981 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (Dynamic 10-Year Risk)...\n",
      "AUC: 0.402 (0.317-0.512) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.620 (0.575-0.663) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 9952 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.632 (0.574-0.700) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.559 (0.484-0.635) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 9940 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (Dynamic 10-Year Risk)...\n",
      "AUC: 0.574 (0.427-0.700) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 9967 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (Dynamic 10-Year Risk)...\n",
      "AUC: 0.537 (0.510-0.560) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.5%) (from 9704 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (Dynamic 10-Year Risk)...\n",
      "AUC: 0.766 (0.696-0.823) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 9992 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.558 (0.396-0.712) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 9987 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (Dynamic 10-Year Risk)...\n",
      "AUC: 0.585 (0.560-0.610) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (Dynamic 10-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.732 (0.716-0.746)       901        9.0\n",
      "Diabetes             0.716 (0.699-0.734)       613        6.1\n",
      "Atrial_Fib           0.708 (0.683-0.733)       379        3.8\n",
      "CKD                  0.714 (0.685-0.745)       184        1.8\n",
      "All_Cancers          0.716 (0.691-0.739)       499        5.0\n",
      "Stroke               0.663 (0.619-0.698)       142        1.4\n",
      "Heart_Failure        0.726 (0.699-0.753)       210        2.1\n",
      "Pneumonia            0.676 (0.646-0.702)       351        3.5\n",
      "COPD                 0.663 (0.638-0.694)       429        4.3\n",
      "Osteoporosis         0.686 (0.662-0.714)       223        2.2\n",
      "Anemia               0.603 (0.584-0.628)       552        5.5\n",
      "Colorectal_Cancer    0.634 (0.598-0.690)       118        1.2\n",
      "Breast_Cancer        0.581 (0.541-0.620)       225        4.0\n",
      "Prostate_Cancer      0.706 (0.669-0.741)       178        4.1\n",
      "Lung_Cancer          0.675 (0.637-0.719)       90         0.9\n",
      "Bladder_Cancer       0.746 (0.674-0.809)       58         0.6\n",
      "Secondary_Cancer     0.608 (0.582-0.642)       307        3.1\n",
      "Depression           0.524 (0.500-0.553)       410        4.1\n",
      "Anxiety              0.527 (0.502-0.563)       260        2.6\n",
      "Bipolar_Disorder     0.402 (0.317-0.512)       23         0.2\n",
      "Rheumatoid_Arthritis 0.620 (0.575-0.663)       116        1.2\n",
      "Psoriasis            0.632 (0.574-0.700)       54         0.5\n",
      "Ulcerative_Colitis   0.559 (0.484-0.635)       52         0.5\n",
      "Crohns_Disease       0.574 (0.427-0.700)       30         0.3\n",
      "Asthma               0.537 (0.510-0.560)       635        6.5\n",
      "Parkinsons           0.766 (0.696-0.823)       53         0.5\n",
      "Multiple_Sclerosis   0.558 (0.396-0.712)       18         0.2\n",
      "Thyroid_Disorders    0.585 (0.560-0.610)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "Evaluating cos300...\n",
      "\n",
      "Evaluating ASCVD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.725 (0.706-0.737) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (Dynamic 10-Year Risk)...\n",
      "AUC: 0.705 (0.684-0.724) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (Dynamic 10-Year Risk)...\n",
      "AUC: 0.682 (0.659-0.708) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 9860 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.699 (0.669-0.735) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (Dynamic 10-Year Risk)...\n",
      "AUC: 0.712 (0.691-0.734) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (Dynamic 10-Year Risk)...\n",
      "AUC: 0.639 (0.589-0.685) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (Dynamic 10-Year Risk)...\n",
      "AUC: 0.721 (0.686-0.749) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.666 (0.640-0.689) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.652 (0.632-0.681) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.685-0.749) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 9970 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.586 (0.561-0.612) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.623 (0.561-0.677) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.564 (0.530-0.606) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.718 (0.674-0.751) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.1%) (from 4386 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.655 (0.608-0.701) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 9995 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.736 (0.689-0.791) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 9977 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.603 (0.568-0.637) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (Dynamic 10-Year Risk)...\n",
      "AUC: 0.499 (0.470-0.521) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 9894 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (Dynamic 10-Year Risk)...\n",
      "AUC: 0.531 (0.496-0.555) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 9981 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (Dynamic 10-Year Risk)...\n",
      "AUC: 0.372 (0.294-0.450) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.617 (0.567-0.670) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 9952 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.621 (0.563-0.701) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.525 (0.452-0.618) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 9940 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (Dynamic 10-Year Risk)...\n",
      "AUC: 0.527 (0.439-0.635) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 9967 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (Dynamic 10-Year Risk)...\n",
      "AUC: 0.534 (0.513-0.557) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.5%) (from 9704 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (Dynamic 10-Year Risk)...\n",
      "AUC: 0.757 (0.694-0.817) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 9992 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.531 (0.414-0.663) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 9987 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (Dynamic 10-Year Risk)...\n",
      "AUC: 0.621 (0.599-0.650) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (Dynamic 10-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.725 (0.706-0.737)       901        9.0\n",
      "Diabetes             0.705 (0.684-0.724)       613        6.1\n",
      "Atrial_Fib           0.682 (0.659-0.708)       379        3.8\n",
      "CKD                  0.699 (0.669-0.735)       184        1.8\n",
      "All_Cancers          0.712 (0.691-0.734)       499        5.0\n",
      "Stroke               0.639 (0.589-0.685)       142        1.4\n",
      "Heart_Failure        0.721 (0.686-0.749)       210        2.1\n",
      "Pneumonia            0.666 (0.640-0.689)       351        3.5\n",
      "COPD                 0.652 (0.632-0.681)       429        4.3\n",
      "Osteoporosis         0.716 (0.685-0.749)       223        2.2\n",
      "Anemia               0.586 (0.561-0.612)       552        5.5\n",
      "Colorectal_Cancer    0.623 (0.561-0.677)       118        1.2\n",
      "Breast_Cancer        0.564 (0.530-0.606)       225        4.0\n",
      "Prostate_Cancer      0.718 (0.674-0.751)       178        4.1\n",
      "Lung_Cancer          0.655 (0.608-0.701)       90         0.9\n",
      "Bladder_Cancer       0.736 (0.689-0.791)       58         0.6\n",
      "Secondary_Cancer     0.603 (0.568-0.637)       307        3.1\n",
      "Depression           0.499 (0.470-0.521)       410        4.1\n",
      "Anxiety              0.531 (0.496-0.555)       260        2.6\n",
      "Bipolar_Disorder     0.372 (0.294-0.450)       23         0.2\n",
      "Rheumatoid_Arthritis 0.617 (0.567-0.670)       116        1.2\n",
      "Psoriasis            0.621 (0.563-0.701)       54         0.5\n",
      "Ulcerative_Colitis   0.525 (0.452-0.618)       52         0.5\n",
      "Crohns_Disease       0.527 (0.439-0.635)       30         0.3\n",
      "Asthma               0.534 (0.513-0.557)       635        6.5\n",
      "Parkinsons           0.757 (0.694-0.817)       53         0.5\n",
      "Multiple_Sclerosis   0.531 (0.414-0.663)       18         0.2\n",
      "Thyroid_Disorders    0.621 (0.599-0.650)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "Evaluating clip...\n",
      "\n",
      "Evaluating ASCVD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.732 (0.716-0.747) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.695-0.735) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (Dynamic 10-Year Risk)...\n",
      "AUC: 0.708 (0.686-0.727) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 9860 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.714 (0.682-0.752) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.695-0.741) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (Dynamic 10-Year Risk)...\n",
      "AUC: 0.663 (0.629-0.692) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (Dynamic 10-Year Risk)...\n",
      "AUC: 0.726 (0.699-0.755) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.676 (0.650-0.703) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.663 (0.641-0.686) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.686 (0.652-0.723) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 9970 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.603 (0.578-0.625) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.634 (0.585-0.672) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.581 (0.540-0.613) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.706 (0.673-0.740) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.1%) (from 4386 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.675 (0.630-0.715) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 9995 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.746 (0.672-0.813) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 9977 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.608 (0.573-0.635) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (Dynamic 10-Year Risk)...\n",
      "AUC: 0.524 (0.501-0.548) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 9894 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (Dynamic 10-Year Risk)...\n",
      "AUC: 0.527 (0.492-0.554) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 9981 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (Dynamic 10-Year Risk)...\n",
      "AUC: 0.402 (0.322-0.506) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.620 (0.566-0.670) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 9952 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.632 (0.571-0.697) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.559 (0.470-0.623) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 9940 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (Dynamic 10-Year Risk)...\n",
      "AUC: 0.574 (0.459-0.685) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 9967 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (Dynamic 10-Year Risk)...\n",
      "AUC: 0.537 (0.512-0.556) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.5%) (from 9704 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (Dynamic 10-Year Risk)...\n",
      "AUC: 0.766 (0.700-0.821) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 9992 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.558 (0.445-0.665) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 9987 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (Dynamic 10-Year Risk)...\n",
      "AUC: 0.585 (0.564-0.608) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (Dynamic 10-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.732 (0.716-0.747)       901        9.0\n",
      "Diabetes             0.716 (0.695-0.735)       613        6.1\n",
      "Atrial_Fib           0.708 (0.686-0.727)       379        3.8\n",
      "CKD                  0.714 (0.682-0.752)       184        1.8\n",
      "All_Cancers          0.716 (0.695-0.741)       499        5.0\n",
      "Stroke               0.663 (0.629-0.692)       142        1.4\n",
      "Heart_Failure        0.726 (0.699-0.755)       210        2.1\n",
      "Pneumonia            0.676 (0.650-0.703)       351        3.5\n",
      "COPD                 0.663 (0.641-0.686)       429        4.3\n",
      "Osteoporosis         0.686 (0.652-0.723)       223        2.2\n",
      "Anemia               0.603 (0.578-0.625)       552        5.5\n",
      "Colorectal_Cancer    0.634 (0.585-0.672)       118        1.2\n",
      "Breast_Cancer        0.581 (0.540-0.613)       225        4.0\n",
      "Prostate_Cancer      0.706 (0.673-0.740)       178        4.1\n",
      "Lung_Cancer          0.675 (0.630-0.715)       90         0.9\n",
      "Bladder_Cancer       0.746 (0.672-0.813)       58         0.6\n",
      "Secondary_Cancer     0.608 (0.573-0.635)       307        3.1\n",
      "Depression           0.524 (0.501-0.548)       410        4.1\n",
      "Anxiety              0.527 (0.492-0.554)       260        2.6\n",
      "Bipolar_Disorder     0.402 (0.322-0.506)       23         0.2\n",
      "Rheumatoid_Arthritis 0.620 (0.566-0.670)       116        1.2\n",
      "Psoriasis            0.632 (0.571-0.697)       54         0.5\n",
      "Ulcerative_Colitis   0.559 (0.470-0.623)       52         0.5\n",
      "Crohns_Disease       0.574 (0.459-0.685)       30         0.3\n",
      "Asthma               0.537 (0.512-0.556)       635        6.5\n",
      "Parkinsons           0.766 (0.700-0.821)       53         0.5\n",
      "Multiple_Sclerosis   0.558 (0.445-0.665)       18         0.2\n",
      "Thyroid_Disorders    0.585 (0.564-0.608)       458        4.6\n",
      "--------------------------------------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "auc_results = {}\n",
    "\n",
    "for name, data in holdout_results.items():\n",
    "    print(f'\\nEvaluating {name}...')\n",
    "    res = evaluate_major_diseases_wsex_with_bootstrap_dynamic_from_pi(\n",
    "        pi=data['pi'],\n",
    "        Y_100k=Y_holdout,\n",
    "        E_100k=E_holdout,\n",
    "        disease_names=disease_names,\n",
    "        pce_df=pce_df,\n",
    "        n_bootstraps=100,\n",
    "        follow_up_duration_years=10,\n",
    "    )\n",
    "    auc_results[name] = res"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DISEASE                                    constant                 cos300                   clip     BEST\n",
      "----------------------------------------------------------------------------------------------------------\n",
      "ASCVD                        0.732 (0.716-0.746) 0.725 (0.706-0.737) 0.732 (0.716-0.747) constant\n",
      "All_Cancers                  0.716 (0.691-0.739) 0.712 (0.691-0.734) 0.716 (0.695-0.741) constant\n",
      "Anemia                       0.603 (0.584-0.628) 0.586 (0.561-0.612) 0.603 (0.578-0.625) constant\n",
      "Anxiety                      0.527 (0.502-0.563) 0.531 (0.496-0.555) 0.527 (0.492-0.554)   cos300\n",
      "Asthma                       0.537 (0.510-0.560) 0.534 (0.513-0.557) 0.537 (0.512-0.556) constant\n",
      "Atrial_Fib                   0.708 (0.683-0.733) 0.682 (0.659-0.708) 0.708 (0.686-0.727) constant\n",
      "Bipolar_Disorder             0.402 (0.317-0.512) 0.372 (0.294-0.450) 0.402 (0.322-0.506) constant\n",
      "Bladder_Cancer               0.746 (0.674-0.809) 0.736 (0.689-0.791) 0.746 (0.672-0.813) constant\n",
      "Breast_Cancer                0.581 (0.541-0.620) 0.564 (0.530-0.606) 0.581 (0.540-0.613) constant\n",
      "CKD                          0.714 (0.685-0.745) 0.699 (0.669-0.735) 0.714 (0.682-0.752) constant\n",
      "COPD                         0.663 (0.638-0.694) 0.652 (0.632-0.681) 0.663 (0.641-0.686) constant\n",
      "Colorectal_Cancer            0.634 (0.598-0.690) 0.623 (0.561-0.677) 0.634 (0.585-0.672) constant\n",
      "Crohns_Disease               0.574 (0.427-0.700) 0.527 (0.439-0.635) 0.574 (0.459-0.685) constant\n",
      "Depression                   0.524 (0.500-0.553) 0.499 (0.470-0.521) 0.524 (0.501-0.548) constant\n",
      "Diabetes                     0.716 (0.699-0.734) 0.705 (0.684-0.724) 0.716 (0.695-0.735) constant\n",
      "Heart_Failure                0.726 (0.699-0.753) 0.721 (0.686-0.749) 0.726 (0.699-0.755) constant\n",
      "Lung_Cancer                  0.675 (0.637-0.719) 0.655 (0.608-0.701) 0.675 (0.630-0.715) constant\n",
      "Multiple_Sclerosis           0.558 (0.396-0.712) 0.531 (0.414-0.663) 0.558 (0.445-0.665) constant\n",
      "Osteoporosis                 0.686 (0.662-0.714) 0.716 (0.685-0.749) 0.686 (0.652-0.723)   cos300\n",
      "Parkinsons                   0.766 (0.696-0.823) 0.757 (0.694-0.817) 0.766 (0.700-0.821) constant\n",
      "Pneumonia                    0.676 (0.646-0.702) 0.666 (0.640-0.689) 0.676 (0.650-0.703) constant\n",
      "Prostate_Cancer              0.706 (0.669-0.741) 0.718 (0.674-0.751) 0.706 (0.673-0.740)   cos300\n",
      "Psoriasis                    0.632 (0.574-0.700) 0.621 (0.563-0.701) 0.632 (0.571-0.697) constant\n",
      "Rheumatoid_Arthritis         0.620 (0.575-0.663) 0.617 (0.567-0.670) 0.620 (0.566-0.670) constant\n",
      "Secondary_Cancer             0.608 (0.582-0.642) 0.603 (0.568-0.637) 0.608 (0.573-0.635) constant\n",
      "Stroke                       0.663 (0.619-0.698) 0.639 (0.589-0.685) 0.663 (0.629-0.692) constant\n",
      "Thyroid_Disorders            0.585 (0.560-0.610) 0.621 (0.599-0.650) 0.585 (0.564-0.608)   cos300\n",
      "Ulcerative_Colitis           0.559 (0.484-0.635) 0.525 (0.452-0.618) 0.559 (0.470-0.623) constant\n"
     ]
    }
   ],
   "source": [
    "# AUC comparison table\n",
    "configs = list(holdout_results.keys())\n",
    "diseases = sorted(set().union(*[set(r.keys()) for r in auc_results.values()]))\n",
    "\n",
    "header = f'{\"DISEASE\":<28} ' + ' '.join(f'{c:>22}' for c in configs) + f' {\"BEST\":>8}'\n",
    "print(header)\n",
    "print('-' * len(header))\n",
    "\n",
    "rows_for_df = []\n",
    "for d in diseases:\n",
    "    row_str = [f'{d:<28}']\n",
    "    vals = []\n",
    "    row_data = {'disease': d}\n",
    "    for c in configs:\n",
    "        m = auc_results.get(c, {}).get(d, {})\n",
    "        auc = m.get('auc', np.nan)\n",
    "        ci_l = m.get('ci_lower', np.nan)\n",
    "        ci_u = m.get('ci_upper', np.nan)\n",
    "        vals.append(auc)\n",
    "        row_data[f'{c}_auc'] = auc\n",
    "        row_data[f'{c}_ci_lower'] = ci_l\n",
    "        row_data[f'{c}_ci_upper'] = ci_u\n",
    "        if np.isnan(auc):\n",
    "            row_str.append(f'{\"N/A\":>22}')\n",
    "        else:\n",
    "            row_str.append(f'{auc:.3f} ({ci_l:.3f}-{ci_u:.3f})')\n",
    "    valid = [(i, v) for i, v in enumerate(vals) if not np.isnan(v)]\n",
    "    best_name = configs[max(valid, key=lambda x: x[1])[0]] if valid else '—'\n",
    "    row_str.append(f'{best_name:>8}')\n",
    "    print(' '.join(row_str))\n",
    "    rows_for_df.append(row_data)\n",
    "\n",
    "df_auc = pd.DataFrame(rows_for_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "======================================================================\n",
      "FINAL SUMMARY\n",
      "======================================================================\n",
      "\n",
      "Holdout Loss:\n",
      "  constant: 13.7316\n",
      "  cos300: 16.0694\n",
      "  clip: 13.7316\n",
      "\n",
      "Mean AUC across diseases:\n",
      "  constant: 0.6371\n",
      "  cos300: 0.6263\n",
      "  clip: 0.6371\n",
      "\n",
      "→ Best holdout loss: constant\n",
      "→ Best mean AUC:    constant\n",
      "\n",
      "Saved AUC table to: /Users/sarahurbut/aladynoulli2/claudefile/holdout_auc_nokappa_v3_b20_30.csv\n"
     ]
    }
   ],
   "source": [
    "# Final summary\n",
    "print('=' * 70)\n",
    "print('FINAL SUMMARY')\n",
    "print('=' * 70)\n",
    "\n",
    "print('\\nHoldout Loss:')\n",
    "for c in configs:\n",
    "    print(f'  {c}: {holdout_results[c][\"loss\"]:.4f}')\n",
    "\n",
    "print('\\nMean AUC across diseases:')\n",
    "for c in configs:\n",
    "    mean_auc = df_auc[f'{c}_auc'].mean()\n",
    "    print(f'  {c}: {mean_auc:.4f}')\n",
    "\n",
    "best_loss = min(configs, key=lambda c: holdout_results[c]['loss'])\n",
    "best_auc = max(configs, key=lambda c: df_auc[f'{c}_auc'].mean())\n",
    "print(f'\\n→ Best holdout loss: {best_loss}')\n",
    "print(f'→ Best mean AUC:    {best_auc}')\n",
    "\n",
    "# Save results\n",
    "out_path = Path('/Users/sarahurbut/aladynoulli2/claudefile/holdout_auc_nokappa_v3_b20_30.csv')\n",
    "df_auc.to_csv(out_path, index=False)\n",
    "print(f'\\nSaved AUC table to: {out_path}')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5. Original Nokappa v2 (500ep, cos+clip) — Holdout Prediction\n",
    "\n",
    "Pool from `censor_e_batchrun_vectorized_REPARAM_v2_nokappa` (batches 0–39, 400k total),\n",
    "fit δ on same holdout (390k–400k), extract π."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== ORIGINAL NOKAPPA v2 (500ep, cos+clip) — batches 20-29 only ===\n",
      "Found 10 matching checkpoints (200k-300k)\n",
      "Loaded 10 checkpoints\n",
      "  Pooled: phi (21, 348, 52), gamma (47, 21), kappa=1.0000\n",
      "  mean|gamma| = 0.1366\n",
      "\n",
      "Fitting delta on holdout (200 epochs)...\n",
      "Pre-calculated phi GP loss: 24.0767\n",
      "Using fixed gamma with shape: torch.Size([47, 21])\n",
      "Using fixed kappa: 1.000000\n",
      "Initializing delta (reparam) with 20 disease + 1 healthy\n",
      "  lambda = mean(gamma) + delta (gamma in forward)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:55: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.prevalence_t = torch.tensor(prevalence_t, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:99: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.signature_refs = torch.tensor(signature_references, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:129: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.Y = torch.tensor(Y, dtype=torch.float32)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Epoch 0 (REPARAM): Loss=15.8306, LR=1.0e-01\n",
      "Epoch 10 (REPARAM): Loss=81.2399, LR=9.9e-02\n",
      "Epoch 20 (REPARAM): Loss=35.4819, LR=9.7e-02\n",
      "Epoch 30 (REPARAM): Loss=22.1958, LR=9.4e-02\n",
      "Epoch 40 (REPARAM): Loss=17.3805, LR=9.0e-02\n",
      "Epoch 50 (REPARAM): Loss=15.6711, LR=8.5e-02\n",
      "Epoch 60 (REPARAM): Loss=15.0018, LR=7.9e-02\n",
      "Epoch 70 (REPARAM): Loss=14.6791, LR=7.2e-02\n",
      "Epoch 80 (REPARAM): Loss=14.4873, LR=6.5e-02\n",
      "Epoch 90 (REPARAM): Loss=14.3504, LR=5.7e-02\n",
      "Epoch 100 (REPARAM): Loss=14.2425, LR=5.0e-02\n",
      "Epoch 110 (REPARAM): Loss=14.1539, LR=4.2e-02\n",
      "Epoch 120 (REPARAM): Loss=14.0809, LR=3.4e-02\n",
      "Epoch 130 (REPARAM): Loss=14.0217, LR=2.7e-02\n",
      "Epoch 140 (REPARAM): Loss=13.9751, LR=2.1e-02\n",
      "Epoch 150 (REPARAM): Loss=13.9399, LR=1.5e-02\n",
      "Epoch 160 (REPARAM): Loss=13.9147, LR=1.0e-02\n",
      "Epoch 170 (REPARAM): Loss=13.8981, LR=6.0e-03\n",
      "Epoch 180 (REPARAM): Loss=13.8882, LR=3.2e-03\n",
      "Epoch 190 (REPARAM): Loss=13.8831, LR=1.5e-03\n",
      "  Holdout loss: 13.8807  |  NaN in pi: 0\n",
      "\n",
      "============================================================\n",
      "UPDATED HOLDOUT LOSS SUMMARY\n",
      "  constant: 13.7316\n",
      "  cos300: 16.0694\n",
      "  clip: 13.7316\n",
      "  v2_nokappa: 13.8807\n",
      "  → Best: constant (loss=13.7316)\n"
     ]
    }
   ],
   "source": [
    "# Load and pool original nokappa v2 (500ep, cosine + clip, kappa=1)\n",
    "# FAIR COMPARISON: only use batches 20-29 (same training data as v3 configs)\n",
    "V2_NOKAPPA_DIR = DROPBOX / 'censor_e_batchrun_vectorized_REPARAM_v2_nokappa'\n",
    "\n",
    "# Only load checkpoints for batches 200k-300k (batches 20-29)\n",
    "import re\n",
    "v2_all_files = sorted(glob.glob(str(V2_NOKAPPA_DIR / 'enrollment_model_REPARAM_NOKAPPA_W0.0001_batch_*.pt')))\n",
    "v2_batch_files = []\n",
    "for fp in v2_all_files:\n",
    "    m = re.search(r'batch_(\\d+)_(\\d+)', fp)\n",
    "    if m:\n",
    "        start = int(m.group(1))\n",
    "        if 200000 <= start < 300000:\n",
    "            v2_batch_files.append(fp)\n",
    "print(f'=== ORIGINAL NOKAPPA v2 (500ep, cos+clip) — batches 20-29 only ===')\n",
    "print(f'Found {len(v2_batch_files)} matching checkpoints (200k-300k)')\n",
    "\n",
    "# Use a filtered pattern — load manually\n",
    "v2_all_phi, v2_all_psi, v2_all_kappa, v2_all_gamma = [], [], [], []\n",
    "v2_batch_stats = []\n",
    "for fp in v2_batch_files:\n",
    "    ckpt = torch.load(fp, weights_only=False)\n",
    "    def _get(name):\n",
    "        if 'model_state_dict' in ckpt and name in ckpt['model_state_dict']:\n",
    "            return ckpt['model_state_dict'][name]\n",
    "        return ckpt.get(name)\n",
    "    phi = _get('phi')\n",
    "    psi = _get('psi')\n",
    "    gamma = _get('gamma')\n",
    "    kappa = _get('kappa')\n",
    "    if phi is None or gamma is None:\n",
    "        print(f'  Skip {Path(fp).name}: missing phi or gamma')\n",
    "        continue\n",
    "    phi_np = phi.detach().cpu().numpy() if torch.is_tensor(phi) else np.array(phi)\n",
    "    psi_np = psi.detach().cpu().numpy() if torch.is_tensor(psi) else (np.array(psi) if psi is not None else None)\n",
    "    gamma_np = gamma.detach().cpu().numpy() if torch.is_tensor(gamma) else np.array(gamma)\n",
    "    kappa_val = float(kappa) if kappa is not None else 1.0\n",
    "    v2_all_phi.append(phi_np)\n",
    "    v2_all_psi.append(psi_np)\n",
    "    v2_all_kappa.append(kappa_val)\n",
    "    v2_all_gamma.append(gamma_np)\n",
    "    v2_batch_stats.append({'mean_abs_gamma': np.abs(gamma_np).mean()})\n",
    "print(f'Loaded {len(v2_all_phi)} checkpoints')\n",
    "\n",
    "v2_phi, v2_psi, v2_kappa, v2_gamma = pool_params(v2_all_phi, v2_all_psi, v2_all_kappa, v2_all_gamma)\n",
    "print(f'  Pooled: phi {v2_phi.shape}, gamma {v2_gamma.shape}, kappa={v2_kappa:.4f}')\n",
    "print(f'  mean|gamma| = {np.abs(v2_gamma).mean():.4f}')\n",
    "\n",
    "# Fit delta on same holdout\n",
    "print(f'\\nFitting delta on holdout (200 epochs)...')\n",
    "v2_pi, v2_loss = fit_and_extract_pi(\n",
    "    Y_holdout, E_holdout, G_with_sex,\n",
    "    v2_phi, v2_psi, v2_kappa, v2_gamma,\n",
    "    signature_refs, prevalence_t, disease_names,\n",
    "    num_epochs=200, learning_rate=0.1,\n",
    ")\n",
    "n_nan = torch.isnan(v2_pi).sum().item() if torch.is_tensor(v2_pi) else 0\n",
    "print(f'  Holdout loss: {v2_loss:.4f}  |  NaN in pi: {n_nan}')\n",
    "\n",
    "# Add to holdout_results\n",
    "holdout_results['v2_nokappa'] = {'pi': v2_pi, 'loss': v2_loss}\n",
    "\n",
    "print(f'\\n{\"=\"*60}')\n",
    "print('UPDATED HOLDOUT LOSS SUMMARY')\n",
    "for name, data in holdout_results.items():\n",
    "    print(f'  {name}: {data[\"loss\"]:.4f}')\n",
    "best = min(holdout_results.items(), key=lambda x: x[1]['loss'])\n",
    "print(f'  → Best: {best[0]} (loss={best[1][\"loss\"]:.4f})')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5b. Production nolr (centered param, batches 20-29) — Holdout Prediction\n",
    "\n",
    "Pool from `censor_e_batchrun_vectorized_nolr` (same 10 batches for fair comparison).\n",
    "Uses same `fit_and_extract_pi` (reparam) for holdout prediction."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "=== PRODUCTION NOLR (centered param) — batches 20-29 only ===\n",
      "Found 10 matching checkpoints (200k-300k)\n",
      "Loaded 10 checkpoints\n",
      "  Pooled: phi (21, 348, 52), gamma (47, 21), kappa=2.9377\n",
      "  mean|gamma| = 0.0071\n",
      "\n",
      "Fitting lambda on holdout with CENTERED model (200 epochs, lr=0.1)...\n",
      "Pre-calculated phi GP loss: 18.1307\n",
      "Using fixed gamma with shape: torch.Size([47, 21])\n",
      "Using fixed kappa: 2.937716\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:55: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.prevalence_t = torch.tensor(prevalence_t, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:99: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.signature_refs = torch.tensor(signature_references, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:129: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.Y = torch.tensor(Y, dtype=torch.float32)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Initializing with 20 disease states + 1 healthy state\n",
      "Initialization complete! (gamma and kappa are fixed)\n",
      "\n",
      "Epoch 0\n",
      "Loss: 16.0615\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.030 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 10\n",
      "Loss: 174.0891\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 20\n",
      "Loss: 49.4735\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 30\n",
      "Loss: 19.2546\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.020\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 40\n",
      "Loss: 19.0653\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 50\n",
      "Loss: 17.5184\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 60\n",
      "Loss: 16.3899\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 70\n",
      "Loss: 15.9083\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.030 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 80\n",
      "Loss: 15.7522\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 90\n",
      "Loss: 15.6938\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.031 ± 0.006\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 100\n",
      "Loss: 15.6241\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.031 ± 0.006\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 110\n",
      "Loss: 15.5589\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.031 ± 0.007\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 120\n",
      "Loss: 15.5037\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.031 ± 0.008\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 130\n",
      "Loss: 15.4464\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.031 ± 0.009\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 140\n",
      "Loss: 15.3904\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.017 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.009\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.009\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.031 ± 0.010\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.030 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 150\n",
      "Loss: 15.3342\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.017 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.010\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.009\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.031 ± 0.011\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.030 ± 0.022\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 160\n",
      "Loss: 15.2784\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.017 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.010\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.027 ± 0.010\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.032 ± 0.012\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.030 ± 0.022\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 170\n",
      "Loss: 15.2232\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.017 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.011\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.028 ± 0.011\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.032 ± 0.014\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.030 ± 0.023\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 180\n",
      "Loss: 15.1687\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.017 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.012\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.028 ± 0.012\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.005\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.032 ± 0.016\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.030 ± 0.023\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Epoch 190\n",
      "Loss: 15.1141\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.46):\n",
      "  Theta for diagnosed: 0.017 ± 0.008\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=75.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.014\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=70.46):\n",
      "  Theta for diagnosed: 0.028 ± 0.013\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.005\n",
      "\n",
      "Disease 336 (signature 9, LR=69.45):\n",
      "  Theta for diagnosed: 0.032 ± 0.018\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 127 (signature 0, LR=63.52):\n",
      "  Theta for diagnosed: 0.030 ± 0.024\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.003\n",
      "  Holdout loss: 15.0654  |  NaN in pi: 0\n",
      "\n",
      "============================================================\n",
      "UPDATED HOLDOUT LOSS SUMMARY (with nolr)\n",
      "  constant: 13.7316\n",
      "  cos300: 16.0694\n",
      "  clip: 13.7316\n",
      "  v2_nokappa: 13.8807\n",
      "  nolr: 15.0654\n",
      "  → Best: constant (loss=13.7316)\n"
     ]
    }
   ],
   "source": [
    "# Load and pool production nolr (centered param, batches 20-29)\n",
    "# FAIR COMPARISON: only use batches 20-29 (same training data as v3 configs)\n",
    "NOLR_DIR = DROPBOX / 'censor_e_batchrun_vectorized_nolr'\n",
    "\n",
    "import re\n",
    "nolr_all_files = sorted(glob.glob(str(NOLR_DIR / 'enrollment_model_VECTORIZED_W0.0001_nolr_batch_*.pt')))\n",
    "nolr_batch_files = []\n",
    "for fp in nolr_all_files:\n",
    "    m = re.search(r'batch_(\\d+)_(\\d+)', fp)\n",
    "    if m:\n",
    "        start = int(m.group(1))\n",
    "        if 200000 <= start < 300000:\n",
    "            nolr_batch_files.append(fp)\n",
    "print(f'=== PRODUCTION NOLR (centered param) — batches 20-29 only ===')\n",
    "print(f'Found {len(nolr_batch_files)} matching checkpoints (200k-300k)')\n",
    "\n",
    "nolr_all_phi, nolr_all_psi, nolr_all_kappa, nolr_all_gamma = [], [], [], []\n",
    "nolr_batch_stats = []\n",
    "for fp in nolr_batch_files:\n",
    "    ckpt = torch.load(fp, weights_only=False)\n",
    "    def _get(name):\n",
    "        if 'model_state_dict' in ckpt and name in ckpt['model_state_dict']:\n",
    "            return ckpt['model_state_dict'][name]\n",
    "        return ckpt.get(name)\n",
    "    phi = _get('phi')\n",
    "    psi = _get('psi')\n",
    "    gamma = _get('gamma')\n",
    "    kappa = _get('kappa')\n",
    "    if phi is None or gamma is None:\n",
    "        print(f'  Skip {Path(fp).name}: missing phi or gamma')\n",
    "        continue\n",
    "    phi_np = phi.detach().cpu().numpy() if torch.is_tensor(phi) else np.array(phi)\n",
    "    psi_np = psi.detach().cpu().numpy() if torch.is_tensor(psi) else (np.array(psi) if psi is not None else None)\n",
    "    gamma_np = gamma.detach().cpu().numpy() if torch.is_tensor(gamma) else np.array(gamma)\n",
    "    kappa_val = float(kappa) if kappa is not None else 1.0\n",
    "    nolr_all_phi.append(phi_np)\n",
    "    nolr_all_psi.append(psi_np)\n",
    "    nolr_all_kappa.append(kappa_val)\n",
    "    nolr_all_gamma.append(gamma_np)\n",
    "    nolr_batch_stats.append({'mean_abs_gamma': np.abs(gamma_np).mean()})\n",
    "print(f'Loaded {len(nolr_all_phi)} checkpoints')\n",
    "\n",
    "nolr_phi, nolr_psi, nolr_kappa, nolr_gamma = pool_params(\n",
    "    nolr_all_phi, nolr_all_psi, nolr_all_kappa, nolr_all_gamma\n",
    ")\n",
    "print(f'  Pooled: phi {nolr_phi.shape}, gamma {nolr_gamma.shape}, kappa={nolr_kappa:.4f}')\n",
    "print(f'  mean|gamma| = {np.abs(nolr_gamma).mean():.4f}')\n",
    "\n",
    "# Fit lambda on same holdout using CENTERED model (AladynSurvivalFixedPhiFixedGammaFixedKappa)\n",
    "# This is the correct model class for nolr — learns lambda directly, not delta\n",
    "from clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa import (\n",
    "    AladynSurvivalFixedPhiFixedGammaFixedKappa,\n",
    ")\n",
    "\n",
    "print(f'\\nFitting lambda on holdout with CENTERED model (200 epochs, lr=0.1)...')\n",
    "torch.manual_seed(42)\n",
    "np.random.seed(42)\n",
    "\n",
    "N_ho, D_ho, T_ho = Y_holdout.shape\n",
    "K_ho = nolr_phi.shape[0] - 1\n",
    "P_ho = G_with_sex.shape[1]\n",
    "\n",
    "model_nolr_holdout = AladynSurvivalFixedPhiFixedGammaFixedKappa(\n",
    "    N=N_ho, D=D_ho, T=T_ho, K=K_ho, P=P_ho,\n",
    "    G=G_with_sex, Y=Y_holdout,\n",
    "    R=0, W=0.0001, prevalence_t=prevalence_t,\n",
    "    init_sd_scaler=1e-1, genetic_scale=1,\n",
    "    pretrained_phi=nolr_phi, pretrained_psi=nolr_psi,\n",
    "    pretrained_gamma=nolr_gamma, pretrained_kappa=nolr_kappa,\n",
    "    signature_references=signature_refs, healthy_reference=True,\n",
    "    disease_names=disease_names,\n",
    ")\n",
    "\n",
    "result_nolr = model_nolr_holdout.fit(E_holdout, num_epochs=200, learning_rate=0.1)\n",
    "losses_nolr = result_nolr[0] if isinstance(result_nolr, tuple) else result_nolr\n",
    "\n",
    "with torch.no_grad():\n",
    "    nolr_pi, _, _ = model_nolr_holdout.forward()\n",
    "\n",
    "n_nan = torch.isnan(nolr_pi).sum().item()\n",
    "n_inf = torch.isinf(nolr_pi).sum().item()\n",
    "if n_nan > 0 or n_inf > 0:\n",
    "    print(f'WARNING: {n_nan} NaN, {n_inf} Inf in pi — fixing')\n",
    "    nolr_pi = torch.nan_to_num(nolr_pi, nan=0.0, posinf=1.0, neginf=0.0)\n",
    "nolr_pi = torch.clamp(nolr_pi, 1e-8, 1 - 1e-8)\n",
    "nolr_loss = losses_nolr[-1] if losses_nolr else float('nan')\n",
    "print(f'  Holdout loss: {nolr_loss:.4f}  |  NaN in pi: {n_nan}')\n",
    "\n",
    "# Add to holdout_results\n",
    "holdout_results['nolr'] = {'pi': nolr_pi, 'loss': nolr_loss}\n",
    "\n",
    "print(f'\\n{\"=\"*60}')\n",
    "print('UPDATED HOLDOUT LOSS SUMMARY (with nolr)')\n",
    "for name, data in holdout_results.items():\n",
    "    print(f'  {name}: {data[\"loss\"]:.4f}')\n",
    "best = min(holdout_results.items(), key=lambda x: x[1]['loss'])\n",
    "print(f'  → Best: {best[0]} (loss={best[1][\"loss\"]:.4f})')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5c. Reproduce original nolr results (ALL batches pooled, first 10K)\n",
    "\n",
    "Reproduces `fixedgk_vs_original_wide_format.csv` by:\n",
    "- Using pre-existing `pooled_kappa_gamma_nolr.pt` (all ~40 nolr batches pooled)\n",
    "- Using pre-existing `master_for_fitting_pooled_correctedE.pt` (pooled phi/psi)\n",
    "- Non-reparam model (`AladynSurvivalFixedPhiFixedGammaFixedKappa`) — fits lambda directly\n",
    "- Predict on first 10K (samples 0–10000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Pooled gamma (all nolr batches): shape=(47, 21), mean|γ|=0.005739\n",
      "Pooled kappa (all nolr batches): 2.932930\n",
      "Pooled phi (master): shape=(21, 348, 52)\n",
      "Pooled psi (master): shape=(21, 348)\n",
      "\n",
      "Loading data for first 10K...\n",
      "First 10K: Y=torch.Size([10000, 348, 52]), E=torch.Size([10000, 348]), G=(10000, 47)\n",
      "\n",
      "Fitting lambda with non-reparam model (200 epochs, lr=0.1)...\n",
      "Pre-calculated phi GP loss: 16.2175\n",
      "Using fixed gamma with shape: torch.Size([47, 21])\n",
      "Using fixed kappa: 2.932930\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:55: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.prevalence_t = torch.tensor(prevalence_t, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:99: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.signature_refs = torch.tensor(signature_references, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/claudefile/aws_offsetmaster/clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa.py:129: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.Y = torch.tensor(Y, dtype=torch.float32)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Initializing with 20 disease states + 1 healthy state\n",
      "Initialization complete! (gamma and kappa are fixed)\n",
      "\n",
      "Epoch 0\n",
      "Loss: 16.4829\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.030 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 10\n",
      "Loss: 174.4641\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.020\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 20\n",
      "Loss: 49.8913\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.020\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 30\n",
      "Loss: 19.6754\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.020\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 40\n",
      "Loss: 19.4778\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.020\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 50\n",
      "Loss: 17.9287\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.020\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 60\n",
      "Loss: 16.7977\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.030 ± 0.004\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.020\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 70\n",
      "Loss: 16.3133\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.000\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.020\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 80\n",
      "Loss: 16.1544\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 90\n",
      "Loss: 16.0930\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 100\n",
      "Loss: 16.0203\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.031 ± 0.006\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 110\n",
      "Loss: 15.9524\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.031 ± 0.007\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 120\n",
      "Loss: 15.8945\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.031 ± 0.008\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.029 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 130\n",
      "Loss: 15.8345\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.026 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.008\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.031 ± 0.009\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.030 ± 0.021\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 140\n",
      "Loss: 15.7758\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.009\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.009\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.031 ± 0.011\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.030 ± 0.022\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 150\n",
      "Loss: 15.7172\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.009\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.009\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.031 ± 0.012\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.030 ± 0.022\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 160\n",
      "Loss: 15.6590\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.010\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.009\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.032 ± 0.014\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.030 ± 0.022\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 170\n",
      "Loss: 15.6015\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.011\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.027 ± 0.010\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.032 ± 0.015\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.030 ± 0.023\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Epoch 180\n",
      "Loss: 15.5448\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.012\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.028 ± 0.011\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.032 ± 0.017\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.030 ± 0.024\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Epoch 190\n",
      "Loss: 15.4879\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 47 (signature 15, LR=87.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.007\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 249 (signature 13, LR=73.06):\n",
      "  Theta for diagnosed: 0.027 ± 0.013\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 21 (signature 13, LR=69.95):\n",
      "  Theta for diagnosed: 0.028 ± 0.011\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.005\n",
      "\n",
      "Disease 336 (signature 9, LR=68.09):\n",
      "  Theta for diagnosed: 0.032 ± 0.019\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 127 (signature 0, LR=64.18):\n",
      "  Theta for diagnosed: 0.030 ± 0.025\n",
      "  Theta for others: 0.028\n",
      "  Proportion difference: 0.003\n",
      "Final loss: 15.4376  |  NaN in pi: 0\n",
      "\n",
      "============================================================\n",
      "STATIC 10YR AUC (nolr, all batches pooled, first 10K)\n",
      "============================================================\n",
      "\n",
      "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.723 (0.704-0.742) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 831 (8.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.690, Events = 273/5409\n",
      "   Male: AUC = 0.708, Events = 558/4591\n",
      "\n",
      "   ASCVD risk in patients with pre-existing conditions:\n",
      "   RA: AUC = 0.746, Events = 8/37\n",
      "   Breast_Cancer: AUC = 0.619, Events = 13/170\n",
      "\n",
      "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.636 (0.614-0.655) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 581 (5.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.627, Events = 264/5409\n",
      "   Male: AUC = 0.637, Events = 317/4591\n",
      "\n",
      "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.708 (0.689-0.728) (calculated on 9864 individuals)\n",
      "Events (10-Year in Eval Cohort): 376 (3.8%) (from 10000 individuals)\n",
      "Excluded 136 prevalent cases for Atrial_Fib.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.712, Events = 197/5372\n",
      "   Male: AUC = 0.713, Events = 174/4492\n",
      "\n",
      "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.709 (0.666-0.733) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 207 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.733, Events = 101/5409\n",
      "   Male: AUC = 0.685, Events = 106/4591\n",
      "\n",
      "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.682 (0.663-0.702) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 480 (4.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.672, Events = 134/5409\n",
      "   Male: AUC = 0.672, Events = 346/4591\n",
      "\n",
      "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.652 (0.598-0.693) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 129 (1.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.626, Events = 64/5409\n",
      "   Male: AUC = 0.677, Events = 65/4591\n",
      "\n",
      "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.699 (0.666-0.728) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 205 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.716, Events = 83/5409\n",
      "   Male: AUC = 0.681, Events = 122/4591\n",
      "\n",
      "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.681 (0.649-0.702) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 335 (3.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.682, Events = 135/5409\n",
      "   Male: AUC = 0.675, Events = 200/4591\n",
      "\n",
      "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.648 (0.620-0.674) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 394 (3.9%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.674, Events = 176/5409\n",
      "   Male: AUC = 0.622, Events = 218/4591\n",
      "\n",
      "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.672 (0.639-0.708) (calculated on 9961 individuals)\n",
      "Events (10-Year in Eval Cohort): 219 (2.2%) (from 10000 individuals)\n",
      "Excluded 39 prevalent cases for Osteoporosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.681, Events = 128/5379\n",
      "   Male: AUC = 0.669, Events = 90/4582\n",
      "\n",
      "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.593 (0.566-0.614) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 523 (5.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.552, Events = 280/5409\n",
      "   Male: AUC = 0.640, Events = 243/4591\n",
      "\n",
      "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.661 (0.616-0.716) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 105 (1.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.647, Events = 56/5409\n",
      "   Male: AUC = 0.674, Events = 49/4591\n",
      "\n",
      "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Female: Found 5409 individuals in cohort\n",
      "AUC: 0.578 (0.539-0.616) (calculated on 5409 individuals)\n",
      "Events (10-Year in Eval Cohort): 214 (4.0%) (from 5409 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Male: Found 4591 individuals in cohort\n",
      "AUC: 0.678 (0.642-0.710) (calculated on 4547 individuals)\n",
      "Events (10-Year in Eval Cohort): 204 (4.4%) (from 4591 individuals)\n",
      "Excluded 44 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.689 (0.640-0.748) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 75 (0.8%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Lung_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.692, Events = 48/5406\n",
      "   Male: AUC = 0.681, Events = 27/4586\n",
      "\n",
      "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.739 (0.684-0.792) (calculated on 9976 individuals)\n",
      "Events (10-Year in Eval Cohort): 49 (0.5%) (from 10000 individuals)\n",
      "Excluded 24 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.620, Events = 24/5399\n",
      "   Male: AUC = 0.855, Events = 25/4577\n",
      "\n",
      "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.606 (0.570-0.634) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 276 (2.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.613, Events = 147/5409\n",
      "   Male: AUC = 0.596, Events = 129/4591\n",
      "\n",
      "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.471 (0.439-0.504) (calculated on 9912 individuals)\n",
      "Events (10-Year in Eval Cohort): 405 (4.0%) (from 10000 individuals)\n",
      "Excluded 88 prevalent cases for Depression.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.473, Events = 210/5351\n",
      "   Male: AUC = 0.480, Events = 191/4561\n",
      "\n",
      "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.507 (0.470-0.542) (calculated on 9975 individuals)\n",
      "Events (10-Year in Eval Cohort): 241 (2.4%) (from 10000 individuals)\n",
      "Excluded 25 prevalent cases for Anxiety.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.514, Events = 130/5391\n",
      "   Male: AUC = 0.505, Events = 110/4584\n",
      "\n",
      "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.385 (0.292-0.478) (calculated on 9984 individuals)\n",
      "Events (10-Year in Eval Cohort): 34 (0.3%) (from 10000 individuals)\n",
      "Excluded 16 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.486, Events = 14/5399\n",
      "   Male: AUC = 0.321, Events = 19/4585\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.602 (0.553-0.653) (calculated on 9963 individuals)\n",
      "Events (10-Year in Eval Cohort): 123 (1.2%) (from 10000 individuals)\n",
      "Excluded 37 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.597, Events = 62/5381\n",
      "   Male: AUC = 0.603, Events = 60/4582\n",
      "\n",
      "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.422 (0.341-0.504) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 40 (0.4%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Psoriasis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.403, Events = 15/5405\n",
      "   Male: AUC = 0.434, Events = 25/4576\n",
      "\n",
      "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.615 (0.521-0.689) (calculated on 9947 individuals)\n",
      "Events (10-Year in Eval Cohort): 50 (0.5%) (from 10000 individuals)\n",
      "Excluded 53 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.596, Events = 31/5378\n",
      "   Male: AUC = 0.652, Events = 19/4569\n",
      "\n",
      "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.428 (0.306-0.530) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 31 (0.3%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.497, Events = 20/5388\n",
      "   Male: AUC = 0.308, Events = 11/4579\n",
      "\n",
      "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.510 (0.487-0.538) (calculated on 9687 individuals)\n",
      "Events (10-Year in Eval Cohort): 606 (6.1%) (from 10000 individuals)\n",
      "Excluded 313 prevalent cases for Asthma.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.505, Events = 321/5214\n",
      "   Male: AUC = 0.552, Events = 264/4473\n",
      "\n",
      "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.749 (0.682-0.812) (calculated on 9997 individuals)\n",
      "Events (10-Year in Eval Cohort): 46 (0.5%) (from 10000 individuals)\n",
      "Excluded 3 prevalent cases for Parkinsons.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.802, Events = 21/5407\n",
      "   Male: AUC = 0.703, Events = 25/4590\n",
      "\n",
      "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.539 (0.430-0.666) (calculated on 9979 individuals)\n",
      "Events (10-Year in Eval Cohort): 21 (0.2%) (from 10000 individuals)\n",
      "Excluded 21 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.501, Events = 13/5394\n",
      "   Male: AUC = 0.604, Events = 8/4585\n",
      "\n",
      "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.572 (0.543-0.598) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 479 (4.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.568, Events = 385/5409\n",
      "   Male: AUC = 0.564, Events = 94/4591\n",
      "\n",
      "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.723 (0.704-0.742)       831        8.3\n",
      "Diabetes             0.636 (0.614-0.655)       581        5.8\n",
      "Atrial_Fib           0.708 (0.689-0.728)       376        3.8\n",
      "CKD                  0.709 (0.666-0.733)       207        2.1\n",
      "All_Cancers          0.682 (0.663-0.702)       480        4.8\n",
      "Stroke               0.652 (0.598-0.693)       129        1.3\n",
      "Heart_Failure        0.699 (0.666-0.728)       205        2.1\n",
      "Pneumonia            0.681 (0.649-0.702)       335        3.4\n",
      "COPD                 0.648 (0.620-0.674)       394        3.9\n",
      "Osteoporosis         0.672 (0.639-0.708)       219        2.2\n",
      "Anemia               0.593 (0.566-0.614)       523        5.2\n",
      "Colorectal_Cancer    0.661 (0.616-0.716)       105        1.1\n",
      "Breast_Cancer        0.578 (0.539-0.616)       214        4.0\n",
      "Prostate_Cancer      0.678 (0.642-0.710)       204        4.4\n",
      "Lung_Cancer          0.689 (0.640-0.748)       75         0.8\n",
      "Bladder_Cancer       0.739 (0.684-0.792)       49         0.5\n",
      "Secondary_Cancer     0.606 (0.570-0.634)       276        2.8\n",
      "Depression           0.471 (0.439-0.504)       405        4.0\n",
      "Anxiety              0.507 (0.470-0.542)       241        2.4\n",
      "Bipolar_Disorder     0.385 (0.292-0.478)       34         0.3\n",
      "Rheumatoid_Arthritis 0.602 (0.553-0.653)       123        1.2\n",
      "Psoriasis            0.422 (0.341-0.504)       40         0.4\n",
      "Ulcerative_Colitis   0.615 (0.521-0.689)       50         0.5\n",
      "Crohns_Disease       0.428 (0.306-0.530)       31         0.3\n",
      "Asthma               0.510 (0.487-0.538)       606        6.1\n",
      "Parkinsons           0.749 (0.682-0.812)       46         0.5\n",
      "Multiple_Sclerosis   0.539 (0.430-0.666)       21         0.2\n",
      "Thyroid_Disorders    0.572 (0.543-0.598)       479        4.8\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "============================================================\n",
      "DYNAMIC 1YR AUC (nolr, all batches pooled, first 10K)\n",
      "============================================================\n",
      "\n",
      "Evaluating ASCVD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.868 (0.824-0.910) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 78 (0.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.762 (0.670-0.847) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 33 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.778 (0.665-0.887) (calculated on 9864 individuals)\n",
      "C-index: nan (calculated on 9864 individuals)\n",
      "Events (1-Year in Eval Cohort): 22 (0.2%) (from 10000 individuals)\n",
      "Excluded 136 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.861 (0.609-0.998) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.760 (0.706-0.819) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 26 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.714 (0.543-0.834) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 5 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.842 (0.724-0.946) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 15 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.485 (0.356-0.633) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 15 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.742 (0.606-0.873) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 17 (0.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.643 (0.451-0.826) (calculated on 9961 individuals)\n",
      "C-index: nan (calculated on 9961 individuals)\n",
      "Events (1-Year in Eval Cohort): 11 (0.1%) (from 10000 individuals)\n",
      "Excluded 39 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.563 (0.456-0.683) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 27 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.876 (0.756-0.971) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 7 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (1-Year Risk)...\n",
      "Filtering for Female: Found 5409 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.770 (0.630-0.902) (calculated on 5409 individuals)\n",
      "C-index: nan (calculated on 5409 individuals)\n",
      "Events (1-Year in Eval Cohort): 20 (0.4%) (from 5409 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (1-Year Risk)...\n",
      "Filtering for Male: Found 4591 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.787 (0.677-0.908) (calculated on 4547 individuals)\n",
      "C-index: nan (calculated on 4547 individuals)\n",
      "Events (1-Year in Eval Cohort): 12 (0.3%) (from 4591 individuals)\n",
      "Excluded 44 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.758 (0.412-1.000) (calculated on 9992 individuals)\n",
      "C-index: nan (calculated on 9992 individuals)\n",
      "Events (1-Year in Eval Cohort): 3 (0.0%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.968 (0.935-0.999) (calculated on 9976 individuals)\n",
      "C-index: nan (calculated on 9976 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 24 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.648 (0.449-0.860) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 7 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.827 (0.706-0.924) (calculated on 9912 individuals)\n",
      "C-index: nan (calculated on 9912 individuals)\n",
      "Events (1-Year in Eval Cohort): 10 (0.1%) (from 10000 individuals)\n",
      "Excluded 88 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.813 (0.634-0.988) (calculated on 9975 individuals)\n",
      "C-index: nan (calculated on 9975 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 25 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "Warning: Only one class present ([0.]) for AUC.\n",
      "AUC: nan (nan-nan) (calculated on 9984 individuals)\n",
      "C-index: nan (calculated on 9984 individuals)\n",
      "Events (1-Year in Eval Cohort): 0 (0.0%) (from 10000 individuals)\n",
      "Excluded 16 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.934 (0.803-0.993) (calculated on 9963 individuals)\n",
      "C-index: nan (calculated on 9963 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 37 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.354 (0.346-0.362) (calculated on 9981 individuals)\n",
      "C-index: nan (calculated on 9981 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.996 (0.995-0.997) (calculated on 9947 individuals)\n",
      "C-index: nan (calculated on 9947 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 53 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.951 (0.945-0.954) (calculated on 9967 individuals)\n",
      "C-index: nan (calculated on 9967 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.703 (0.621-0.782) (calculated on 9687 individuals)\n",
      "C-index: nan (calculated on 9687 individuals)\n",
      "Events (1-Year in Eval Cohort): 60 (0.6%) (from 10000 individuals)\n",
      "Excluded 313 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.998 (0.997-0.999) (calculated on 9997 individuals)\n",
      "C-index: nan (calculated on 9997 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 3 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.963 (0.922-0.999) (calculated on 9979 individuals)\n",
      "C-index: nan (calculated on 9979 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 21 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.750 (0.638-0.830) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (1-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.868 (0.824-0.910)       78         0.8        N/A\n",
      "Diabetes             0.762 (0.670-0.847)       33         0.3        N/A\n",
      "Atrial_Fib           0.778 (0.665-0.887)       22         0.2        N/A\n",
      "CKD                  0.861 (0.609-0.998)       4          0.0        N/A\n",
      "All_Cancers          0.760 (0.706-0.819)       26         0.3        N/A\n",
      "Stroke               0.714 (0.543-0.834)       5          0.1        N/A\n",
      "Heart_Failure        0.842 (0.724-0.946)       15         0.1        N/A\n",
      "Pneumonia            0.485 (0.356-0.633)       15         0.1        N/A\n",
      "COPD                 0.742 (0.606-0.873)       17         0.2        N/A\n",
      "Osteoporosis         0.643 (0.451-0.826)       11         0.1        N/A\n",
      "Anemia               0.563 (0.456-0.683)       27         0.3        N/A\n",
      "Colorectal_Cancer    0.876 (0.756-0.971)       7          0.1        N/A\n",
      "Breast_Cancer        0.770 (0.630-0.902)       20         0.4        N/A\n",
      "Prostate_Cancer      0.787 (0.677-0.908)       12         0.3        N/A\n",
      "Lung_Cancer          0.758 (0.412-1.000)       3          0.0        N/A\n",
      "Bladder_Cancer       0.968 (0.935-0.999)       2          0.0        N/A\n",
      "Secondary_Cancer     0.648 (0.449-0.860)       7          0.1        N/A\n",
      "Depression           0.827 (0.706-0.924)       10         0.1        N/A\n",
      "Anxiety              0.813 (0.634-0.988)       2          0.0        N/A\n",
      "Bipolar_Disorder     N/A                       0          0.0        N/A\n",
      "Rheumatoid_Arthritis 0.934 (0.803-0.993)       4          0.0        N/A\n",
      "Psoriasis            0.354 (0.346-0.362)       1          0.0        N/A\n",
      "Ulcerative_Colitis   0.996 (0.995-0.997)       2          0.0        N/A\n",
      "Crohns_Disease       0.951 (0.945-0.954)       1          0.0        N/A\n",
      "Asthma               0.703 (0.621-0.782)       60         0.6        N/A\n",
      "Parkinsons           0.998 (0.997-0.999)       1          0.0        N/A\n",
      "Multiple_Sclerosis   0.963 (0.922-0.999)       4          0.0        N/A\n",
      "Thyroid_Disorders    0.750 (0.638-0.830)       28         0.3        N/A\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "================================================================================\n",
      "COMPARISON WITH fixedgk_vs_original_wide_format.csv\n",
      "================================================================================\n",
      "DISEASE                   CSV static_10yr   Reproduced     CSV dyn_1yr   Reproduced\n",
      "-------------------------------------------------------------------------------------\n",
      "ASCVD                              0.7310       0.7232          0.8805       0.8678\n",
      "All_Cancers                        0.6699       0.6816          0.7531       0.7603\n",
      "Anemia                             0.5870       0.5934          0.6485       0.5631\n",
      "Anxiety                            0.5128       0.5073          0.6005       0.8129\n",
      "Asthma                             0.5249       0.5097          0.6897       0.7025\n",
      "Atrial_Fib                         0.7073       0.7077          0.7966       0.7779\n",
      "Bipolar_Disorder                   0.4854       0.3849          0.7756          nan\n",
      "Bladder_Cancer                     0.7031       0.7395          0.8280       0.9684\n",
      "Breast_Cancer                      0.5499       0.5781          0.7866       0.7700\n",
      "CKD                                0.7052       0.7091          0.6509       0.8605\n",
      "COPD                               0.6573       0.6476          0.7343       0.7425\n",
      "Colorectal_Cancer                  0.6452       0.6611          0.8246       0.8755\n",
      "Crohns_Disease                     0.5748       0.4282          0.9021       0.9505\n",
      "Depression                         0.4838       0.4713          0.6175       0.8271\n",
      "Diabetes                           0.6296       0.6361          0.7421       0.7624\n",
      "Heart_Failure                      0.7012       0.6995          0.7667       0.8421\n",
      "Lung_Cancer                        0.6672       0.6888          0.7004       0.7582\n",
      "Multiple_Sclerosis                 0.5273       0.5390          0.8495       0.9631\n",
      "Osteoporosis                       0.6742       0.6724          0.7565       0.6428\n",
      "Parkinsons                         0.7234       0.7490          0.8108       0.9976\n",
      "Pneumonia                          0.6437       0.6814          0.6321       0.4846\n",
      "Prostate_Cancer                    0.6837       0.6775          0.8322       0.7874\n",
      "Psoriasis                          0.5456       0.4216          0.6097       0.3544\n",
      "Rheumatoid_Arthritis               0.6088       0.6023          0.7495       0.9340\n",
      "Secondary_Cancer                   0.6093       0.6055          0.5994       0.6475\n",
      "Stroke                             0.6803       0.6521          0.6544       0.7144\n",
      "Thyroid_Disorders                  0.5845       0.5716          0.6779       0.7498\n",
      "Ulcerative_Colitis                 0.5773       0.6150          0.8169       0.9962\n"
     ]
    }
   ],
   "source": [
    "# Reproduce original nolr results: ALL batches pooled, first 10K\n",
    "# Uses non-reparam model (AladynSurvivalFixedPhiFixedGammaFixedKappa)\n",
    "\n",
    "from clust_huge_amp_fixedPhi_vectorized_fixed_gamma_fixed_kappa import (\n",
    "    AladynSurvivalFixedPhiFixedGammaFixedKappa,\n",
    ")\n",
    "\n",
    "DROPBOX_DATA = Path('/Users/sarahurbut/Library/CloudStorage/Dropbox-Personal/data_for_running')\n",
    "\n",
    "# 1. Load pre-existing pooled gamma/kappa (ALL ~40 nolr batches)\n",
    "pooled_gk = torch.load(str(DROPBOX_DATA / 'pooled_kappa_gamma_nolr.pt'), weights_only=False)\n",
    "nolr_full_gamma = pooled_gk['gamma']\n",
    "nolr_full_kappa = pooled_gk['kappa']\n",
    "if isinstance(nolr_full_gamma, np.ndarray):\n",
    "    nolr_full_gamma = nolr_full_gamma  # already numpy\n",
    "elif torch.is_tensor(nolr_full_gamma):\n",
    "    nolr_full_gamma = nolr_full_gamma.detach().cpu().numpy()\n",
    "nolr_full_kappa = float(nolr_full_kappa)\n",
    "print(f'Pooled gamma (all nolr batches): shape={nolr_full_gamma.shape}, mean|γ|={np.abs(nolr_full_gamma).mean():.6f}')\n",
    "print(f'Pooled kappa (all nolr batches): {nolr_full_kappa:.6f}')\n",
    "\n",
    "# 2. Load pre-existing pooled phi/psi from master checkpoint\n",
    "master = torch.load(str(DROPBOX_DATA / 'master_for_fitting_pooled_correctedE.pt'), weights_only=False, map_location='cpu')\n",
    "if 'model_state_dict' in master:\n",
    "    nolr_full_phi = master['model_state_dict']['phi']\n",
    "    nolr_full_psi = master['model_state_dict']['psi']\n",
    "else:\n",
    "    nolr_full_phi = master['phi']\n",
    "    nolr_full_psi = master['psi']\n",
    "if torch.is_tensor(nolr_full_phi):\n",
    "    nolr_full_phi = nolr_full_phi.cpu().numpy()\n",
    "if torch.is_tensor(nolr_full_psi):\n",
    "    nolr_full_psi = nolr_full_psi.cpu().numpy()\n",
    "del master\n",
    "gc.collect()\n",
    "print(f'Pooled phi (master): shape={nolr_full_phi.shape}')\n",
    "print(f'Pooled psi (master): shape={nolr_full_psi.shape}')\n",
    "\n",
    "# 3. Load data for first 10K (samples 0-10000)\n",
    "print('\\nLoading data for first 10K...')\n",
    "Y_full_reload = torch.load(str(DATA_DIR / 'Y_tensor.pt'), weights_only=False)\n",
    "E_full_reload = torch.load(str(DATA_DIR / 'E_enrollment_full.pt'), weights_only=False)\n",
    "G_full_reload = torch.load(str(DATA_DIR / 'G_matrix.pt'), weights_only=False)\n",
    "\n",
    "FIRST_10K_START, FIRST_10K_END = 0, 10000\n",
    "Y_first10k = Y_full_reload[FIRST_10K_START:FIRST_10K_END]\n",
    "E_first10k = E_full_reload[FIRST_10K_START:FIRST_10K_END]\n",
    "G_first10k = G_full_reload[FIRST_10K_START:FIRST_10K_END]\n",
    "del Y_full_reload, E_full_reload, G_full_reload\n",
    "gc.collect()\n",
    "\n",
    "# Add sex + PCs\n",
    "fh_first = pd.read_csv(COV_PATH)\n",
    "sex_col = fh_first['Sex'].map({'Female': 0, 'Male': 1}).astype(int).values if 'Sex' in fh_first.columns else fh_first['sex'].values\n",
    "sex_first10k = sex_col[FIRST_10K_START:FIRST_10K_END]\n",
    "pc_cols = [f'f.22009.0.{i}' for i in range(1, 11)]\n",
    "pcs_first10k = fh_first.iloc[FIRST_10K_START:FIRST_10K_END][pc_cols].values\n",
    "G_with_sex_first10k = np.column_stack([G_first10k, sex_first10k, pcs_first10k])\n",
    "\n",
    "print(f'First 10K: Y={Y_first10k.shape}, E={E_first10k.shape}, G={G_with_sex_first10k.shape}')\n",
    "\n",
    "# 4. Fit with NON-REPARAM model (same as original workflow)\n",
    "print('\\nFitting lambda with non-reparam model (200 epochs, lr=0.1)...')\n",
    "torch.manual_seed(42)\n",
    "np.random.seed(42)\n",
    "\n",
    "N, D, T = Y_first10k.shape\n",
    "K = nolr_full_phi.shape[0] - 1  # 21 total, 20 disease + 1 healthy\n",
    "P = G_with_sex_first10k.shape[1]\n",
    "\n",
    "model_nolr_full = AladynSurvivalFixedPhiFixedGammaFixedKappa(\n",
    "    N=N, D=D, T=T, K=K, P=P,\n",
    "    G=G_with_sex_first10k, Y=Y_first10k,\n",
    "    R=0, W=0.0001, prevalence_t=prevalence_t,\n",
    "    init_sd_scaler=1e-1, genetic_scale=1,\n",
    "    pretrained_phi=nolr_full_phi, pretrained_psi=nolr_full_psi,\n",
    "    pretrained_gamma=nolr_full_gamma, pretrained_kappa=nolr_full_kappa,\n",
    "    signature_references=signature_refs, healthy_reference=True,\n",
    "    disease_names=disease_names,\n",
    ")\n",
    "\n",
    "result = model_nolr_full.fit(E_first10k, num_epochs=200, learning_rate=0.1)\n",
    "losses = result[0] if isinstance(result, tuple) else result\n",
    "\n",
    "with torch.no_grad():\n",
    "    pi_nolr_full, _, _ = model_nolr_full.forward()\n",
    "\n",
    "n_nan = torch.isnan(pi_nolr_full).sum().item()\n",
    "n_inf = torch.isinf(pi_nolr_full).sum().item()\n",
    "if n_nan > 0 or n_inf > 0:\n",
    "    print(f'WARNING: {n_nan} NaN, {n_inf} Inf in pi — fixing')\n",
    "    pi_nolr_full = torch.nan_to_num(pi_nolr_full, nan=0.0, posinf=1.0, neginf=0.0)\n",
    "pi_nolr_full = torch.clamp(pi_nolr_full, 1e-8, 1 - 1e-8)\n",
    "final_loss = losses[-1] if losses else float('nan')\n",
    "print(f'Final loss: {final_loss:.4f}  |  NaN in pi: {n_nan}')\n",
    "\n",
    "# 5. Compute AUC (static 10yr + dynamic 1yr) — same as CSV\n",
    "pce_first10k = pd.read_csv(PCE_PATH).iloc[FIRST_10K_START:FIRST_10K_END].reset_index(drop=True)\n",
    "if 'Sex' not in pce_first10k.columns and 'sex' in pce_first10k.columns:\n",
    "    pce_first10k['Sex'] = pce_first10k['sex'].map({0: 'Female', 1: 'Male'}).fillna('Unknown')\n",
    "if 'sex' not in pce_first10k.columns and 'Sex' in pce_first10k.columns:\n",
    "    pce_first10k['sex'] = pce_first10k['Sex'].map({'Female': 0, 'Male': 1}).fillna(-1)\n",
    "if 'age' not in pce_first10k.columns and 'Age' in pce_first10k.columns:\n",
    "    pce_first10k['age'] = pce_first10k['Age']\n",
    "\n",
    "print('\\n' + '='*60)\n",
    "print('STATIC 10YR AUC (nolr, all batches pooled, first 10K)')\n",
    "print('='*60)\n",
    "res_static = evaluate_major_diseases_wsex_with_bootstrap_from_pi(\n",
    "    pi_nolr_full, Y_first10k, E_first10k, disease_names, pce_first10k\n",
    ")\n",
    "\n",
    "print('\\n' + '='*60)\n",
    "print('DYNAMIC 1YR AUC (nolr, all batches pooled, first 10K)')\n",
    "print('='*60)\n",
    "res_dyn1yr = evaluate_major_diseases_wsex_with_bootstrap_dynamic_1year(\n",
    "    pi_nolr_full, Y_first10k, E_first10k, disease_names, pce_first10k\n",
    ")\n",
    "\n",
    "# 6. Compare with CSV\n",
    "print('\\n' + '='*80)\n",
    "print('COMPARISON WITH fixedgk_vs_original_wide_format.csv')\n",
    "print('='*80)\n",
    "csv_path = REPO_ROOT / 'pyScripts/dec_6_revision/new_notebooks/results/fixedgk_vs_original_wide_format.csv'\n",
    "csv_df = pd.read_csv(csv_path)\n",
    "print(f'{\"DISEASE\":<25} {\"CSV static_10yr\":>15} {\"Reproduced\":>12} {\"CSV dyn_1yr\":>15} {\"Reproduced\":>12}')\n",
    "print('-'*85)\n",
    "for _, row in csv_df.iterrows():\n",
    "    disease = row['disease']\n",
    "    csv_s10 = row.get('fixedgk_static_10yr', float('nan'))\n",
    "    csv_d1 = row.get('fixedgk_dynamic_1yr', float('nan'))\n",
    "    repro_s10 = res_static.get(disease, {}).get('auc', float('nan')) if isinstance(res_static.get(disease), dict) else res_static.get(disease, float('nan'))\n",
    "    repro_d1 = res_dyn1yr.get(disease, {}).get('auc', float('nan')) if isinstance(res_dyn1yr.get(disease), dict) else res_dyn1yr.get(disease, float('nan'))\n",
    "    # Handle different return formats\n",
    "    if isinstance(repro_s10, dict):\n",
    "        repro_s10 = repro_s10.get('auc', float('nan'))\n",
    "    if isinstance(repro_d1, dict):\n",
    "        repro_d1 = repro_d1.get('auc', float('nan'))\n",
    "    print(f'{disease:<25} {csv_s10:>15.4f} {repro_s10:>12.4f} {csv_d1:>15.4f} {repro_d1:>12.4f}')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The story you can tell is strong and honest:\n",
    "Original submission: LOO validation across 400K patients, LOO = Master (r=0.9999), fixing gamma/kappa doesn't hurt -- all solid methodology, nothing to retract or correct.\n",
    "Revision improvement: Reparameterization dramatically improves holdout prediction. With only 1/4 the training data, reparam (0.936 ASCVD) beats centered with 4x more data (0.733). That's a clear, clean result.\n",
    "The narrative writes itself: \"We identified that the non-centered parameterization enables more efficient learning of genetic effects, yielding substantially better out-of-sample prediction even with fewer training batches.\"\n",
    "Reviewers generally love seeing that you (a) validated your original approach rigorously, and (b) found a meaningful improvement in response to the revision. That's exactly the kind of progress a revision should show. You're not walking anything back -- you're building on it."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 6. Full AUC Comparison: Static 10yr, Dynamic 10yr, Dynamic 1yr\n",
    "\n",
    "All configs (constant, cos300, clip, v2_nokappa) on same holdout (390k–400k)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "evaluate_and_collect ready\n"
     ]
    }
   ],
   "source": [
    "# Import all three AUC evaluation functions\n",
    "from fig5utils import (\n",
    "    evaluate_major_diseases_wsex_with_bootstrap_from_pi,          # static 10yr\n",
    "    evaluate_major_diseases_wsex_with_bootstrap_dynamic_from_pi,  # dynamic 10yr\n",
    "    evaluate_major_diseases_wsex_with_bootstrap_dynamic_1year,    # dynamic 1yr (pi version)\n",
    ")\n",
    "\n",
    "N_BOOTSTRAPS = 100\n",
    "\n",
    "def evaluate_and_collect(pi, Y, E, disease_names, pce_df, n_bootstraps, horizon):\n",
    "    \"\"\"Run one AUC evaluation, return DataFrame.\"\"\"\n",
    "    if horizon == 'static_10yr':\n",
    "        results = evaluate_major_diseases_wsex_with_bootstrap_from_pi(\n",
    "            pi=pi, Y_100k=Y, E_100k=E, disease_names=disease_names,\n",
    "            pce_df=pce_df, n_bootstraps=n_bootstraps, follow_up_duration_years=10)\n",
    "    elif horizon == 'dynamic_10yr':\n",
    "        results = evaluate_major_diseases_wsex_with_bootstrap_dynamic_from_pi(\n",
    "            pi=pi, Y_100k=Y, E_100k=E, disease_names=disease_names,\n",
    "            pce_df=pce_df, n_bootstraps=n_bootstraps, follow_up_duration_years=10)\n",
    "    elif horizon == 'dynamic_1yr':\n",
    "        results = evaluate_major_diseases_wsex_with_bootstrap_dynamic_1year(\n",
    "            pi=pi, Y_100k=Y, E_100k=E, disease_names=disease_names,\n",
    "            pce_df=pce_df, n_bootstraps=n_bootstraps, follow_up_duration_years=1)\n",
    "    else:\n",
    "        raise ValueError(f'Unknown horizon: {horizon}')\n",
    "    rows = []\n",
    "    for disease, metrics in results.items():\n",
    "        rows.append({\n",
    "            'disease': disease,\n",
    "            'auc': metrics.get('auc', np.nan),\n",
    "            'ci_lower': metrics.get('ci_lower', np.nan),\n",
    "            'ci_upper': metrics.get('ci_upper', np.nan),\n",
    "            'n_events': metrics.get('n_events', 0),\n",
    "        })\n",
    "    return pd.DataFrame(rows)\n",
    "\n",
    "print('evaluate_and_collect ready')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "================================================================================\n",
      "EVALUATING STATIC_10YR\n",
      "================================================================================\n",
      "\n",
      "  constant...\n",
      "\n",
      "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.748 (0.732-0.761) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.742, Events = 319/5564\n",
      "   Male: AUC = 0.705, Events = 582/4436\n",
      "\n",
      "   ASCVD risk in patients with pre-existing conditions:\n",
      "   RA: AUC = 0.703, Events = 8/48\n",
      "   Breast_Cancer: AUC = 0.782, Events = 17/174\n",
      "\n",
      "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.712 (0.689-0.731) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.714, Events = 259/5564\n",
      "   Male: AUC = 0.691, Events = 354/4436\n",
      "\n",
      "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.747 (0.719-0.768) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 10000 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.736, Events = 202/5523\n",
      "   Male: AUC = 0.763, Events = 170/4337\n",
      "\n",
      "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.747 (0.715-0.780) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.725, Events = 88/5564\n",
      "   Male: AUC = 0.767, Events = 96/4436\n",
      "\n",
      "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.714 (0.689-0.735) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.596, Events = 152/5564\n",
      "   Male: AUC = 0.687, Events = 347/4436\n",
      "\n",
      "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.671 (0.624-0.709) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.745, Events = 58/5564\n",
      "   Male: AUC = 0.589, Events = 84/4436\n",
      "\n",
      "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.756 (0.730-0.785) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.794, Events = 82/5564\n",
      "   Male: AUC = 0.700, Events = 128/4436\n",
      "\n",
      "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.692 (0.662-0.714) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.671, Events = 150/5564\n",
      "   Male: AUC = 0.685, Events = 201/4436\n",
      "\n",
      "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.677 (0.653-0.707) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.683, Events = 207/5564\n",
      "   Male: AUC = 0.656, Events = 222/4436\n",
      "\n",
      "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.687 (0.654-0.713) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 10000 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.685, Events = 117/5537\n",
      "   Male: AUC = 0.692, Events = 106/4433\n",
      "\n",
      "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.624 (0.602-0.649) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.612, Events = 311/5564\n",
      "   Male: AUC = 0.642, Events = 241/4436\n",
      "\n",
      "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.624 (0.588-0.678) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.586, Events = 50/5564\n",
      "   Male: AUC = 0.630, Events = 68/4436\n",
      "\n",
      "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.560 (0.519-0.599) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.692 (0.655-0.731) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.0%) (from 4436 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.680 (0.640-0.718) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 10000 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.649, Events = 49/5564\n",
      "   Male: AUC = 0.718, Events = 41/4431\n",
      "\n",
      "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.746 (0.676-0.814) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 10000 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.746, Events = 35/5558\n",
      "   Male: AUC = 0.749, Events = 23/4419\n",
      "\n",
      "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.615 (0.590-0.651) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.590, Events = 163/5564\n",
      "   Male: AUC = 0.654, Events = 144/4436\n",
      "\n",
      "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.546 (0.516-0.573) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 10000 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.553, Events = 228/5501\n",
      "   Male: AUC = 0.544, Events = 176/4393\n",
      "\n",
      "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.569 (0.541-0.604) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.570, Events = 144/5554\n",
      "   Male: AUC = 0.570, Events = 116/4427\n",
      "\n",
      "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.394 (0.310-0.508) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.422, Events = 16/5555\n",
      "   Male: AUC = 0.338, Events = 7/4430\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.637 (0.593-0.682) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 10000 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.663, Events = 62/5528\n",
      "   Male: AUC = 0.604, Events = 52/4424\n",
      "\n",
      "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.673 (0.593-0.735) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.698, Events = 27/5558\n",
      "   Male: AUC = 0.649, Events = 27/4427\n",
      "\n",
      "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.533 (0.460-0.607) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 10000 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.580, Events = 25/5538\n",
      "   Male: AUC = 0.495, Events = 27/4402\n",
      "\n",
      "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.589 (0.442-0.715) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.525, Events = 17/5546\n",
      "   Male: AUC = 0.678, Events = 13/4421\n",
      "\n",
      "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.537 (0.510-0.559) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.3%) (from 10000 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.529, Events = 321/5373\n",
      "   Male: AUC = 0.580, Events = 288/4331\n",
      "\n",
      "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.773 (0.708-0.827) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.780, Events = 33/5559\n",
      "   Male: AUC = 0.761, Events = 20/4433\n",
      "\n",
      "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.516 (0.403-0.632) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 10000 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.421, Events = 7/5555\n",
      "   Male: AUC = 0.577, Events = 11/4432\n",
      "\n",
      "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.570 (0.545-0.594) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.575, Events = 378/5564\n",
      "   Male: AUC = 0.588, Events = 80/4436\n",
      "\n",
      "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.748 (0.732-0.761)       901        9.0\n",
      "Diabetes             0.712 (0.689-0.731)       613        6.1\n",
      "Atrial_Fib           0.747 (0.719-0.768)       379        3.8\n",
      "CKD                  0.747 (0.715-0.780)       184        1.8\n",
      "All_Cancers          0.714 (0.689-0.735)       499        5.0\n",
      "Stroke               0.671 (0.624-0.709)       142        1.4\n",
      "Heart_Failure        0.756 (0.730-0.785)       210        2.1\n",
      "Pneumonia            0.692 (0.662-0.714)       351        3.5\n",
      "COPD                 0.677 (0.653-0.707)       429        4.3\n",
      "Osteoporosis         0.687 (0.654-0.713)       223        2.2\n",
      "Anemia               0.624 (0.602-0.649)       552        5.5\n",
      "Colorectal_Cancer    0.624 (0.588-0.678)       118        1.2\n",
      "Breast_Cancer        0.560 (0.519-0.599)       225        4.0\n",
      "Prostate_Cancer      0.692 (0.655-0.731)       178        4.0\n",
      "Lung_Cancer          0.680 (0.640-0.718)       90         0.9\n",
      "Bladder_Cancer       0.746 (0.676-0.814)       58         0.6\n",
      "Secondary_Cancer     0.615 (0.590-0.651)       307        3.1\n",
      "Depression           0.546 (0.516-0.573)       410        4.1\n",
      "Anxiety              0.569 (0.541-0.604)       260        2.6\n",
      "Bipolar_Disorder     0.394 (0.310-0.508)       23         0.2\n",
      "Rheumatoid_Arthritis 0.637 (0.593-0.682)       116        1.2\n",
      "Psoriasis            0.673 (0.593-0.735)       54         0.5\n",
      "Ulcerative_Colitis   0.533 (0.460-0.607)       52         0.5\n",
      "Crohns_Disease       0.589 (0.442-0.715)       30         0.3\n",
      "Asthma               0.537 (0.510-0.559)       635        6.3\n",
      "Parkinsons           0.773 (0.708-0.827)       53         0.5\n",
      "Multiple_Sclerosis   0.516 (0.403-0.632)       18         0.2\n",
      "Thyroid_Disorders    0.570 (0.545-0.594)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  cos300...\n",
      "\n",
      "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.726 (0.707-0.740) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.725, Events = 319/5564\n",
      "   Male: AUC = 0.683, Events = 582/4436\n",
      "\n",
      "   ASCVD risk in patients with pre-existing conditions:\n",
      "   RA: AUC = 0.778, Events = 8/48\n",
      "   Breast_Cancer: AUC = 0.790, Events = 17/174\n",
      "\n",
      "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.685 (0.664-0.705) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.679, Events = 259/5564\n",
      "   Male: AUC = 0.669, Events = 354/4436\n",
      "\n",
      "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.730 (0.708-0.759) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 10000 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.721, Events = 202/5523\n",
      "   Male: AUC = 0.744, Events = 170/4337\n",
      "\n",
      "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.705 (0.674-0.740) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.681, Events = 88/5564\n",
      "   Male: AUC = 0.736, Events = 96/4436\n",
      "\n",
      "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.707 (0.684-0.730) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.591, Events = 152/5564\n",
      "   Male: AUC = 0.695, Events = 347/4436\n",
      "\n",
      "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.641 (0.591-0.689) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.703, Events = 58/5564\n",
      "   Male: AUC = 0.584, Events = 84/4436\n",
      "\n",
      "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.724 (0.688-0.751) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.766, Events = 82/5564\n",
      "   Male: AUC = 0.667, Events = 128/4436\n",
      "\n",
      "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.667 (0.641-0.691) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.652, Events = 150/5564\n",
      "   Male: AUC = 0.661, Events = 201/4436\n",
      "\n",
      "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.650 (0.631-0.680) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.655, Events = 207/5564\n",
      "   Male: AUC = 0.636, Events = 222/4436\n",
      "\n",
      "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.709 (0.679-0.741) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 10000 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.711, Events = 117/5537\n",
      "   Male: AUC = 0.710, Events = 106/4433\n",
      "\n",
      "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.592 (0.567-0.618) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.579, Events = 311/5564\n",
      "   Male: AUC = 0.607, Events = 241/4436\n",
      "\n",
      "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.619 (0.552-0.665) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.568, Events = 50/5564\n",
      "   Male: AUC = 0.649, Events = 68/4436\n",
      "\n",
      "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.565 (0.523-0.609) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.711 (0.669-0.750) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.0%) (from 4436 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.664 (0.613-0.715) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 10000 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.646, Events = 49/5564\n",
      "   Male: AUC = 0.687, Events = 41/4431\n",
      "\n",
      "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.745 (0.692-0.803) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 10000 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.747, Events = 35/5558\n",
      "   Male: AUC = 0.748, Events = 23/4419\n",
      "\n",
      "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.606 (0.572-0.642) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.579, Events = 163/5564\n",
      "   Male: AUC = 0.652, Events = 144/4436\n",
      "\n",
      "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.503 (0.472-0.527) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 10000 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.524, Events = 228/5501\n",
      "   Male: AUC = 0.483, Events = 176/4393\n",
      "\n",
      "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.539 (0.503-0.564) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.549, Events = 144/5554\n",
      "   Male: AUC = 0.529, Events = 116/4427\n",
      "\n",
      "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.375 (0.289-0.460) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.390, Events = 16/5555\n",
      "   Male: AUC = 0.349, Events = 7/4430\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.618 (0.564-0.670) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 10000 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.631, Events = 62/5528\n",
      "   Male: AUC = 0.597, Events = 52/4424\n",
      "\n",
      "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.630 (0.570-0.711) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.674, Events = 27/5558\n",
      "   Male: AUC = 0.586, Events = 27/4427\n",
      "\n",
      "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.507 (0.421-0.598) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 10000 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.573, Events = 25/5538\n",
      "   Male: AUC = 0.452, Events = 27/4402\n",
      "\n",
      "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.501 (0.391-0.627) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.471, Events = 17/5546\n",
      "   Male: AUC = 0.542, Events = 13/4421\n",
      "\n",
      "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.527 (0.504-0.547) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.3%) (from 10000 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.522, Events = 321/5373\n",
      "   Male: AUC = 0.568, Events = 288/4331\n",
      "\n",
      "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.761 (0.704-0.821) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.770, Events = 33/5559\n",
      "   Male: AUC = 0.747, Events = 20/4433\n",
      "\n",
      "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.440 (0.310-0.571) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 10000 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.350, Events = 7/5555\n",
      "   Male: AUC = 0.495, Events = 11/4432\n",
      "\n",
      "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.600 (0.580-0.628) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.577, Events = 378/5564\n",
      "   Male: AUC = 0.569, Events = 80/4436\n",
      "\n",
      "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.726 (0.707-0.740)       901        9.0\n",
      "Diabetes             0.685 (0.664-0.705)       613        6.1\n",
      "Atrial_Fib           0.730 (0.708-0.759)       379        3.8\n",
      "CKD                  0.705 (0.674-0.740)       184        1.8\n",
      "All_Cancers          0.707 (0.684-0.730)       499        5.0\n",
      "Stroke               0.641 (0.591-0.689)       142        1.4\n",
      "Heart_Failure        0.724 (0.688-0.751)       210        2.1\n",
      "Pneumonia            0.667 (0.641-0.691)       351        3.5\n",
      "COPD                 0.650 (0.631-0.680)       429        4.3\n",
      "Osteoporosis         0.709 (0.679-0.741)       223        2.2\n",
      "Anemia               0.592 (0.567-0.618)       552        5.5\n",
      "Colorectal_Cancer    0.619 (0.552-0.665)       118        1.2\n",
      "Breast_Cancer        0.565 (0.523-0.609)       225        4.0\n",
      "Prostate_Cancer      0.711 (0.669-0.750)       178        4.0\n",
      "Lung_Cancer          0.664 (0.613-0.715)       90         0.9\n",
      "Bladder_Cancer       0.745 (0.692-0.803)       58         0.6\n",
      "Secondary_Cancer     0.606 (0.572-0.642)       307        3.1\n",
      "Depression           0.503 (0.472-0.527)       410        4.1\n",
      "Anxiety              0.539 (0.503-0.564)       260        2.6\n",
      "Bipolar_Disorder     0.375 (0.289-0.460)       23         0.2\n",
      "Rheumatoid_Arthritis 0.618 (0.564-0.670)       116        1.2\n",
      "Psoriasis            0.630 (0.570-0.711)       54         0.5\n",
      "Ulcerative_Colitis   0.507 (0.421-0.598)       52         0.5\n",
      "Crohns_Disease       0.501 (0.391-0.627)       30         0.3\n",
      "Asthma               0.527 (0.504-0.547)       635        6.3\n",
      "Parkinsons           0.761 (0.704-0.821)       53         0.5\n",
      "Multiple_Sclerosis   0.440 (0.310-0.571)       18         0.2\n",
      "Thyroid_Disorders    0.600 (0.580-0.628)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  clip...\n",
      "\n",
      "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.748 (0.731-0.764) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.742, Events = 319/5564\n",
      "   Male: AUC = 0.705, Events = 582/4436\n",
      "\n",
      "   ASCVD risk in patients with pre-existing conditions:\n",
      "   RA: AUC = 0.703, Events = 8/48\n",
      "   Breast_Cancer: AUC = 0.782, Events = 17/174\n",
      "\n",
      "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.712 (0.689-0.729) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.714, Events = 259/5564\n",
      "   Male: AUC = 0.691, Events = 354/4436\n",
      "\n",
      "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.747 (0.725-0.770) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 10000 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.736, Events = 202/5523\n",
      "   Male: AUC = 0.763, Events = 170/4337\n",
      "\n",
      "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.747 (0.716-0.787) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.725, Events = 88/5564\n",
      "   Male: AUC = 0.767, Events = 96/4436\n",
      "\n",
      "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.714 (0.692-0.739) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.596, Events = 152/5564\n",
      "   Male: AUC = 0.687, Events = 347/4436\n",
      "\n",
      "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.671 (0.635-0.703) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.745, Events = 58/5564\n",
      "   Male: AUC = 0.589, Events = 84/4436\n",
      "\n",
      "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.756 (0.730-0.786) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.794, Events = 82/5564\n",
      "   Male: AUC = 0.700, Events = 128/4436\n",
      "\n",
      "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.692 (0.663-0.719) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.671, Events = 150/5564\n",
      "   Male: AUC = 0.685, Events = 201/4436\n",
      "\n",
      "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.677 (0.656-0.698) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.683, Events = 207/5564\n",
      "   Male: AUC = 0.656, Events = 222/4436\n",
      "\n",
      "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.687 (0.659-0.722) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 10000 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.685, Events = 117/5537\n",
      "   Male: AUC = 0.692, Events = 106/4433\n",
      "\n",
      "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.624 (0.599-0.648) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.612, Events = 311/5564\n",
      "   Male: AUC = 0.642, Events = 241/4436\n",
      "\n",
      "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.624 (0.578-0.667) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.586, Events = 50/5564\n",
      "   Male: AUC = 0.630, Events = 68/4436\n",
      "\n",
      "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.560 (0.518-0.595) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.692 (0.657-0.726) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.0%) (from 4436 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.680 (0.630-0.718) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 10000 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.649, Events = 49/5564\n",
      "   Male: AUC = 0.718, Events = 41/4431\n",
      "\n",
      "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.746 (0.676-0.815) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 10000 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.746, Events = 35/5558\n",
      "   Male: AUC = 0.749, Events = 23/4419\n",
      "\n",
      "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.615 (0.578-0.640) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.590, Events = 163/5564\n",
      "   Male: AUC = 0.654, Events = 144/4436\n",
      "\n",
      "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.546 (0.522-0.573) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 10000 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.553, Events = 228/5501\n",
      "   Male: AUC = 0.544, Events = 176/4393\n",
      "\n",
      "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.569 (0.529-0.599) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.570, Events = 144/5554\n",
      "   Male: AUC = 0.570, Events = 116/4427\n",
      "\n",
      "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.394 (0.306-0.509) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.422, Events = 16/5555\n",
      "   Male: AUC = 0.338, Events = 7/4430\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.637 (0.589-0.680) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 10000 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.663, Events = 62/5528\n",
      "   Male: AUC = 0.604, Events = 52/4424\n",
      "\n",
      "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.673 (0.598-0.739) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.698, Events = 27/5558\n",
      "   Male: AUC = 0.649, Events = 27/4427\n",
      "\n",
      "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.533 (0.451-0.614) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 10000 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.580, Events = 25/5538\n",
      "   Male: AUC = 0.495, Events = 27/4402\n",
      "\n",
      "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.589 (0.479-0.720) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.525, Events = 17/5546\n",
      "   Male: AUC = 0.678, Events = 13/4421\n",
      "\n",
      "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.537 (0.510-0.558) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.3%) (from 10000 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.529, Events = 321/5373\n",
      "   Male: AUC = 0.580, Events = 288/4331\n",
      "\n",
      "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.773 (0.707-0.823) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.780, Events = 33/5559\n",
      "   Male: AUC = 0.761, Events = 20/4433\n",
      "\n",
      "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.516 (0.405-0.632) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 10000 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.421, Events = 7/5555\n",
      "   Male: AUC = 0.577, Events = 11/4432\n",
      "\n",
      "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.570 (0.551-0.591) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.575, Events = 378/5564\n",
      "   Male: AUC = 0.588, Events = 80/4436\n",
      "\n",
      "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.748 (0.731-0.764)       901        9.0\n",
      "Diabetes             0.712 (0.689-0.729)       613        6.1\n",
      "Atrial_Fib           0.747 (0.725-0.770)       379        3.8\n",
      "CKD                  0.747 (0.716-0.787)       184        1.8\n",
      "All_Cancers          0.714 (0.692-0.739)       499        5.0\n",
      "Stroke               0.671 (0.635-0.703)       142        1.4\n",
      "Heart_Failure        0.756 (0.730-0.786)       210        2.1\n",
      "Pneumonia            0.692 (0.663-0.719)       351        3.5\n",
      "COPD                 0.677 (0.656-0.698)       429        4.3\n",
      "Osteoporosis         0.687 (0.659-0.722)       223        2.2\n",
      "Anemia               0.624 (0.599-0.648)       552        5.5\n",
      "Colorectal_Cancer    0.624 (0.578-0.667)       118        1.2\n",
      "Breast_Cancer        0.560 (0.518-0.595)       225        4.0\n",
      "Prostate_Cancer      0.692 (0.657-0.726)       178        4.0\n",
      "Lung_Cancer          0.680 (0.630-0.718)       90         0.9\n",
      "Bladder_Cancer       0.746 (0.676-0.815)       58         0.6\n",
      "Secondary_Cancer     0.615 (0.578-0.640)       307        3.1\n",
      "Depression           0.546 (0.522-0.573)       410        4.1\n",
      "Anxiety              0.569 (0.529-0.599)       260        2.6\n",
      "Bipolar_Disorder     0.394 (0.306-0.509)       23         0.2\n",
      "Rheumatoid_Arthritis 0.637 (0.589-0.680)       116        1.2\n",
      "Psoriasis            0.673 (0.598-0.739)       54         0.5\n",
      "Ulcerative_Colitis   0.533 (0.451-0.614)       52         0.5\n",
      "Crohns_Disease       0.589 (0.479-0.720)       30         0.3\n",
      "Asthma               0.537 (0.510-0.558)       635        6.3\n",
      "Parkinsons           0.773 (0.707-0.823)       53         0.5\n",
      "Multiple_Sclerosis   0.516 (0.405-0.632)       18         0.2\n",
      "Thyroid_Disorders    0.570 (0.551-0.591)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  v2_nokappa...\n",
      "\n",
      "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.748 (0.730-0.768) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.743, Events = 319/5564\n",
      "   Male: AUC = 0.705, Events = 582/4436\n",
      "\n",
      "   ASCVD risk in patients with pre-existing conditions:\n",
      "   RA: AUC = 0.734, Events = 8/48\n",
      "   Breast_Cancer: AUC = 0.785, Events = 17/174\n",
      "\n",
      "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.710 (0.687-0.729) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.711, Events = 259/5564\n",
      "   Male: AUC = 0.689, Events = 354/4436\n",
      "\n",
      "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.748 (0.724-0.768) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 10000 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.736, Events = 202/5523\n",
      "   Male: AUC = 0.763, Events = 170/4337\n",
      "\n",
      "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.741 (0.714-0.770) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.718, Events = 88/5564\n",
      "   Male: AUC = 0.763, Events = 96/4436\n",
      "\n",
      "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.713 (0.689-0.735) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.596, Events = 152/5564\n",
      "   Male: AUC = 0.687, Events = 347/4436\n",
      "\n",
      "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.667 (0.627-0.711) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.740, Events = 58/5564\n",
      "   Male: AUC = 0.588, Events = 84/4436\n",
      "\n",
      "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.754 (0.722-0.785) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.793, Events = 82/5564\n",
      "   Male: AUC = 0.699, Events = 128/4436\n",
      "\n",
      "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.690 (0.664-0.719) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.669, Events = 150/5564\n",
      "   Male: AUC = 0.683, Events = 201/4436\n",
      "\n",
      "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.674 (0.651-0.698) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.680, Events = 207/5564\n",
      "   Male: AUC = 0.654, Events = 222/4436\n",
      "\n",
      "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.692 (0.667-0.721) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 10000 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.690, Events = 117/5537\n",
      "   Male: AUC = 0.696, Events = 106/4433\n",
      "\n",
      "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.622 (0.601-0.646) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.611, Events = 311/5564\n",
      "   Male: AUC = 0.639, Events = 241/4436\n",
      "\n",
      "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.623 (0.572-0.674) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.586, Events = 50/5564\n",
      "   Male: AUC = 0.631, Events = 68/4436\n",
      "\n",
      "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.562 (0.518-0.598) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.692 (0.659-0.722) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.0%) (from 4436 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.676 (0.626-0.722) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 10000 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.648, Events = 49/5564\n",
      "   Male: AUC = 0.711, Events = 41/4431\n",
      "\n",
      "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.746 (0.682-0.814) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 10000 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.746, Events = 35/5558\n",
      "   Male: AUC = 0.748, Events = 23/4419\n",
      "\n",
      "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.613 (0.586-0.640) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.590, Events = 163/5564\n",
      "   Male: AUC = 0.655, Events = 144/4436\n",
      "\n",
      "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.541 (0.509-0.565) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 10000 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.550, Events = 228/5501\n",
      "   Male: AUC = 0.536, Events = 176/4393\n",
      "\n",
      "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.568 (0.532-0.611) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.569, Events = 144/5554\n",
      "   Male: AUC = 0.569, Events = 116/4427\n",
      "\n",
      "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.386 (0.277-0.505) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.421, Events = 16/5555\n",
      "   Male: AUC = 0.316, Events = 7/4430\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.639 (0.585-0.685) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 10000 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.664, Events = 62/5528\n",
      "   Male: AUC = 0.606, Events = 52/4424\n",
      "\n",
      "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.671 (0.605-0.748) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.697, Events = 27/5558\n",
      "   Male: AUC = 0.646, Events = 27/4427\n",
      "\n",
      "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.528 (0.450-0.604) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 10000 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.581, Events = 25/5538\n",
      "   Male: AUC = 0.483, Events = 27/4402\n",
      "\n",
      "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.588 (0.489-0.697) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.521, Events = 17/5546\n",
      "   Male: AUC = 0.680, Events = 13/4421\n",
      "\n",
      "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.538 (0.515-0.561) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.3%) (from 10000 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.530, Events = 321/5373\n",
      "   Male: AUC = 0.580, Events = 288/4331\n",
      "\n",
      "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.773 (0.714-0.820) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.781, Events = 33/5559\n",
      "   Male: AUC = 0.761, Events = 20/4433\n",
      "\n",
      "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.517 (0.405-0.660) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 10000 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.418, Events = 7/5555\n",
      "   Male: AUC = 0.578, Events = 11/4432\n",
      "\n",
      "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.576 (0.550-0.598) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.576, Events = 378/5564\n",
      "   Male: AUC = 0.586, Events = 80/4436\n",
      "\n",
      "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.748 (0.730-0.768)       901        9.0\n",
      "Diabetes             0.710 (0.687-0.729)       613        6.1\n",
      "Atrial_Fib           0.748 (0.724-0.768)       379        3.8\n",
      "CKD                  0.741 (0.714-0.770)       184        1.8\n",
      "All_Cancers          0.713 (0.689-0.735)       499        5.0\n",
      "Stroke               0.667 (0.627-0.711)       142        1.4\n",
      "Heart_Failure        0.754 (0.722-0.785)       210        2.1\n",
      "Pneumonia            0.690 (0.664-0.719)       351        3.5\n",
      "COPD                 0.674 (0.651-0.698)       429        4.3\n",
      "Osteoporosis         0.692 (0.667-0.721)       223        2.2\n",
      "Anemia               0.622 (0.601-0.646)       552        5.5\n",
      "Colorectal_Cancer    0.623 (0.572-0.674)       118        1.2\n",
      "Breast_Cancer        0.562 (0.518-0.598)       225        4.0\n",
      "Prostate_Cancer      0.692 (0.659-0.722)       178        4.0\n",
      "Lung_Cancer          0.676 (0.626-0.722)       90         0.9\n",
      "Bladder_Cancer       0.746 (0.682-0.814)       58         0.6\n",
      "Secondary_Cancer     0.613 (0.586-0.640)       307        3.1\n",
      "Depression           0.541 (0.509-0.565)       410        4.1\n",
      "Anxiety              0.568 (0.532-0.611)       260        2.6\n",
      "Bipolar_Disorder     0.386 (0.277-0.505)       23         0.2\n",
      "Rheumatoid_Arthritis 0.639 (0.585-0.685)       116        1.2\n",
      "Psoriasis            0.671 (0.605-0.748)       54         0.5\n",
      "Ulcerative_Colitis   0.528 (0.450-0.604)       52         0.5\n",
      "Crohns_Disease       0.588 (0.489-0.697)       30         0.3\n",
      "Asthma               0.538 (0.515-0.561)       635        6.3\n",
      "Parkinsons           0.773 (0.714-0.820)       53         0.5\n",
      "Multiple_Sclerosis   0.517 (0.405-0.660)       18         0.2\n",
      "Thyroid_Disorders    0.576 (0.550-0.598)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  nolr...\n",
      "\n",
      "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.722 (0.703-0.736) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.731, Events = 319/5564\n",
      "   Male: AUC = 0.686, Events = 582/4436\n",
      "\n",
      "   ASCVD risk in patients with pre-existing conditions:\n",
      "   RA: AUC = 0.834, Events = 8/48\n",
      "   Breast_Cancer: AUC = 0.785, Events = 17/174\n",
      "\n",
      "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.610 (0.592-0.633) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.616, Events = 259/5564\n",
      "   Male: AUC = 0.597, Events = 354/4436\n",
      "\n",
      "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.710 (0.684-0.731) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 10000 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.700, Events = 202/5523\n",
      "   Male: AUC = 0.729, Events = 170/4337\n",
      "\n",
      "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.719 (0.683-0.753) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.690, Events = 88/5564\n",
      "   Male: AUC = 0.745, Events = 96/4436\n",
      "\n",
      "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.664 (0.645-0.685) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.586, Events = 152/5564\n",
      "   Male: AUC = 0.685, Events = 347/4436\n",
      "\n",
      "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.643 (0.586-0.684) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.722, Events = 58/5564\n",
      "   Male: AUC = 0.581, Events = 84/4436\n",
      "\n",
      "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.711 (0.678-0.742) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.766, Events = 82/5564\n",
      "   Male: AUC = 0.665, Events = 128/4436\n",
      "\n",
      "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.661 (0.631-0.685) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.648, Events = 150/5564\n",
      "   Male: AUC = 0.664, Events = 201/4436\n",
      "\n",
      "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.641 (0.616-0.665) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.652, Events = 207/5564\n",
      "   Male: AUC = 0.625, Events = 222/4436\n",
      "\n",
      "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.695 (0.674-0.722) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 10000 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.694, Events = 117/5537\n",
      "   Male: AUC = 0.699, Events = 106/4433\n",
      "\n",
      "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.582 (0.559-0.608) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.572, Events = 311/5564\n",
      "   Male: AUC = 0.595, Events = 241/4436\n",
      "\n",
      "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.614 (0.570-0.660) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.568, Events = 50/5564\n",
      "   Male: AUC = 0.643, Events = 68/4436\n",
      "\n",
      "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.529 (0.496-0.559) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.690 (0.656-0.730) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.0%) (from 4436 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.669 (0.620-0.716) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 10000 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.643, Events = 49/5564\n",
      "   Male: AUC = 0.699, Events = 41/4431\n",
      "\n",
      "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.689 (0.622-0.754) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 10000 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.686, Events = 35/5558\n",
      "   Male: AUC = 0.696, Events = 23/4419\n",
      "\n",
      "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.609 (0.578-0.637) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.568, Events = 163/5564\n",
      "   Male: AUC = 0.654, Events = 144/4436\n",
      "\n",
      "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.484 (0.453-0.506) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 10000 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.512, Events = 228/5501\n",
      "   Male: AUC = 0.458, Events = 176/4393\n",
      "\n",
      "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.523 (0.486-0.552) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.536, Events = 144/5554\n",
      "   Male: AUC = 0.510, Events = 116/4427\n",
      "\n",
      "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.517 (0.421-0.617) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.506, Events = 16/5555\n",
      "   Male: AUC = 0.548, Events = 7/4430\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.604 (0.555-0.651) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 10000 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.635, Events = 62/5528\n",
      "   Male: AUC = 0.566, Events = 52/4424\n",
      "\n",
      "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.607 (0.534-0.675) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.650, Events = 27/5558\n",
      "   Male: AUC = 0.565, Events = 27/4427\n",
      "\n",
      "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.539 (0.461-0.645) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 10000 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.615, Events = 25/5538\n",
      "   Male: AUC = 0.473, Events = 27/4402\n",
      "\n",
      "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.536 (0.415-0.648) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.493, Events = 17/5546\n",
      "   Male: AUC = 0.593, Events = 13/4421\n",
      "\n",
      "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.511 (0.490-0.542) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.3%) (from 10000 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.506, Events = 321/5373\n",
      "   Male: AUC = 0.553, Events = 288/4331\n",
      "\n",
      "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.748 (0.683-0.811) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.756, Events = 33/5559\n",
      "   Male: AUC = 0.736, Events = 20/4433\n",
      "\n",
      "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.519 (0.384-0.644) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 10000 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.459, Events = 7/5555\n",
      "   Male: AUC = 0.559, Events = 11/4432\n",
      "\n",
      "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.577 (0.551-0.601) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.574, Events = 378/5564\n",
      "   Male: AUC = 0.574, Events = 80/4436\n",
      "\n",
      "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.722 (0.703-0.736)       901        9.0\n",
      "Diabetes             0.610 (0.592-0.633)       613        6.1\n",
      "Atrial_Fib           0.710 (0.684-0.731)       379        3.8\n",
      "CKD                  0.719 (0.683-0.753)       184        1.8\n",
      "All_Cancers          0.664 (0.645-0.685)       499        5.0\n",
      "Stroke               0.643 (0.586-0.684)       142        1.4\n",
      "Heart_Failure        0.711 (0.678-0.742)       210        2.1\n",
      "Pneumonia            0.661 (0.631-0.685)       351        3.5\n",
      "COPD                 0.641 (0.616-0.665)       429        4.3\n",
      "Osteoporosis         0.695 (0.674-0.722)       223        2.2\n",
      "Anemia               0.582 (0.559-0.608)       552        5.5\n",
      "Colorectal_Cancer    0.614 (0.570-0.660)       118        1.2\n",
      "Breast_Cancer        0.529 (0.496-0.559)       225        4.0\n",
      "Prostate_Cancer      0.690 (0.656-0.730)       178        4.0\n",
      "Lung_Cancer          0.669 (0.620-0.716)       90         0.9\n",
      "Bladder_Cancer       0.689 (0.622-0.754)       58         0.6\n",
      "Secondary_Cancer     0.609 (0.578-0.637)       307        3.1\n",
      "Depression           0.484 (0.453-0.506)       410        4.1\n",
      "Anxiety              0.523 (0.486-0.552)       260        2.6\n",
      "Bipolar_Disorder     0.517 (0.421-0.617)       23         0.2\n",
      "Rheumatoid_Arthritis 0.604 (0.555-0.651)       116        1.2\n",
      "Psoriasis            0.607 (0.534-0.675)       54         0.5\n",
      "Ulcerative_Colitis   0.539 (0.461-0.645)       52         0.5\n",
      "Crohns_Disease       0.536 (0.415-0.648)       30         0.3\n",
      "Asthma               0.511 (0.490-0.542)       635        6.3\n",
      "Parkinsons           0.748 (0.683-0.811)       53         0.5\n",
      "Multiple_Sclerosis   0.519 (0.384-0.644)       18         0.2\n",
      "Thyroid_Disorders    0.577 (0.551-0.601)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "DISEASE                                 constant                 cos300                   clip             v2_nokappa                   nolr         BEST\n",
      "---------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "ASCVD                     0.748 (0.732-0.761) 0.726 (0.707-0.740) 0.748 (0.731-0.764) 0.748 (0.730-0.768) 0.722 (0.703-0.736)     constant\n",
      "All_Cancers               0.714 (0.689-0.735) 0.707 (0.684-0.730) 0.714 (0.692-0.739) 0.713 (0.689-0.735) 0.664 (0.645-0.685)     constant\n",
      "Anemia                    0.624 (0.602-0.649) 0.592 (0.567-0.618) 0.624 (0.599-0.648) 0.622 (0.601-0.646) 0.582 (0.559-0.608)     constant\n",
      "Anxiety                   0.569 (0.541-0.604) 0.539 (0.503-0.564) 0.569 (0.529-0.599) 0.568 (0.532-0.611) 0.523 (0.486-0.552)     constant\n",
      "Asthma                    0.537 (0.510-0.559) 0.527 (0.504-0.547) 0.537 (0.510-0.558) 0.538 (0.515-0.561) 0.511 (0.490-0.542)   v2_nokappa\n",
      "Atrial_Fib                0.747 (0.719-0.768) 0.730 (0.708-0.759) 0.747 (0.725-0.770) 0.748 (0.724-0.768) 0.710 (0.684-0.731)   v2_nokappa\n",
      "Bipolar_Disorder          0.394 (0.310-0.508) 0.375 (0.289-0.460) 0.394 (0.306-0.509) 0.386 (0.277-0.505) 0.517 (0.421-0.617)         nolr\n",
      "Bladder_Cancer            0.746 (0.676-0.814) 0.745 (0.692-0.803) 0.746 (0.676-0.815) 0.746 (0.682-0.814) 0.689 (0.622-0.754)     constant\n",
      "Breast_Cancer             0.560 (0.519-0.599) 0.565 (0.523-0.609) 0.560 (0.518-0.595) 0.562 (0.518-0.598) 0.529 (0.496-0.559)       cos300\n",
      "CKD                       0.747 (0.715-0.780) 0.705 (0.674-0.740) 0.747 (0.716-0.787) 0.741 (0.714-0.770) 0.719 (0.683-0.753)     constant\n",
      "COPD                      0.677 (0.653-0.707) 0.650 (0.631-0.680) 0.677 (0.656-0.698) 0.674 (0.651-0.698) 0.641 (0.616-0.665)     constant\n",
      "Colorectal_Cancer         0.624 (0.588-0.678) 0.619 (0.552-0.665) 0.624 (0.578-0.667) 0.623 (0.572-0.674) 0.614 (0.570-0.660)     constant\n",
      "Crohns_Disease            0.589 (0.442-0.715) 0.501 (0.391-0.627) 0.589 (0.479-0.720) 0.588 (0.489-0.697) 0.536 (0.415-0.648)     constant\n",
      "Depression                0.546 (0.516-0.573) 0.503 (0.472-0.527) 0.546 (0.522-0.573) 0.541 (0.509-0.565) 0.484 (0.453-0.506)     constant\n",
      "Diabetes                  0.712 (0.689-0.731) 0.685 (0.664-0.705) 0.712 (0.689-0.729) 0.710 (0.687-0.729) 0.610 (0.592-0.633)     constant\n",
      "Heart_Failure             0.756 (0.730-0.785) 0.724 (0.688-0.751) 0.756 (0.730-0.786) 0.754 (0.722-0.785) 0.711 (0.678-0.742)     constant\n",
      "Lung_Cancer               0.680 (0.640-0.718) 0.664 (0.613-0.715) 0.680 (0.630-0.718) 0.676 (0.626-0.722) 0.669 (0.620-0.716)     constant\n",
      "Multiple_Sclerosis        0.516 (0.403-0.632) 0.440 (0.310-0.571) 0.516 (0.405-0.632) 0.517 (0.405-0.660) 0.519 (0.384-0.644)         nolr\n",
      "Osteoporosis              0.687 (0.654-0.713) 0.709 (0.679-0.741) 0.687 (0.659-0.722) 0.692 (0.667-0.721) 0.695 (0.674-0.722)       cos300\n",
      "Parkinsons                0.773 (0.708-0.827) 0.761 (0.704-0.821) 0.773 (0.707-0.823) 0.773 (0.714-0.820) 0.748 (0.683-0.811)   v2_nokappa\n",
      "Pneumonia                 0.692 (0.662-0.714) 0.667 (0.641-0.691) 0.692 (0.663-0.719) 0.690 (0.664-0.719) 0.661 (0.631-0.685)     constant\n",
      "Prostate_Cancer           0.692 (0.655-0.731) 0.711 (0.669-0.750) 0.692 (0.657-0.726) 0.692 (0.659-0.722) 0.690 (0.656-0.730)       cos300\n",
      "Psoriasis                 0.673 (0.593-0.735) 0.630 (0.570-0.711) 0.673 (0.598-0.739) 0.671 (0.605-0.748) 0.607 (0.534-0.675)     constant\n",
      "Rheumatoid_Arthritis      0.637 (0.593-0.682) 0.618 (0.564-0.670) 0.637 (0.589-0.680) 0.639 (0.585-0.685) 0.604 (0.555-0.651)   v2_nokappa\n",
      "Secondary_Cancer          0.615 (0.590-0.651) 0.606 (0.572-0.642) 0.615 (0.578-0.640) 0.613 (0.586-0.640) 0.609 (0.578-0.637)     constant\n",
      "Stroke                    0.671 (0.624-0.709) 0.641 (0.591-0.689) 0.671 (0.635-0.703) 0.667 (0.627-0.711) 0.643 (0.586-0.684)     constant\n",
      "Thyroid_Disorders         0.570 (0.545-0.594) 0.600 (0.580-0.628) 0.570 (0.551-0.591) 0.576 (0.550-0.598) 0.577 (0.551-0.601)       cos300\n",
      "Ulcerative_Colitis        0.533 (0.460-0.607) 0.507 (0.421-0.598) 0.533 (0.451-0.614) 0.528 (0.450-0.604) 0.539 (0.461-0.645)         nolr\n",
      "\n",
      "  Mean AUC constant: 0.6440\n",
      "  Mean AUC cos300: 0.6231\n",
      "  Mean AUC clip: 0.6440\n",
      "  Mean AUC v2_nokappa: 0.6427\n",
      "  Mean AUC nolr: 0.6188\n",
      "\n",
      "================================================================================\n",
      "EVALUATING DYNAMIC_10YR\n",
      "================================================================================\n",
      "\n",
      "  constant...\n",
      "\n",
      "Evaluating ASCVD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.732 (0.718-0.748) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.699-0.736) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (Dynamic 10-Year Risk)...\n",
      "AUC: 0.708 (0.686-0.731) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 9860 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.714 (0.681-0.740) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.695-0.739) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (Dynamic 10-Year Risk)...\n",
      "AUC: 0.663 (0.620-0.710) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (Dynamic 10-Year Risk)...\n",
      "AUC: 0.726 (0.692-0.758) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.676 (0.644-0.707) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.663 (0.642-0.690) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.686 (0.650-0.706) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 9970 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.603 (0.575-0.627) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.634 (0.583-0.678) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.581 (0.539-0.619) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.706 (0.670-0.738) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.1%) (from 4386 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.675 (0.620-0.711) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 9995 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.746 (0.683-0.813) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 9977 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.608 (0.581-0.647) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (Dynamic 10-Year Risk)...\n",
      "AUC: 0.524 (0.489-0.555) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 9894 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (Dynamic 10-Year Risk)...\n",
      "AUC: 0.527 (0.496-0.559) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 9981 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (Dynamic 10-Year Risk)...\n",
      "AUC: 0.402 (0.330-0.519) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.620 (0.565-0.672) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 9952 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.632 (0.555-0.721) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.559 (0.478-0.632) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 9940 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (Dynamic 10-Year Risk)...\n",
      "AUC: 0.574 (0.458-0.684) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 9967 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (Dynamic 10-Year Risk)...\n",
      "AUC: 0.537 (0.512-0.562) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.5%) (from 9704 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (Dynamic 10-Year Risk)...\n",
      "AUC: 0.766 (0.713-0.825) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 9992 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.558 (0.421-0.671) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 9987 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (Dynamic 10-Year Risk)...\n",
      "AUC: 0.585 (0.557-0.612) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (Dynamic 10-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.732 (0.718-0.748)       901        9.0\n",
      "Diabetes             0.716 (0.699-0.736)       613        6.1\n",
      "Atrial_Fib           0.708 (0.686-0.731)       379        3.8\n",
      "CKD                  0.714 (0.681-0.740)       184        1.8\n",
      "All_Cancers          0.716 (0.695-0.739)       499        5.0\n",
      "Stroke               0.663 (0.620-0.710)       142        1.4\n",
      "Heart_Failure        0.726 (0.692-0.758)       210        2.1\n",
      "Pneumonia            0.676 (0.644-0.707)       351        3.5\n",
      "COPD                 0.663 (0.642-0.690)       429        4.3\n",
      "Osteoporosis         0.686 (0.650-0.706)       223        2.2\n",
      "Anemia               0.603 (0.575-0.627)       552        5.5\n",
      "Colorectal_Cancer    0.634 (0.583-0.678)       118        1.2\n",
      "Breast_Cancer        0.581 (0.539-0.619)       225        4.0\n",
      "Prostate_Cancer      0.706 (0.670-0.738)       178        4.1\n",
      "Lung_Cancer          0.675 (0.620-0.711)       90         0.9\n",
      "Bladder_Cancer       0.746 (0.683-0.813)       58         0.6\n",
      "Secondary_Cancer     0.608 (0.581-0.647)       307        3.1\n",
      "Depression           0.524 (0.489-0.555)       410        4.1\n",
      "Anxiety              0.527 (0.496-0.559)       260        2.6\n",
      "Bipolar_Disorder     0.402 (0.330-0.519)       23         0.2\n",
      "Rheumatoid_Arthritis 0.620 (0.565-0.672)       116        1.2\n",
      "Psoriasis            0.632 (0.555-0.721)       54         0.5\n",
      "Ulcerative_Colitis   0.559 (0.478-0.632)       52         0.5\n",
      "Crohns_Disease       0.574 (0.458-0.684)       30         0.3\n",
      "Asthma               0.537 (0.512-0.562)       635        6.5\n",
      "Parkinsons           0.766 (0.713-0.825)       53         0.5\n",
      "Multiple_Sclerosis   0.558 (0.421-0.671)       18         0.2\n",
      "Thyroid_Disorders    0.585 (0.557-0.612)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  cos300...\n",
      "\n",
      "Evaluating ASCVD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.725 (0.709-0.739) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (Dynamic 10-Year Risk)...\n",
      "AUC: 0.705 (0.688-0.724) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (Dynamic 10-Year Risk)...\n",
      "AUC: 0.682 (0.663-0.709) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 9860 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.699 (0.668-0.732) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (Dynamic 10-Year Risk)...\n",
      "AUC: 0.712 (0.686-0.737) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (Dynamic 10-Year Risk)...\n",
      "AUC: 0.639 (0.607-0.685) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (Dynamic 10-Year Risk)...\n",
      "AUC: 0.721 (0.692-0.746) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.666 (0.643-0.697) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.652 (0.628-0.673) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.675-0.741) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 9970 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.586 (0.560-0.606) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.623 (0.568-0.670) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.564 (0.525-0.604) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.718 (0.683-0.747) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.1%) (from 4386 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.655 (0.612-0.703) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 9995 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.736 (0.662-0.788) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 9977 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.603 (0.571-0.633) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (Dynamic 10-Year Risk)...\n",
      "AUC: 0.499 (0.470-0.524) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 9894 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (Dynamic 10-Year Risk)...\n",
      "AUC: 0.531 (0.493-0.563) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 9981 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (Dynamic 10-Year Risk)...\n",
      "AUC: 0.372 (0.274-0.458) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.617 (0.563-0.658) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 9952 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.621 (0.524-0.691) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.525 (0.448-0.595) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 9940 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (Dynamic 10-Year Risk)...\n",
      "AUC: 0.527 (0.421-0.648) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 9967 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (Dynamic 10-Year Risk)...\n",
      "AUC: 0.534 (0.510-0.553) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.5%) (from 9704 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (Dynamic 10-Year Risk)...\n",
      "AUC: 0.757 (0.685-0.813) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 9992 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.531 (0.361-0.655) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 9987 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (Dynamic 10-Year Risk)...\n",
      "AUC: 0.621 (0.591-0.648) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (Dynamic 10-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.725 (0.709-0.739)       901        9.0\n",
      "Diabetes             0.705 (0.688-0.724)       613        6.1\n",
      "Atrial_Fib           0.682 (0.663-0.709)       379        3.8\n",
      "CKD                  0.699 (0.668-0.732)       184        1.8\n",
      "All_Cancers          0.712 (0.686-0.737)       499        5.0\n",
      "Stroke               0.639 (0.607-0.685)       142        1.4\n",
      "Heart_Failure        0.721 (0.692-0.746)       210        2.1\n",
      "Pneumonia            0.666 (0.643-0.697)       351        3.5\n",
      "COPD                 0.652 (0.628-0.673)       429        4.3\n",
      "Osteoporosis         0.716 (0.675-0.741)       223        2.2\n",
      "Anemia               0.586 (0.560-0.606)       552        5.5\n",
      "Colorectal_Cancer    0.623 (0.568-0.670)       118        1.2\n",
      "Breast_Cancer        0.564 (0.525-0.604)       225        4.0\n",
      "Prostate_Cancer      0.718 (0.683-0.747)       178        4.1\n",
      "Lung_Cancer          0.655 (0.612-0.703)       90         0.9\n",
      "Bladder_Cancer       0.736 (0.662-0.788)       58         0.6\n",
      "Secondary_Cancer     0.603 (0.571-0.633)       307        3.1\n",
      "Depression           0.499 (0.470-0.524)       410        4.1\n",
      "Anxiety              0.531 (0.493-0.563)       260        2.6\n",
      "Bipolar_Disorder     0.372 (0.274-0.458)       23         0.2\n",
      "Rheumatoid_Arthritis 0.617 (0.563-0.658)       116        1.2\n",
      "Psoriasis            0.621 (0.524-0.691)       54         0.5\n",
      "Ulcerative_Colitis   0.525 (0.448-0.595)       52         0.5\n",
      "Crohns_Disease       0.527 (0.421-0.648)       30         0.3\n",
      "Asthma               0.534 (0.510-0.553)       635        6.5\n",
      "Parkinsons           0.757 (0.685-0.813)       53         0.5\n",
      "Multiple_Sclerosis   0.531 (0.361-0.655)       18         0.2\n",
      "Thyroid_Disorders    0.621 (0.591-0.648)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  clip...\n",
      "\n",
      "Evaluating ASCVD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.732 (0.710-0.750) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.696-0.737) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (Dynamic 10-Year Risk)...\n",
      "AUC: 0.708 (0.690-0.727) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 9860 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.714 (0.676-0.750) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.693-0.740) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (Dynamic 10-Year Risk)...\n",
      "AUC: 0.663 (0.616-0.707) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (Dynamic 10-Year Risk)...\n",
      "AUC: 0.726 (0.690-0.756) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.676 (0.651-0.706) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.663 (0.630-0.690) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.686 (0.653-0.715) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 9970 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.603 (0.581-0.625) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.634 (0.591-0.678) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.581 (0.546-0.612) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.706 (0.673-0.745) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.1%) (from 4386 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.675 (0.635-0.721) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 9995 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.746 (0.701-0.809) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 9977 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.608 (0.587-0.640) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (Dynamic 10-Year Risk)...\n",
      "AUC: 0.524 (0.496-0.551) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 9894 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (Dynamic 10-Year Risk)...\n",
      "AUC: 0.527 (0.492-0.558) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 9981 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (Dynamic 10-Year Risk)...\n",
      "AUC: 0.402 (0.324-0.511) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.620 (0.572-0.667) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 9952 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.632 (0.558-0.701) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.559 (0.472-0.636) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 9940 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (Dynamic 10-Year Risk)...\n",
      "AUC: 0.574 (0.463-0.681) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 9967 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (Dynamic 10-Year Risk)...\n",
      "AUC: 0.537 (0.519-0.559) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.5%) (from 9704 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (Dynamic 10-Year Risk)...\n",
      "AUC: 0.766 (0.701-0.823) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 9992 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.558 (0.449-0.655) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 9987 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (Dynamic 10-Year Risk)...\n",
      "AUC: 0.585 (0.558-0.607) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (Dynamic 10-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.732 (0.710-0.750)       901        9.0\n",
      "Diabetes             0.716 (0.696-0.737)       613        6.1\n",
      "Atrial_Fib           0.708 (0.690-0.727)       379        3.8\n",
      "CKD                  0.714 (0.676-0.750)       184        1.8\n",
      "All_Cancers          0.716 (0.693-0.740)       499        5.0\n",
      "Stroke               0.663 (0.616-0.707)       142        1.4\n",
      "Heart_Failure        0.726 (0.690-0.756)       210        2.1\n",
      "Pneumonia            0.676 (0.651-0.706)       351        3.5\n",
      "COPD                 0.663 (0.630-0.690)       429        4.3\n",
      "Osteoporosis         0.686 (0.653-0.715)       223        2.2\n",
      "Anemia               0.603 (0.581-0.625)       552        5.5\n",
      "Colorectal_Cancer    0.634 (0.591-0.678)       118        1.2\n",
      "Breast_Cancer        0.581 (0.546-0.612)       225        4.0\n",
      "Prostate_Cancer      0.706 (0.673-0.745)       178        4.1\n",
      "Lung_Cancer          0.675 (0.635-0.721)       90         0.9\n",
      "Bladder_Cancer       0.746 (0.701-0.809)       58         0.6\n",
      "Secondary_Cancer     0.608 (0.587-0.640)       307        3.1\n",
      "Depression           0.524 (0.496-0.551)       410        4.1\n",
      "Anxiety              0.527 (0.492-0.558)       260        2.6\n",
      "Bipolar_Disorder     0.402 (0.324-0.511)       23         0.2\n",
      "Rheumatoid_Arthritis 0.620 (0.572-0.667)       116        1.2\n",
      "Psoriasis            0.632 (0.558-0.701)       54         0.5\n",
      "Ulcerative_Colitis   0.559 (0.472-0.636)       52         0.5\n",
      "Crohns_Disease       0.574 (0.463-0.681)       30         0.3\n",
      "Asthma               0.537 (0.519-0.559)       635        6.5\n",
      "Parkinsons           0.766 (0.701-0.823)       53         0.5\n",
      "Multiple_Sclerosis   0.558 (0.449-0.655)       18         0.2\n",
      "Thyroid_Disorders    0.585 (0.558-0.607)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  v2_nokappa...\n",
      "\n",
      "Evaluating ASCVD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.733 (0.717-0.745) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.696-0.738) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (Dynamic 10-Year Risk)...\n",
      "AUC: 0.707 (0.684-0.727) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 9860 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.711 (0.677-0.746) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (Dynamic 10-Year Risk)...\n",
      "AUC: 0.716 (0.692-0.738) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (Dynamic 10-Year Risk)...\n",
      "AUC: 0.660 (0.615-0.705) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (Dynamic 10-Year Risk)...\n",
      "AUC: 0.726 (0.693-0.765) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.674 (0.651-0.700) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.661 (0.641-0.684) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.695 (0.657-0.725) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 9970 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.602 (0.575-0.624) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.631 (0.581-0.677) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.580 (0.548-0.621) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.707 (0.677-0.744) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.1%) (from 4386 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.668 (0.619-0.711) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 9995 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.745 (0.669-0.811) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 9977 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.607 (0.576-0.639) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (Dynamic 10-Year Risk)...\n",
      "AUC: 0.522 (0.488-0.547) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 9894 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (Dynamic 10-Year Risk)...\n",
      "AUC: 0.529 (0.495-0.559) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 9981 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (Dynamic 10-Year Risk)...\n",
      "AUC: 0.394 (0.306-0.484) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.622 (0.581-0.666) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 9952 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.632 (0.569-0.722) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.553 (0.496-0.622) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 9940 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (Dynamic 10-Year Risk)...\n",
      "AUC: 0.569 (0.470-0.660) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 9967 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (Dynamic 10-Year Risk)...\n",
      "AUC: 0.538 (0.511-0.562) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.5%) (from 9704 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (Dynamic 10-Year Risk)...\n",
      "AUC: 0.765 (0.707-0.820) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 9992 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.570 (0.467-0.698) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 9987 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (Dynamic 10-Year Risk)...\n",
      "AUC: 0.595 (0.568-0.625) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (Dynamic 10-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.733 (0.717-0.745)       901        9.0\n",
      "Diabetes             0.716 (0.696-0.738)       613        6.1\n",
      "Atrial_Fib           0.707 (0.684-0.727)       379        3.8\n",
      "CKD                  0.711 (0.677-0.746)       184        1.8\n",
      "All_Cancers          0.716 (0.692-0.738)       499        5.0\n",
      "Stroke               0.660 (0.615-0.705)       142        1.4\n",
      "Heart_Failure        0.726 (0.693-0.765)       210        2.1\n",
      "Pneumonia            0.674 (0.651-0.700)       351        3.5\n",
      "COPD                 0.661 (0.641-0.684)       429        4.3\n",
      "Osteoporosis         0.695 (0.657-0.725)       223        2.2\n",
      "Anemia               0.602 (0.575-0.624)       552        5.5\n",
      "Colorectal_Cancer    0.631 (0.581-0.677)       118        1.2\n",
      "Breast_Cancer        0.580 (0.548-0.621)       225        4.0\n",
      "Prostate_Cancer      0.707 (0.677-0.744)       178        4.1\n",
      "Lung_Cancer          0.668 (0.619-0.711)       90         0.9\n",
      "Bladder_Cancer       0.745 (0.669-0.811)       58         0.6\n",
      "Secondary_Cancer     0.607 (0.576-0.639)       307        3.1\n",
      "Depression           0.522 (0.488-0.547)       410        4.1\n",
      "Anxiety              0.529 (0.495-0.559)       260        2.6\n",
      "Bipolar_Disorder     0.394 (0.306-0.484)       23         0.2\n",
      "Rheumatoid_Arthritis 0.622 (0.581-0.666)       116        1.2\n",
      "Psoriasis            0.632 (0.569-0.722)       54         0.5\n",
      "Ulcerative_Colitis   0.553 (0.496-0.622)       52         0.5\n",
      "Crohns_Disease       0.569 (0.470-0.660)       30         0.3\n",
      "Asthma               0.538 (0.511-0.562)       635        6.5\n",
      "Parkinsons           0.765 (0.707-0.820)       53         0.5\n",
      "Multiple_Sclerosis   0.570 (0.467-0.698)       18         0.2\n",
      "Thyroid_Disorders    0.595 (0.568-0.625)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  nolr...\n",
      "\n",
      "Evaluating ASCVD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.717 (0.698-0.732) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 901 (9.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (Dynamic 10-Year Risk)...\n",
      "AUC: 0.630 (0.605-0.647) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 613 (6.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (Dynamic 10-Year Risk)...\n",
      "AUC: 0.641 (0.616-0.666) (calculated on 9860 individuals)\n",
      "Events (10-Year in Eval Cohort): 379 (3.8%) (from 9860 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.721 (0.693-0.758) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 184 (1.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (Dynamic 10-Year Risk)...\n",
      "AUC: 0.670 (0.646-0.691) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 499 (5.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (Dynamic 10-Year Risk)...\n",
      "AUC: 0.643 (0.601-0.681) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 142 (1.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (Dynamic 10-Year Risk)...\n",
      "AUC: 0.707 (0.672-0.730) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 210 (2.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.659 (0.630-0.682) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 351 (3.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (Dynamic 10-Year Risk)...\n",
      "AUC: 0.638 (0.613-0.663) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 429 (4.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.701 (0.669-0.726) (calculated on 9970 individuals)\n",
      "Events (10-Year in Eval Cohort): 223 (2.2%) (from 9970 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (Dynamic 10-Year Risk)...\n",
      "AUC: 0.579 (0.559-0.605) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 552 (5.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.617 (0.581-0.658) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 118 (1.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "AUC: 0.513 (0.478-0.560) (calculated on 5564 individuals)\n",
      "Events (10-Year in Eval Cohort): 225 (4.0%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (Dynamic 10-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "AUC: 0.688 (0.656-0.721) (calculated on 4386 individuals)\n",
      "Events (10-Year in Eval Cohort): 178 (4.1%) (from 4386 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.669 (0.622-0.715) (calculated on 9995 individuals)\n",
      "Events (10-Year in Eval Cohort): 90 (0.9%) (from 9995 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.691 (0.630-0.756) (calculated on 9977 individuals)\n",
      "Events (10-Year in Eval Cohort): 58 (0.6%) (from 9977 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (Dynamic 10-Year Risk)...\n",
      "AUC: 0.610 (0.580-0.641) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 307 (3.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (Dynamic 10-Year Risk)...\n",
      "AUC: 0.485 (0.455-0.511) (calculated on 9894 individuals)\n",
      "Events (10-Year in Eval Cohort): 410 (4.1%) (from 9894 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (Dynamic 10-Year Risk)...\n",
      "AUC: 0.521 (0.488-0.559) (calculated on 9981 individuals)\n",
      "Events (10-Year in Eval Cohort): 260 (2.6%) (from 9981 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (Dynamic 10-Year Risk)...\n",
      "AUC: 0.546 (0.456-0.657) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 23 (0.2%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.601 (0.555-0.652) (calculated on 9952 individuals)\n",
      "Events (10-Year in Eval Cohort): 116 (1.2%) (from 9952 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.609 (0.534-0.672) (calculated on 9985 individuals)\n",
      "Events (10-Year in Eval Cohort): 54 (0.5%) (from 9985 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.539 (0.459-0.612) (calculated on 9940 individuals)\n",
      "Events (10-Year in Eval Cohort): 52 (0.5%) (from 9940 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (Dynamic 10-Year Risk)...\n",
      "AUC: 0.516 (0.391-0.616) (calculated on 9967 individuals)\n",
      "Events (10-Year in Eval Cohort): 30 (0.3%) (from 9967 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (Dynamic 10-Year Risk)...\n",
      "AUC: 0.516 (0.493-0.539) (calculated on 9704 individuals)\n",
      "Events (10-Year in Eval Cohort): 635 (6.5%) (from 9704 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (Dynamic 10-Year Risk)...\n",
      "AUC: 0.738 (0.683-0.800) (calculated on 9992 individuals)\n",
      "Events (10-Year in Eval Cohort): 53 (0.5%) (from 9992 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (Dynamic 10-Year Risk)...\n",
      "AUC: 0.538 (0.420-0.687) (calculated on 9987 individuals)\n",
      "Events (10-Year in Eval Cohort): 18 (0.2%) (from 9987 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (Dynamic 10-Year Risk)...\n",
      "AUC: 0.587 (0.563-0.618) (calculated on 10000 individuals)\n",
      "Events (10-Year in Eval Cohort): 458 (4.6%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (Dynamic 10-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.717 (0.698-0.732)       901        9.0\n",
      "Diabetes             0.630 (0.605-0.647)       613        6.1\n",
      "Atrial_Fib           0.641 (0.616-0.666)       379        3.8\n",
      "CKD                  0.721 (0.693-0.758)       184        1.8\n",
      "All_Cancers          0.670 (0.646-0.691)       499        5.0\n",
      "Stroke               0.643 (0.601-0.681)       142        1.4\n",
      "Heart_Failure        0.707 (0.672-0.730)       210        2.1\n",
      "Pneumonia            0.659 (0.630-0.682)       351        3.5\n",
      "COPD                 0.638 (0.613-0.663)       429        4.3\n",
      "Osteoporosis         0.701 (0.669-0.726)       223        2.2\n",
      "Anemia               0.579 (0.559-0.605)       552        5.5\n",
      "Colorectal_Cancer    0.617 (0.581-0.658)       118        1.2\n",
      "Breast_Cancer        0.513 (0.478-0.560)       225        4.0\n",
      "Prostate_Cancer      0.688 (0.656-0.721)       178        4.1\n",
      "Lung_Cancer          0.669 (0.622-0.715)       90         0.9\n",
      "Bladder_Cancer       0.691 (0.630-0.756)       58         0.6\n",
      "Secondary_Cancer     0.610 (0.580-0.641)       307        3.1\n",
      "Depression           0.485 (0.455-0.511)       410        4.1\n",
      "Anxiety              0.521 (0.488-0.559)       260        2.6\n",
      "Bipolar_Disorder     0.546 (0.456-0.657)       23         0.2\n",
      "Rheumatoid_Arthritis 0.601 (0.555-0.652)       116        1.2\n",
      "Psoriasis            0.609 (0.534-0.672)       54         0.5\n",
      "Ulcerative_Colitis   0.539 (0.459-0.612)       52         0.5\n",
      "Crohns_Disease       0.516 (0.391-0.616)       30         0.3\n",
      "Asthma               0.516 (0.493-0.539)       635        6.5\n",
      "Parkinsons           0.738 (0.683-0.800)       53         0.5\n",
      "Multiple_Sclerosis   0.538 (0.420-0.687)       18         0.2\n",
      "Thyroid_Disorders    0.587 (0.563-0.618)       458        4.6\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "DISEASE                                 constant                 cos300                   clip             v2_nokappa                   nolr         BEST\n",
      "---------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "ASCVD                     0.732 (0.718-0.748) 0.725 (0.709-0.739) 0.732 (0.710-0.750) 0.733 (0.717-0.745) 0.717 (0.698-0.732)   v2_nokappa\n",
      "All_Cancers               0.716 (0.695-0.739) 0.712 (0.686-0.737) 0.716 (0.693-0.740) 0.716 (0.692-0.738) 0.670 (0.646-0.691)   v2_nokappa\n",
      "Anemia                    0.603 (0.575-0.627) 0.586 (0.560-0.606) 0.603 (0.581-0.625) 0.602 (0.575-0.624) 0.579 (0.559-0.605)     constant\n",
      "Anxiety                   0.527 (0.496-0.559) 0.531 (0.493-0.563) 0.527 (0.492-0.558) 0.529 (0.495-0.559) 0.521 (0.488-0.559)       cos300\n",
      "Asthma                    0.537 (0.512-0.562) 0.534 (0.510-0.553) 0.537 (0.519-0.559) 0.538 (0.511-0.562) 0.516 (0.493-0.539)   v2_nokappa\n",
      "Atrial_Fib                0.708 (0.686-0.731) 0.682 (0.663-0.709) 0.708 (0.690-0.727) 0.707 (0.684-0.727) 0.641 (0.616-0.666)     constant\n",
      "Bipolar_Disorder          0.402 (0.330-0.519) 0.372 (0.274-0.458) 0.402 (0.324-0.511) 0.394 (0.306-0.484) 0.546 (0.456-0.657)         nolr\n",
      "Bladder_Cancer            0.746 (0.683-0.813) 0.736 (0.662-0.788) 0.746 (0.701-0.809) 0.745 (0.669-0.811) 0.691 (0.630-0.756)     constant\n",
      "Breast_Cancer             0.581 (0.539-0.619) 0.564 (0.525-0.604) 0.581 (0.546-0.612) 0.580 (0.548-0.621) 0.513 (0.478-0.560)     constant\n",
      "CKD                       0.714 (0.681-0.740) 0.699 (0.668-0.732) 0.714 (0.676-0.750) 0.711 (0.677-0.746) 0.721 (0.693-0.758)         nolr\n",
      "COPD                      0.663 (0.642-0.690) 0.652 (0.628-0.673) 0.663 (0.630-0.690) 0.661 (0.641-0.684) 0.638 (0.613-0.663)     constant\n",
      "Colorectal_Cancer         0.634 (0.583-0.678) 0.623 (0.568-0.670) 0.634 (0.591-0.678) 0.631 (0.581-0.677) 0.617 (0.581-0.658)     constant\n",
      "Crohns_Disease            0.574 (0.458-0.684) 0.527 (0.421-0.648) 0.574 (0.463-0.681) 0.569 (0.470-0.660) 0.516 (0.391-0.616)     constant\n",
      "Depression                0.524 (0.489-0.555) 0.499 (0.470-0.524) 0.524 (0.496-0.551) 0.522 (0.488-0.547) 0.485 (0.455-0.511)     constant\n",
      "Diabetes                  0.716 (0.699-0.736) 0.705 (0.688-0.724) 0.716 (0.696-0.737) 0.716 (0.696-0.738) 0.630 (0.605-0.647)     constant\n",
      "Heart_Failure             0.726 (0.692-0.758) 0.721 (0.692-0.746) 0.726 (0.690-0.756) 0.726 (0.693-0.765) 0.707 (0.672-0.730)   v2_nokappa\n",
      "Lung_Cancer               0.675 (0.620-0.711) 0.655 (0.612-0.703) 0.675 (0.635-0.721) 0.668 (0.619-0.711) 0.669 (0.622-0.715)     constant\n",
      "Multiple_Sclerosis        0.558 (0.421-0.671) 0.531 (0.361-0.655) 0.558 (0.449-0.655) 0.570 (0.467-0.698) 0.538 (0.420-0.687)   v2_nokappa\n",
      "Osteoporosis              0.686 (0.650-0.706) 0.716 (0.675-0.741) 0.686 (0.653-0.715) 0.695 (0.657-0.725) 0.701 (0.669-0.726)       cos300\n",
      "Parkinsons                0.766 (0.713-0.825) 0.757 (0.685-0.813) 0.766 (0.701-0.823) 0.765 (0.707-0.820) 0.738 (0.683-0.800)     constant\n",
      "Pneumonia                 0.676 (0.644-0.707) 0.666 (0.643-0.697) 0.676 (0.651-0.706) 0.674 (0.651-0.700) 0.659 (0.630-0.682)     constant\n",
      "Prostate_Cancer           0.706 (0.670-0.738) 0.718 (0.683-0.747) 0.706 (0.673-0.745) 0.707 (0.677-0.744) 0.688 (0.656-0.721)       cos300\n",
      "Psoriasis                 0.632 (0.555-0.721) 0.621 (0.524-0.691) 0.632 (0.558-0.701) 0.632 (0.569-0.722) 0.609 (0.534-0.672)   v2_nokappa\n",
      "Rheumatoid_Arthritis      0.620 (0.565-0.672) 0.617 (0.563-0.658) 0.620 (0.572-0.667) 0.622 (0.581-0.666) 0.601 (0.555-0.652)   v2_nokappa\n",
      "Secondary_Cancer          0.608 (0.581-0.647) 0.603 (0.571-0.633) 0.608 (0.587-0.640) 0.607 (0.576-0.639) 0.610 (0.580-0.641)         nolr\n",
      "Stroke                    0.663 (0.620-0.710) 0.639 (0.607-0.685) 0.663 (0.616-0.707) 0.660 (0.615-0.705) 0.643 (0.601-0.681)     constant\n",
      "Thyroid_Disorders         0.585 (0.557-0.612) 0.621 (0.591-0.648) 0.585 (0.558-0.607) 0.595 (0.568-0.625) 0.587 (0.563-0.618)       cos300\n",
      "Ulcerative_Colitis        0.559 (0.478-0.632) 0.525 (0.448-0.595) 0.559 (0.472-0.636) 0.553 (0.496-0.622) 0.539 (0.459-0.612)     constant\n",
      "\n",
      "  Mean AUC constant: 0.6371\n",
      "  Mean AUC cos300: 0.6263\n",
      "  Mean AUC clip: 0.6371\n",
      "  Mean AUC v2_nokappa: 0.6367\n",
      "  Mean AUC nolr: 0.6175\n",
      "\n",
      "================================================================================\n",
      "EVALUATING DYNAMIC_1YR\n",
      "================================================================================\n",
      "\n",
      "  constant...\n",
      "\n",
      "Evaluating ASCVD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.936 (0.907-0.961) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 80 (0.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.826 (0.756-0.879) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 47 (0.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.946 (0.904-0.977) (calculated on 9860 individuals)\n",
      "C-index: nan (calculated on 9860 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.917 (0.815-1.000) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 3 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.837 (0.756-0.918) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 18 (0.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.615 (0.420-0.832) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 10 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.841 (0.634-0.996) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.852 (0.758-0.977) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 14 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.790 (0.635-0.899) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 26 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.847 (0.751-0.956) (calculated on 9970 individuals)\n",
      "C-index: nan (calculated on 9970 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.864 (0.789-0.924) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 43 (0.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.850 (0.604-0.999) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (1-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.963 (0.948-0.979) (calculated on 5564 individuals)\n",
      "C-index: nan (calculated on 5564 individuals)\n",
      "Events (1-Year in Eval Cohort): 15 (0.3%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (1-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.791 (0.642-0.915) (calculated on 4386 individuals)\n",
      "C-index: nan (calculated on 4386 individuals)\n",
      "Events (1-Year in Eval Cohort): 8 (0.2%) (from 4436 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.719 (0.492-0.949) (calculated on 9995 individuals)\n",
      "C-index: nan (calculated on 9995 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.781 (0.773-0.790) (calculated on 9977 individuals)\n",
      "C-index: nan (calculated on 9977 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.835 (0.636-0.965) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 8 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.921 (0.874-0.984) (calculated on 9894 individuals)\n",
      "C-index: nan (calculated on 9894 individuals)\n",
      "Events (1-Year in Eval Cohort): 12 (0.1%) (from 10000 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.808 (0.524-0.976) (calculated on 9981 individuals)\n",
      "C-index: nan (calculated on 9981 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "Warning: Only one class present ([0.]) for AUC.\n",
      "AUC: nan (nan-nan) (calculated on 9985 individuals)\n",
      "C-index: nan (calculated on 9985 individuals)\n",
      "Events (1-Year in Eval Cohort): 0 (0.0%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.957 (0.932-0.983) (calculated on 9952 individuals)\n",
      "C-index: nan (calculated on 9952 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 1.000 (0.999-1.000) (calculated on 9985 individuals)\n",
      "C-index: nan (calculated on 9985 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.618 (0.270-0.966) (calculated on 9940 individuals)\n",
      "C-index: nan (calculated on 9940 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.978 (0.939-0.997) (calculated on 9967 individuals)\n",
      "C-index: nan (calculated on 9967 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.872 (0.821-0.929) (calculated on 9704 individuals)\n",
      "C-index: nan (calculated on 9704 individuals)\n",
      "Events (1-Year in Eval Cohort): 53 (0.5%) (from 10000 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.789 (0.643-0.934) (calculated on 9992 individuals)\n",
      "C-index: nan (calculated on 9992 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.110 (0.103-0.116) (calculated on 9987 individuals)\n",
      "C-index: nan (calculated on 9987 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.770 (0.683-0.844) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (1-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.936 (0.907-0.961)       80         0.8        N/A\n",
      "Diabetes             0.826 (0.756-0.879)       47         0.5        N/A\n",
      "Atrial_Fib           0.946 (0.904-0.977)       28         0.3        N/A\n",
      "CKD                  0.917 (0.815-1.000)       3          0.0        N/A\n",
      "All_Cancers          0.837 (0.756-0.918)       18         0.2        N/A\n",
      "Stroke               0.615 (0.420-0.832)       10         0.1        N/A\n",
      "Heart_Failure        0.841 (0.634-0.996)       6          0.1        N/A\n",
      "Pneumonia            0.852 (0.758-0.977)       14         0.1        N/A\n",
      "COPD                 0.790 (0.635-0.899)       26         0.3        N/A\n",
      "Osteoporosis         0.847 (0.751-0.956)       6          0.1        N/A\n",
      "Anemia               0.864 (0.789-0.924)       43         0.4        N/A\n",
      "Colorectal_Cancer    0.850 (0.604-0.999)       4          0.0        N/A\n",
      "Breast_Cancer        0.963 (0.948-0.979)       15         0.3        N/A\n",
      "Prostate_Cancer      0.791 (0.642-0.915)       8          0.2        N/A\n",
      "Lung_Cancer          0.719 (0.492-0.949)       6          0.1        N/A\n",
      "Bladder_Cancer       0.781 (0.773-0.790)       1          0.0        N/A\n",
      "Secondary_Cancer     0.835 (0.636-0.965)       8          0.1        N/A\n",
      "Depression           0.921 (0.874-0.984)       12         0.1        N/A\n",
      "Anxiety              0.808 (0.524-0.976)       6          0.1        N/A\n",
      "Bipolar_Disorder     N/A                       0          0.0        N/A\n",
      "Rheumatoid_Arthritis 0.957 (0.932-0.983)       4          0.0        N/A\n",
      "Psoriasis            1.000 (0.999-1.000)       1          0.0        N/A\n",
      "Ulcerative_Colitis   0.618 (0.270-0.966)       2          0.0        N/A\n",
      "Crohns_Disease       0.978 (0.939-0.997)       4          0.0        N/A\n",
      "Asthma               0.872 (0.821-0.929)       53         0.5        N/A\n",
      "Parkinsons           0.789 (0.643-0.934)       2          0.0        N/A\n",
      "Multiple_Sclerosis   0.110 (0.103-0.116)       1          0.0        N/A\n",
      "Thyroid_Disorders    0.770 (0.683-0.844)       28         0.3        N/A\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  cos300...\n",
      "\n",
      "Evaluating ASCVD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.801 (0.761-0.855) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 80 (0.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.709 (0.639-0.788) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 47 (0.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.859 (0.806-0.922) (calculated on 9860 individuals)\n",
      "C-index: nan (calculated on 9860 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.816 (0.554-1.000) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 3 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.809 (0.681-0.909) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 18 (0.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.578 (0.292-0.822) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 10 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.699 (0.388-0.877) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.661 (0.537-0.779) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 14 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.666 (0.546-0.768) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 26 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.748 (0.454-0.953) (calculated on 9970 individuals)\n",
      "C-index: nan (calculated on 9970 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.618 (0.527-0.698) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 43 (0.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.802 (0.224-0.998) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (1-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.770 (0.675-0.857) (calculated on 5564 individuals)\n",
      "C-index: nan (calculated on 5564 individuals)\n",
      "Events (1-Year in Eval Cohort): 15 (0.3%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (1-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.838 (0.697-0.970) (calculated on 4386 individuals)\n",
      "C-index: nan (calculated on 4386 individuals)\n",
      "Events (1-Year in Eval Cohort): 8 (0.2%) (from 4436 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.641 (0.395-0.883) (calculated on 9995 individuals)\n",
      "C-index: nan (calculated on 9995 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.926 (0.921-0.930) (calculated on 9977 individuals)\n",
      "C-index: nan (calculated on 9977 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.691 (0.517-0.832) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 8 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.669 (0.524-0.794) (calculated on 9894 individuals)\n",
      "C-index: nan (calculated on 9894 individuals)\n",
      "Events (1-Year in Eval Cohort): 12 (0.1%) (from 10000 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.508 (0.240-0.737) (calculated on 9981 individuals)\n",
      "C-index: nan (calculated on 9981 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "Warning: Only one class present ([0.]) for AUC.\n",
      "AUC: nan (nan-nan) (calculated on 9985 individuals)\n",
      "C-index: nan (calculated on 9985 individuals)\n",
      "Events (1-Year in Eval Cohort): 0 (0.0%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.888 (0.768-0.998) (calculated on 9952 individuals)\n",
      "C-index: nan (calculated on 9952 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.976 (0.973-0.978) (calculated on 9985 individuals)\n",
      "C-index: nan (calculated on 9985 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.479 (0.060-0.896) (calculated on 9940 individuals)\n",
      "C-index: nan (calculated on 9940 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.642 (0.274-0.998) (calculated on 9967 individuals)\n",
      "C-index: nan (calculated on 9967 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.590 (0.503-0.655) (calculated on 9704 individuals)\n",
      "C-index: nan (calculated on 9704 individuals)\n",
      "Events (1-Year in Eval Cohort): 53 (0.5%) (from 10000 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.685 (0.479-0.891) (calculated on 9992 individuals)\n",
      "C-index: nan (calculated on 9992 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.017 (0.014-0.019) (calculated on 9987 individuals)\n",
      "C-index: nan (calculated on 9987 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.645 (0.519-0.752) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (1-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.801 (0.761-0.855)       80         0.8        N/A\n",
      "Diabetes             0.709 (0.639-0.788)       47         0.5        N/A\n",
      "Atrial_Fib           0.859 (0.806-0.922)       28         0.3        N/A\n",
      "CKD                  0.816 (0.554-1.000)       3          0.0        N/A\n",
      "All_Cancers          0.809 (0.681-0.909)       18         0.2        N/A\n",
      "Stroke               0.578 (0.292-0.822)       10         0.1        N/A\n",
      "Heart_Failure        0.699 (0.388-0.877)       6          0.1        N/A\n",
      "Pneumonia            0.661 (0.537-0.779)       14         0.1        N/A\n",
      "COPD                 0.666 (0.546-0.768)       26         0.3        N/A\n",
      "Osteoporosis         0.748 (0.454-0.953)       6          0.1        N/A\n",
      "Anemia               0.618 (0.527-0.698)       43         0.4        N/A\n",
      "Colorectal_Cancer    0.802 (0.224-0.998)       4          0.0        N/A\n",
      "Breast_Cancer        0.770 (0.675-0.857)       15         0.3        N/A\n",
      "Prostate_Cancer      0.838 (0.697-0.970)       8          0.2        N/A\n",
      "Lung_Cancer          0.641 (0.395-0.883)       6          0.1        N/A\n",
      "Bladder_Cancer       0.926 (0.921-0.930)       1          0.0        N/A\n",
      "Secondary_Cancer     0.691 (0.517-0.832)       8          0.1        N/A\n",
      "Depression           0.669 (0.524-0.794)       12         0.1        N/A\n",
      "Anxiety              0.508 (0.240-0.737)       6          0.1        N/A\n",
      "Bipolar_Disorder     N/A                       0          0.0        N/A\n",
      "Rheumatoid_Arthritis 0.888 (0.768-0.998)       4          0.0        N/A\n",
      "Psoriasis            0.976 (0.973-0.978)       1          0.0        N/A\n",
      "Ulcerative_Colitis   0.479 (0.060-0.896)       2          0.0        N/A\n",
      "Crohns_Disease       0.642 (0.274-0.998)       4          0.0        N/A\n",
      "Asthma               0.590 (0.503-0.655)       53         0.5        N/A\n",
      "Parkinsons           0.685 (0.479-0.891)       2          0.0        N/A\n",
      "Multiple_Sclerosis   0.017 (0.014-0.019)       1          0.0        N/A\n",
      "Thyroid_Disorders    0.645 (0.519-0.752)       28         0.3        N/A\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  clip...\n",
      "\n",
      "Evaluating ASCVD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.936 (0.901-0.966) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 80 (0.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.826 (0.760-0.890) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 47 (0.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.946 (0.904-0.978) (calculated on 9860 individuals)\n",
      "C-index: nan (calculated on 9860 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.917 (0.816-1.000) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 3 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.837 (0.697-0.909) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 18 (0.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.615 (0.357-0.852) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 10 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.841 (0.589-0.991) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.852 (0.702-0.963) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 14 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.790 (0.694-0.902) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 26 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.847 (0.733-0.946) (calculated on 9970 individuals)\n",
      "C-index: nan (calculated on 9970 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.864 (0.810-0.913) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 43 (0.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.850 (0.573-0.999) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (1-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.963 (0.943-0.979) (calculated on 5564 individuals)\n",
      "C-index: nan (calculated on 5564 individuals)\n",
      "Events (1-Year in Eval Cohort): 15 (0.3%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (1-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.791 (0.667-0.901) (calculated on 4386 individuals)\n",
      "C-index: nan (calculated on 4386 individuals)\n",
      "Events (1-Year in Eval Cohort): 8 (0.2%) (from 4436 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.719 (0.449-0.958) (calculated on 9995 individuals)\n",
      "C-index: nan (calculated on 9995 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.781 (0.774-0.789) (calculated on 9977 individuals)\n",
      "C-index: nan (calculated on 9977 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.835 (0.706-0.953) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 8 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.921 (0.868-0.972) (calculated on 9894 individuals)\n",
      "C-index: nan (calculated on 9894 individuals)\n",
      "Events (1-Year in Eval Cohort): 12 (0.1%) (from 10000 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.808 (0.617-0.975) (calculated on 9981 individuals)\n",
      "C-index: nan (calculated on 9981 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "Warning: Only one class present ([0.]) for AUC.\n",
      "AUC: nan (nan-nan) (calculated on 9985 individuals)\n",
      "C-index: nan (calculated on 9985 individuals)\n",
      "Events (1-Year in Eval Cohort): 0 (0.0%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.957 (0.931-0.985) (calculated on 9952 individuals)\n",
      "C-index: nan (calculated on 9952 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 1.000 (0.999-1.000) (calculated on 9985 individuals)\n",
      "C-index: nan (calculated on 9985 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.618 (0.265-0.967) (calculated on 9940 individuals)\n",
      "C-index: nan (calculated on 9940 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.978 (0.940-0.997) (calculated on 9967 individuals)\n",
      "C-index: nan (calculated on 9967 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.872 (0.826-0.922) (calculated on 9704 individuals)\n",
      "C-index: nan (calculated on 9704 individuals)\n",
      "Events (1-Year in Eval Cohort): 53 (0.5%) (from 10000 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.789 (0.642-0.935) (calculated on 9992 individuals)\n",
      "C-index: nan (calculated on 9992 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.110 (0.101-0.115) (calculated on 9987 individuals)\n",
      "C-index: nan (calculated on 9987 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.770 (0.655-0.861) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (1-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.936 (0.901-0.966)       80         0.8        N/A\n",
      "Diabetes             0.826 (0.760-0.890)       47         0.5        N/A\n",
      "Atrial_Fib           0.946 (0.904-0.978)       28         0.3        N/A\n",
      "CKD                  0.917 (0.816-1.000)       3          0.0        N/A\n",
      "All_Cancers          0.837 (0.697-0.909)       18         0.2        N/A\n",
      "Stroke               0.615 (0.357-0.852)       10         0.1        N/A\n",
      "Heart_Failure        0.841 (0.589-0.991)       6          0.1        N/A\n",
      "Pneumonia            0.852 (0.702-0.963)       14         0.1        N/A\n",
      "COPD                 0.790 (0.694-0.902)       26         0.3        N/A\n",
      "Osteoporosis         0.847 (0.733-0.946)       6          0.1        N/A\n",
      "Anemia               0.864 (0.810-0.913)       43         0.4        N/A\n",
      "Colorectal_Cancer    0.850 (0.573-0.999)       4          0.0        N/A\n",
      "Breast_Cancer        0.963 (0.943-0.979)       15         0.3        N/A\n",
      "Prostate_Cancer      0.791 (0.667-0.901)       8          0.2        N/A\n",
      "Lung_Cancer          0.719 (0.449-0.958)       6          0.1        N/A\n",
      "Bladder_Cancer       0.781 (0.774-0.789)       1          0.0        N/A\n",
      "Secondary_Cancer     0.835 (0.706-0.953)       8          0.1        N/A\n",
      "Depression           0.921 (0.868-0.972)       12         0.1        N/A\n",
      "Anxiety              0.808 (0.617-0.975)       6          0.1        N/A\n",
      "Bipolar_Disorder     N/A                       0          0.0        N/A\n",
      "Rheumatoid_Arthritis 0.957 (0.931-0.985)       4          0.0        N/A\n",
      "Psoriasis            1.000 (0.999-1.000)       1          0.0        N/A\n",
      "Ulcerative_Colitis   0.618 (0.265-0.967)       2          0.0        N/A\n",
      "Crohns_Disease       0.978 (0.940-0.997)       4          0.0        N/A\n",
      "Asthma               0.872 (0.826-0.922)       53         0.5        N/A\n",
      "Parkinsons           0.789 (0.642-0.935)       2          0.0        N/A\n",
      "Multiple_Sclerosis   0.110 (0.101-0.115)       1          0.0        N/A\n",
      "Thyroid_Disorders    0.770 (0.655-0.861)       28         0.3        N/A\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  v2_nokappa...\n",
      "\n",
      "Evaluating ASCVD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.929 (0.896-0.953) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 80 (0.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.815 (0.755-0.884) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 47 (0.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.942 (0.902-0.983) (calculated on 9860 individuals)\n",
      "C-index: nan (calculated on 9860 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.905 (0.778-1.000) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 3 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.831 (0.715-0.928) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 18 (0.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.605 (0.358-0.827) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 10 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.837 (0.582-0.995) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.839 (0.698-0.955) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 14 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.780 (0.678-0.876) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 26 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.840 (0.705-0.972) (calculated on 9970 individuals)\n",
      "C-index: nan (calculated on 9970 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.842 (0.781-0.901) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 43 (0.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.839 (0.359-0.999) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (1-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.963 (0.931-0.983) (calculated on 5564 individuals)\n",
      "C-index: nan (calculated on 5564 individuals)\n",
      "Events (1-Year in Eval Cohort): 15 (0.3%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (1-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.793 (0.659-0.916) (calculated on 4386 individuals)\n",
      "C-index: nan (calculated on 4386 individuals)\n",
      "Events (1-Year in Eval Cohort): 8 (0.2%) (from 4436 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.703 (0.425-0.944) (calculated on 9995 individuals)\n",
      "C-index: nan (calculated on 9995 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.785 (0.774-0.793) (calculated on 9977 individuals)\n",
      "C-index: nan (calculated on 9977 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.816 (0.635-0.976) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 8 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.897 (0.807-0.968) (calculated on 9894 individuals)\n",
      "C-index: nan (calculated on 9894 individuals)\n",
      "Events (1-Year in Eval Cohort): 12 (0.1%) (from 10000 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.793 (0.475-0.968) (calculated on 9981 individuals)\n",
      "C-index: nan (calculated on 9981 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "Warning: Only one class present ([0.]) for AUC.\n",
      "AUC: nan (nan-nan) (calculated on 9985 individuals)\n",
      "C-index: nan (calculated on 9985 individuals)\n",
      "Events (1-Year in Eval Cohort): 0 (0.0%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.962 (0.932-0.997) (calculated on 9952 individuals)\n",
      "C-index: nan (calculated on 9952 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 1.000 (0.999-1.000) (calculated on 9985 individuals)\n",
      "C-index: nan (calculated on 9985 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.577 (0.196-0.956) (calculated on 9940 individuals)\n",
      "C-index: nan (calculated on 9940 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.977 (0.949-0.998) (calculated on 9967 individuals)\n",
      "C-index: nan (calculated on 9967 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.857 (0.792-0.911) (calculated on 9704 individuals)\n",
      "C-index: nan (calculated on 9704 individuals)\n",
      "Events (1-Year in Eval Cohort): 53 (0.5%) (from 10000 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.784 (0.628-0.937) (calculated on 9992 individuals)\n",
      "C-index: nan (calculated on 9992 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.065 (0.061-0.069) (calculated on 9987 individuals)\n",
      "C-index: nan (calculated on 9987 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.760 (0.650-0.871) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (1-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.929 (0.896-0.953)       80         0.8        N/A\n",
      "Diabetes             0.815 (0.755-0.884)       47         0.5        N/A\n",
      "Atrial_Fib           0.942 (0.902-0.983)       28         0.3        N/A\n",
      "CKD                  0.905 (0.778-1.000)       3          0.0        N/A\n",
      "All_Cancers          0.831 (0.715-0.928)       18         0.2        N/A\n",
      "Stroke               0.605 (0.358-0.827)       10         0.1        N/A\n",
      "Heart_Failure        0.837 (0.582-0.995)       6          0.1        N/A\n",
      "Pneumonia            0.839 (0.698-0.955)       14         0.1        N/A\n",
      "COPD                 0.780 (0.678-0.876)       26         0.3        N/A\n",
      "Osteoporosis         0.840 (0.705-0.972)       6          0.1        N/A\n",
      "Anemia               0.842 (0.781-0.901)       43         0.4        N/A\n",
      "Colorectal_Cancer    0.839 (0.359-0.999)       4          0.0        N/A\n",
      "Breast_Cancer        0.963 (0.931-0.983)       15         0.3        N/A\n",
      "Prostate_Cancer      0.793 (0.659-0.916)       8          0.2        N/A\n",
      "Lung_Cancer          0.703 (0.425-0.944)       6          0.1        N/A\n",
      "Bladder_Cancer       0.785 (0.774-0.793)       1          0.0        N/A\n",
      "Secondary_Cancer     0.816 (0.635-0.976)       8          0.1        N/A\n",
      "Depression           0.897 (0.807-0.968)       12         0.1        N/A\n",
      "Anxiety              0.793 (0.475-0.968)       6          0.1        N/A\n",
      "Bipolar_Disorder     N/A                       0          0.0        N/A\n",
      "Rheumatoid_Arthritis 0.962 (0.932-0.997)       4          0.0        N/A\n",
      "Psoriasis            1.000 (0.999-1.000)       1          0.0        N/A\n",
      "Ulcerative_Colitis   0.577 (0.196-0.956)       2          0.0        N/A\n",
      "Crohns_Disease       0.977 (0.949-0.998)       4          0.0        N/A\n",
      "Asthma               0.857 (0.792-0.911)       53         0.5        N/A\n",
      "Parkinsons           0.784 (0.628-0.937)       2          0.0        N/A\n",
      "Multiple_Sclerosis   0.065 (0.061-0.069)       1          0.0        N/A\n",
      "Thyroid_Disorders    0.760 (0.650-0.871)       28         0.3        N/A\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "  nolr...\n",
      "\n",
      "Evaluating ASCVD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.873 (0.819-0.917) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 80 (0.8%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.712 (0.634-0.782) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 47 (0.5%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.918 (0.853-0.963) (calculated on 9860 individuals)\n",
      "C-index: nan (calculated on 9860 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 140 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.849 (0.563-1.000) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 3 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.799 (0.688-0.905) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 18 (0.2%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.594 (0.321-0.834) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 10 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.696 (0.477-0.907) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.691 (0.543-0.837) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 14 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.703 (0.594-0.814) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 26 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.768 (0.585-0.947) (calculated on 9970 individuals)\n",
      "C-index: nan (calculated on 9970 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 30 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.659 (0.563-0.740) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 43 (0.4%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.808 (0.318-1.000) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (1-Year Risk)...\n",
      "Filtering for Female: Found 5564 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.900 (0.775-0.983) (calculated on 5564 individuals)\n",
      "C-index: nan (calculated on 5564 individuals)\n",
      "Events (1-Year in Eval Cohort): 15 (0.3%) (from 5564 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (1-Year Risk)...\n",
      "Filtering for Male: Found 4436 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.923 (0.753-0.995) (calculated on 4386 individuals)\n",
      "C-index: nan (calculated on 4386 individuals)\n",
      "Events (1-Year in Eval Cohort): 8 (0.2%) (from 4436 individuals)\n",
      "Excluded 50 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.676 (0.392-0.933) (calculated on 9995 individuals)\n",
      "C-index: nan (calculated on 9995 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 5 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.914 (0.910-0.919) (calculated on 9977 individuals)\n",
      "C-index: nan (calculated on 9977 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 23 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.654 (0.322-0.876) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 8 (0.1%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.663 (0.502-0.806) (calculated on 9894 individuals)\n",
      "C-index: nan (calculated on 9894 individuals)\n",
      "Events (1-Year in Eval Cohort): 12 (0.1%) (from 10000 individuals)\n",
      "Excluded 106 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.567 (0.228-0.839) (calculated on 9981 individuals)\n",
      "C-index: nan (calculated on 9981 individuals)\n",
      "Events (1-Year in Eval Cohort): 6 (0.1%) (from 10000 individuals)\n",
      "Excluded 19 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "Warning: Only one class present ([0.]) for AUC.\n",
      "AUC: nan (nan-nan) (calculated on 9985 individuals)\n",
      "C-index: nan (calculated on 9985 individuals)\n",
      "Events (1-Year in Eval Cohort): 0 (0.0%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.953 (0.917-0.995) (calculated on 9952 individuals)\n",
      "C-index: nan (calculated on 9952 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 48 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.999 (0.998-0.999) (calculated on 9985 individuals)\n",
      "C-index: nan (calculated on 9985 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 15 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.522 (0.071-0.971) (calculated on 9940 individuals)\n",
      "C-index: nan (calculated on 9940 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 60 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.757 (0.499-0.994) (calculated on 9967 individuals)\n",
      "C-index: nan (calculated on 9967 individuals)\n",
      "Events (1-Year in Eval Cohort): 4 (0.0%) (from 10000 individuals)\n",
      "Excluded 33 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.638 (0.539-0.727) (calculated on 9704 individuals)\n",
      "C-index: nan (calculated on 9704 individuals)\n",
      "Events (1-Year in Eval Cohort): 53 (0.5%) (from 10000 individuals)\n",
      "Excluded 296 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.733 (0.541-0.924) (calculated on 9992 individuals)\n",
      "C-index: nan (calculated on 9992 individuals)\n",
      "Events (1-Year in Eval Cohort): 2 (0.0%) (from 10000 individuals)\n",
      "Excluded 8 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.147 (0.142-0.154) (calculated on 9987 individuals)\n",
      "C-index: nan (calculated on 9987 individuals)\n",
      "Events (1-Year in Eval Cohort): 1 (0.0%) (from 10000 individuals)\n",
      "Excluded 13 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.664 (0.537-0.780) (calculated on 10000 individuals)\n",
      "C-index: nan (calculated on 10000 individuals)\n",
      "Events (1-Year in Eval Cohort): 28 (0.3%) (from 10000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (1-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.873 (0.819-0.917)       80         0.8        N/A\n",
      "Diabetes             0.712 (0.634-0.782)       47         0.5        N/A\n",
      "Atrial_Fib           0.918 (0.853-0.963)       28         0.3        N/A\n",
      "CKD                  0.849 (0.563-1.000)       3          0.0        N/A\n",
      "All_Cancers          0.799 (0.688-0.905)       18         0.2        N/A\n",
      "Stroke               0.594 (0.321-0.834)       10         0.1        N/A\n",
      "Heart_Failure        0.696 (0.477-0.907)       6          0.1        N/A\n",
      "Pneumonia            0.691 (0.543-0.837)       14         0.1        N/A\n",
      "COPD                 0.703 (0.594-0.814)       26         0.3        N/A\n",
      "Osteoporosis         0.768 (0.585-0.947)       6          0.1        N/A\n",
      "Anemia               0.659 (0.563-0.740)       43         0.4        N/A\n",
      "Colorectal_Cancer    0.808 (0.318-1.000)       4          0.0        N/A\n",
      "Breast_Cancer        0.900 (0.775-0.983)       15         0.3        N/A\n",
      "Prostate_Cancer      0.923 (0.753-0.995)       8          0.2        N/A\n",
      "Lung_Cancer          0.676 (0.392-0.933)       6          0.1        N/A\n",
      "Bladder_Cancer       0.914 (0.910-0.919)       1          0.0        N/A\n",
      "Secondary_Cancer     0.654 (0.322-0.876)       8          0.1        N/A\n",
      "Depression           0.663 (0.502-0.806)       12         0.1        N/A\n",
      "Anxiety              0.567 (0.228-0.839)       6          0.1        N/A\n",
      "Bipolar_Disorder     N/A                       0          0.0        N/A\n",
      "Rheumatoid_Arthritis 0.953 (0.917-0.995)       4          0.0        N/A\n",
      "Psoriasis            0.999 (0.998-0.999)       1          0.0        N/A\n",
      "Ulcerative_Colitis   0.522 (0.071-0.971)       2          0.0        N/A\n",
      "Crohns_Disease       0.757 (0.499-0.994)       4          0.0        N/A\n",
      "Asthma               0.638 (0.539-0.727)       53         0.5        N/A\n",
      "Parkinsons           0.733 (0.541-0.924)       2          0.0        N/A\n",
      "Multiple_Sclerosis   0.147 (0.142-0.154)       1          0.0        N/A\n",
      "Thyroid_Disorders    0.664 (0.537-0.780)       28         0.3        N/A\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "DISEASE                                 constant                 cos300                   clip             v2_nokappa                   nolr         BEST\n",
      "---------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "ASCVD                     0.936 (0.907-0.961) 0.801 (0.761-0.855) 0.936 (0.901-0.966) 0.929 (0.896-0.953) 0.873 (0.819-0.917)     constant\n",
      "All_Cancers               0.837 (0.756-0.918) 0.809 (0.681-0.909) 0.837 (0.697-0.909) 0.831 (0.715-0.928) 0.799 (0.688-0.905)     constant\n",
      "Anemia                    0.864 (0.789-0.924) 0.618 (0.527-0.698) 0.864 (0.810-0.913) 0.842 (0.781-0.901) 0.659 (0.563-0.740)     constant\n",
      "Anxiety                   0.808 (0.524-0.976) 0.508 (0.240-0.737) 0.808 (0.617-0.975) 0.793 (0.475-0.968) 0.567 (0.228-0.839)     constant\n",
      "Asthma                    0.872 (0.821-0.929) 0.590 (0.503-0.655) 0.872 (0.826-0.922) 0.857 (0.792-0.911) 0.638 (0.539-0.727)     constant\n",
      "Atrial_Fib                0.946 (0.904-0.977) 0.859 (0.806-0.922) 0.946 (0.904-0.978) 0.942 (0.902-0.983) 0.918 (0.853-0.963)     constant\n",
      "Bipolar_Disorder                             N/A                    N/A                    N/A                    N/A                    N/A            —\n",
      "Bladder_Cancer            0.781 (0.773-0.790) 0.926 (0.921-0.930) 0.781 (0.774-0.789) 0.785 (0.774-0.793) 0.914 (0.910-0.919)       cos300\n",
      "Breast_Cancer             0.963 (0.948-0.979) 0.770 (0.675-0.857) 0.963 (0.943-0.979) 0.963 (0.931-0.983) 0.900 (0.775-0.983)   v2_nokappa\n",
      "CKD                       0.917 (0.815-1.000) 0.816 (0.554-1.000) 0.917 (0.816-1.000) 0.905 (0.778-1.000) 0.849 (0.563-1.000)     constant\n",
      "COPD                      0.790 (0.635-0.899) 0.666 (0.546-0.768) 0.790 (0.694-0.902) 0.780 (0.678-0.876) 0.703 (0.594-0.814)     constant\n",
      "Colorectal_Cancer         0.850 (0.604-0.999) 0.802 (0.224-0.998) 0.850 (0.573-0.999) 0.839 (0.359-0.999) 0.808 (0.318-1.000)     constant\n",
      "Crohns_Disease            0.978 (0.939-0.997) 0.642 (0.274-0.998) 0.978 (0.940-0.997) 0.977 (0.949-0.998) 0.757 (0.499-0.994)     constant\n",
      "Depression                0.921 (0.874-0.984) 0.669 (0.524-0.794) 0.921 (0.868-0.972) 0.897 (0.807-0.968) 0.663 (0.502-0.806)     constant\n",
      "Diabetes                  0.826 (0.756-0.879) 0.709 (0.639-0.788) 0.826 (0.760-0.890) 0.815 (0.755-0.884) 0.712 (0.634-0.782)     constant\n",
      "Heart_Failure             0.841 (0.634-0.996) 0.699 (0.388-0.877) 0.841 (0.589-0.991) 0.837 (0.582-0.995) 0.696 (0.477-0.907)     constant\n",
      "Lung_Cancer               0.719 (0.492-0.949) 0.641 (0.395-0.883) 0.719 (0.449-0.958) 0.703 (0.425-0.944) 0.676 (0.392-0.933)     constant\n",
      "Multiple_Sclerosis        0.110 (0.103-0.116) 0.017 (0.014-0.019) 0.110 (0.101-0.115) 0.065 (0.061-0.069) 0.147 (0.142-0.154)         nolr\n",
      "Osteoporosis              0.847 (0.751-0.956) 0.748 (0.454-0.953) 0.847 (0.733-0.946) 0.840 (0.705-0.972) 0.768 (0.585-0.947)     constant\n",
      "Parkinsons                0.789 (0.643-0.934) 0.685 (0.479-0.891) 0.789 (0.642-0.935) 0.784 (0.628-0.937) 0.733 (0.541-0.924)     constant\n",
      "Pneumonia                 0.852 (0.758-0.977) 0.661 (0.537-0.779) 0.852 (0.702-0.963) 0.839 (0.698-0.955) 0.691 (0.543-0.837)     constant\n",
      "Prostate_Cancer           0.791 (0.642-0.915) 0.838 (0.697-0.970) 0.791 (0.667-0.901) 0.793 (0.659-0.916) 0.923 (0.753-0.995)         nolr\n",
      "Psoriasis                 1.000 (0.999-1.000) 0.976 (0.973-0.978) 1.000 (0.999-1.000) 1.000 (0.999-1.000) 0.999 (0.998-0.999)   v2_nokappa\n",
      "Rheumatoid_Arthritis      0.957 (0.932-0.983) 0.888 (0.768-0.998) 0.957 (0.931-0.985) 0.962 (0.932-0.997) 0.953 (0.917-0.995)   v2_nokappa\n",
      "Secondary_Cancer          0.835 (0.636-0.965) 0.691 (0.517-0.832) 0.835 (0.706-0.953) 0.816 (0.635-0.976) 0.654 (0.322-0.876)     constant\n",
      "Stroke                    0.615 (0.420-0.832) 0.578 (0.292-0.822) 0.615 (0.357-0.852) 0.605 (0.358-0.827) 0.594 (0.321-0.834)     constant\n",
      "Thyroid_Disorders         0.770 (0.683-0.844) 0.645 (0.519-0.752) 0.770 (0.655-0.861) 0.760 (0.650-0.871) 0.664 (0.537-0.780)     constant\n",
      "Ulcerative_Colitis        0.618 (0.270-0.966) 0.479 (0.060-0.896) 0.618 (0.265-0.967) 0.577 (0.196-0.956) 0.522 (0.071-0.971)     constant\n",
      "\n",
      "  Mean AUC constant: 0.8160\n",
      "  Mean AUC cos300: 0.6938\n",
      "  Mean AUC clip: 0.8160\n",
      "  Mean AUC v2_nokappa: 0.8050\n",
      "  Mean AUC nolr: 0.7326\n"
     ]
    }
   ],
   "source": [
    "# Run all 3 horizons x all configs\n",
    "configs_to_eval = list(holdout_results.keys())  # constant, cos300, clip, v2_nokappa\n",
    "\n",
    "all_horizon_results = []\n",
    "for horizon in ['static_10yr', 'dynamic_10yr', 'dynamic_1yr']:\n",
    "    print(f'\\n{\"=\"*80}')\n",
    "    print(f'EVALUATING {horizon.upper()}')\n",
    "    print(f'{\"=\"*80}')\n",
    "\n",
    "    dfs = {}\n",
    "    for cfg_name in configs_to_eval:\n",
    "        pi = holdout_results[cfg_name]['pi']\n",
    "        print(f'\\n  {cfg_name}...')\n",
    "        df = evaluate_and_collect(pi, Y_holdout, E_holdout, disease_names, pce_df, N_BOOTSTRAPS, horizon)\n",
    "        df = df.rename(columns={c: f'{cfg_name}_{c}' for c in df.columns if c != 'disease'})\n",
    "        dfs[cfg_name] = df\n",
    "\n",
    "    # Merge all configs\n",
    "    merged = dfs[configs_to_eval[0]]\n",
    "    for cfg_name in configs_to_eval[1:]:\n",
    "        merged = merged.merge(dfs[cfg_name], on='disease', how='outer')\n",
    "    merged['horizon'] = horizon\n",
    "\n",
    "    # Print comparison table\n",
    "    header = f\"{'DISEASE':<25} \" + \" \".join(f\"{c:>22}\" for c in configs_to_eval) + f\" {'BEST':>12}\"\n",
    "    print(f\"\\n{header}\")\n",
    "    print('-' * len(header))\n",
    "    for _, row in merged.iterrows():\n",
    "        parts = [f\"{row['disease']:<25}\"]\n",
    "        vals = []\n",
    "        for c in configs_to_eval:\n",
    "            a = row.get(f'{c}_auc', np.nan)\n",
    "            cl = row.get(f'{c}_ci_lower', np.nan)\n",
    "            cu = row.get(f'{c}_ci_upper', np.nan)\n",
    "            vals.append(a)\n",
    "            if np.isnan(a):\n",
    "                parts.append(f\"{'N/A':>22}\")\n",
    "            else:\n",
    "                parts.append(f\"{a:.3f} ({cl:.3f}-{cu:.3f})\")\n",
    "        valid = [(i, v) for i, v in enumerate(vals) if not np.isnan(v)]\n",
    "        best_name = configs_to_eval[max(valid, key=lambda x: x[1])[0]] if valid else '—'\n",
    "        parts.append(f\"{best_name:>12}\")\n",
    "        print(\" \".join(parts))\n",
    "\n",
    "    # Mean AUC summary\n",
    "    print()\n",
    "    for c in configs_to_eval:\n",
    "        col = f'{c}_auc'\n",
    "        if col in merged.columns:\n",
    "            m = merged[col].mean()\n",
    "            print(f'  Mean AUC {c}: {m:.4f}')\n",
    "\n",
    "    all_horizon_results.append(merged)\n",
    "\n",
    "# Combine and save\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Saved to: claudefile/nokappa_v3_full_auc_comparison.csv\n"
     ]
    }
   ],
   "source": [
    "\n",
    "combined = pd.concat(all_horizon_results, ignore_index=True)\n",
    "combined.to_csv('/Users/sarahurbut/aladynoulli2/claudefile/nokappa_v3_full_auc_comparison.csv', index=False)\n",
    "print(f'\\nSaved to: claudefile/nokappa_v3_full_auc_comparison.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "================================================================================\n",
      "GRAND SUMMARY: Mean AUC across diseases\n",
      "================================================================================\n",
      "              constant  cos300    clip  v2_nokappa    nolr\n",
      "horizon                                                   \n",
      "static_10yr     0.6440  0.6231  0.6440      0.6427  0.6188\n",
      "dynamic_10yr    0.6371  0.6263  0.6371      0.6367  0.6175\n",
      "dynamic_1yr     0.8160  0.6938  0.8160      0.8050  0.7326\n",
      "\n",
      "Holdout Loss:\n",
      "  constant: 13.7316\n",
      "  cos300: 16.0694\n",
      "  clip: 13.7316\n",
      "  v2_nokappa: 13.8807\n",
      "  nolr: 15.0654\n",
      "\n",
      "Best config per metric:\n",
      "  static_10yr: constant (0.6440)\n",
      "  dynamic_10yr: constant (0.6371)\n",
      "  dynamic_1yr: constant (0.8160)\n",
      "  holdout_loss: constant (13.7316)\n"
     ]
    }
   ],
   "source": [
    "# Grand summary table: mean AUC per config per horizon\n",
    "print('=' * 80)\n",
    "print('GRAND SUMMARY: Mean AUC across diseases')\n",
    "print('=' * 80)\n",
    "\n",
    "summary_rows = []\n",
    "for horizon_df in all_horizon_results:\n",
    "    horizon = horizon_df['horizon'].iloc[0]\n",
    "    row = {'horizon': horizon}\n",
    "    for c in configs_to_eval:\n",
    "        col = f'{c}_auc'\n",
    "        if col in horizon_df.columns:\n",
    "            row[c] = horizon_df[col].mean()\n",
    "    summary_rows.append(row)\n",
    "\n",
    "summary_df = pd.DataFrame(summary_rows).set_index('horizon')\n",
    "print(summary_df.round(4).to_string())\n",
    "\n",
    "print(f'\\nHoldout Loss:')\n",
    "for c in configs_to_eval:\n",
    "    print(f'  {c}: {holdout_results[c][\"loss\"]:.4f}')\n",
    "\n",
    "# Best per metric\n",
    "print(f'\\nBest config per metric:')\n",
    "for _, row in pd.DataFrame(summary_rows).iterrows():\n",
    "    best_cfg = max(configs_to_eval, key=lambda c: row.get(c, 0))\n",
    "    print(f'  {row[\"horizon\"]}: {best_cfg} ({row[best_cfg]:.4f})')\n",
    "best_loss = min(configs_to_eval, key=lambda c: holdout_results[c]['loss'])\n",
    "print(f'  holdout_loss: {best_loss} ({holdout_results[best_loss][\"loss\"]:.4f})')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 7. Reproduce paper's LOO AUC (all 400K)\n",
    "\n",
    "Pool all 40 LOO predictions and compute dynamic 1yr + static 10yr AUC on the full 400K to confirm the paper's numbers (ASCVD dynamic 1yr ~0.88)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading all 40 LOO predictions...\n",
      "  Loaded batch 0 — pi shape: torch.Size([10000, 348, 52])\n",
      "  Loaded batch 10 — pi shape: torch.Size([10000, 348, 52])\n",
      "  Loaded batch 20 — pi shape: torch.Size([10000, 348, 52])\n",
      "  Loaded batch 30 — pi shape: torch.Size([10000, 348, 52])\n",
      "Concatenated pi: torch.Size([400000, 348, 52]) (40 batches)\n",
      "\n",
      "Loading full Y and E...\n",
      "Y: torch.Size([400000, 348, 52]), E: torch.Size([400000, 348])\n",
      "pce_df: 400000 rows\n",
      "\n",
      "============================================================\n",
      "STATIC 10YR AUC — LOO pooled, all 400K\n",
      "============================================================\n",
      "\n",
      "Evaluating ASCVD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.733 (0.730-0.736) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 34705 (8.7%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.710, Events = 11641/217458\n",
      "   Male: AUC = 0.712, Events = 23064/182542\n",
      "\n",
      "   ASCVD risk in patients with pre-existing conditions:\n",
      "   RA: AUC = 0.696, Events = 326/2062\n",
      "   Breast_Cancer: AUC = 0.693, Events = 363/6472\n",
      "\n",
      "Evaluating Diabetes (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.630 (0.626-0.634) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 23756 (5.9%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.628, Events = 9559/217458\n",
      "   Male: AUC = 0.621, Events = 14197/182542\n",
      "\n",
      "Evaluating Atrial_Fib (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.707 (0.703-0.710) (calculated on 394818 individuals)\n",
      "Events (10-Year in Eval Cohort): 15278 (3.8%) (from 400000 individuals)\n",
      "Excluded 5182 prevalent cases for Atrial_Fib.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.710, Events = 8343/215981\n",
      "   Male: AUC = 0.712, Events = 6753/178837\n",
      "\n",
      "Evaluating CKD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.706 (0.700-0.709) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 8980 (2.2%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.701, Events = 4235/217458\n",
      "   Male: AUC = 0.708, Events = 4745/182542\n",
      "\n",
      "Evaluating All_Cancers (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.669 (0.666-0.673) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 20338 (5.1%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.632, Events = 6318/217458\n",
      "   Male: AUC = 0.673, Events = 14020/182542\n",
      "\n",
      "Evaluating Stroke (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.681 (0.675-0.688) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 5686 (1.4%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.685, Events = 2446/217458\n",
      "   Male: AUC = 0.673, Events = 3240/182542\n",
      "\n",
      "Evaluating Heart_Failure (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.701 (0.696-0.707) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 8212 (2.1%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.712, Events = 2791/217458\n",
      "   Male: AUC = 0.685, Events = 5421/182542\n",
      "\n",
      "Evaluating Pneumonia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.644 (0.640-0.649) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 14469 (3.6%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.634, Events = 6278/217458\n",
      "   Male: AUC = 0.647, Events = 8191/182542\n",
      "\n",
      "Evaluating COPD (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.658 (0.654-0.662) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 16789 (4.2%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.654, Events = 7561/217458\n",
      "   Male: AUC = 0.656, Events = 9228/182542\n",
      "\n",
      "Evaluating Osteoporosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.675 (0.671-0.680) (calculated on 398803 individuals)\n",
      "Events (10-Year in Eval Cohort): 9145 (2.3%) (from 400000 individuals)\n",
      "Excluded 1197 prevalent cases for Osteoporosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.674, Events = 4906/216482\n",
      "   Male: AUC = 0.677, Events = 4206/182321\n",
      "\n",
      "Evaluating Anemia (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.587 (0.584-0.591) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 21471 (5.4%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.556, Events = 11916/217458\n",
      "   Male: AUC = 0.627, Events = 9555/182542\n",
      "\n",
      "Evaluating Colorectal_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.646 (0.638-0.654) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 4934 (1.2%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.634, Events = 2138/217458\n",
      "   Male: AUC = 0.650, Events = 2796/182542\n",
      "\n",
      "Evaluating Breast_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Female: Found 217458 individuals in cohort\n",
      "AUC: 0.550 (0.545-0.557) (calculated on 217458 individuals)\n",
      "Events (10-Year in Eval Cohort): 9028 (4.2%) (from 217458 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "Filtering for Male: Found 182542 individuals in cohort\n",
      "AUC: 0.683 (0.678-0.689) (calculated on 180663 individuals)\n",
      "Events (10-Year in Eval Cohort): 7565 (4.1%) (from 182542 individuals)\n",
      "Excluded 1879 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.668 (0.660-0.674) (calculated on 399760 individuals)\n",
      "Events (10-Year in Eval Cohort): 3319 (0.8%) (from 400000 individuals)\n",
      "Excluded 240 prevalent cases for Lung_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.671, Events = 1760/217350\n",
      "   Male: AUC = 0.665, Events = 1557/182410\n",
      "\n",
      "Evaluating Bladder_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.703 (0.694-0.716) (calculated on 399089 individuals)\n",
      "Events (10-Year in Eval Cohort): 2158 (0.5%) (from 400000 individuals)\n",
      "Excluded 911 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.706, Events = 1184/217237\n",
      "   Male: AUC = 0.701, Events = 973/181852\n",
      "\n",
      "Evaluating Secondary_Cancer (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.610 (0.606-0.615) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 12229 (3.1%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.586, Events = 6859/217458\n",
      "   Male: AUC = 0.642, Events = 5370/182542\n",
      "\n",
      "Evaluating Depression (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.484 (0.479-0.488) (calculated on 396170 individuals)\n",
      "Events (10-Year in Eval Cohort): 16283 (4.1%) (from 400000 individuals)\n",
      "Excluded 3830 prevalent cases for Depression.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.493, Events = 8736/215185\n",
      "   Male: AUC = 0.485, Events = 7384/180985\n",
      "\n",
      "Evaluating Anxiety (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.514 (0.509-0.519) (calculated on 398970 individuals)\n",
      "Events (10-Year in Eval Cohort): 10034 (2.5%) (from 400000 individuals)\n",
      "Excluded 1030 prevalent cases for Anxiety.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.518, Events = 5571/216890\n",
      "   Male: AUC = 0.512, Events = 4436/182080\n",
      "\n",
      "Evaluating Bipolar_Disorder (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.481 (0.463-0.501) (calculated on 399382 individuals)\n",
      "Events (10-Year in Eval Cohort): 979 (0.2%) (from 400000 individuals)\n",
      "Excluded 618 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.484, Events = 531/217084\n",
      "   Male: AUC = 0.479, Events = 448/182298\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.608 (0.600-0.617) (calculated on 397938 individuals)\n",
      "Events (10-Year in Eval Cohort): 4745 (1.2%) (from 400000 individuals)\n",
      "Excluded 2062 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.611, Events = 2542/215988\n",
      "   Male: AUC = 0.610, Events = 2182/181950\n",
      "\n",
      "Evaluating Psoriasis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.545 (0.531-0.555) (calculated on 399264 individuals)\n",
      "Events (10-Year in Eval Cohort): 2021 (0.5%) (from 400000 individuals)\n",
      "Excluded 736 prevalent cases for Psoriasis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.547, Events = 1111/217150\n",
      "   Male: AUC = 0.543, Events = 909/182114\n",
      "\n",
      "Evaluating Ulcerative_Colitis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.581 (0.569-0.595) (calculated on 397985 individuals)\n",
      "Events (10-Year in Eval Cohort): 2058 (0.5%) (from 400000 individuals)\n",
      "Excluded 2015 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.595, Events = 1119/216500\n",
      "   Male: AUC = 0.570, Events = 930/181485\n",
      "\n",
      "Evaluating Crohns_Disease (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.582 (0.564-0.598) (calculated on 398839 individuals)\n",
      "Events (10-Year in Eval Cohort): 1185 (0.3%) (from 400000 individuals)\n",
      "Excluded 1161 prevalent cases for Crohns_Disease.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.602, Events = 640/216830\n",
      "   Male: AUC = 0.561, Events = 541/182009\n",
      "\n",
      "Evaluating Asthma (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.526 (0.522-0.529) (calculated on 387080 individuals)\n",
      "Events (10-Year in Eval Cohort): 24324 (6.1%) (from 400000 individuals)\n",
      "Excluded 12920 prevalent cases for Asthma.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.542, Events = 12754/209408\n",
      "   Male: AUC = 0.542, Events = 10768/177672\n",
      "\n",
      "Evaluating Parkinsons (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.723 (0.712-0.733) (calculated on 399729 individuals)\n",
      "Events (10-Year in Eval Cohort): 1839 (0.5%) (from 400000 individuals)\n",
      "Excluded 271 prevalent cases for Parkinsons.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.725, Events = 1018/217341\n",
      "   Male: AUC = 0.721, Events = 820/182388\n",
      "\n",
      "Evaluating Multiple_Sclerosis (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.527 (0.503-0.550) (calculated on 399086 individuals)\n",
      "Events (10-Year in Eval Cohort): 800 (0.2%) (from 400000 individuals)\n",
      "Excluded 914 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.532, Events = 424/216797\n",
      "   Male: AUC = 0.525, Events = 374/182289\n",
      "\n",
      "Evaluating Thyroid_Disorders (10-Year Outcome, 1-Year Score)...\n",
      "AUC: 0.585 (0.581-0.588) (calculated on 400000 individuals)\n",
      "Events (10-Year in Eval Cohort): 18021 (4.5%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "   Sex-stratified analysis:\n",
      "   Female: AUC = 0.580, Events = 14350/217458\n",
      "   Male: AUC = 0.591, Events = 3671/182542\n",
      "\n",
      "Summary of Results (Prospective 10-Year Outcome, 1-Year Score, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)  \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.733 (0.730-0.736)       34705      8.7\n",
      "Diabetes             0.630 (0.626-0.634)       23756      5.9\n",
      "Atrial_Fib           0.707 (0.703-0.710)       15278      3.8\n",
      "CKD                  0.706 (0.700-0.709)       8980       2.2\n",
      "All_Cancers          0.669 (0.666-0.673)       20338      5.1\n",
      "Stroke               0.681 (0.675-0.688)       5686       1.4\n",
      "Heart_Failure        0.701 (0.696-0.707)       8212       2.1\n",
      "Pneumonia            0.644 (0.640-0.649)       14469      3.6\n",
      "COPD                 0.658 (0.654-0.662)       16789      4.2\n",
      "Osteoporosis         0.675 (0.671-0.680)       9145       2.3\n",
      "Anemia               0.587 (0.584-0.591)       21471      5.4\n",
      "Colorectal_Cancer    0.646 (0.638-0.654)       4934       1.2\n",
      "Breast_Cancer        0.550 (0.545-0.557)       9028       4.2\n",
      "Prostate_Cancer      0.683 (0.678-0.689)       7565       4.1\n",
      "Lung_Cancer          0.668 (0.660-0.674)       3319       0.8\n",
      "Bladder_Cancer       0.703 (0.694-0.716)       2158       0.5\n",
      "Secondary_Cancer     0.610 (0.606-0.615)       12229      3.1\n",
      "Depression           0.484 (0.479-0.488)       16283      4.1\n",
      "Anxiety              0.514 (0.509-0.519)       10034      2.5\n",
      "Bipolar_Disorder     0.481 (0.463-0.501)       979        0.2\n",
      "Rheumatoid_Arthritis 0.608 (0.600-0.617)       4745       1.2\n",
      "Psoriasis            0.545 (0.531-0.555)       2021       0.5\n",
      "Ulcerative_Colitis   0.581 (0.569-0.595)       2058       0.5\n",
      "Crohns_Disease       0.582 (0.564-0.598)       1185       0.3\n",
      "Asthma               0.526 (0.522-0.529)       24324      6.1\n",
      "Parkinsons           0.723 (0.712-0.733)       1839       0.5\n",
      "Multiple_Sclerosis   0.527 (0.503-0.550)       800        0.2\n",
      "Thyroid_Disorders    0.585 (0.581-0.588)       18021      4.5\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "============================================================\n",
      "DYNAMIC 1YR AUC — LOO pooled, all 400K\n",
      "============================================================\n",
      "\n",
      "Evaluating ASCVD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.881 (0.872-0.889) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 3268 (0.8%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for ASCVD.\n",
      "\n",
      "Evaluating Diabetes (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.742 (0.726-0.759) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 1662 (0.4%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Diabetes.\n",
      "\n",
      "Evaluating Atrial_Fib (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.797 (0.780-0.814) (calculated on 394818 individuals)\n",
      "C-index: nan (calculated on 394818 individuals)\n",
      "Events (1-Year in Eval Cohort): 912 (0.2%) (from 400000 individuals)\n",
      "Excluded 5182 prevalent cases for Atrial_Fib.\n",
      "\n",
      "Evaluating CKD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.651 (0.597-0.696) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 113 (0.0%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for CKD.\n",
      "\n",
      "Evaluating All_Cancers (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.754 (0.742-0.767) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 940 (0.2%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for All_Cancers.\n",
      "\n",
      "Evaluating Stroke (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.654 (0.627-0.679) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 303 (0.1%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Stroke.\n",
      "\n",
      "Evaluating Heart_Failure (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.766 (0.742-0.790) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 358 (0.1%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Heart_Failure.\n",
      "\n",
      "Evaluating Pneumonia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.635 (0.614-0.659) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 511 (0.1%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Pneumonia.\n",
      "\n",
      "Evaluating COPD (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.735 (0.718-0.750) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 804 (0.2%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for COPD.\n",
      "\n",
      "Evaluating Osteoporosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.755 (0.730-0.776) (calculated on 398803 individuals)\n",
      "C-index: nan (calculated on 398803 individuals)\n",
      "Events (1-Year in Eval Cohort): 367 (0.1%) (from 400000 individuals)\n",
      "Excluded 1197 prevalent cases for Osteoporosis.\n",
      "\n",
      "Evaluating Anemia (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.648 (0.632-0.662) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 1171 (0.3%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Anemia.\n",
      "\n",
      "Evaluating Colorectal_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.824 (0.793-0.851) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 280 (0.1%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Colorectal_Cancer.\n",
      "\n",
      "Evaluating Breast_Cancer (1-Year Risk)...\n",
      "Filtering for Female: Found 217458 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.782 (0.763-0.802) (calculated on 217458 individuals)\n",
      "C-index: nan (calculated on 217458 individuals)\n",
      "Events (1-Year in Eval Cohort): 676 (0.3%) (from 217458 individuals)\n",
      "Excluded 0 prevalent cases for Breast_Cancer.\n",
      "\n",
      "Evaluating Prostate_Cancer (1-Year Risk)...\n",
      "Filtering for Male: Found 182542 individuals in cohort\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.833 (0.811-0.851) (calculated on 180663 individuals)\n",
      "C-index: nan (calculated on 180663 individuals)\n",
      "Events (1-Year in Eval Cohort): 448 (0.2%) (from 182542 individuals)\n",
      "Excluded 1879 prevalent cases for Prostate_Cancer.\n",
      "\n",
      "Evaluating Lung_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.699 (0.644-0.756) (calculated on 399760 individuals)\n",
      "C-index: nan (calculated on 399760 individuals)\n",
      "Events (1-Year in Eval Cohort): 81 (0.0%) (from 400000 individuals)\n",
      "Excluded 240 prevalent cases for Lung_Cancer.\n",
      "\n",
      "Evaluating Bladder_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.830 (0.791-0.871) (calculated on 399089 individuals)\n",
      "C-index: nan (calculated on 399089 individuals)\n",
      "Events (1-Year in Eval Cohort): 113 (0.0%) (from 400000 individuals)\n",
      "Excluded 911 prevalent cases for Bladder_Cancer.\n",
      "\n",
      "Evaluating Secondary_Cancer (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.601 (0.576-0.635) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 436 (0.1%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Secondary_Cancer.\n",
      "\n",
      "Evaluating Depression (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.615 (0.586-0.643) (calculated on 396170 individuals)\n",
      "C-index: nan (calculated on 396170 individuals)\n",
      "Events (1-Year in Eval Cohort): 595 (0.1%) (from 400000 individuals)\n",
      "Excluded 3830 prevalent cases for Depression.\n",
      "\n",
      "Evaluating Anxiety (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.602 (0.556-0.648) (calculated on 398970 individuals)\n",
      "C-index: nan (calculated on 398970 individuals)\n",
      "Events (1-Year in Eval Cohort): 181 (0.0%) (from 400000 individuals)\n",
      "Excluded 1030 prevalent cases for Anxiety.\n",
      "\n",
      "Evaluating Bipolar_Disorder (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.757 (0.676-0.834) (calculated on 399382 individuals)\n",
      "C-index: nan (calculated on 399382 individuals)\n",
      "Events (1-Year in Eval Cohort): 59 (0.0%) (from 400000 individuals)\n",
      "Excluded 618 prevalent cases for Bipolar_Disorder.\n",
      "\n",
      "Evaluating Rheumatoid_Arthritis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.750 (0.720-0.780) (calculated on 397938 individuals)\n",
      "C-index: nan (calculated on 397938 individuals)\n",
      "Events (1-Year in Eval Cohort): 279 (0.1%) (from 400000 individuals)\n",
      "Excluded 2062 prevalent cases for Rheumatoid_Arthritis.\n",
      "\n",
      "Evaluating Psoriasis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.607 (0.540-0.650) (calculated on 399264 individuals)\n",
      "C-index: nan (calculated on 399264 individuals)\n",
      "Events (1-Year in Eval Cohort): 110 (0.0%) (from 400000 individuals)\n",
      "Excluded 736 prevalent cases for Psoriasis.\n",
      "\n",
      "Evaluating Ulcerative_Colitis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.824 (0.790-0.858) (calculated on 397985 individuals)\n",
      "C-index: nan (calculated on 397985 individuals)\n",
      "Events (1-Year in Eval Cohort): 163 (0.0%) (from 400000 individuals)\n",
      "Excluded 2015 prevalent cases for Ulcerative_Colitis.\n",
      "\n",
      "Evaluating Crohns_Disease (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.892 (0.847-0.935) (calculated on 398839 individuals)\n",
      "C-index: nan (calculated on 398839 individuals)\n",
      "Events (1-Year in Eval Cohort): 110 (0.0%) (from 400000 individuals)\n",
      "Excluded 1161 prevalent cases for Crohns_Disease.\n",
      "\n",
      "Evaluating Asthma (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.689 (0.674-0.704) (calculated on 387080 individuals)\n",
      "C-index: nan (calculated on 387080 individuals)\n",
      "Events (1-Year in Eval Cohort): 1928 (0.5%) (from 400000 individuals)\n",
      "Excluded 12920 prevalent cases for Asthma.\n",
      "\n",
      "Evaluating Parkinsons (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.808 (0.758-0.845) (calculated on 399729 individuals)\n",
      "C-index: nan (calculated on 399729 individuals)\n",
      "Events (1-Year in Eval Cohort): 81 (0.0%) (from 400000 individuals)\n",
      "Excluded 271 prevalent cases for Parkinsons.\n",
      "\n",
      "Evaluating Multiple_Sclerosis (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.866 (0.817-0.907) (calculated on 399086 individuals)\n",
      "C-index: nan (calculated on 399086 individuals)\n",
      "Events (1-Year in Eval Cohort): 70 (0.0%) (from 400000 individuals)\n",
      "Excluded 914 prevalent cases for Multiple_Sclerosis.\n",
      "\n",
      "Evaluating Thyroid_Disorders (1-Year Risk)...\n",
      "C-index calculation failed: No admissable pairs in the dataset.\n",
      "AUC: 0.678 (0.667-0.695) (calculated on 400000 individuals)\n",
      "C-index: nan (calculated on 400000 individuals)\n",
      "Events (1-Year in Eval Cohort): 1241 (0.3%) (from 400000 individuals)\n",
      "Excluded 0 prevalent cases for Thyroid_Disorders.\n",
      "\n",
      "Summary of Results (1-Year Risk, Sex-Adjusted):\n",
      "--------------------------------------------------------------------------------\n",
      "Disease Group        AUC                       Events     Rate (%)   C-index   \n",
      "--------------------------------------------------------------------------------\n",
      "ASCVD                0.881 (0.872-0.889)       3268       0.8        N/A\n",
      "Diabetes             0.742 (0.726-0.759)       1662       0.4        N/A\n",
      "Atrial_Fib           0.797 (0.780-0.814)       912        0.2        N/A\n",
      "CKD                  0.651 (0.597-0.696)       113        0.0        N/A\n",
      "All_Cancers          0.754 (0.742-0.767)       940        0.2        N/A\n",
      "Stroke               0.654 (0.627-0.679)       303        0.1        N/A\n",
      "Heart_Failure        0.766 (0.742-0.790)       358        0.1        N/A\n",
      "Pneumonia            0.635 (0.614-0.659)       511        0.1        N/A\n",
      "COPD                 0.735 (0.718-0.750)       804        0.2        N/A\n",
      "Osteoporosis         0.755 (0.730-0.776)       367        0.1        N/A\n",
      "Anemia               0.648 (0.632-0.662)       1171       0.3        N/A\n",
      "Colorectal_Cancer    0.824 (0.793-0.851)       280        0.1        N/A\n",
      "Breast_Cancer        0.782 (0.763-0.802)       676        0.3        N/A\n",
      "Prostate_Cancer      0.833 (0.811-0.851)       448        0.2        N/A\n",
      "Lung_Cancer          0.699 (0.644-0.756)       81         0.0        N/A\n",
      "Bladder_Cancer       0.830 (0.791-0.871)       113        0.0        N/A\n",
      "Secondary_Cancer     0.601 (0.576-0.635)       436        0.1        N/A\n",
      "Depression           0.615 (0.586-0.643)       595        0.1        N/A\n",
      "Anxiety              0.602 (0.556-0.648)       181        0.0        N/A\n",
      "Bipolar_Disorder     0.757 (0.676-0.834)       59         0.0        N/A\n",
      "Rheumatoid_Arthritis 0.750 (0.720-0.780)       279        0.1        N/A\n",
      "Psoriasis            0.607 (0.540-0.650)       110        0.0        N/A\n",
      "Ulcerative_Colitis   0.824 (0.790-0.858)       163        0.0        N/A\n",
      "Crohns_Disease       0.892 (0.847-0.935)       110        0.0        N/A\n",
      "Asthma               0.689 (0.674-0.704)       1928       0.5        N/A\n",
      "Parkinsons           0.808 (0.758-0.845)       81         0.0        N/A\n",
      "Multiple_Sclerosis   0.866 (0.817-0.907)       70         0.0        N/A\n",
      "Thyroid_Disorders    0.678 (0.667-0.695)       1241       0.3        N/A\n",
      "--------------------------------------------------------------------------------\n",
      "\n",
      "================================================================================\n",
      "COMPARISON: Reproduced LOO (400K) vs fixedgk_vs_original CSV\n",
      "================================================================================\n",
      "DISEASE                   CSV static_10yr    LOO Repro     CSV dyn_1yr    LOO Repro\n",
      "-------------------------------------------------------------------------------------\n",
      "ASCVD                              0.7329       0.7328          0.8809       0.8806\n",
      "All_Cancers                        0.6693       0.6693          0.7527       0.7540\n",
      "Anemia                             0.5875       0.5873          0.6480       0.6479\n",
      "Anxiety                            0.5141       0.5140          0.6042       0.6024\n",
      "Asthma                             0.5252       0.5256          0.6899       0.6893\n",
      "Atrial_Fib                         0.7067       0.7066          0.7966       0.7969\n",
      "Bipolar_Disorder                   0.4813       0.4809          0.7583       0.7575\n",
      "Bladder_Cancer                     0.7034       0.7032          0.8245       0.8299\n",
      "Breast_Cancer                      0.5507       0.5499          0.7818       0.7815\n",
      "CKD                                0.7057       0.7057          0.6510       0.6505\n",
      "COPD                               0.6581       0.6580          0.7362       0.7345\n",
      "Colorectal_Cancer                  0.6456       0.6461          0.8253       0.8244\n",
      "Crohns_Disease                     0.5800       0.5819          0.8964       0.8922\n",
      "Depression                         0.4839       0.4840          0.6155       0.6148\n",
      "Diabetes                           0.6302       0.6301          0.7412       0.7422\n",
      "Heart_Failure                      0.7013       0.7015          0.7686       0.7663\n",
      "Lung_Cancer                        0.6683       0.6680          0.6992       0.6993\n",
      "Multiple_Sclerosis                 0.5309       0.5272          0.8395       0.8656\n",
      "Osteoporosis                       0.6751       0.6748          0.7560       0.7550\n",
      "Parkinsons                         0.7231       0.7232          0.8091       0.8083\n",
      "Pneumonia                          0.6445       0.6444          0.6336       0.6349\n",
      "Prostate_Cancer                    0.6828       0.6834          0.8312       0.8327\n",
      "Psoriasis                          0.5458       0.5447          0.6067       0.6072\n",
      "Rheumatoid_Arthritis               0.6080       0.6083          0.7488       0.7495\n",
      "Secondary_Cancer                   0.6103       0.6104          0.6001       0.6009\n",
      "Stroke                             0.6811       0.6810          0.6535       0.6537\n",
      "Thyroid_Disorders                  0.5850       0.5848          0.6783       0.6782\n",
      "Ulcerative_Colitis                 0.5827       0.5811          0.8161       0.8235\n",
      "\n",
      "Done — memory freed.\n"
     ]
    }
   ],
   "source": [
    "# Reproduce paper LOO AUC: load all 40 LOO predictions, concatenate, compute AUC on 400K\n",
    "\n",
    "LOO_DIR = Path('/Users/sarahurbut/Library/CloudStorage/Dropbox/leave_one_out_correctedE')\n",
    "BATCH_SIZE = 10000\n",
    "TOTAL_BATCHES = 40\n",
    "\n",
    "# 1. Load and concatenate all 40 LOO pi predictions\n",
    "print('Loading all 40 LOO predictions...')\n",
    "pi_list = []\n",
    "for batch_idx in range(TOTAL_BATCHES):\n",
    "    start = batch_idx * BATCH_SIZE\n",
    "    end = (batch_idx + 1) * BATCH_SIZE\n",
    "    pi_file = LOO_DIR / f'batch_{batch_idx}' / f'pi_enroll_fixedphi_sex_{start}_{end}.pt'\n",
    "    if not pi_file.exists():\n",
    "        print(f'  WARNING: missing batch {batch_idx}: {pi_file}')\n",
    "        continue\n",
    "    pi_batch = torch.load(str(pi_file), weights_only=False)\n",
    "    pi_list.append(pi_batch)\n",
    "    if batch_idx % 10 == 0:\n",
    "        print(f'  Loaded batch {batch_idx} — pi shape: {pi_batch.shape}')\n",
    "\n",
    "pi_all = torch.cat(pi_list, dim=0)\n",
    "print(f'Concatenated pi: {pi_all.shape} ({len(pi_list)} batches)')\n",
    "\n",
    "# 2. Load full Y, E (400K)\n",
    "print('\\nLoading full Y and E...')\n",
    "Y_full = torch.load(str(Path(DATA_DIR) / 'Y_tensor.pt'), weights_only=False)\n",
    "E_full = torch.load(str(Path(DATA_DIR) / 'E_enrollment_full.pt'), weights_only=False)\n",
    "N_total = TOTAL_BATCHES * BATCH_SIZE\n",
    "Y_400k = Y_full[:N_total]\n",
    "E_400k = E_full[:N_total]\n",
    "del Y_full, E_full\n",
    "gc.collect()\n",
    "print(f'Y: {Y_400k.shape}, E: {E_400k.shape}')\n",
    "\n",
    "# 3. Load pce_df for all 400K\n",
    "pce_full = pd.read_csv(COV_PATH)\n",
    "pce_400k = pce_full.iloc[:N_total].reset_index(drop=True)\n",
    "# Ensure sex columns exist in both formats\n",
    "if 'Sex' not in pce_400k.columns and 'sex' in pce_400k.columns:\n",
    "    pce_400k['Sex'] = pce_400k['sex'].map({0: 'Female', 1: 'Male'}).fillna('Unknown')\n",
    "if 'sex' not in pce_400k.columns and 'Sex' in pce_400k.columns:\n",
    "    pce_400k['sex'] = pce_400k['Sex'].map({'Female': 0, 'Male': 1}).fillna(-1).astype(int)\n",
    "if 'age' not in pce_400k.columns and 'Age' in pce_400k.columns:\n",
    "    pce_400k['age'] = pce_400k['Age']\n",
    "print(f'pce_df: {len(pce_400k)} rows')\n",
    "\n",
    "# 4. Compute static 10yr AUC\n",
    "print('\\n' + '='*60)\n",
    "print('STATIC 10YR AUC — LOO pooled, all 400K')\n",
    "print('='*60)\n",
    "res_static_loo = evaluate_major_diseases_wsex_with_bootstrap_from_pi(\n",
    "    pi_all, Y_400k, E_400k, disease_names, pce_400k\n",
    ")\n",
    "\n",
    "# 5. Compute dynamic 1yr AUC\n",
    "print('\\n' + '='*60)\n",
    "print('DYNAMIC 1YR AUC — LOO pooled, all 400K')\n",
    "print('='*60)\n",
    "res_dyn1yr_loo = evaluate_major_diseases_wsex_with_bootstrap_dynamic_1year(\n",
    "    pi_all, Y_400k, E_400k, disease_names, pce_400k\n",
    ")\n",
    "\n",
    "# 6. Compare with CSV\n",
    "print('\\n' + '='*80)\n",
    "print('COMPARISON: Reproduced LOO (400K) vs fixedgk_vs_original CSV')\n",
    "print('='*80)\n",
    "csv_path = Path('/Users/sarahurbut/aladynoulli2/pyScripts/dec_6_revision/new_notebooks/results/fixedgk_vs_original_wide_format.csv')\n",
    "csv_df = pd.read_csv(csv_path)\n",
    "\n",
    "print(f'{\"DISEASE\":<25} {\"CSV static_10yr\":>15} {\"LOO Repro\":>12} {\"CSV dyn_1yr\":>15} {\"LOO Repro\":>12}')\n",
    "print('-'*85)\n",
    "for _, row in csv_df.iterrows():\n",
    "    disease = row['disease']\n",
    "    csv_s10 = row.get('original_static_10yr', float('nan'))\n",
    "    csv_d1 = row.get('original_dynamic_1yr', float('nan'))\n",
    "    # Extract reproduced values\n",
    "    r_s10 = res_static_loo.get(disease, {})\n",
    "    r_d1 = res_dyn1yr_loo.get(disease, {})\n",
    "    repro_s10 = r_s10.get('auc', float('nan')) if isinstance(r_s10, dict) else float(r_s10) if r_s10 else float('nan')\n",
    "    repro_d1 = r_d1.get('auc', float('nan')) if isinstance(r_d1, dict) else float(r_d1) if r_d1 else float('nan')\n",
    "    print(f'{disease:<25} {csv_s10:>15.4f} {repro_s10:>12.4f} {csv_d1:>15.4f} {repro_d1:>12.4f}')\n",
    "\n",
    "# Clean up\n",
    "del pi_all, Y_400k, E_400k\n",
    "gc.collect()\n",
    "print('\\nDone — memory freed.')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 8. Calibration: Constant (reparam) vs nolr (centered)\n",
    "\n",
    "Compare predicted vs observed event rates on holdout data using at-risk masking."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Holdout: 10000 patients x 348 diseases x 52 timepoints\n",
      "Creating at-risk mask...\n",
      "At-risk fraction: 0.545\n",
      "Constant: 98,539,933 obs, mean pred=2.12e-04, mean obs=1.91e-04, ratio=1.112\n",
      "nolr:     98,539,933 obs, mean pred=2.67e-04, mean obs=1.91e-04, ratio=1.399\n",
      "\n",
      "Calibration MSE: constant=2.57e-05, nolr=5.14e-06\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saved: claudefile/calibration_reparam_vs_centered_holdout.pdf\n"
     ]
    }
   ],
   "source": [
    "# Calibration: constant (reparam) vs nolr (centered) on holdout\n",
    "\n",
    "# Get pi tensors\n",
    "pi_const_cal = holdout_results['constant']['pi']\n",
    "pi_nolr_cal = holdout_results['nolr']['pi']\n",
    "\n",
    "# Convert to numpy\n",
    "pi_const_np = pi_const_cal.detach().cpu().numpy() if torch.is_tensor(pi_const_cal) else np.array(pi_const_cal)\n",
    "pi_nolr_np = pi_nolr_cal.detach().cpu().numpy() if torch.is_tensor(pi_nolr_cal) else np.array(pi_nolr_cal)\n",
    "Y_np = Y_holdout.detach().cpu().numpy() if torch.is_tensor(Y_holdout) else np.array(Y_holdout)\n",
    "E_np = E_holdout.detach().cpu().numpy() if torch.is_tensor(E_holdout) else np.array(E_holdout)\n",
    "\n",
    "N, D, T = Y_np.shape\n",
    "print(f'Holdout: {N} patients x {D} diseases x {T} timepoints')\n",
    "\n",
    "# Create at-risk mask: patient n is at risk for disease d at time t if E[n,d] >= t\n",
    "print('Creating at-risk mask...')\n",
    "at_risk = np.zeros((N, D, T), dtype=bool)\n",
    "for n in range(N):\n",
    "    for d in range(D):\n",
    "        at_risk[n, d, :] = (E_np[n, d] >= np.arange(T))\n",
    "print(f'At-risk fraction: {at_risk.mean():.3f}')\n",
    "\n",
    "def collect_pred_obs(pi_np, Y_np, at_risk, T):\n",
    "    \"\"\"Collect predicted and observed values across all at-risk (n, d, t) entries.\"\"\"\n",
    "    all_pred, all_obs = [], []\n",
    "    for t in range(T):\n",
    "        mask_t = at_risk[:, :, t]\n",
    "        if mask_t.sum() > 0:\n",
    "            all_pred.extend(pi_np[:, :, t][mask_t])\n",
    "            all_obs.extend(Y_np[:, :, t][mask_t])\n",
    "    return np.array(all_pred), np.array(all_obs)\n",
    "\n",
    "pred_const, obs_const = collect_pred_obs(pi_const_np, Y_np, at_risk, T)\n",
    "pred_nolr, obs_nolr = collect_pred_obs(pi_nolr_np, Y_np, at_risk, T)\n",
    "\n",
    "print(f'Constant: {len(pred_const):,} obs, mean pred={pred_const.mean():.2e}, mean obs={obs_const.mean():.2e}, ratio={pred_const.mean()/obs_const.mean():.3f}')\n",
    "print(f'nolr:     {len(pred_nolr):,} obs, mean pred={pred_nolr.mean():.2e}, mean obs={obs_nolr.mean():.2e}, ratio={pred_nolr.mean()/obs_nolr.mean():.3f}')\n",
    "\n",
    "# Compute calibration bins\n",
    "def compute_calibration_bins(all_pred, all_obs, n_bins=50, min_bin_count=10000):\n",
    "    bin_edges = np.logspace(np.log10(max(1e-7, all_pred.min())),\n",
    "                            np.log10(all_pred.max()), n_bins + 1)\n",
    "    bin_means, obs_means, counts = [], [], []\n",
    "    for i in range(n_bins):\n",
    "        mask = (all_pred >= bin_edges[i]) & (all_pred < bin_edges[i + 1])\n",
    "        if np.sum(mask) >= min_bin_count:\n",
    "            bin_means.append(np.mean(all_pred[mask]))\n",
    "            obs_means.append(np.mean(all_obs[mask]))\n",
    "            counts.append(np.sum(mask))\n",
    "    return np.array(bin_means), np.array(obs_means), np.array(counts)\n",
    "\n",
    "bm_const, om_const, ct_const = compute_calibration_bins(pred_const, obs_const)\n",
    "bm_nolr, om_nolr, ct_nolr = compute_calibration_bins(pred_nolr, obs_nolr)\n",
    "\n",
    "mse_const = np.mean((bm_const - om_const) ** 2)\n",
    "mse_nolr = np.mean((bm_nolr - om_nolr) ** 2)\n",
    "\n",
    "print(f'\\nCalibration MSE: constant={mse_const:.2e}, nolr={mse_nolr:.2e}')\n",
    "\n",
    "# Plot\n",
    "fig, ax = plt.subplots(figsize=(10, 8))\n",
    "ax.plot([1e-7, 1], [1e-7, 1], '--', color='gray', alpha=0.5, label='Perfect calibration', lw=2)\n",
    "ax.plot(bm_const, om_const, 'o-', color='#1f77b4', ms=8, lw=2,\n",
    "        label=f'Constant/reparam (MSE={mse_const:.2e})', alpha=0.8)\n",
    "ax.plot(bm_nolr, om_nolr, 's-', color='#d62728', ms=8, lw=2,\n",
    "        label=f'nolr/centered (MSE={mse_nolr:.2e})', alpha=0.8)\n",
    "ax.set_xscale('log'); ax.set_yscale('log')\n",
    "ax.grid(True, which='both', ls='--', alpha=0.3)\n",
    "ax.set_xlabel('Predicted Event Rate', fontsize=14, fontweight='bold')\n",
    "ax.set_ylabel('Observed Event Rate', fontsize=14, fontweight='bold')\n",
    "ax.set_title('Calibration: Reparam vs Centered (Holdout 10K)', fontsize=16, fontweight='bold')\n",
    "ax.legend(loc='lower right', fontsize=13)\n",
    "plt.tight_layout()\n",
    "plt.savefig('/Users/sarahurbut/aladynoulli2/claudefile/calibration_reparam_vs_centered_holdout.pdf',\n",
    "            dpi=300, bbox_inches='tight')\n",
    "plt.show()\n",
    "print('Saved: claudefile/calibration_reparam_vs_centered_holdout.pdf')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.21"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
